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ABSTRACT 
 
Background: To understand the pathophysiology of obesity, the role of hedonic eating 
needs to be considered. Neuroimaging research has suggested that activity in brain 
reward systems is modulated by the rewarding properties of food, nutritional state, and 
individual differences in eating behaviour. The interaction between these factors and the 
influence of gut hormones, such as the stomach-derived orexigenic hormone ghrelin, on 
these systems remains unclear. 
 
Methods: In the first study, 20 non-obese subjects were either fasted or ate a filling 
breakfast of their choice (fed). In the second study, 18 non-obese subjects were either 
fasted or given a fixed breakfast and received a subcutaneous saline or ghrelin injection. 
Subjects underwent functional MRI scanning while viewing and rating the appeal of food 
and object pictures and completed appetite and psychological questionnaires. 
 
Results: The first fMRI study showed that fasting increased activation to pictures of high-
calorie over low-calorie foods in the ventral striatum, amygdala, anterior insula, medial 
and lateral orbitofrontal cortex (OFC). Fasting also biased the appeal towards high-calorie 
foods. Dietary restraint positively correlated with activation in executive systems when 
viewing high-calorie compared to low-calorie foods, but negatively correlated with 
activation in affective systems. Reward drive positively correlated with activation in the 
ventral striatum to high-calorie foods. 
 In the second fMRI study activation to high-calorie foods in the insula and/or OFC 
when fasted and fed was shown to correlate with hunger and predict subsequent food 
intake. Administration of ghrelin was shown to mimic fasting to increase the appeal of 
high-calorie, especially sweet foods, and OFC activation to high-calorie foods. 
 
Conclusion: The results suggest an interaction between homeostatic and hedonic aspects 
of eating behaviour, with fasting and ghrelin biasing brain reward systems towards high-
calorie foods.  
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1.1. Epidemiology of obesity 
“We must do nothing less than transform the environment in which we all live” promoted 
the former prime minister Gordon Brown in the “Healthy Weight, Healthy Lives” report for 
England (Cross-Government Obesity Unit, 2008). Paradoxically, the Department of Health 
reports that in 2006, 24% of adults (aged over 16 years) and 16% of the children in 
England were classified as obese (NHS-Information-Centre, 2006). The World Health 
Organisation now estimates that 1.6 billion people are overweight (Body Mass Index, BMI, 
between 25 and 30 kg/m2) and 400 million are obese (BMI above 30 kg/m2) (WHO, 
2006). Overweight and obesity are major contributors to cardiovascular disease, type II 
diabetes mellitus, musculoskeletal disorders and some cancers (WHO, 2006). In 2003, 
annual U.S. obesity attributable medical expenditure was estimated at $75 billion 
(Finkelstein et al., 2004) and surgical treatments such as bariatric surgery are associated 
with potential significant risks (le Roux CW, 2005). Other non-surgical therapies have 
proven effective at causing weight loss, but the magnitude and maintenance desired by 
many patients and physicians cannot yet be delivered, and many drugs have been 
withdrawn because of significant side effects (Bray, 2005; Christensen et al., 2007; Perrio 
et al., 2007; Johansson et al., 2009; Sayburn, 2010). 
 
The epidemiology of obesity is complex. The fundamental cause of obesity and overweight 
is an energy imbalance between calories consumed and calories expended, a global shift 
in diet towards high-calorie, high palatable energy-dense foods that are high in fat and 
sugars and a trend towards decreased physical activity due to the increasingly sedentary 
nature of many forms of work, changing modes of transportation, and increasing 
urbanization (WHO, 2006). However, for some of the populations it is not as simple as 
“eating less” and “walking more” in order to lose or maintain body weight. We need to 
better understand what appetite means, the underlying mechanisms and individual 
differences in the regulation of human eating behaviour with the aim to develop new 
strategies to tackle the obesity epidemic. 
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1.2. Appetite and eating behaviour 
The etymology of “Appetite” is as follows: Old English appetite, French appétit, Latin 
appetitus, appetere (“‘to strive after, long for’”); ad + petere (“‘to seek’”). Appetite is 
described as an instinctive and physical strong desire; an eagerness or longing of, food or 
drink; hunger; the desire for some personal gratification, either of the body or of the mind 
(Davis and Faulds, 1996; FDA, 1997; Bray, 2005; Harper, 2009; Johansson et al., 2009; 
Sayburn, 2010). 
 
Appetite control seems to be complex (Figure 1.1.) and the evolution of a physiological 
system that facilitates weight-gain in times of nutritional plenty, with little capacity to lose 
this again easily, and food seeking behaviour in times of food depriviation challenges the 
ability of researchers to find therapeutic targets to combat obesity.  
 
Anti-obesity drugs such as Orlistat, Dexfenfluramine, Sibutramine and Rimonabant 
combined with exercise and diet decrease body weight by 5-15% but a regain of weight is 
often seen after 4-12 months (Pi-Sunyer et al., 1999, Thearle and Aronne, 2003, Curioni 
and Andre, 2006). The anorexigenic drugs produce dangerous side-effects and have 
therefore been withdrawn from the market (FDA, 1997; Bray, 2005; Christensen et al., 
2007; Perrio et al., 2007; Sayburn, 2010). As a result of this, just one obesity drug 
treatment option is left, Orlistat, a drug that reduces intestinal fat absorption (Hartmann 
et al., 1993). The limited efficacy of pharmacological interventions means it is even more 
vital for scientists to study the body’s own psychological and physiological signals for 
therapeutic purposes (Figure 1.1.). Furthermore, it is important to consider in addition to 
brain systems that control our eating behaviour, the role of food hedonics, individual food 
preference, nutritional state, gender, BMI, genetic factors and psychological cues and 
traits that influence these systems (Figure 1.1., Figure 1.5.). 
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Figure 1.1. Appetite control systems 
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1.2.1. Peripheral signals 
  
1.2.1.1. Adiposity signals 
The discovery of leptin (Greek: thin) and its receptor (Ob-R) in 1994 opened a new era in 
obesity research (Figure 1.2.). This anorexigenic hormone is a 167-amino acid protein 
encoded by the ob gene and released from adipose tissue in proportion to fat stores 
(Zhang et al., 1994, Campfield et al., 1995, Halaas et al., 1995, Sinha et al., 1996). 
Crossing the blood-brain barrier into the central nervous system, it acts at the level of the 
hypothalamus (activates POMC/CART neurons, inhibit NPY/AgRP neurons) by binding to its 
receptor and activating secondary signals that inhibit food intake and increase energy 
expenditure in ob/ob mice and diet-induced obese mice (Campfield et al., 1995, Golden et 
al., 1997).  
Restriction of food intake, over a period of days, results in a suppression of leptin 
levels, which can be reversed by refeeding. Exogenous leptin replacement decreases fast-
induced hyperphagia, and chronic peripheral administration of leptin to wild-type rodents 
results in reduced food intake, loss of body weight and fat mass (Wynne et al., 2005). 
 Although a small subset of obese human subjects have a relative leptin deficiency, 
the majority of obese animals and humans have a proportionally high circulating leptin 
(Maffei et al., 1995, Considine et al., 1996), suggesting possible leptin resistance. Leptin 
administered subcutaneously to obese human subjects has only shown a modest effect on 
body weight (Heymsfield et al. 1999, Fogteloo et al. 2003). 
 
Plasma insulin was first described in 1992 (Schwartz et al., 1992). It is released from the 
pancreas and increases at times of positive energy balance and decreases at times of 
negative energy balance (Woods et al., 1974) (Figure 1.2.). Unlike leptin, insulin secretion 
increases rapidly after a meal (Polonsky et al., 1988). Insulin penetrates the blood–brain 
barrier and acts in the brain as an anorexigenic signal, decreasing food intake and body 
weight in rodents (Baura et al., 1993, Wynne et al., 2005b). There are several insulin 
receptor substrates (IRSs) including IRS-1 and IRS-2, both identified in neurons (Baskin 
 28 
et al., 1994, Burks et al., 2000). The phenotype of IRS-2-knockout mice is associated with 
an increase in food intake, increased fat stores and infertility (Burks et al., 2000). Insulin 
receptors are widely distributed in the brain, with highest concentrations found in the 
olfactory bulbs, hypothalamus and ventral tegmental area (VTA) (Marks et al., 1990; 
Iniguez et al., 2008). The mechanisms by which insulin acts as an adiposity signal remain 
to be fully elucidated (Wynne et al., 2005b).  
 
 
Figure 1.2. Peripheral control of appetite 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anorexigenic and orexigenic gut hormone signals and adiposity signals influencing homeostatic and hedonic brain 
systems. 
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1.2.1.2. Gastrointestinal (GI) signals 
The GI tract is the largest endocrine organ in the body. Gut hormones have a key role in 
signaling nutrient intake. Together with metabolic and neural signals they regulate 
appetite and energy expenditure. After entering the gut lumen, nutrients trigger the 
secretion of several peptides which activate the central nervous system via different 
pathways. Apart from ghrelin (orexigenic), which stimulates appetite and food intake, all 
other gut hormones have anorexigenic effects: they promote satiation (cause meal 
termination) and/or satiety (postponing the initiation of the next meal) (Moran et al., 
2005).  
 
 
Orexigenic hormones 
Ghrelin  
History 
Ghrelin was discovered after the identification of its receptor, the growth hormone (GH) 
secretagogue receptor 1a (GHSR-1a) (Kojima et al., 1999; Howard et al. 1996) (Figure 
1.2.). The name is based on its role as a GH-releasing peptide, with reference to the 
Proto-Indo-European root ghre, meaning to grow. 
 
Synthesis and forms 
It is primarily synthesized as a pre-prohormone consisting of 117 amino acids. Cleavage 
of preproghrelin results in two mature ghrelin molecules, a 28 amino acid form (C-
terminal Arg) or 27 amino acid form (C-terminal Pro) (Hosoda et al., 2003).  Ghrelin is 
released from X/A-like cells of the gastric oxyntic glands, with lower levels also expressed 
in the small intestine and the hypothalamus (Kojima et al., 1999; Tschop et al., 2001). In 
order to be biologically active, ghrelin requires post-translational modification in which the 
third amino acid residue (serine) is acylated with n-octanoid acid or n-decanoic acid 
(Kojima et al., 1999) (Figure 1.3.). The enzyme responsible for this acylation, ghrelin O-
acyl transferase (GOAT), was recently identified (Yang et al., 2008). 
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Figure 1.3. Post-translational modification of ghrelin. 
 
 
 
 
 
 
 
 
 
 
 
Post-translational modification of ghrelin: the third amino acid residue (serine) is acylated with n-octanoid acid or 
n-decanoic acid via GOAT (ghrelin O-acyl transferase). 
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Mechanism of ghrelin action 
The acylated peptides are widely believed to be the biologically active forms of ghrelin 
based upon only their capability to bind and activate the only identified ghrelin receptor 
GHSR-1a and the fact that their administration triggers both GH secretion and food intake 
(Bednarek et al., 2000, Banks et al., 2002, Hosoda and Kangawa, 2003). Ghrelin is the 
only orexigenic gut hormone which stimulates acute food intake after peripheral and 
central administration of ghrelin in rats (Wren et al., 2001) and over a 7-day period, this 
also results in weight gain (Tschop et al., 2000). Recent data also reported that transgenic 
mice overexpressing the non-octanylated form (des-acyl ghrelin) have lower body weight 
and body length when compared with control mice (Ariyasu et al., 2005). Inhoff and 
colleagues suggested that the biological role of des-acyl ghrelin is paradoxically to 
decrease food intake (Inhoff et al., 2009).  
Neary et al. demonstrated that only 30 minutes after intravenous infusion of 
5.0pmol/kg/min of ghrelin, energy intake is increased by 28 percent in cancer patients 
with anorexia compared to infusion of saline (Neary et al., 2004). Druce et al. showed that 
subcutaneous ghrelin injection (3.6 nmol/kg) increases food intake in obese as well as 
lean healthy subjects by 20 percent after only 30 minutes compared to injection of saline 
(Druce et al., 2005; Druce et al., 2006). Other studies demonstrated that subcutaneous 
ghrelin injection (3.6 nmol/kg) to malnourished dialysis patients increases food intake by 
25 percent after only 30 minutes compared to injection of saline (Wynne et al., 2005b; 
Ashby et al., 2009). Wren and colleagues showed that an intravenous infusion of 
5.0pmol/kg/min of ghrelin to non-obese volunteers increased energy intake by 28% 
compared to infusion of saline (Wren et al., 2001). 
 Ghrelin is broken down by various enzymes including butyrylcholinesterase and 
isophospholipase (De Vriese et al., 2004). Ghrelin plasma levels rise before the start of a 
meal and fall again rapidly after the meal (Cummings et al., 2001). The suppression is 
proportional to the caloric load of the meal (Callahan et al., 2004). Studies employing 
exogenous ghrelin administration show that the half-life of total ghrelin is between 10 and 
31 minutes in the bloodstream (Akamizu et al., 2004). A steady-state level of total ghrelin 
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(acylated and des-acylated ghrelin) was reached within 60-90 minutes after intravenous 
infusion in humans (Vestergaard et al., 2007). Suppression of acyl-ghrelin and total 
ghrelin (acylated and des-acylated) is strongly stimulated by ingested proteins and weakly 
by lipids (Foster-Schubert et al., 2008). However, the timing of ghrelin spikes differ 
depending on individual eating habits; someone who does not eat breakfast would not 
exhibit the usual morning ghrelin spike, for example (Drazen et al., 2006). Recent data 
suggested that acyl-ghrelin levels decline with longterm fasting (61.5 hours), whereas 
des-acyl ghrelin levels are increased (Liu et al., 2008). Thus, increased appetite occurs 
during short-term fasting but wanes over time; this may relate to the lowering of acyl-
ghrelin (Liu et al., 2008). Acylation may be regulated independently of secretion by 
nutrient availability in the gut or by esterases that cleave the acyl group. The new ‘lipid-
sensor’ GOAT, which is essential for ghrelin acylation, is regulated by nutrient availability, 
depending on specific dietary lipids as acylation substrates (Kirchner et al., 2009).  
A recent study demonstrated that GOAT KO mice which lack acylated ghrelin and 
therefore GH decreased blood glucose levels after prolonged fasting (Zhao et al., 2010). 
Therefore, the body’s response to hypoglycemia is to mount a stress response, including 
the release of corticotropin and GH that act to raise blood glucose. This study suggests 
that the ghrelin-producing cell senses glucose to regulate ghrelin release. A GOAT 
antagonist GO-CoA-Tat potently inhibits GOAT in vitro, in cultured cells, and in mice and 
therefore acylated ghrelin which results in an increase in insulin and reduction in blood 
glucose. This study further showed that GO-CoA-Tat prevents weight gain in mice through 
the same mechanism (Barnett et al., 2010). 
  
Ghrelin’s action on the homeostatic regulation of metabolism 
Studies suggest that the appetite-stimulating effects of ghrelin are centrally mediated, in 
part by neurons within the arcuate nucleus (ARC) of the hypothalamus, the brainstem and 
the vagus nerve (Nakazato et al., 2001, Tamura et al., 2002, Williams et al., 2003, le 
Roux et al., 2005). The brainstem also seems to have separate hyperphagic effects; 
administration of ghrelin to the hindbrain ventricle induced hyperphagia and c-fos 
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expression in the nucleus solitary tract (NTS), but not hypothalamus (Faulconbridge et al., 
2008). Ghrelin is able to increase growth hormone (GH) secretion through the 
phospholipase C –protein kinase C (PLC-PKC) pathway via activation of the GHSR-1a 
(Chen et al., 1996), which in turn promotes nutrient incorporation into muscle and other 
tissue.  The highest density of the classic G-protein-coupled receptors GHS-1a in the CNS 
is found in the hypothalamus and the pituitary gland; with lower expression in the 
hippocampus, midbrain and hindbrain (Zigman et al., 2006; Cummings et al., 2007; Kuo 
et al., 2007). Peripheral ghrelin may also act in the gut, relaying on information to the 
brain via the vagus nerve (Date et al., 2002).  
Specifically, GHSR-1a is expressed in the ARC of the hypothalamus predominantly 
on orexigenic Neuropeptide Y (NPY) and Agouti-related petide (AGRP) neurons (Hahn et 
al., 1998, Willesen et al., 1999, Nakazato et al., 2001). NPY/AGRP neurons project directly 
and indirectly via the lateral hypothalamus to the ventral tegmental aera (VTA) and 
amygdala (Saper et al., 2002, Kelley, 2004). Functional activation of this neuronal 
NPY/AGRP population by ghrelin has been demonstrated electrophysiologically (Cowley et 
al., 2003), by induction of early gene expression (Hewson and Dickson, 2000), and by 
increased expression of the peptides themselves (Kamegai et al., 2001; Nakazato et al., 
2001). When GHSR-1a expression is diminished in the ARC, rats exhibit decreased body 
weight, lower adipose tissue and reduced food intake. Further, administration of ghrelin to 
rats with lower GHSR-1a expression fails to stimulate either feeding or GH secretion 
(Shuto et al., 2002; Castaneda et al., 2010).  
 Kuo and colleagues introduced a new imaging technique in rodents to show the 
effect of ghrelin on the hypothalamus. Using the manganese ion (Mn2+) as an activity-
dependent magnetic resonance imaging (MRI) contrast agent, they showed a dose-
dependant increase in signal intensity in the hypothalamus, including the arcuate, 
paraventricular, and ventromedial nuclei, after peripheral injection of the orexigenic 
peptide ghrelin (Kuo et al., 2007). 
In rodents, intracerebroventricular administration of ghrelin induced c-fos 
expression, a marker of neuronal activation, in orexin-producing neurons in the lateral 
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hypothalamus. Ghrelin-induced feeding is also suppressed in orexin knockout mice. This 
study identifies a novel hypothalamic pathway that links ghrelin and orexin in the 
regulation of feeding behavior and energy homeostasis (Toshinai et al., 2003). Orexin 
neurons can project to brain reward centres especially the VTA which will be discussed in 
more detail later (see 1.2.2.1.). 
  
Ghrelin’s action on brain reward systems 
Circulating ghrelin may also act directly on the corticolimbic reward and memory systems, 
involving the VTA, ventral striatum, amygdala, orbitofrontal cortex (OFC), insula and 
hippocampus (Abizaid et al., 2006; Zigman et al., 2006; Cummings et al., 2007; Malik et 
al., 2008). New research suggests that peripheral ghrelin enhances the intake of 
rewarding foods in rodents (Egecioglu et al., 2010), especially sweet taste consumption 
and preference regardless of its caloric content (Disse et al., 2010). Ghrelin has been 
shown to increase sweet food palatability in humans: in previous ghrelin feeding studies in 
healthy volunteers, researchers used sweet foods, e.g. Madeira cake, cinnamon and raisin 
loaf or sweet brioche rolls, as the ad libitum meal to demonstrate its ability to increase 
food intake (Druce et al., 2005; Wynne et al., 2005a). Some of the previous ghrelin 
studies on food intake in humans, using savoury ham sandwiches, curry, spaghetti 
bolognese or pasta as test meals were still able to see an increase in food intake in cancer 
cachexia and renal dialysis patients (Neary et al., 2004; Goldstone et al., 2005; le Roux et 
al., 2005b; Ashby et al., 2009), though interestingly one using a savoury test meal in 
vagotomised but otherwise healthy patients did not see any orexigenic effect of ghrelin (le 
Roux et al., 2005b).  
 
Ghrelin and obesity 
Although ghrelin has been reported to increase food intake and body weight in rodents 
and humans (Tschop et al., 2000; Castaneda et al., 2010), circulating plasma ghrelin 
levels in obese people, both children and adults, are lower than in matched lean controls 
(Goldstone et al., 2001; Shiiya et al., 2002; le Roux et al., 2005a; Castaneda et al., 
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2010). In binge eating patients (i.e. compulsive overeating) (Tanaka et al., 2003) and in 
hyperphagic patients with Prader-Willi syndrome (Cummings et al., 2002; Goldstone et 
al., 2005) plasma ghrelin levels are high, suggesting that peripheral hyperghrelinaemia 
might be involved in the pathophysiology of compulsive eating and therefore obesity. 
Interestingly, gastric by-pass surgery patients experience a 72% reduction in 24 hour 
ghrelin levels and a profound reduction in hunger (Cummings et al., 2004). Furthermore, 
12 months following surgery, the average ghrelin levels increase by 62% whereas the BMI 
decreased by 30% (Holdstock et al., 2003). However, while decreases in circulating 
ghrelin have been reported after such surgery, in other studies ghrelin levels 
inappropriately remain unchanged despite weight loss, and additional studies have found 
appropriate increases after surgery (le Roux et al., 2007, Pournaras and leRoux, 2010). 
One recent study measured both acylated and deacylated ghrelin at fasting levels after 
bypass surgery and found that immediately after surgery acylated ghrelin significantly 
decreased when total ghrelin remained unchanged (Isbell et al., 2010). To date, most 
research studies measured fasting ghrelin levels after bariatric surgery and and only few 
studies have measured postprandial ghrelin levels (Pournaras and leRoux, 2010).  
Although the role of ghrelin in the aetiology of obesity is not fully understood, it is 
considered as a vital target because of its capacity to induce a positive energy balance 
state (Castaneda et al., 2010). Recent studies show that the absence of both ghrelin and 
its receptor GHSR-1a protects mice against diet induced obesity (Wortley et al., 2005; 
Zigman et al., 2005). However, ghrelin immunization to reduce body weight has failed 
(Zorrilla et al., 2006) and some studies with knockout for ghrelin or ghrelin receptor with 
mice from a pure C57BL/6 background found only small differences in food intake and 
body weight under caloric restriction or high fat diet compared with wild-type control mice 
(Sun et al., 2008). Investigators are now looking at GHSR-1a antagonists (BIM-28163, L-
NOX-B11) to reduce food intake and body weight but results are controversial and more 
research, and also long-term studies are needed to determine whether these antagonists 
could be used in the treatment of obesity (Neary et al., 2009). The antagonist GO-CoA-Tat 
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potently inhibits GOAT and has been demonstrated to prevent weight gain in mice 
(Barnett et al., 2010). 
More work is required to understand whether surgical or pharmacological 
manipulations of ghrelin levels will be a useful way to treat obesity (Castaneda et al., 
2010). In the last couple of years researchers have also begun to focus not only on 
traditional homeostatic systems but also the effect of ghrelin and other internal signals on 
brain reward systems (see Section 1.2.2.2). 
 
 
Anorexigenic hormones 
 
Cholecystokinin (CCK) was the first gut hormone identified to have satiety effects 
(Gibbs et al., 1973). CCK is secreted by the I-cells in the proximal part of the small 
intestine, inhibits gastric emptying, and is thought to play a role in meal termination 
(Figure 1.2.). Fat and protein-rich foods stimulate CCK release (Polak et al., 1975, Liddle 
et al., 1985). Previous studies suggest that the CCK-1 receptor is responsible for the 
ability of CCK to reduce food intake in rats (Gibbs et al., 1973), and humans (Kissileff et 
al., 1981, Pi-Sunyer et al., 1982, Lieverse et al., 1994, Lieverse et al., 1995). CCK-
induced satiation is mediated by binding CCK-1 receptors on the vagus nerve (MacLean, 
1985, Ritter and Ladenheim, 1985, Moran et al., 1997, Kopin et al., 1999, Beglinger et al., 
2001), brainstem (Edwards et al., 1986) and hypothalamus (Blevins et al., 2000). 
Morbidly obese individuals showed lower fasting CCK levels than obese and lean 
individuals (Zwirska-Korczala et al., 2007). CCK gene and CCK-1 receptor gene variations 
may increase predeposition to obesity (Arya et al., 2004, de Krom et al., 2007).  
 However, the usefulness of CCK as an obesity therapeutic target may be limited by 
side effects such as vomiting, nausea and taste aversion (Swerdlow et al., 1983). CCK 
may also be limited by its short term effect on satiety. CCK does not reduce feeding when 
injected more than 30 minutes before a meal in rats (Gibbs et al., 1973). 
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Peptide Tyrosine Tyrosine or Peptide YY (PYY) is related to the pancreatic peptide 
family (Figure 1.2.). PYY1-36 is synthesised by endocrine L cells throughout the distal gut 
(Adrian et al., 1985). Amino acids tyrosine and proline, are cleaved from the N-terminus 
of PYY1-36 by the enzyme di-peptidyl peptidase IV (DPP-IV), which produces PYY3-36, the 
major circulating form of the hormone in the fed and fasted state (Batterham et al., 2006, 
le Roux et al., 2006). PYY is important in postponing initiation of the next meal rather 
than acting as a meal terminator. Peak concentrations of PYY correlate with caloric 
content, macronutrient composition and consistency of the meal (Adrian et al., 1985, 
Batterham et al., 2006, Helou et al., 2008). The effects of PYY are mediated by the Y2-
receptor, found in the central nervous system, nodose ganglion and vagal afferents 
(Batterham et al., 2002, Abbott et al., 2005a, Koda et al., 2005). Kuo and colleagues 
showed that the effect of PYY on food intake is regulated via the hypothalamus, including 
the arcuate, paraventricular, and ventromedial nuclei, after peripheral injection of peptide 
YY(3-36) caused a reduction in signal intensity in those areas imaged using Maganese 
Enhanced MRI (Kuo et al., 2007). 
Pyy knockout mice display hyperphagia and increased subcutaneous and visceral 
adiposity with the phenotype reversed after exogenous replacement (Batterham et al., 
2006). Researchers demonstrated how combination therapy could increase the potency of 
PYY3-36 when co-administration of PYY3-36 and GLP-1 (Neary et al., 2005) and PYY3-36 
and oxyntomodulin (Field et al., 2010) in humans and rodents resulted in greater 
reductions of food intake.  
 
Pancreatic polypeptide (PP) belongs to the polypeptide-fold family, like NPY and PYY. 
PP is produced in the pancreatic islets of Langerhans (Adrian et al., 1976) (Figure 1.2.). 
PP concentrations remain elevated for up to 6 hours after food ingestions and PP 
concentrations reflect the caloric content of the meal (Adrian et al., 1976). Anorexigenic 
actions of the hormone are thought to be mediated by the brainstem, parventricular 
nucleus (PVN) and ARC of the hypothalamus with highest affinity for Y4-receptors, 
followed by Y1-and Y5-receptors (Berglund et al., 2003). PP reduced food intake after 
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repeated peripheral administration in rodents (Asakawa et al., 1999, Asakawa et al., 
2003). Over-expression of PP in the pancreatic islets of mice resulted in a lean phenotype 
with reduced food intake (Ueno et al., 1999). Chronic administration of PP to ob/ob mice 
decreases body weight (Asakawa et al., 2003). In humans, intravenous infusion of PP in 
normal-weight volunteers resulted in a 25% reduction in food intake, lasting 24 hours 
after the infusion stopped (Batterham et al., 2003). PP also reduces food intake in 
patients with the genetic obesity Prader-Willi syndrome (Berntson et al., 1993).  
 
Glucagon-like peptide (GLP-1) belongs to the family of incretins (gut-derived 
hormones that increase insulin secretion) (Figure 1.2.). GLP-1 is produced from pre-
proglucagon in the pancreas, intestine and CNS. Prohormones convertase 1 and 2 direct 
the cleavage of pre-proglucagon resulting in a specific balance of hormones (GLP-1 and 
Oxyntomodulin, see next paragraph). The main stimulus to GLP-1 secretion is food intake. 
Fast absorbable proteins, such as whey-protein, evoke greater GLP-1 responses than slow 
proteins, like caseins (Tessari et al., 2007). GLP-1 acts mainly via the vagus nerve and 
the brainstem (Abbott et al., 2005a). GLP-1 acts on the GLP-1 receptor, which is widely 
expressed throughout the CNS including hypothalamus and amygdala (Turton et al., 
1996), brainstem (area postrema and nucleus of the solitary tract (NTS)) (Tang-
Christensen et al., 2001; Baggio et al., 2004) and peripheral tissues such as pancreatic ß-
cells (Bullock et al., 1996, Naslund et al., 1999). Administration of GLP-1 reduces food 
intake in rats when administered peripherally or centrally (Tang-Christensen et al., 1996, 
Turton et al., 1996). GLP-1 also has an anorectic effect in both lean and obese humans 
with gastric emptying and dose-dependent reduction in food intake (Verdich et al., 2001). 
After 5 days of subcutaneous GLP-1 injections, obese subjects lost 0.55 kg in weight 
(Naslund et al., 2004). The peptide exendin-4 has proved a useful tool in determining the 
mechanisms by which the actions of GLP-1 on appetite are mediated. Exendin-4 is a 39-
amino acid peptide extracted from the saliva of the Gila monster. It is structurally related 
to GLP-1 and is a potent agonist at GLP-1 receptors. This GLP-1 agonist, called Exenatide, 
has been recently licensed as a drug for diabetes mellitus type 2 as it effectively controls 
 39 
blood glucose without producing dangerous side effects (Chaudhri et al., 2006; 
Chakraborti, 2010). Simultanously, Exenatide significantly reduces weight in patients with 
type 2 diabetes mellitus (Diamant et al., 2010). Exenatide, like other GLP-1 targeting 
drugs can have side effects, like nausea. Therefore therapy could be ameliorated by 
combining lower doses of two or more gut hormones in order to achieve the desired 
reduction in weight loss (Chaudhri et al., 2006). 
 
Oxyntomodulin (OXM) also belongs to the family of incretins (Figure 1.2.). OXM is 
released from the intestinal L-cells in proportion to caloric intake, remaining elevated for 
several hours (Ghatei et al., 1983, Le Quellec et al., 1992). The downstream anorectic 
effects of OXM appear to be mediated by GLP-1 receptor since these effects were 
abolished in GLP-1 receptor null mice (Cohen et al., 2003; Baggio et al., 2004; Dakin et 
al., 2004). Compared to GLP-1, OXM has an equal potency for inhibiting food intake and 
reducing body weight in rodents and humans (Fehmann et al., 1994; Dakin et al., 2001; 
Dakin et al., 2002; Cohen et al., 2003; Baggio et al., 2004; Wynne et al., 2006). 
Peripheral OXM administration altered activity in the hypothalamic ARC, PVN and supra-
optic nuclei using manganese-enhanced magnetic resonance imaging (MEMRI) in fasted 
mice. In contrast, peripheral GLP-1 injection modulated activity in the PVN and VMN 
suggesting that they may have differential effects (Chaudhri et al., 2006, Parkinson et al., 
2009).  
 
There are more than 50 other gut hormones and peptides, but only a few have been 
investigated for their potential as anti-obesity agents.  
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1.2.2. Appetite control systems  
 
1.2.2.1. Homeostatic brain systems 
The hypothalamus regulates many aspects of energy homeostatis, is implicated in the 
process of balancing food intake and maintaining body weight (Figure 1.4.). The ARC in 
particular, is thought to play a key role in the integration of signals regulating appetite. 
The ARC encloses the third ventricle and is located near the median eminence, a region 
with an incomplete blood brain barrier (Broadwell and Brightman, 1976).  
 
Figure 1.4. Central control of appetite. 
 
Complex homeostatic control of feeding: Internal signals enter the hypothalamus via the median eminence or 
the brainstem via the vagus nerve. First order neurons in the arcuate nucleus (ARC) project to second order 
neurons such as the lateral hypothalamus (LH) which then sends orexigenic signals to brain reward systems 
(ventral tegemental area – VTA). All abbreviations can be found in the “Abbreviations” – list on page 7. 
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Primary neurons within ARC 
There are two primary populations of neurons within the ARC which influence energy 
homeostasis (Cone et al., 2001). One neuronal circuit reduces food intake, via the 
expression of the neuropeptides pro-opiomelanocortin (POMC) and cocaine- and 
amphetamine-regulated transccript (CART) (Elias et al., 1998a, Kristensen et al., 
1998, Wynne et al., 2005b). Another neuronal circuit stimulates food intake, via the 
expression of NPY and AGRP (Broberger et al., 1998, Hahn et al., 1998) (Figure 1.4.). 
 NPY and AgRP neurons are inhibited by leptin, insulin, PYY3-36 and GLP-1 which 
inhibit food intake while they are stimulated by ghrelin which stimulates food (Mercer et 
al., 1996, Christophe, 1998, Nakazato et al., 2001, Flier, 2004, Zigman et al., 2006). 
POMC/CART neurons are stimulated by leptin, PYY3-36, GLP-1 and insulin but inhibited by 
neighbouring NPY/AgRP neurons and ghrelin (Mercer et al., 1996, Christophe, 1998, 
Cowley et al., 2001, Nakazato et al., 2001, Zigman et al., 2006) (Figure 1.4.).  
 
Secondary neurons within ARC 
Hypothalamic second order nuclei receive neuronal projections from the axons of 
NPY/AgRP and POMC/CART neurons in the ARC (Elias et al., 1998b, Elmquist et al., 1998, 
Kalra et al., 1999) (Figure 1.4.). NPY/AgRP and POMC/CART can project to the 
paraventricular nucleus (PVN), where the anorexigenic neuropeptides thyrotropin-
releasing hormone (TRH), corticotropin-releasing hormone (CRH) and oxytocin are 
synthesised (Sawchenko and Swanson, 1983, Verbalis et al., 1993, Richard et al., 2000).  
 Projections from first order neurons to the lateral hypothalamic area (LHA) and 
perifornical area (PFA), where the orexigenic molecules melanin-concentrating 
hormone (MCH) and orexins A and B are produced, can lead to increased food intake and 
body weight (Qu et al., 1996, Elias et al., 1998b, Sweet et al., 1999, Nahon, 2006).  
Sakurai et al. characterised two individual receptors for the orexin system, OxR1 
and OxR2 (Sakurai et al., 1998). Orexin neurons can project to brain reward centres 
especially the VTA; and in circumstances of starvation, the orexin peptide may mediate 
both arousal and feeding responses in order to initiate food-seeking behaviour (Chemelli 
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et al., 1999). Administration of orexin has been shown to stimulate food consumption, and 
orexin signaling in VTA has been implicated in intake of high-fat food.  
Recent studies have shown that orexin is involved in motivated behavior for drugs 
of abuse as well as natural rewards. In self-administration studies, the OxR1 antagonist 
SB-334867 (SB) reduced the reponse to high-fat pellets, sucrose pellets and ethanol, but 
not cocaine, demonstrating that signalling at orexin receptors is necessary for 
reinforcement of specific rewards (Cason et al., 2010). 
 First order axons NPY/AgRP and POMC/CART can also project to the ventromedial 
hypothalamus (VMH) and dorsomedial hypothalamus (DMH). The DMH expresses NPY 
cells whose activation leads to hyperphagia in rats (Kalra et al., 1999, Chen et al., 2004). 
Lesions in the VMH produce hyperphagia and obesity (King et al., 1978). 
 
Brainstem feeding pathways 
In addition to hypothalamic circuits, the brainstem, in particular the NTS, also plays a 
vital role in the regulation of energy homeostasis (Ricardo and Koh, 1978) (Figure 1.4.). It 
can respond to peripheral signaling and also receives vagal afferents from the 
gastrointestinal tract, and from here information can be transferred to the ARC (Kalia and 
Sullivan, 1982, Sawchenko and Swanson, 1983).  
 
The architecture and functioning of the opposing hypothalamic circuits enables rapid 
control over energy homeostasis because the brain can simultaneously turn up and down 
anabolic or catabolic systems in order to control feeding. Yet, it is important to understand 
that the pleasure of eating derives from the taste, smell and texture of food and that each 
individual shows different eating behaviour and food perception. We therefore need to 
include study of the links between homeostatic and hedonic control of appetite. Hedonic 
eating is thought to be able to override the satiety effect of positive energy balance 
signals (Saper et al., 2002, Harrold and Williams, 2003, Kringelbach, 2004, Mela, 2006, 
Lowe et al., 2009), but the hedonic systems may also be responsive to negative energy 
balance states. 
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1.2.2.2. Hedonic brain reward systems 
Mesocorticolimbic brain regions are involved in reward and emotional processing, learning 
and memory, and have been implicated in hedonic eating. These include the prefrontal 
cortex (dorsolateral PFC), orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), 
insula, amygdala, nucleus accumbens (NAc, ventral striatum) and VTA (midbrain) (Van 
Vugt, 2009) (Figure 1.5., Table 1.1.).  
 
Figure 1.5. Hedonic brain reward systems 
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Sagittal view of the brain showing those areas involved in the hedonic control of eating behaviour: VTA (ventral 
tegmental area) – dopaminergic projections to corticolimibic brain areas; ventral striatum – motivation, reward 
expectancy, novelty processing; insular cortex – taste processing; amygdala – emotional processing; ACC 
(anterior cingulate cortex) – descision making; PFC (prefrontal cortex) – translation of external and internal cues 
into behavioural responses; DLPFC (dorsolateral prefrontal cortex) – self-control; OFC (orbitofrontal cortex) – 
encoding of reward value. 
 44 
Table 1.1. Brain reward areas involved in eating behaviour 
Brain reward area Function 
Midbrain / VTA 
Dopaminergic projections to limbic areas (NAc (ventral striatum), PFC, amygdala, LH and hippocampus), implicated in motivation and positive 
reinforcement, expression of GHS-R receptors and receives input from the hypotahalmus (e.g. orexin) 
NAc / ventral stritum 
 
Expression of D1-, D2- and D3 receptors and endogenous opioids, projection to the midbrain (VTA, substantia nigra), incentive motivational 
role in food intake and activation of this reward system enables behavioural responses necessary for obtaining a goal object, aimed at 
anticipated food receipt 
 
Insula 
 
Primary gustatory cortex involved in taste aversion as well as in sensory and rewarding aspects of taste processing, sends efferent projections 
to the anterior cingulate cortex (ACC), OFC, LH and NAc, and innervates the amygdala 
  
Amygdala Emotional processing particularly positive and negative affect, reward processing, and behaviour, projections to the OFC, PFC, NAc and ACC  
OFC 
 
Role in encoding taste, flavour, and food reward; medial OFC is related to the monitoring, learning and memory of the incentive salience of 
reward value of reinforcers, whereas lateral OFC is related to encoding reward value supported by the decrease in activation seen during taste 
of a food repeatedly consumed to a state of aversion (‘sensory-specific satiety’), close contact with the amygdala, insula and hippocamous  
 
ACC 
 
The ventral affective subdivision: assessment of the salience of emotional and motivational information, connected to the amygdala, NAc, 
hypothalamus, anterior insula, hippocampus and OFC 
The dorsal cognitive subdivision: Modulation of attention or executive function, influence on response selection, motivation, conflict monitoring 
and cost/benefit or reward/risk assessment, influenced by anxiety and fearful situations, reciprocal interconnected with the lateral PFC and 
motor areas 
 
PFC / DLPFC 
 
PFC: Executive control, translates homeostatic and environmental information into adaptive behavioural responses making choices, decisions 
DLPFC: goal-directed decisions and exercising self-control, reduce conflict  
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The VTA is located medial to the substantia nigra in the midbrain (Fields et al., 2007) 
(Figure 1.5.). Although the VTA is positioned strategically between the caudal 
hypothalamus and brainstem its physiological function was largely ignored until the 
discovery that it includes dopaminergic neurons (Dahlstroem and Fuxe, 1964) and that 
these neurons project widely to limbic areas implicated in motivation and positive 
reinforcement (Fallon and Moore, 1978, Swanson, 1982). This conclusion was supported 
by the observation that destruction of midbrain dopamine system produced profound 
motivational deficits (Ungerstedt, 1971). Previous studies have showed that VTA neurons 
fire when animals receive an unexpected reward (Schultz et al., 1993). Approximately 
60% of VTA neurons in the rat are dopaminergic (Swanson, 1982) and a large number are 
indentified as GABAergic neurons (Van Bockstaele and Pickel, 1995, Fields et al., 2007). 
The VTA receives input from many brain areas. It receives glutamatergic projections from 
the prefrontal cortex (PFC) (Sesack and Pickel, 1992), amygdala (Semba and Fibiger, 
1992) and lateral hypothalamus (Rosin et al., 2003). The input from the LH also includes 
afferents that contain the peptides orexin (Fadel and Deutch, 2002) or MCH (Semba and 
Fibiger, 1992, Fields et al., 2007). The VTA sends dopaminergic projections to the NAc 
(ventral striatum), PFC, amygdala, LH and hippocampus (Fields et al., 2007).  
 
The NAc comprises the ventral components of the striatum (Figure 1.5.). There are two 
major fuctional components of the NAc, the core and the shell, which are characterized by 
differential inputs and outputs (Carlezon and Thomas, 2009). The NAc contains GABAergic 
neurons, cholinergic neurons and GABA-containing medium spine neurons (Meredith, 
1999). These neurons express D1-, D2- and D3-like receptors and endogenous opioids 
and project back to the midbrain (VTA, subtantia nigra) (Carlezon and Thomas, 2009).  
It is well established that the NAc plays a key role in reward. The ventral striatum 
plays an incentive motivational role in food intake and activation of this reward system 
enables behavioural responses necessary for obtaining a goal object, aimed at anticipated 
food receipt (Berridge, 1996, Kelley, 2004). Imaging work in humans has shown that 
fasting increases the activation of the ventral striatum when viewing visual food stimuli 
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(Hinton et al., 2004, Beaver et al., 2006, Farooqi et al., 2007, Fuhrer et al., 2008, 
Stoeckel et al., 2008, Goldstone et al., 2009, Passamonti et al., 2009, Schur et al., 2009, 
Wang et al., 2009). Drugs of abuse and natural rewards have the common action of 
elevating extracellular concentrations of dopamine in the NAc (Kelley, 2004). Moreover, 
lesions of the NAc reduce the rewarding effects of stimulants (i.e. cocaine) and opiates 
(Kelsey et al., 1989). Pharmacological studies in the rat and monkeys suggest that D2-
and D3 receptors play a critical role in reward (Caine et al., 1999, Caine et al., 2000). 
Mice lacking dopamine D2-receptors have reduced sensitivity to the rewarding effects of 
cocaine (Welter et al., 2007) and morphine (Maldonado et al., 1997). D3 receptor 
antagonists have been shown to reduce cocaine-seeking behaviour and nicotine self-
administration in rats (Heidebreder et al., 2005). These data suggests that the D2/D3 
receptors and therefore the NAc/ventral striatum play an essential role in reward 
expectations (Volkow et al., 2007).   
 
The insula cortex is a cerebral cortex structure within the temporal lobe and the frontal 
lobe, and is divided into two parts: the larger anterior insula and the smaller posterior 
insula (Figure 1.5.). The insula is considered to be the primary gustatory cortex involved 
in taste aversion as well as in sensory and rewarding aspects of taste processing (Welzl et 
al., 2001, James et al., 2009). Previous studies suggest that representations of experience 
with food (colour, taste, flavour, reward value) are generated in the insula (de Araujo et 
al., 2003). Functional MRI studies in humans show a role for the insula in taste processing 
but also increased insula activation after smell or sight of food stimuli (Gordon et al., 
2000, Small et al., 2001, Wang et al., 2004, DelParigi et al., 2005, Holsen et al., 2005, 
Simmons et al., 2005, St-Onge et al., 2005, Porubska et al., 2006, Fuhrer et al., 2008, 
Stice et al., 2008, Cornier et al., 2009, James et al., 2009, Schienle et al., 2009, Schur et 
al., 2009, Siep et al., 2009, Wang et al., 2009). The insula receives visceral information 
by way of afferent inputs from the NTS and lateral parabrachial nucleus, and sends 
efferent projections to the ACC, OFC, LH, NAc, and amygdala (Van Vugt, 2009). 
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The amygdala is a part of the telencephalon, appears almond shaped and lies in the 
anterior temporal lobe (Murray, 2007) (Figure 1.5.). The amygdala contains an enormous 
diversity of nuclei and cell types. According to current thinking, the amygdala contributes 
to emotion, reward, motivation, learning, memory and attention (Murray, 2007). The 
amygdala is involved in emotional processing and particularly responds to positive and 
negative affect (Pessoa and Ungerleider, 2004). Bilateral damage of the amygdala 
disrupts emotional responses (Murray, 2007) and monkeys with amygdala lesions are 
fearless, have impairments in emotional learning, deficits in the perception of emotion, 
and impaired memory for emotional events (Cardinal et al., 2002). Recent functional 
imaging research has shown that the amygdala is activated when viewing or tasting a 
food (LaBar et al., 2001; Gottfried et al., 2003; Killgore et al., 2003; Hinton et al., 2004; 
Holsen et al., 2005; Fuhrer et al., 2008; Stoeckel et al., 2008; Goldstone et al., 2009; 
James et al., 2009; Passamonti et al., 2009; Schur et al., 2009; Wang et al., 2009). The 
amygdala receives projections from the insula, fusiforum (visual cortex) and VTA (Van 
Vugt, 2009) and usually returns them to the OFC, PFC, NAc and ACC (Amaral and Price, 
1984, Morgane et al., 2005). Some amygdala functions are carried out in concert with the 
OFC, such as updating the values of expected outcomes stored in the OFC (Holland and 
Gallagher, 2004). 
 
The OFC occupies the ventral surface of the frontal part of the brain (Kringelbach, 2005) 
(Figure 1.5.). The human OFC plays an important role in encoding taste, flavour, and food 
reward (Small et al., 2007). Olfactory, visual, gustatory, and somatosensory information 
(e.g crunchiness) are determinants for the palatability of food and such signals reach the 
OFC through different sensory brain pathways (de Araujo et al., 2003, Rolls et al., 2003, 
Verhagen and Engelen, 2006, Verhagen, 2007). It is important to distinguish between the 
lateral and the medial OFC (Kringelbach and Rolls, 2004). A large meta-analysis of the 
existing neuroimaging data was used to show that activity in the medial OFC is related to 
the monitoring, learning and memory of the reward value of reinforcers, whereas activity 
in the lateral OFC is related to the evaluation of punishers that can lead to a change in 
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behaviour (Kringelbach & Rolls, 2005). This meta-analysis further showed that a 
posterior–anterior OFC distinction was shown, with more complex or abstract reinforcers 
(such as monetary gain and loss) being represented more anteriorly in the OFC than less 
complex reinforcers such as taste.  
A large number of functional imaging studies have implicated the OFC in processing 
of reward value when fasting and viewing visual food stimuli (O'Doherty et al., 2000, 
Small et al., 2001, Gottfried et al., 2003, Hinton et al., 2004, Wang et al., 2004, DelParigi 
et al., 2005, Holsen et al., 2005, Simmons et al., 2005, Killgore and Yurgelun-Todd, 2006, 
Porubska et al., 2006, DelParigi et al., 2007, Fuhrer et al., 2008, Stoeckel et al., 2008, 
Schienle et al., 2009, Schur et al., 2009, Wang et al., 2009). The proposed primary role 
for the OFC in encoding reward value is further supported by the decrease in activation 
seen during taste of a food repeatedly consumed to a state of aversion (‘sensory-specific 
satiety’) (Kringelbach & Rolls, 2004). Small and colleagues further showed that the OFC 
also encodes retronasal olfaction and oral somatosensation as during eating, distinct 
sensory inputs fuse into a unitary flavor percept, and there is evidence that this percept is 
encoded in the OFC (Small et al., 2007). One fMRI study found that activation in the mid-
anterior parts of the OFC correlate with subjective pleasantness ratings of liquid foods 
when eaten to satiety providing a neural correlate of sensory-specific satiety to a liquid 
whole food (Kringelbach et al., 2003). The posterior parts of the OFC process the sensory 
information for further multimodal intergration (Kringelbach, 2005). The OFC is in close 
contact with the amygdala, insula and hippocampus (Verhagen and Engelen, 2006). 
 
The cingulate cortex is one of the largest parts of the limbic system. The anterior 
cingulated cortex (ACC) can be differentiated from the posterior cingulate cortex (PCC) 
on the basis of cytoarchitecture and patterns of projections, as well as function (Figure 
1.5.). The ACC has been characterized as ‘executive’ in function, whereas the PCC is 
characterized as ‘evaluative’ (Devinsky et al., 1995). The two major subdivisions of the 
ACC include the dorsal cognitive ACC and the ventral affective ACC (Bush et al., 2000). 
Functional imaging techniques have shown activation of the ACC when presented with 
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food stimuli (Bohon et al., 2009, Martin et al., 2009, Passamonti et al., 2009, Schienle et 
al., 2009). Activity in the ACC is seen during the delay period before the outcome of 
reward-related decisions, and is modulated by both outcome risk and anticipatory arousal 
(Critchley et al., 2001). The affective ventral ACC subdivision is primarly involved in 
assessing the salience of emotional and motivational information and the regulation of 
emotional responses (Devinsky et al., 1995, Whalen et al., 1998, Bush et al., 2000, 
Passamonti et al., 2008). It is connected to the amygdala, NAc, hypothalamus, anterior 
insula, hippocampus and OFC (Devinsky et al., 1995). The dorsal ACC, by contrast, is able 
to modulate attention or executive function, influencing response selection, motivation, 
conflict monitoring and cost/benefit or reward/risk assessment, and is influenced by 
anxiety and fearful situations (Devinsky et al., 1995, Carter et al., 1999, Bush et al., 
2000, Carter and van Veen, 2007). It is reciprocally interconnected with the lateral PFC 
and motor areas (Devinsky et al., 1995).  
 
Cortico-limbic reward systems of reward appear to be under executive control of the 
prefrontal cortex (PFC) (Figure 1.5.). The PFC receives internal and external sensory 
information, emotional and cognitive information from the limbic system, and motor and 
executive information from the cortical areas. It is thus able to translate homeostatic and 
environmental information into adaptive behavioural responses making choices and 
decisions (Kringelbach, 2005; Lenard and Berthoud, 2008; Piech et al., 2010). The 
dorsolateral PFC (DLPFC) is especially crucial for cognitive regulation of behaviour, 
goal-directed decisions and exercising self-control (Heekeren et al., 2004; Rorie and 
Newsome, 2005; Hare et al., 2009; Kable and Glimcher, 2009; Piech et al., 2010) (Figure 
1.5.). Self-reported dieters show greater activation in the left DLPFC during a food picture 
choice paradigm using fMRI (Hare et al., 2009). Activation of the DLPFC has been reported 
when subjects view high-calorie compared to low-calorie foods especially when fasted 
(Davids et al. 2010, Killgore et al., 2003, Goldstone et al., 2009, Schur et al., 2009). 
Interestingly, compared with lean men, obese men have less postprandial activation in the 
left DLPFC, irrespective of meal size (Le et al., 2006). Since top-down control appears to 
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be mostly implemented in the DLPFC, it is suggested that following detection of conflict by 
the ACC, the lateral areas of the dorsal PFC are engaged to reduce conflict (Carter & van 
Veen, 2007).  
 
In the following section techniques on how to image brain reward systems will be 
discussed. 
 
 
1.3. Neuroimaging techniques 
Imaging studies have shown that peripheral signals, central brain systems, and individual 
differences in food preference, nutritional state, gender, BMI, genetic polymorphisms as 
well as eating behaviour, reward sensitivity and mood have an influence on brain reward 
systems. The ability to study the neural networks that influence ingestive behaviour in 
humans has improved immensely with significant advances in imaging technology in the 
past 15 years. The physical principle of PET, MRI and fMRI are described in this 
paragraph. 
 
 
1.3.1. Positron-emission-tomography (PET) 
PET is a powerful functional imaging technique that has been used to study the 
relationship between energy consumption and neuronal activity (Bacharach et al., 2000; 
Huettel, 2004; Catana et al., 2008). PET uses positron-emitting radioactive tracers that 
are attached to molecules that enter biological pathways of interest. For example, 18F, a 
radioactive isotope of fluorine, can be attached to glucose, creating the molecule fluoro-2-
desoxy-D-glucose, or FDG. The fluorine tracer does not prevent FDG from entering into 
the normal pathways for glucose metabolism. Thus, researchers can inject a bolus of FDG 
into an artery and then use imaging to determine where it is taken up in the cells. As the 
radioactive isotope decays, it emits a positron (the antimatter counterpart of an electron). 
When the emitted positron collides with a nearby electron, they are mutually annihilated 
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and produce two gamma rays that take path 180° apart and are subsequently detected by 
their near simultaneous impact on opposite sides of a ring of scintillation crystals that 
surround the subject’s head. A computer algorithm then evaluates the number and timing 
of impact at all of the crystals surrounding head and traces the path taken by the gamma 
rays back to their origins. Through this method, the distribution of glucose uptake in the 
brain can be measured, and changes in glucose uptake in different brain regions caused 
by sensory, motor, or cognitive activity can be determined. PET imaging can also study 
cerebral blood flow using 15O, a radioactive isotope of oxygen. Certain neurotransmitters 
can be similarly labeled. For example 18F can be attached to L-DOPA to study its 
distribution of uptake in the human brain. 
 
1.3.1.1. Limitations 
PET scanning is very expensive. The spatial resolution of PET is limited by physical factors 
associated with positron physics and by the difficulty of acquiring sufficient counting 
statistics. Furthermore, PET images often lack definitive anatomical information, making 
interpretation of the precise location of radiotracer accumulation difficult (Catana et al., 
2008). Also radiation exposure in human research is carefully regulated, and subjects can 
participate in only a few PET scans (Huettel, 2004). 
 
 
1.3.2. Magnetic Resonance Imaging (MRI) 
Magnetic resonance imaging (MRI or MR scanning) was developed in the 1970s by 
researchers including Peter Mansfield and Paul Lauterbur. It is a non-invasive and non-
ionising imaging technique for creating 3D-images of the soft tissues of the human body. 
MRI is based on the physical phenomenon of nuclear magnetic resonance (NMR) 
(Westbrook, 2005).   
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1.3.2.1. Prinicple 
The human body is made of atoms (electrons, protons and neutrons) (Figure 1.6.). Nuclei 
that have an odd number of protons and neutrons both possess a magnetic moment. 
These are MR active nuclei (hydrogen, oxygen etc.). Thus, hydrogen nuclei are utilised in 
MRI as they consist of single protons that move. Hydrogen nuclei have a magnetic field 
induced around them, and act as small magnets. The north/south axis of each nucleus is 
represented by a magnetic moment (M0) and is used as the classical principle of MRI. The 
magnetic moments of the hydrogen nuclei are randomly orientated. Hydrogen nuclei 
possess energy in two discrete quantities or populations termed low (+1/2) and high (-
1/2) states.  Low-energy nuclei align their magnetic moment parallel to the external 
magnetic field and are termed spin-up nuclei. High-energy nuclei align their magnetic 
moments in the anti-parallel direction and are termed spin-down nuclei. As soon as a 
magnetic field is applied, the hydrogen nucleus will tend to align with the external 
magnetic field (B0) causing the magnetic moment to follow a circular path around B0 
(precession). This path is called the precessional path and the speed at which they wobble 
around B0 is called precessional frequency. The unit of precessional frequency is 
megahertz (MHz) whereby one Hz is one cycle per second and one MHz is 1 million cycles 
per second. The value of the precessional frequency is governed by the Lamor equation: 
 
ω0 = precessional frequency 
Bo = magnetic field strength of the magnet 
  γ = gyro-magnetic ratio in MHz/T (relationship between angular moment and magnetic  
                 moment of each active nucleus   
 
 
Thus, Larmor precession (named after Joseph Larmor) is the precession of the magnetic 
moments of electrons, atomic nuclei, and atoms about an external magnetic field. 
Applying a radio frequency (RF) pulse (with same energy as Lamor frequency of 
hydrogen), causes an increase in the number of the spin-down hydrogen nuclei as some 
spin-up nuclei gain energy via resonance and become high-energy nuclei. The result of 
the resonance is that the magnetic moment moves out of alignment away from B0, from 
ω0 = − γBo 
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the longitudinal to the transverse plane. The angle through which a magnetic moment 
moves out of alignment is the flip angle. The magnetic moment rotates then in the 
transverse plane at Lamor frequency. After the RF pulse is switched off the magnetic 
moment is again influenced by B0 and tries to realign with it. Spins return to the low 
energy state by releasing absorbed energy gained from the RF pulse. The process by 
which hydrogen loses energy is called T1 relaxation. The recovery of longitudinal 
magnetization is caused by the process termed T1 recovery (= nuclei are giving up their 
energy to the surrounding environment). The decay of transverse magnetization is caused 
by a process termed T2 decay (= nuclei exchange energy with neighbouring nuclei). As 
the magnitude of the transverse magnetization decreases, so does the magnitude of the 
voltage induced in the receiver coil. Thus, the released energy or MR signal can be 
measured by the receiver coil. The induction of reduced signal is called the free induction 
decay (FID) signal. The signal is Fourier transformed and converted into images (from 
signals to transverse slices) (Westbrook, 2005) (Figure 1.6.).  
 
Figure 1.6. Physical principle of MRI. 
 
 
 
 
 
 
Physical principle of MRI: applying a radio frequency (RF) pulse causes the magnetic moment (M0) to move out 
of alignment (away from the magnetic field B0) from the longitudinal to the transverse plane. After the RF pulse 
is switched off, M0 is again influenced by B0 and tries to realign with it. The released energy from the RF pulse or 
MR signal can be measured by the receiver coil. The signal is Fourier transformed and converted into images. 
 
In brief, the MR images are generated by a complex coordinated series (pulse sequences) 
of radio frequencies (RF) pulses and magnetic field gradient oscillations in a strong 
background static magnetic field. A pulse sequence is a combination of RF pulse, gradients 
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and intervening periods of recovery. The main components of a pulse sequence are 
repetition time (TR) and echo time (TE). The TR is the time from the application of one RF 
pulse to the application of the next RF pulse for each slice and is measured in milliseconds 
(ms). The TR reflects the amount of T1 relaxation that occurrs when the signal is read. 
The TE is the time from the application of the RF pulse to the peak of the signal induced in 
the coil and is also measured in ms. The TE determines how much decay of transverse 
magnetization is allowed to occur.  
 
MRI images are obtained from volumes, so pixels in an MR image are more accurately 
referred to as voxels. The signal intensity of a voxel within a given pulse sequence can 
reliably be predicted by knowing three parameters of the region of the object from which 
the voxel was acquired - the T1, T2 and T2* relaxation times. Most sequences do not 
isolate an individual parameter, but are instead weighted to being affected by one more 
than others (McRobbie, 2003). One method, using T2-weighted echo-planar images (uses 
rapid gradient switching following a single exication to fill the entire k-space) is functional 
MRI. 
 
 
1.3.3. Functional MRI (fMRI) 
In the early 1980s, MRI was introduced clinically, and during the 1980s a veritable 
explosion of technical refinements and diagnostic MR applications to study the brain took 
place. Scientists soon learned that the large blood flow changes measured by PET could 
also be imaged by the correct type of MRI. Functional magnetic resonance imaging (fMRI) 
was born, and since the 1990s, fMRI has come to dominate the brain mapping field due to 
its low invasiveness, lack of radiation exposure, reduced costs and relatively wide 
availability. Functional MRI refers to a rapidly developing technology that enables the 
creation of images which reveal localized neural activity in human brains during sensory, 
motor, and cognitive activity (Savoy, 1999; Huettel, 2004). 
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1.3.3.1 Blood Oxygenation Level Dependant (BOLD) signal 
The BOLD effect is based on the fact that there are local blood flow and blood oxygenation 
changes in response to neuronal activity. Applying a sensory, motor, or cognitive stimulus 
increases neuronal activity. This neuronal activity requires energy in form of adenosine 
triphosphate, or ATP. Because the brain is able to store limited amounts of energy, it must 
create the ATP energy through the oxidation of glucose. Both oxygen and glucose are 
supplied by increased blood flow. Through the increase in blood flow, volume and oxygen, 
deoxyhaemoglobin flushes from the capillaries, and small veins. Since deoxyhaemoglobin 
molecules are paramagnetic this alters the spins of nearby diffusing hydrogen nuclei, the 
presence of deoxyhaemoglobin reduces the MRI signal intensity. By displacing the 
deoxyhaemoglobin with oxygenated haemoglobin, the increase in blood flow results in a 
local increase in MRI signal. The magnetic properties and the change of the ratio of 
oxygenated and deoxygenated haemoglobin can be therefore used to construct images 
based upon blood-oxygenation-level dependant (BOLD) contrast. In brief, BOLD-fMRI 
detects a change in the concentration of a paramagnetic molecule (deoxyhaemoglobin) 
whose levels are correlated with neuronal activity through neurovascular-coupling 
(Huettel, 2004).  
 
Principle of fMRI preprocessing 
After the MRI signal has been recorded, the images need to be reconstructed and quality 
control assured.  
Each imaged slice is acquired at slightly different time points within the TR (e.g. in 
my studies 44 slices within 3 seconds). Thus correction for slice timing is necessary 
and consistency can be achieved by shifting and then interpolating the data, or including 
temporal derivatives in the analysis. 
Motion correction is important to adjust the time series of images so that the 
brain is in the same position in every image. For motion correction, image volumes in the 
same time series are coregistered to a single reference volume by a combination of three 
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translation (moving the entire image volume along the x-, y-, z-axes) and three rotations 
(rotating the entire image volume through the roll, yaw and tilt planes). 
 Geometric distortions caused by inhomogenities in the magnetic field can lead to 
loss or compression of signal in important brain reward areas such as the OFC as well as 
temporal cortex due to vicinity to air-filled sinuses. It is possible to correct to some extent 
for the effects of these inhomogenities by using field maps acquiring two images of 
signal phase with slightly different echo times. The differences between the two images 
results in an image of the intensity of the magnetic field across space (at any given 
location) which can be registered with the EPI (echo planar imaging) image and therefore 
correct geometric distortions, though not recover EPI signal drop-out (Huettel, 2004).  
Spatial filtering or smoothing is used to increase the signal to noise-ratio. Each 
voxel intensity is replaced by a weighted average of neighbouring intensities. As a result 
the image looks as if it is viewed through a blurred glass and the rate of false-positives is 
reduced. The image can be smoothed by using a Gaussian kernel (Spatial filter width for 
fMRI) expressed in millimeters at Full Width Half Maximum (FWHM). Thus, by using this 
filter, is is possible to average the data over adjacent voxels, reducing the likelihood that 
a cluster of voxels will pass the same threshold (Huettel, 2004). 
Time series from each voxel contain low frequency drifts and high-frequency noise. 
Drifts are scanner-related and physiological (cardiac cycle, breating, etc.). Both high and 
low frequency noise hide activation. Using temporal filtering, high frequencies, low 
frequencies or both can be removed without removing signals of interest. For example 
low-pass filters are used to remove high frequencies. 
 The differences between functional and structural images of the same brain region 
are striking. High-resolutional T1 structural brain images appear remarkely detailed with 
clear boundaries between grey and white matter whereas in functional EPI images 
boundaries are difficult to visualise. Human brains also have remarkably variable 
morphology and shape. Normalisation or registration to standard space is used to 
compensate for differences in brain shape. Normalisation of data within a study allows 
combination of data (brain areas) across individuals. A commonly used standard space 
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was created by the Monreal Neurological Insitute and consists of an average of 152 T1-
weighted brain images. Therefore, the EPI image must first be registered with the 
individual’s T1 image using 6 degrees of freedom which in turn must be registered within 
standard space using 12 degrees of freedom registration which may be linear or non-
linear, and these warping parameters applied to the T1-registered EPI image. 
 
fMRI experimental analysis 
Each acquired voxel in an EPI scan contains a time-varying signal (BOLD signal). It is 
important to model the stimulus-induced changes in BOLD signal (predicted response) in 
order to find which voxels have signals that match the model. A good match implies 
activation related to a particular stimulus. The haemodynamic response to a stimulus is 
blurred and delayed. In order to compare the BOLD signal, the process can be modeled by 
convolving the activity curve with a haemodynamic response function (HRF), giving the 
predicted response. A standard General Linear Model (GLM) allows multiple comparisons 
and correlates the model (predicted response) with each voxel separately. For example, 
time-series statistical analysis can be carried out using autocorrelation correction including 
picture onsets (e.g. in my study high-calorie and low-calorie food, object and blurred 
pictures), with temporal derivatives (to correct for slice timing variation and differences in 
time of onset of brain activation relative to stimulus in different brain regions) and motion 
parameters (to deweight scans which may be subject to motion artifact) as co-variates. 
This gives parameter estimates (beta) and under the null hyothesis beta is 0. If the ‘null 
hypothesis testing’ results in a small p-value, the null hypothesis is unlikely and then the 
voxel would be active. In this way it is possible to create group mean statistical 
parametric maps for the whole brain or for each region of interest (ROI) to see which 
voxel in which brain region is significantly activated by one particular stimulus compared 
to another. 
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1.4. Signalling in brain reward systems 
Although there has been a tremendous progress describing the central homeostatic 
control of food intake, this system does not work very well in an environment where little 
effort is necessary to obtain palatable foods with high-calorie density. During the past 40 
years, there has been 42% per capita increase in the consumption of added fats in foods 
and a 162% increase in cheese relatively to only a 20% increase in fruits and vegetabales 
(Frazao and Allshouse, 2003). Reduced costs of sugar and vegetable oils worldwide have 
also contributed to the production of highly palatable processed foods (Drewnowski, 
2000). There is also a “portion-distorted embarassment of food” in today’s supermarkets 
and restaurants (Wansink and van Ittersum, 2007). Evidence in rodents and humans now 
supports the theory that both drugs of abuse and the consumption of highly palatable 
foods converge on a shared addiction pathway within brain reward systems to mediate 
motivated behaviour (Nestler, 2001, Wang et al., 2004, Nestler, 2005). Much of the 
previous work has focused on the mesocorticolimbic dopamine pathway.  
 
1.4.1. Dopamine  
Synthesis 
Dopamine is produced in several areas of the brain, including the substantia nigra and the 
ventral tegmental area of the midbrain.  Dopamine signaling on feeding is thought to be 
mediated by D1 and D2 receptors (G protein-coupled receptors) (Schneider, 1989, Kuo, 
2002). Tyrosine hydroxylase or tyrosine 3-monooxygenase is the enzyme responsible for 
catalyzing the conversion of the amino acid L-tyrosine to dihydroxyphenylalanine (DOPA) 
(Kaufman, 1995, Nagatsu, 1995). DOPA is a precursor for dopamine, which, in turn, is a 
precursor for noradrenaline and adrenaline. In humans, tyrosine hydroxylase is encoded 
by the TH gene (Nagatsu, 1995).  
 
Function 
Mice which lack dopamine, due to the absence of the TH gene, have fatal hypophagia. 
Dopamine replacement into the caudate putamen (dorsal striatum) restores feeding, 
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whereas replacement into the nucleus accumbens restores preference for a palatable diet 
(Szczypka et al., 2001). The exact role of dopamine in the process of reward has been 
vigorously debated in recent years. Berridge has argued that dopamine fosters the 
motivation to engage in rewarding behaviours - the so called “wanting” of reward, rather 
than “liking” of reward (Berridge, 2007). In other words, dopamine may not be central to 
the normal pleasure or hedonic reactions to food or drugs. Dopamine has been 
hypothesised to encode reward prediction error and would act to shape future behaviour 
to maximize reward (Montague et al., 2004). Because a reward prediction error forms the 
basis of Pavlovian learning theories, it has been postulated that dopamine neurons provide 
an error signal for the learning of stimulus-reward association (Schultz, 2002). 
  
Hypo-dopaminergic functioning 
A key focus in research of addiction disorders and obesity is that hypo-dopaminergic 
functioning (Reward Deficiency Syndrome - RDS) in brain reward pathways is a key risk 
factor for their development (Blum et al., 2000). The premise is that addictive substances, 
which increase brain dopamine levels, are used as a form of “self-medication” to boost a 
sluggish dopamine system and increase hedonic capacity and promote excessive 
behaviour. The same arguments have been recently extended to the risk for obesity; 
focusing on dopamine D2 receptors. There is reasonable evidence that individuals with the 
Taq1A+ allele (polymorphism of D2 receptor) have reduced brain dopamine function in 
the dorsal stritum due to a 30-40% reduction in D2 receptor density in the striatal region 
(Davis et al., 2008, Stice et al., 2008). Stice and colleagues performed an fMRI study 
after subjects received a chocolate milkshake or a tasteless solution. Obese individuals, 
relative to lean individuals, showed a blunted dorsal striatal response to milkshake receipt, 
and this effect was amplified in those with the A1 allele. Thus, the dorsal striatum was less 
responsive to food reward in obese, relative to lean, individuals, potentially because obese 
are suggested to have reduced D2 receptor density and compromised dopamine signaling, 
which may prompt them to overeat in an effort to compensate for this reward deficit  
(Stice et al., 2008). 
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Hyper-sensitivity to reward 
The counter argument is that hyper-sensitivity to reward contributes to increased risk of 
obesity because of enhanced motivation to approach pleasurable activities such as eating 
(Beaver et al., 2006, Davis et al., 2007). Addictive drugs and food could also share a 
tolerance of their rewarding properties by the downregulation of dopamine receptors in 
the striatum (Volkow et al., 2002), and a decrease in the function of the amygdala, which 
produces negative affect and anxiety associated with abstinence (Koob, 2006). There is 
now evidence that highly palatable foods cause the same neuroadaptions which increase 
strong cravings, and contribute to the symptoms of withdrawl (Grigson, 2002, Pelchat, 
2002). 
Davis and Carter suggest a dual vulnerability to addictions whereby both hypo-
dopaminergic functioning and hyper-sensitivity to reward can confer risk, albeit in 
different individuals and perhaps with different levels of severity (Davis and Carter, 2009).  
 
Dopamine signalling 
All common drugs of abuse increase dopamine signaling from the VTA to the NAc, the 
prefrontal cortex, the hippocampus, and the amygdala. Increasd dopaminergic 
transmissions occur either by direct action on dopaminergic neurons (cocaine, nicotine) or 
indirectly through inhibition of GABAergic interneurons in the VTA (alcohol, opiates) 
(Nestler, 2001, 2005). Natural rewards such as presentation and ingestion of palatable 
food induces potent release of dopamine into the nucleus accumbens (Nestler, 2001). The 
mechanism by which food stimulates dopamine signaling is unclear. It does not appear 
that taste receptors are required, as mice lacking sweet receptors are still able to develop 
a strong preference for sucrose solutions (de Araujo et al., 2008).  
A new concept is that hormones such as leptin, insulin and ghrelin directly affect 
the dopamine reward pathways. These hormones activate receptors on VTA dopamine 
neurons, thereby either stimulating (ghrelin) or inhibiting (leptin and insulin) dopamine 
signaling in the NAc, which is described later in more detail. Other neurotransmitters such 
as GABA, opioids and serotonin are also integral to reward process and will be described 
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later (Wang et al., 2004). NPY has been shown to enhance the extracellular levels of 
accumbal dopamine (Salin et al., 1990). There is also evidence that orexin receptors are 
located on dopamine neurons, where they couple to the same receptor as ghrelin and 
microinjection of orexin into the VTA increases the levels of dopamine in the NAc (Narita 
et al., 2006). Endogenous cannabinoids are an important player in the reward circuits, 
since they interact with opioid and dopaminergic systems to enhance satisfaction coming 
from the ingestion of palatable food (Pagotto et al., 2006).  
 
 
1.4.2. Endocannabinoids  
Endocannabinoid receptor CB1 is localised in high concentrations in the hippocamous, 
cerebellum, prefrontal cortex and striatum, but in low concentrations in the VTA 
(Herkenham et al., 1990, Tsou et al., 1998). Previous research has shown that CB1 
receptor antagonists reduces intake of food and sweet solutions (Arnone et al., 1997; 
Simiand et al., 1998). CB1-null mice, however, do not show dramatic changes in body 
weight and food consumption, suggesting that CB1 receptors rather modulate than 
mediate basic reward functions or other systems compensate for their absence (Ledent et 
al., 1999, Zimmer et al., 1999, Marsicano et al., 2002). The anti-obesity drug, 
rimonabant, a CB1-receptor blocker has been shown to inhibit the effect of ghrelin (Kola 
et al., 2008). In this study, ghrelin was unable to induce an orexigenic effect in CB1-
knockout mice suggesting that the endocannabinoid system may mediate ghrelin’s actions 
(Kola et al., 2008).  
 Exposure to food increases dopamine levels in the NAc and activation of dopamine 
D2 receptors in this region increases extracellular levels of the endocannabinoid 
anandamide (Giuffrida et al., 1999, Di Chiara et al., 2004). The endocannabinoids 
anandamide and 2-arachidonoylglycerol (2-AG) appear to increase the palatability of food, 
indicating that they are more important for hedonic aspects than consumatory aspects of 
food reward (Kirkham et al., 2002, Mahler et al., 2007). 
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1.4.3. Opiates 
Opioids, especially the mu-opioids, also regulate the “hedonics of feeding” – what Berridge 
calls the “liking” – by their modulation of the palatability of food (Berridge, 1996, 2007). 
In humans, opiate antagonists are found to reduce food palatability without reducing 
subjective hunger (Yeomans et al., 1990, Drewnowski et al., 1992). Recent studies have 
demonstrated a major role for mu-opioid receptors (OPRM1), especially in the ventral 
striatum and amygdala where their activation enhances positive hedonic reactions to 
sweet and fatty foods (Olszewski and Levine, 2007). Particularly in the midbrain, mu-
opioid receptors are localized on gamma-amino butyric acid neurons (GABAergic 
signaling) that normally inhibit the dopamine system; mu-opioids inhibit this input, thus 
disinhibiting the dopamine release in the nucleus NAc and related regions (MacDonald et 
al., 2004).  
 
1.4.4. Leptin 
Early studies showed that leptin receptors are expressed in the VTA (Figlewicz et al., 
2003). Co-expression of the leptin receptor with tyrosine hydroxylase, a marker of 
dopamine neurons has also been demonstrated (Figlewicz et al., 2003, Fulton et al., 2006, 
Hommel et al., 2006).  
The observation that the transcription factor STAT3, is phosphorylated (pSTAT3) in 
dopamine neurons in response to leptin treatment provides evidence that leptin receptors 
on dopamine neurons are functional (Fulton et al., 2006, Hommel et al., 2006). In 
anaesthetized rats, the firing rate of dopamine neurons decreased by ~40% following 
intravenous infusion of leptin (Hommel et al., 2006), and leptin inhibited dopamine neuron 
firing when applied to slices containing VTA neurons (Korotkova et al., 2006).  
Leptin is also suggested to affect hedonic aspects of feeding behaviour as infusion 
into the 3rd ventricle and subcutaneous injection reduced sucrose self administration, 
suppressed the conditional place preference (CPP) for sucrose pellets and reversed CPP for 
high-fat foods (Figlewicz et al., 2001, Figlewicz et al., 2004). CPP measures the ability of 
an animal to associate the rewarding aspects of food (or a drug) with a particular 
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environment. Thus, a reduction in CPP by suggests an interference with subjective reward 
value and associated learning. Another animal study has shown that inactivation of leptin 
receptors in the VTA increased feeding, but the mice did not gain weight (Hommel et al., 
2006).  
A functional MRI study measured brain responses in two human patients with 
congenital leptin deficiency (Farooqi et al., 2007). They showed images of food before and 
after 7 days of leptin replacement therapy. Leptin was found to reduce neural activation in 
key striatal regions (accumbens-caudate and putamen–globus pallidus) in both subjects, 
suggesting that the hormone acts on neural circuits governing food intake to diminish the 
perception of food reward. After leptin treatment, hunger ratings in the fasted state 
decreased, and satiety following a meal also increased (Farooqi et al., 2007). Baicy et al. 
further reported an fMRI study where leptin-deficient patients (missense mutation in the 
OB gene) with leptin replacement had reduced hunger ratings and reduced activation in 
brain reward areas (insula, parietal lobe and temporal cortex) when viewing food pictures, 
but increased activation in self-control areas (prefrontal cortex) (Baicy et al., 2007). A 
third leptin study measured brain responses to visual food cues in (non-leptin deficient) 
obese patients who had achieved a 10% reduction in body weight through food restriction 
(Rosenbaum et al., 2008). Five weeks of twice-daily subcutanous injection of leptin 
(0.08mg/kg fat mass), following weight-loss (during which leptin levels would naturally 
decline), increased activation in brain areas known to be involved in the emotional and 
cognitive control of food intake (brainstem, culmen, parahippocampal gyrus, inferior and 
middle frontal gyri, middle temporal gyrus, and lingual gyrus) and decreased activation in 
the hypothalamus, cingulate gyrus, and middle frontal gyrus. Thus, circulating leptin 
seems to inhibit dopamine signaling in brain reward systems and influence the subjective 
reward value of food and hence motivation to eat (Palmiter, 2007). 
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1.4.5. Insulin 
Early studies also showed that insulin receptors are co-expressed with tyrosine 
hydroxylase, a marker of dopamine neurons, in the VTA (Figlewicz, 2003). Downstream 
substrates of insulin receptors, such as insulin receptor substrate 2 and 
phosphatidylinositol (3,4,5)-triphosphate, are expressed in dopamine neurons (Pardini et 
al., 2006). Figlewicz and colleagues showed that intravenous administration of insulin 
increased the mRNA levels and the functional activity of dopamine transporters; this 
increase would be expected to facilitate clearing dopamine from synapses and hence 
reduce dopamine signaling (Figlewicz et al., 1994, Figlewicz et al., 2003).  
 Insulin is also suggested to affect feeding behaviour as infusion into the 3rd 
ventricle reversed CPP for high-fat foods (Figlewicz et al., 2004).  
 Functional MRI research demonstrated the important role of insulin in the 
modulation of food hedonic responses and related information processing. Guthoff and 
colleagues showed that activation of brain reward areas (fusiforum gyrus, hippocampus, 
temporal superior cortex, and frontal middle cortex) by food pictures is down-regulated by 
intranasal insulin (Guthoff et al., 2009). Thus, circulating insulin also seems to inhibit 
dopamine signaling in ‘reward circuits’ and influence the subjective reward value of food 
and hence motivation to eat (Palmiter, 2007). 
 
 
1.4.6. PYY3-36 
Recent research has also suggested an influence of the gut hormone PYY3-36 on ‘reward 
circuits’ (Batterham et al., 2007). Unlike the previous described fMRI studies, this study 
did not use visual food cues. Infusion of PYY3-36 to fasted subjects that mimicked post-
prandial concentrations of PYY increased the resting BOLD signal in the caudolateral OFC 
and significantly reduced the number of calories consumed at a subsequent meal. The 
magnitude of activation in the OFC was inversely correlated with the number of calories 
eaten; suggesting that PYY-induced activation of the OFC was in part responsible for the 
reduced appetite. This suggests an inhibiting role of PYY on brain ‘reward circuits’ but not 
 65 
traditional homeostatic hypothalamic centres. On the fasted day, saline-induced 
hypothalamic activation correlated with subsequent caloric intake (Batterham et al., 
2007).  
 
 
1.4.7. Ghrelin 
An important novel player in the mesocorticolimbic dopamine reward system is the 
stomach-derived orexigenic hormone ghrelin. The hypothalamus has the highest 
concentration of GHS-R in the brain but other regions such as the VTA express this 
receptor in relatively high concentrations (60-70%) (Abizaid et al., 2006, Zigman et al., 
2006). Pharmacological blockade of GHS-R in the VTA decreases feeding in fasted mice 
(Abizaid et al., 2006). Behavioural data in animals showed that ghrelin injection enhances 
the willingness to work harder to obtain food (Keen-Rhinehart and Bartness, 2005).  
New research suggests that peripheral ghrelin enhances the intake of rewarding 
food in rodents (Egecioglu et al., 2010), especially sweet taste consumption and 
preference regardless of its caloric content (Disse et al., 2010). Rats can develop CPP to 
high fat food after being injected subcutaneously with ghrelin (Jerlhag, 2008, Quarta et 
al., 2009). Intracerebroventricular administration of ghrelin increases locomotor activity 
and extracellular levels of accumbal dopamine in mice (Jerlhag et al., 2006). These effects 
of ghrelin are mediated via central nicotine receptors, suggesting that ghrelin can activate 
the acetylcholine-dopamine reward link. This reward link consists of cholinergic input from 
the laterodorsal tegmental area (LDTA) to the mesolimbic dopamine system that 
originates in the VTA and projects to the nucleus accumbens. Other studies have 
confirmed that local ghrelin administration into the VTA activates dopamine neurons, 
subsequently increases dopamine in the nucleus accumbens and locomotor activity, and 
directly stimulates food intake (Naleid et al., 2005, Jerlhag et al., 2007, Quarta et al., 
2009). GHSR-1A is suggested to be expressed in the VTA and LDTA (Jerlhag et al., 2007). 
Local administration of ghrelin into the LDTA caused a locomotor stimulation and an 
increase in the extracellular levels of accumbal dopamine (Jerlhag et al., 2007). Taken 
 66 
together, this indicates that ghrelin might, via activation of GHSR-1A in the VTA and 
LDTA, stimulate the acetylcholine-dopamine reward link.  
Ghrelin does indeed bind to the VTA when directly delivered to these regions 
(Abizaid et al., 2006). It is important to note that approximately 30% of GABA neurons in 
the VTA have ghrelin receptors, yet it is unclear how they are affected by ghrelin (Abizaid, 
2009). Similarly, ghrelin infusions into brain regions targeted by dopamine cells in the 
VTA, such as the NAc, amygdala, and hippocampus, produce alterations in feeding 
responses suggesting that ghrelin acts mostly like a neuromodulator and enhances 
dopamine release in the synapse  (Cowley et al., 2003, Carlini et al., 2004, Naleid et al., 
2005, Toth et al., 2008). The possibility must be considered that the effects of ghrelin on 
the activity and neurotransmitter of the VTA dopamine neurons may be produced 
indirectly through the actions of ghrelin on afferent systems connected to the VTA (Geisler 
and Zahm, 2005).  Also implicated in activation of VTA dopamine neurons is the peptide 
neurotransmitter orexin, which is expressed by a population of lateral hypothalamic 
neurons (Perello et al., 2010). 
The presence of GHS-R had already been identified in the hippocampal formation 
even before ghrelin and its functions were discovered (Guan et al., 1997). Peripheral 
ghrelin has a robust impact on hippocampal synaptology (Diano et al., 2006). Ghrelin 
enters the hippocampus and binds to neurons of the hippocampal formation, where it 
promotes dendritic spine synapse formation and generation of long-term potentiation. 
Ghrelin enhances learning and memory, whereas the absence of ghrelin due to targeted 
gene disruption causes impairment of these functions (Diano et al., 2006).  
The effect of ghrelin on the amygdala could be also direct, as the amygdala 
contains ghrelin-positive axon terminals (Cowley et al., 2003), or indirect via the 
hypothalamus or the VTA, which send dopaminergic projections to the amygdala (Carlini 
et al., 2004). However, injection of ghrelin into the amygdala failed to increase food 
intake in one study (Carlini et al., 2004).  
A recent study showed that substantia negra pars compacta (SNpc), a brain region 
where dopamine cell degeneration leads to Parkinson disease, expresses GHS-R. Thus 
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ghrelin binds to SNpc, activates dopamine neurons, increases tyrosine hydroxylase mRNA 
and dopamine concentration in the dorsal striatum (Andrews et al., 2009).  
One study in humans showed that an i.v. single injection of ghrelin increased the 
imagination of individual preferred foods (Schmid et al., 2005). Malik and colleagues 
recently showed that administration of ghrelin, in comparison to saline, produced greater 
activation in brain reward centres such as the OFC, PFC, amygdala, and anterior insula 
when subjects viewed food pictures (Malik et al., 2008). Furthermore the magnitude of 
activation in the OFC and amygdala correlated with increased self-rated hunger levels 
elicited by ghrelin, suggesting that behavioural effects and BOLD effects of ghrelin were 
related.   
 
The next paragraph will discuss various factors other then internal hormonal signals such 
as food preference, nutritional state, gender, obesity and psychological cues and how 
these factors influence brain reward systems (Figure 1.1., Figure 1.5.). 
 
 
1.5. Other cues effecting brain reward systems (Table 1.1.-1.8.) 
 
1.5.1. Food preference 
The sensory properties of food play a very important role in the way people select their 
food and how much they eat (Sorensen et al., 2003). The palatability of food is often 
measured by using visual analogue scales where subjects are asked questions like ‘how 
pleasant was the food’ (van Strien, 1986).  
Generally, people prefer high-fat over low-fat foods (Mizushige et al., 2007). One 
study compared the taste of high-fat foods, high-protein foods, and high-carbohydrate 
foods using 13 strains of mice (Smith et al., 2000). Ten strains of mice preferred the high-
fat food over the other selections.  
Sweetness is also a major contributor to palatability, although there is an individual 
difference in optimal level of sweetness. In two studies, the palatability of a test food was 
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manipulated by using yoghurt with different concentrations of the intense sweetener, 
aspartame, and sucrose (Monneuse et al., 1991, Perez et al., 1994). In both studies, 
yoghurt intake was greater at the individual subject’s most preferred concentration than 
at all the other concentrations. Sugars are reinforcing, indicating a high incentive salience 
(McCaughey, 2008). Rats will run towards a known source of sugar rapidly and will work 
hard to obtain them (Guttman, 1954, Young and Shuford, 1955). Access to sugar can 
condition a place preference (Agmo and Marroquin, 1997). There is widespread 
assumption that sugar consumption can lead to addiction (Benton, 2009). A study by Rolls 
et al. revealed that pleasantness ratings of chocolate and chocolate-related stimuli had 
higher positive correlations with fMRI activation in the pregenual cingulate cortex and 
medial OFC in chocolate cravers than in non-cravers (Rolls and McCabe, 2007). 
Furthermore a picture of chocolate with chocolate in the mouth produced greater 
activation in the medial OFC and pregenual cingulate cortex in cravers than non-cravers.  
Access to fat can also condition a place preference. One previous study showed 
that CPP to high-fat diet was blocked in ad-lib fed rats given intraventricular insulin or 
leptin (Figlewicz et al., 2004).   
Thus, does the evolutionary effect of eating high-calorie foods in times of plenty in 
order to store more energy for times without food, lead to a preference for high-calorie, 
fatty and sugary foods? Obese people might also prefer high-calorie, highly palatable 
foods in order to compensate for a reduced dopamine signaling in the brain reward 
circuitry. More research is needed to understand the association between taste preference 
and development of obesity. 
 
 
1.5.2. The effect of food stimuli on the human brain (Table 1.2.-1.8.) 
Brain activation varies depending on which food stimuli are presented (e.g. high-calorie or 
low-calorie) and how they are presented (taste, smell, pictures). With the help of new 
functional imaging research it is now possible to determine the effect of different food 
types on brain reward systems. Indeed, exposure to highly appetizing food cues can 
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override satiety signals and promote overeating (Cornell et al., 1989; Bender et al., 2009; 
Frank et al., 2010).  
 
1.5.2.1. Food versus non-food 
PET and BOLD imaging research has shown, in non-obese healthy volunteers, that 
compared to non-food pictures, visual food stimuli induce greater activity in the amygdala, 
ACC, hippocampus, insula and OFC, DLPFC and striatum (Gordon et al., 2000, LaBar et 
al., 2001, Morris and Dolan, 2001, Wang et al., 2004, Holsen et al., 2005, Simmons et al., 
2005, St-Onge et al., 2005, Porubska et al., 2006, Fuhrer et al., 2008, Schur et al., 
2009). Similar areas are activated when subjects have to smell and/or taste food 
(O'Doherty et al., 2000, Small et al., 2001, Gottfried et al., 2003). 
 
1.5.2.2. Appetizing versus bland or disgusting foods 
Imaging studies also demonstrated that activity is greater in the ventral striatum, OFC, 
amygdala and insula when viewing appetizing compared with bland or disgusting foods 
(Beaver et al., 2006, Calder et al., 2007). Activity is also greater in the amygdala and OFC 
when chosing highly preferred foods from a menu (Hinton et al., 2004; Piech et al., 
2009). 
 
1.5.2.3. High-calorie versus low-calorie foods 
Compared to low-calorie food pictures, viewing high-calorie food stimuli induced a greater 
activity in the insula, medial OFC, medial and dorsolateral PFC, when using functional MRI 
(Goldstone et al., 2009; Gordon et al., 2000; Killgore et al., 2003; Siep et al., 2009; 
Frank et al., 2010).  
 
 
1.5.3. Nutritional states (Table 1.2.-1.8.) 
Although there are significant variations in the regions reported to be activated by food 
cues in the individual studies, it is likely that experimental variables such as stimulus 
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paradigms, gender, BMI, and individual differences in eating behaviour, reward sensitivity 
and mood, but also hunger and satiety levels may contribute to these differences. Thus, 
the sensation of reward is influenced by energy status, as the subject’s palatability of food 
is altered in the fed, compared with the fasting states (Berridge, 1991).  
 
1.5.3.1. Hunger 
Food-deprived rats show even larger intake of sugars than do those that are non-deprived 
(Smith and Duffy, 1957). A human study by Stoeckel and colloeagues found that women 
(though not men) have enhanced valence of food images when fasted. No evidence was 
found of hunger-induced enhancement of hedonic ratings of non-foods (Stoeckel et al., 
2007; Haase et al., 2009b). In normal weight subjects in a fasted hungry state, visual 
food versus non-food stimuli is reported to produce greater activation in regions including 
the amygdala, insula, OFC, striatum, and DLPFC using functional neuroimaging techniques 
(Gordon et al., 2000, LaBar et al., 2001, Hinton et al., 2004, Wang et al., 2004, Holsen et 
al., 2005, Simmons et al., 2005, St-Onge et al., 2005, Porubska et al., 2006, Fuhrer et 
al., 2008, Goldstone et al., 2009, Schur et al., 2009). These areas are also implicated in 
the neural response to smell and taste (Small et al., 2001; Gottfried et al., 2003; 
DelParigi et al., 2005; Small et al., 2007; Haase et al., 2009b; Grabenhorst et al., 2010; 
Smeets et al., 2010).  
Brain activity at rest in the insula and OFC also increased under conditions of 
prolonged fasting (Del Parigi, 2002). The subjective rating of hunger when fasted for at 
least 5 hours has been shown to correlate with activation in the insula to food pictures 
(Porubska et al., 2006). Activity in the amgydala and OFC has also been associated with 
enhanced memory of food stimuli when fasted (Morris and Dolan, 2001).  
 Another neuroimaging stuy demonstrated that 10% weight loss during a period of 
maximal 62 days resulted in increased activation in the brainstem and parahippocampal 
gyrus and pallidum as well as middle temporal gyrus, inferior frontal gyrus, middle frontal 
gyrus, and lingual gyrus when when viewing food vs. non-food. These areas are involved 
in reward and decision-making functions (Rosenbaum et al., 2008). 
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1.5.3.2. Sensory-specific satiety 
Interestingly, when a food is repeatedly viewed, smelled or consumed, it drops in ratings 
of pleasantness relative to foods that have not been eaten and this phenomenon is 
referred to as sensory-specific satiety (Rolls et al., 1981). Kringelbach et al. showed that a 
sensory-specific reduction in activation of the OFC correlates with subjective pleasantness 
when repeatedly eating a liquid food to satiety (Kringelbach et al., 2003). Similar imaging 
investigations have shown that activation of the OFC is decreased to the odour of a food 
eaten to satiety (O'Doherty et al., 2000, Small et al., 2001).  
 Cornier et al. has shown that in the state of positive energy balance (30% 
overfeeding for two days) activation in brain areas such as the insula and the 
hypothalamus when viewing foods of neutral hedonic value were reduced in lean 
individuals. This pattern was reversed in obese individuals and thus no reduced activation 
in the hypothalamus after two days of overfeeding was observed (Cornier et al., 2009).  
 
1.5.3.3. Hunger versus satiety 
A large numer of functional imaging studies using BOLD fMRI or PET have shown 
differences in neuronal activation in brain reward system when comparing hungry (fasted) 
and satiated (fed) states in humans. Acute fasting increased activity in the ventral 
striatum, amygdala, insula and medial OFC in response to food versus non-food stimuli 
compared with when fed (LaBar et al., 2001, Hinton et al., 2004, Holsen et al., 2005, Uher 
et al., 2006, Farooqi et al., 2007, Fuhrer et al., 2008, Goldstone et al., 2009). 
 
 
1.5.4. Gender (Table 1.2.-1.8.) 
The prevalence in obesity is higher in women than in men in most countries around the 
world (Lovejoy and Sainsbury, 2009). The factors driving the greater propensity for 
excess body weight in women are not well understood. Research has focused on 
evolution, gonadal hormones, pregnancy, behavioural differences and environment, and 
their influences on peripheral and central mechanisms that control appetite and body 
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weight. Women have lower energy expenditure than men (Tooze et al., 2007). Rodent 
studies have shown that oestrogen treatment in mice increases lipolysis in abdominal fat 
cells (D'Eon et al., 2005) but differences in eating behaviour might also be important.  
Oestrogen deficiency in female animals is associated with hyperphagia and 
increased body weight and adiposity (Asarian and Geary, 2006, Clegg et al., 2006). 
Similarly, in women some studies report that menopause is associated with weight gain 
independent of age (Aloia et al., 1995).  
It is also important to note that menstrual cycle is associated with changes in food 
intake (Davidsen et al., 2007). Functional imaging research has shown that, in women, 
activation of brain reward system (midbrain, striatum, amygdala, OFC) is increased in the 
follicular phase compared to the luteal phase (Van Vugt, 2009; Frank et al., 2010). 
 Using [15O]H2O PET, Del Parigi and colleagues demonstrated that, in response to 
hunger, men tended to have greater resting activity in frontotemporal lobe than women 
(Del Parigi, 2002). In response to satiation (liquid meal), women tended to have greater 
activation in occipital and parietal sensory association areas and DLPFC than did the men; 
in contrast, the men tended to have greater activation in the ventromedial PFC than did 
the women.  
An fMRI study showed that gender predicts activation in brain reward centres after 
chocolate satiation (Smeets et al., 2006). In men, chocolate satiation was associated with 
increased activation in the ventral striatum, insula, and medial OFC and with decreased 
activation in somatosensory areas. Women showed increased activation in the precentral 
gyrus, superior temporal gyrus, and putamen and decreased activation in the 
hypothalamus and amygdala. Sex differences in the effect of chocolate satiation were 
found in the hypothalamus, ventral striatum, and medial PFC. A recent study showed that 
voluntary inhibition of hunger during food stimulation (smelling, viewing and tasting food) 
in men decreased activation in the amygdala, hippocampus, insula, OFC, and striatum, 
but not in women, using PET and 18FDG (Wang et al., 2009).  
Several fMRI studies have also found that women are more likely to be emotional 
eaters and have greater activation in brain reward centres such as the amygdala, OFC, 
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insula, ACC and hippocampus (Born et al. 2010, Koch et al., 2007, Bohon et al., 2009, 
Schienle et al., 2009). Interestingly, food cravings appear to be a rewarding experience in 
response to negative feelings in women, and men’s food craving appears to be more 
related to a positive mood (Lafay et al., 2001). Nevertheless, women are more interested 
in health and taste aspects of foods than are men (Roininen et al., 1999). 
 
 
1.5.5. Obesity (Table 1.6., 1.7.) 
In obese individuals, stimuli associated with high-incentive foods, such as those high in fat 
and energy density, may possess greater than normal potency for activating reward 
systems and, as a result, trigger excessive motivation for non-homeostatic eating 
(Berthoud, 2004). In obese subjects, but not in control subjects, dopamine D2 receptors 
abundance, is inversely correlated to BMI, suggesting the dopamine system is involved in 
compulsive food intake (Volkow and Wise, 2005). In humans, imaging studies show 
reduction in dopamine D2 receptors in the striatum of obese vs. non-obese individuals 
(Wang et al., 2001). When tasting or viewing food stimuli (food vs. non-food or high-
calorie vs. low-calorie food), activation of brain reward centres (DLPFC, medial and ventral 
PFC, hippocampus, insula, amygdala, medial and lateral OFC, NAc, dorsal striatum) is 
increased in obese subjects compared to lean subjects (Gautier et al., 2000; Gautier et 
al., 2001; DelParigi et al., 2004; DelParigi et al., 2005; Holsen et al., 2005; Stoeckel et 
al., 2008; Cornier, 2009; Martin et al., 2009; Stoeckel et al., 2009; Davids et al., 2010). 
BMI predicts activation in the OFC and insula when viewing high-calorie vs. neutral stimuli 
in obese compared to control individuals (Killgore and Yurgelun-Todd, 2005, Rothemund 
et al., 2007).  
Meanwhile other studies have shown decreased activation in the DLPFC in obese 
compared to lean men (Le et al., 2006, Le et al., 2007). Lean subjects also show greater 
activation in the hippocampus, ACC and insula compared to obese subjects (Cornier et al., 
2009; Martin et al., 2009; Davids et al., 2010). DLPFC, hippocampus and insula were 
found to be activated in both lean and obese subjects, and the ACC was only activated in 
 74 
lean individuals which might be explained by the executive function of the ACC. The 
discrepancy of these results could arise from using different methods (i.e. PET or fMRI) in 
each study, but also from different protocols and stimuli paradigms.  
 Previous fMRI research also revealed increased activation in the premotor area 
(involved in planning and motor behaviour) on visual and auditory stimuli of binge type 
foods in obese binge eaters (Geliebter et al., 2006). Another study showed that obese 
binge eaters have stronger medial OFC activation on viewing food vs. neutral pictures 
compared to normal weight and overweight controls, and normal weight patients with 
bulimia nervosa (Schienle et al., 2009).  
 
 
1.5.6. Psychological cues (Table 1.8.) 
Eating behaviour can be triggered by internal signals of energy homeostatis such as 
hunger and satiety. However, individual differences in reward sensitivity, dietary restraint, 
emotional and external eating sensitivity, impulsivity and mood can override internal 
signals of positive or negative energy balance. 
 
1.5.6.1. Reward sensitivity 
Obesity, food craving, overeating, binge eating and drug abuse are associated with 
increased levels of reward drive and sensitivity (Davis et al., 2004, Dawe and Loxton, 
2004, Schienle et al., 2009). Interestingly, individual differences in trait reward sensitivity 
measures have been linked to alcohol and drug use in healthy and clinical populations 
(Dawe and Loxton, 2004, Franken et al., 2006). The first connection between reward 
sensitivity and overeating was supplied by questionnaire studies (Franken and Muris, 
2005, Davis et al., 2007).  
Reward sensitivity can be measured by using different psychological 
questionnaires, such as the Behavioural Activation Scale (BAS) (Carver and White, 1994; 
Beaver et al., 2006) (Appendix 4). The BAS scale measures individual’s tendency to 
actively pursue reward. The BAS consists of three BAS questionnaires that measure 
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personality traits related to reward sensitivity. First, goal drive describes persistence in 
obtaining desired goals (e.g. “I go out of my way to get things I want”). Secondly, fun 
seeking describes willingness to seek out and spontaneously approach potentially 
rewarding experiences (e.g. “I'm always willing to try something new if I think it will be 
fun”). Thirdly, reward responsiveness measures anticipation and positive response 
towards reward (e.g. “When I get something I want, I feel excited and energized”). A 
number of functional imaging studies have analysed the correlation between individual 
differences in reward drive and neural responses to images of food. Healthy volunteers 
and binge eating disorder patients with hightened reward sensitivity and reward 
responsiveness showed increased activation in the ventral striatum, VTA, OFC, and ACC 
when viewing appetizing vs. bland food or food vs. non-food stimuli (Beaver et al., 2006; 
Geliebter et al., 2006; Schienle et al., 2009).  
 
1.5.6.2. Eating behaviour  
Identifying the neural pathways that regulate cognitive, emotional and appetitive 
responses to different foods is particularly relevant to understand individual differences in 
eating behaviour. Adult eating behaviour is strongly correlated with weight gain and BMI 
(Hays et al., 2002, Drapeau et al., 2003). Three recognized eating behaviour constructs 
are “dietary restraint”, “disinhibition or emotional eating”, and “external food sensitivity” 
which are commonly assessed by using psychometric questionnaires such as the Dutch 
Eating Behaviour Questionnaire (DEBQ) (Appendix 5) or the Three-Factor-Eating 
Questionnaire (TEFQ) (Stunkard and Messick, 1985, van Strien, 1986).  
 
Dietary restraint is a psychological trait that assesses cognitive self-control of food 
intake and conscious avoidance of consumption of fattening foods and weight gain (DEBQ 
restraint: e.g. “I deliberately eat foods that are slimming”, “I take into account my weight 
with what I eat”) (Wing and Hill, 2001). Dietary restraint is associated with healthier 
eating habits and long-term weight loss (Wing and Hill, 2001, Moreira et al., 2005, Savage 
et al., 2009). Psychological programs that emphasize dietary restraint appear to be more 
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effective interventions for preventing weight gain (Shaw et al., 2005). Altered neural 
activity in executive control and/or affective reward systems (dorsal PFC and OFC) to food 
stimuli has been reported in previously obese subjects who are successful dieters, and 
individuals concerned about the healthiness of food and exerting self-control (DelParigi et 
al., 2007; Hare et al., 2009; McCaffery et al., 2009). Activation in executive systems 
(ACC) has also been reported in patients recovered from compared to ongoing anorexia 
nervosa, where conflict between increased desire to eat and fear of weight gain would be 
hypothesized to be greater (Uher et al., 2003). 
 
Disinhibition or emotional eating is the tendency to overeat in response to different 
stimuli, and can occur in a variety of circumstances such as when an individual is 
presented with an array of palatable foods or is under emotional distress (DEBQ-
emotional: e.g. “Do you have a desire to eat when you are depressed or discouraged?”). 
Disinhibition or emotional eating has been associated with BMI or weight change (Hill et 
al., 1991, Lindroos et al., 1997, Hays et al., 2002, Drapeau et al., 2003, Provencher et al., 
2003). Recent fMRI studies showed that self-reported measures of disinhibition (as 
measured by the TFEQ) negatively correlated with executive self-control sytem activation 
(ACC) on viewing food vs. non-food pictures in obese, compared to healthy weight 
individuals (Martin et al., 2009). Bohon and colleagues demonstrated that female 
emotional eaters (as measured by the DEBQ) who underwent fMRI showed greater 
activation in the parahippocampal gyrus and ACC in response to anticipated receipt of 
milkshake compared to non-emotional eaters (Bohon et al., 2009). Thus, emotional eaters 
appear to have increased neural response to anticipatory and consumatory food reward, 
but this effect was only found in the negative mood state.  
 
External cues such as the sight of appetizing foods can also evoke a desire to eat, even in 
the absence of hunger. This external food sensitivity (as measured by the DEBQ-
external: e.g. “If food tastes good, I eat more than usual” or “If you walk past the baker I 
have the desire to buy something delicious”) varies across individuals, and high sensitivity 
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to external eating has been associated with increased risk of overeating, food craving and 
obesity when exposed to a food-rich environment (Braet and Van Strien, 1997, Horchner 
et al., 2002, Burton et al., 2007, Elfhag et al., 2007). An fMRI study by Passamonti and 
colleagues revealed that individuals with high external food sensitivity show altered brain 
connectivity to the sight of appetizing food (Passamonti et al., 2009). External food 
sensitivity (as measured by the DEBQ-external) correlated with changes in connectivity 
between brain regions implicated in motivational aspects of food processing and in 
emotional regulation (ventral striatum, amygdala, ACC) on viewing appetizing compared 
with bland foods. These results are particularly pertinent to recent concerns regarding the 
power of food advertisements to promote food intake and prefernces. 
  
1.5.6.2. Mood 
Fluctuations in emotions or mood can influence the human appetite (Macht, 1999) and 
food cravings correlate with emotional-related eating (Hill et al., 1991). Substantial 
individual differences exist in the level of activation of the affective valence system, which 
are related to an individual’s propensity to experience either positive or negative affect in 
response to emotionally relevant stimuli (Tomarken et al., 1992, Davidson, 2003). For 
example, since food and drugs can distract from emotional distress, negative emotions are 
major triggers for both eating and substance use (Macht, 1999). For example, craving 
intensity is positively correlated with a variety of negative mood states in self-described 
carbohydrate cravers (Christensen and Pettijohn, 2001). The Positive and Negative Affect 
Schedule (PANAS) measures the tendency to experience positive and negative affect 
(Watson et al., 1988, Killgore and Yurgelun-Todd, 2006) (Appendix 6). Research proposes 
that affect in the human brain is primarily controlled by the PFC (Davidson and Irwin, 
1999, Tataranni et al., 1999). Recent evidence suggests that these systems within the 
PFC may regulate both excitatory and inhibitory reactions to appetitive stimuli (Berthoud 
and Morrison, 2008). Using fMRI, one study demonstrated that when viewing high-calorie 
foods, positive affect (as measured by the PANAS) was associated with increased activity 
in the lateral OFC (Killgore and Yurgelun-Todd, 2006). However, when viewing low-calorie 
foods, positive affect was associated with increased activity in the medial OFC and the 
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insula. The opposite pattern was observed for negative affect. This suggests that mood-
dependent changes in appetite are directly associated with changes in brain reward 
activation. 
 
1.5.6.4. Impulsivity 
Impulsivity typically refers to behvaiour that incoperates a component of rashness, lack of 
foresight or planning or as a behaviour that occurs without reflection or carful 
deliberation. Impulsivity can be measured by using psychological questionnaires like the 
Barret Impulsivness Scale which describes a tendency to act rashly and without 
consideration of consequences and assesses frequency of impulsive-related behaviour or 
cognitions (Patton et al., 1995). The trait of impulsiveness may be another important 
individual difference variable in identifying those most vulnerable to overating and weight 
gain (Guerrieri et al., 2007, Lowe et al., 2009). A relationship between obesity and 
impulsivity has also been frequently described (Nederkoorn et al., 2006b, Lowe et al., 
2009). In a study by of obese children with and without binge eating, it was confirmed 
that the binge eaters were more impulsive on a reward based measure of this personality 
trait (Nederkoorn et al., 2006b). Several brain areas (ACC, PFC, OFC) have been 
described as associated with different types of impulsivity (Winstanley et al., 2004, 
Torregrossa et al., 2008). There is growthing evidence that different measures of 
impulsivity correlate with food intake and weight gain (Guerrieri et al., 2009, Nederkoorn 
et al., 2009). 
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Table 1.2. Human neuroimaging studies in non-obese FASTED POPULATIONS (classified by food stimulus).  
Author/ year Type Subjectsa 
(n, sex) 
BMI Food stimulus Nutritional 
state 
Brain reward activity (increased if not other indicated) 
Fuhrer et al. 2008 fMRI 12; male Non-obese Viewing food vs. non-food Fasted (14h) Left and right anterior OFC 
Holsen et al. 2005 fMRI 9; 4 male non-obese,  
Children  
Viewing food vs. non-food Fasted (4h) Medial and lateral OFC 
La Bar et al. 2001 fMRI 17; 9 male Non-obese, 
healthy 
Viewing food vs. non-food Fasted (8h) Amygdala 
Morris et al. 2001 H215O 
PET  
 
10; 9 male Non-obese Viewing food vs. non-food Fasted (16h) OFC, amygdale, insula 
Porubska et al. 
2006 
fMRI 12; 7 male Non-obese Viewing food vs. non-food Fasted (5h) Insula, OFC 
St-Onge et al. 2005 fMRI 12; 6 male Non-obese Food vs. non-food Fasted (12h) Cingulate gyrus, superior temporal gyrus, hippocampus, parahippocampal 
gyrus, insula 
Gordon et al. 2000 15O-
CO2 
PET 
8; female Non-obese, 
healthy 
Viewing High-calorie food vs. 
non-food 
Fasted overnight Decreased insula activation 
Killgore et al. 2003 fMRI 13, female None-obese Viwing high-and low-calorie and 
non-foods 
Fasted for 1.6-
6.8h) 
High-calorie foods: Frontal, temporal and occipital gyrus, amygdala, 
parahippocampus, thalamus, vmPFC, DLPFC, hypothalamus 
Low-calorie foods: Temporal and lingual gyrus, parahipocampus, OFC, 
amygdala, vmPFC 
Non-foods: Frontal and occipital gyrus 
High > Low:Frontal, temporal and occipital gyrus, thalamus 
Low > high: temporal, lingual and frontal gyrus 
Siep et al. 2009 fMRI 12; female Non-obese Viewing food (high-and low-
calorie) vs. non-food (objects) 
Fasted (18h) H>O: PCC, lateral and medial OFC, insula, caudate putamen, fusiforum 
gyrus 
L>O: medial and lateral OFC 
H>L: medial OFC, fusiforum gyrus 
Schur et al. 2009 fMRI 10; female Non-obese Viewing of food (fattening and 
non-fattening) vs. non-food 
Fasted (2-4h) Food > Objects: Hypothalamus, DLPFC, insula, putamen, ventral striatum, 
thalamus, occipital lobe 
Fatteneing > Objects: Hypothalamus, ventral striatum, thalamus, occipital 
lobe 
Objects > Fattening: Occipital lobe 
Frank et al. 2010 fMRI 12; 6 male Non-obese, men 
vs. women 
Viewing high- vs low-calorie 
foods  
Fasted (3h) High-calorie >  Low-calorie: OFC, insula 
Women > men: fusiforum gyrus when hungry 
Goldstone et al. 
2009 
fMRI 20; male Non-obese Viewing high-calorie vs. low-
calorie food 
Overnight fast 
(1.6h) 
Ventral striatum, amygdala, anterior insula, medial and lateral OFC 
Simmons et al. 
2005 
fMRI 9; 3 male Non-obese , 
healthy 
Viewing of appetizing food vs. 
non-food 
Fasted ? Appetizing > Objects: Insula, OFC, ACC, inferior temporal, fusiforum gyrus 
Objects > Appetizing: Fusiforum 
Passamonti et al.  
2009 
fMRI 21; 11 male Non-obese Viewing of appetizing or bland 
food 
Fasted (2h) Viewing appetizing > bland foods: 
vACC, DLPFC, frontal and temporal gyrus, pCC, ventral striatum, amygdala 
Beaver et al. 2006 fMRI 12; 5 males Non-obese Viewing appetizing, disgusting, 
bland foods and objects 
Fasted (2h) Appetizing > Objects: insula, DLPFC, OFC, Parahippocampus 
Appetizing > Disgusting: OFC, Parahippocampus, DLPFC 
Appetizing > Bland: ventral striatum, insula, parahippocampus, DLPFC 
Disgusting > Bland: OFC, ventral striatum, insula 
Disgusting > Appetizing: insula, OFC 
Disgusting > Objects: insula, OFC 
a Adult unless other indicated 
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Table 1.2. (CONTINUED). Human neuroimaging studies in non-obese FASTED POPULATIONS (classified by food stimulus).  
Author/ year Type Subjectsa 
(n, sex) 
BMI Food stimulus Nutritional 
state 
Brain reward activity (increased if not other indicated) 
Uher et al. 2006 fMRI 18; 8 male Non-obese men 
and women 
Viewing food vs. non-food, and 
tasting chocolate and chicken 
Overnight fast 
(23h) 
Food > Non food: 
Fusiforum gyrus, insula 
Tasting chocolate: 
Hippocampus, precentral sulcus and caudate 
Taste chicken: 
Hypothalamus, thalamus, insula, frontal gyrus, precentral sulcus 
Fasting > Fed: 
Visula foods: None; taste chocolate: DLPFC; taste chicken: mPFC 
Gender: Insula (stronger in women) for visual food stimul 
Hinton et a. 2004 H215O 
PET  
12; male Non-obese Imagining of restaurant menu 
(high and low-incentive foods) 
Fasted (18h) and 
Fed comined 
All food categories combined: Amygdala and OFC 
Piech et al. 2009 fMRI 8; 5 male Non-obese Imagining + choosing written 
food items from restaurant 
menu (high and low attractive) 
Fasted (6h) Fasted (Food > Non-food): Thalamus, Insula, lateral PFC,  
Fasted and Fed combined H>L: Amygdala 
O’Doherty et al. 
2000 
fMRI No info 
given 
Non-obese Food-related odours (banana) Fasted (?) OFC (Olfactory sensory-specific satiety) 
Gottfried et al. 
2003 
fMRI 14; gender? Non-obese Visual stimuli before + after 
odor stimui (Vanilla) 
Fasted (6h) After odor: amygdala, OFC 
Wang et al. 2004 PET+ 
18FDG  
 
12; 5 male Non-obese Viewing, smelling and tasting 
food vs. non-food 
Fasted (17-19h) Food > Non-food: Postcentral gyrus, superior temporal cortex, insula, OFC 
 
Koch et al 2007 fMRI 40; 21 male Non-obese, 
women vs. men 
Positive or negative olfactory 
stimuli 
? Negative olfactory stimuli in women > men: Insula, frontal and temporal 
gyrus. 
Wang et al. 2009 PET+ 
18FDG 
23; 10 men Non-obese , men 
vs. women 
Viewing, smelling and tasting 
food with cognitive inhibition 
task 
Overnight fast 
(17-19h) 
When cognitive inhibition in men (not women):  decreased amygdala, 
hippocampus, insula, OFC, striatum Æ inhibition correlated with decreased 
self-reports of hunger 
Grabenhorst et al. 
2010 
fMRI 12; 9 male Non-obese Tasting pleasant vanilla drink + 
unpleasant strawberry drink 
Fasted (3h) Ventral PFC correlates with subjective pleasantness ratings 
Haase et al. 2009  18; 9 male Non-obese Tasting caffeine, citric acid, 
GMP, saccharin, sucrose, NaCl 
Fasted (12h) For all tastes: Hunger: increased insula, thalamus, and substantia nigra 
Satiety: decreased parahippocampus, hippocampus, amygdala, ACC, 
Activation varies when tasting sucrose only 
Rolls et al. 2007 fMRI 16; female Non-obese 
cravers vs. non 
cravers 
Taste and sight of chocolate Fasted  Sight chocolate in cravers > non-cravers: medial OFC, ventral striatum; 
sight+taste in cravers > non-cravers: medial OFC, pregenual cingulated 
cortex 
Cravers > non-cravers: Positive correlation of pleasantness ratings of 
chocolate with activation in the pregenual cingulated cortex and medial 
orbitofrontal cortex 
Small et al. 2001 H215O 
PET  
 
9; 4 male Non-obese, 
chocolate lovers 
vs. non-lovers 
Tasting chocolate Fasted (3-4h) Insula, medial OFC, striatum 
Bender et al. 2009 fMRI 15; 6 male Non-obese Tasting sweet, sour, salty or 
tasteless solution 
Fasted ? Taste vs tasteless: Insula and operculum  
Del Parigi et al. 
2002 
H215 O 
PET  
 Non-obese, men 
vs women 
Tasting liquid meal Fasted (36h) 
before tasting 
Hunger: men > women: DLPFC, middle tempiral gyrus, posterior cingulated 
and parahippocampal gryus 
a Adult unless other indicated 
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Table 1.3. Human neuroimaging studies in non-obese FED POPULATIONS (classified by food stimulus).  
Author/ year Type Subjectsa 
(n, sex) 
BMI Food stimulus Nutritional state Brain reward activity 
Fuhrer et al. 2008 fMRI 12; male Non-obese Viewing food vs. non-food Fed (1h) Parietal lobe, posterior middle temporal gyrus 
Holsen et al. 2005 fMRI 9; 4 male non-obese,  
Children  
Viewing food vs. non-food Fed None 
La Bar et al. 2001 fMRI 17; 9 male Non-obese, healthy Viewing food vs. non-food Fed  None 
Morris et al. 2001 H215O 
PET  
 
10; 9 male Non-obese Viewing food and non-food Fed during scanning Reduced insula activation 
Siep et al. 2009 fMRI 12; female Non-obese Viewing food (high-and low-
calorie) vs. non-food 
(objects) 
Fed (lunch) L>O: PCC, lateral and medial OFC, insula, caudate putamen, fusiforum 
gyrus 
L>H: PCC, medial and lateral OFC 
Frank et al. 2010 fMRI 12; 6 male Non-obese, men 
vs. women 
Viewing high- vs low-calorie 
foods 
Fed None 
Goldstone et al. 2009 fMRI 20; male Non-obese Viewing high-calorie vs. low-
calorie food 
Fed None 
Piech et al. 2009 fMRI 8; 5 male Non-obese Imagining + choosing written 
food items from restaurant 
menu (high and low 
attractive) 
Fed Food > Non-food: Caudate, lateral PFC 
Kringelbach et al. 
2003 
fMRI 10; male Non-obese Tasting food vs neutral 
solution 
Fed with solution Pleasantness ratings correlated negatively with activation in the OFC 
(sensory specific satiety)  
Haase et al. 2009  18; 9 male Non-obese Tasting caffeine, citric acid, 
GMP, saccharin, sucrose, 
NaCl 
Fed For all tastes: (Satiety) decreased parahippocampus, hippocampus, 
amygdala, ACC, Activation varies when tasting sucrose only 
Small et al. 2001 H215O 
PET  
 
9; 4 male Non-obese, 
chocolate lovers vs. 
non-lovers 
Tasting chocolate Fed (3-4h) Parahippocampus gyrus, lateral OFC, PFC (sensory-specific satiety) 
Smeets et al. 2006 fMRI 24; 12 male None-obese men 
vs. women 
Tasting chocolate milk Fed (Senosry-specific 
satiety)  
Men: increased in ventral striatum, insula, and medial OFC and 
decreased somatosensory areas 
Women: increased in precentral gyrus, superior temporal gyrus, and 
putamen and decreased in hypothalamus and amygdala 
Men vs women: hypothalamus, ventral striatum, and medial PFC 
Smeets et al. 2010 fMRI 10; male None-obese, 
healthy 
Tasting of orangeade  Fed (caloric or non-
caloric orangeade) 
Amygdala more activated by non-caloric vs. caloric orangeade; Striatum 
more activated by caloric vs. non-caloric orangeade 
Del Parigi et al. 2002 H215O 
PET  
 Non-obese, men vs 
women 
Tasting liquid meal Fed after liquid meal Satiety women > men: DLPFC, precuneus 
Satiety men > women: ventromedial PFC 
a Adult unless other indicated 
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Table 1.4. Human neuroimaging studies in non-obese FASTED > FED POPULATIONS (classified by food stimulus).  
Author/ year Type Subjectsa 
(n, sex) 
BMI Food stimulus Nutritional state Brain reward activity 
Fuhrer et al. 2008 fMRI 12; male Non-obese Viewing food vs. non-food Fasted > Fed Amygdala, ACC 
Holsen et al. 2005 fMRI 9; 4 male non-obese,  
Children  
Viewing food vs. non-food Fasted > Fed Amygdala, medial and lateral OFC, medial frontal cortex, basal 
operculum/insula, parahippocampal gyrus, cingulate and fusiform gyrus 
La Bar et al. 2001 fMRI 17; 9 male Non-obese, healthy Viewing food vs. non-food Fasted > Fed Parahippocampal gyrus, anterior fusiform gyrus 
Hinton et a. 2004 H215O 
PET  
12; male Non-obese Imagining of restaurant menu 
(high and low-incentive 
foods) 
Fasted (18h) and Fed  All fod categories combined: hypothalamus, amygdala, insula 
High > Low incentive: OFC 
a Adult unless other indicated 
 
Table 1.5. Human neuroimaging studies in non-obese FED > FASTED POPULATIONS (classified by food stimulus).  
Author/ year Type Subjectsa 
(n, sex) 
BMI Food stimulus Nutritional state Brain reward activity (increased if not other indicated) 
La Bar et al. 2001 fMRI 17; 9 male Non-obese, healthy Viewing food vs. non-food Fed v> Fasted None 
Hinton et a. 2004 H215O 
PET  
12; male Non-obese Imagining of restaurant menu 
(high and low-incentive 
foods) 
Fasted (18h) and Fed  All fod categories combined: OFC 
a Adult unless other indicated 
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Table 1.6. Human functional neuroimaging studies in non-obese vs. obese (FASTED AND FED) populations (classified by food stimulus).  
Author/ 
year 
Type Subjectsa (n, sex) BMI Food stimulus Nutritional 
state 
Brain reward activity (increased if not other indicated) 
Davids et al. 
2009 
fMRI 22 obese; 7 male 
22 NW*; 10 male 
Obese vs. non-
obese children 
Viewing food pictures Fasted (2h) Obese > NW: DLPFC 
Nw > Obese: Fusiforum gyrus, ACC, caudate, hippocampus, 
parahippocampus gyrus, thalamus 
Martin et al. 
2009 
fMRI 10 in each group, 5 
male in each group 
Obese vs. lean Viewing of food vs. non-food Fasted (4h) 
Fed 
(500kcal) 
Fasted: 
Obese > lean: mPFC, frontal gryus, ACC, fusiforum gyrus,  
Lean > Obese: Temporal gryus 
Fed: 
Obese > Lean: mPFC, frontal + temporal gyrus, hippocampus, 
precuneus 
Lean > Obese: None 
Geliebter  et 
al. 2006 
fMRI 10 in each group; 
female 
Obese and lean, 
binge eaters vs. 
non-binge reaters 
Viewing binge eating and none 
binge eating foods and non-
foods 
Fasted (3h) Viewing binge eating foods: 
Obese binge eaters: ventral premotor cortex, precentral gyrus, frontal 
and fusiforum gyrus, lingual gyrus 
Obese non-bingers: None 
Lean bingers: None 
Lean non-bingers: occipital gyrus and lingual gyrus 
Viewing none-binge eating foods: 
Obese binge eaters: fusiforum and frontal gyrus 
Obese non-bingers: None 
Lean bingers: None 
Lean non-bingers: occipital, lingual and temporal gyrus 
Non-food stimuli: None 
Rothemund 
et al. 2007 
fMRI 13 obese, 13 lean; 
female 
Obese vs. Non-
obese 
Viewing food pictures (high-
calorie and low-calorie) 
Fasted (3-
4h) 
BMI correlated with activation in putamen, caudate, insula, cingulate 
cortex, pallidum, lateral OFC 
Obese > control 
HC: putamen, caudate, insula, hippocampus 
LC: Frontal and temporal gyrus 
Objects: Frontal gyrus and parietal lobe 
H>L: Putamen 
Control > Obese:  
HC and LC: None 
Objects: Caudate 
Stice et al. 
2009 
fMRI 33; female* Obese vs. Non-
obese adolescents  
Anticipation and tasting of 
milkshake and tastless solution  
Fasted (4-
6h) 
Obese > lean: Anticipation and tasting of milkshake > tasteless: insula 
increased, caudate decreased 
Stoeckel et 
al. 2008 
fMRI 12 obese, 12 lean; 
female 
Obese vs. lean Viewing high-calorie +low-
calorie food and objects 
Fasted (8-
9h) 
Obese  > controls: 
H>O: Medial/ lateral OFC, amygdala, ventral striatum, mPFC insula, 
ACC, hippocampus 
L>O: Putamen, caudate 
Controls >  obese: 
H>O: mPFC 
L>O: lateral OFC, mPFC, ACC 
Stoeckel et 
al. 2009 
fMRI 12 obese + 12 NW*; 
female 
Obese vs. lean Viewing of food (high-vs low-
calorie) vs. non-food 
Fasted (8-
9h) 
Obese > non-obese for all food categories: 
Reduced connectivity from amygdala to OFC and NAc; 
Increased connectivity from OFC  to NAc  
Controls but not obese: 
Greater connectivity between amygdala and OFC when viewing high-
calorie foods 
a Adult unless other indicated, *normal weight 
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Table 1.6. (CONTINUED). Human functional neuroimaging studies in non-obese vs. obese (FASTED AND FED) populations (classified by food 
stimulus).  
Author/ 
year 
Type Subjectsa (n, sex) BMI Food stimulus Nutritional 
state 
Brain reward activity (increased if not other indicated) 
Schienle et 
al. 2008 
fMRI 67; female Overweight bingers 
(BED), bulemics 
and overweight and 
lean controls 
Viewing high-caloric, distgust-
inducing and non-foods 
? Food > Non-food  
All groups: Occipital, ACC, OFC, insula 
BED > Bulemics: lateral and medial OFC 
BED > overweight/ lean: medial OFC 
Bulemics > BED/ overweight/lean: insula, ACC 
Disgusting > Non-food: 
All groups: amygdala, insula, lateral OFC 
Bulemics > overweight controls: insula 
Lean > BED: insula and lateral OFC 
Killgore et al. 
2005 
fMRI 13; female Non-obese Viewing low-calorie, high-calorie 
and non-food 
? High-calorie: BMI negatively related with ACC, OFC; Low-calorie: BMI 
negatively related with OFC; Non-food: BMI positively related with OFC 
McCaffery et 
al. 2009 
fMRI ~17 in each group, ~ 2 
male in each group 
Obese, weightloss 
maintainers (SWLs) 
vs. normal weight 
Viewing food pictures (high and 
low-calorie) and non-foods 
Fasted for 
4h 
High-and low calorie foods > non-foods: 
SWLs > NW/ obese: frontal and temporal regions  
Obese > SWLs, NW: precentral gyrus 
Viewing high-calorie foods only: 
NW > Obese: Frontal gyrus, precuneus 
NW > SWLs: cingulate gyrus 
SWLs > Obese: occipital, lingual, frontal gyrus, pre- and postcentral, 
insula, cuneus 
Obese > SWLs: ACC 
Del Parigi et 
al. 2004 
H215O 
PET  
 
23 obese; 11 male 
11 postobese; 3 male; 
21NW*; 11 male 
Post-obese, obese, 
lean 
Tasting liquid meal after 36h 
fast 
Fed Obese and postobese: greater insula + lower hippocampus;  
Obese > lean: insula, amygdala, posterior CC, hippocampus 
Del Parigi et 
al. 2005 
H215O 
PET  
21 obese; 10 male 
20 lean; 10 male 
Obese vs. lean Tasting liquid meal Fasted 
(36h) 
Obese > Lean: 
Increase: insula, midbrain 
Decrease: OFC, posterior cingulate gyrus and temporal gyrus 
Lean > Obese: 
None 
Gautier et al. 
2000 
H215O 
PET  
11 obese, 11lean; male Obese vs lean, men Taste of liquid after fasting Fed Satiation in both obese and lean:  
Increase in vmPFC and DLPFC and decrease in striatum, hippocamous, 
temporal lobe, precuneus;  
Satiation in obese > lean: 
In crease in PFC, hypothamaus and thalamus 
Gautier et al. 
2001 
H215O 
PET  
12 obese, 10 lean; 
female 
Obese vs lean, 
women 
Taste of liquid after fasting Fed Lean and obese: 
Increase PFC and decreased thalamus, insula, parahippocampus and 
temporal cortex 
Obese only: 
Decreased hypopthalamus, cingulate, ventral striatum and amygdala 
Obese > lean: 
Increased ventral PFC and decreased frontal and temporal cortex 
Le et al. 
2006 
PET  
 
9 obese, 9 lean; male Obese vs. Non-
obese 
Tasting liquid meal after fasting Fed Obese > Lean: Less DLPFC activation 
Le et al. 
2007 
PET  
 
9 obese, 10 lean, 8 
postobese; female 
Lean, obese and 
postobese 
Tasting liquid meal after fasting Fed Obese > lean and post-obese: less DLPFC 
a Adult unless other indicated, *normal weight 
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Table 1.7. Human functional neuroimaging studies with experimental hormonal or dietary manipulation (classified by hormone).  
Author/ 
year 
Type Subjectsa (n, sex) Manipulation and BMI Food stimulus Nutritional 
state 
Brain reward activity (increased if not other indicated) 
Baicy et al. 
2007 
fMRI 3 ; gender ? Leptin-deficient subjects; 
Leptin supplementation 
Viewing of food (high and 
low-calorie) vs. non-food 
Fed (3h) Leptin supplementation: 
Decreased: insula, parietal and temporal cortex 
Increased: PFC 
Farroqui et 
al. 2007 
fMRI 1 male, 1 female Leptin-deficient subjects, 
before + 7 days after leptin 
treatment 
Viewing food vs. non-food Fasted 
Fed 
Leptin-deficient state > leptin-repleaced state: ventral striatum 
Leptin-deficient state: Positive correalation of Food Liking Ratings and 
activation in the ventral striatum when fasted and fed 
Leptin-replaced state: Positive correalation of Food Liking Ratings and 
activation in the ventral striatum only when fasted 
Rosenbaum 
et al. 2008 
fMRI 6; 2 male Obese > 10% weight loss; 
Leptin > saline injection after 
weight loss 
Viewing of food vs. non-food ? Weight loss > Weight Baseline: 
Frontal and temporal gryus, parahippocampus gyrus 
Weight Baseline > Weight loss: 
Amygdala, ACC, CC, fusiforum gyrus, hypothalamus, frontal grysu, 
parahippocampal gryus 
Weight loss leptin > Weight Baseline placebo: 
CC, hypothalamus, frontal gyrus, temporal gyrus, putamen, 
precuneus, thalamus 
Weight Baseline placebo >Weight loss leptin: 
Frontal gyrus, insula, parahippocampal gyrus, precuneus 
Batterham et 
al. 2007 
fMRI 8; male Non-obese, PYY and Saline 
infusion 
Viewing of food vs. non-food Overnight 
fast 
PYY infusion:  
increased activation in VTA , insula, ACC and OFC 
Correlation analysis: 
After PYY infusion OFC predicts food intake at lunch; After Saline 
infusion hypothalamus predicts food intake at lunch 
Malik et al. 
2008 
fMRI 20 ; male Non-obese, Ghrelin iv. 
infusion 
Viewing food vs. scenery  Fasted (3h) Amygdala, OFC, anterior insula 
Effect of ghrelin on the amygdala and OFC response correlated 
with self-rated hunger ratings 
Cornier et al. 
2007 
fMRI 25; 1 men Eucaloric diet (2 days) and 
30% overfeeding (2 days) 
Viewing foods (high (H) and 
neutral (N) hedonic value) 
and non-foods (NF) 
Fasted 
overnight 
Eucaloric diet: 
N>NF: Insula and DLPFC 
H>N: Hypothalamus, hippocampus and parietal lobe 
Overfeeding: 
H>N: Decreased hypothalamus 
Eucaloric diet > Overfeeding: 
H>N: Hypothalamus; N>NF: None 
Cornier et al. 
2009 
fMRI 22 thin; 12 male 
19 reduced weight; 
9 male 
Thin vs reduced obese, 
eucaloric or 30% overfeeding 
diet 
Viewing high-calorie food, 
neutral food and non-food  
Overnight 
fast 
Lean: 
Eucaloric: HC > non-food Æ insula, OFC, ventral striatum, 
hippocampus 
Eucaloric >Overfeeding: HC  >non-food Ædecrease insula and 
hypothalamus 
Overfeeding > Eucaloric: None 
Reduced Obese: 
Eucaloric >Overfeeding: high-calorie > non-food: None 
Reduced Obese > Thin: 
Eucaloric: High-calorie > non-food: Only visual cortex 
Thin > Reduced Obese: 
Eucaloric: High-calorie > non-food: None 
Eucaloric >Overfeeding: High-calorie food >non-food Ædecrease in 
visual cortex, insula and hypothalamus 
a Adult unless other indicated 
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Table 1.8. Human functional neuroimaging studies with individual differences in psychological traits (classified by co-variable).  
Author/ 
year 
Type Subjectsa (n, 
sex) 
BMI Food stimulus Nutritional 
state 
Co-variable Brain reward activity (increased if not other indicated) 
Born et al. 
2009 
fMRI 9; females Non-obese,  Visual food stimuli Fasted and 
Fed 
Stressed vs. 
rest 
When Fasted and stressed: Redcued amygdala, hippocamous and 
ACC activation 
When Fed and stressed: Reduced Putamen activation 
Calder et al. 
2007 
fMRI 12; 5 male Non-obese Viewing disgusting, 
appetizing + bland foods 
Fasted ? Disgust 
sensitivity 
questionnaire 
Correlation with disgust sensitivity questionnaire: 
Disgusting > Non-food: insula, ventral pallidum 
Disgusting > Bland: ventral pallidum 
Disgusting > Appetizing: insula, pre-and postcentral gyrus 
Martin et al. 
2009 
fMRI 10 in each 
group, 5 male 
in each group 
Obese vs. lean Viewing of food vs. non-
food 
Fasted (4h) 
Fed 
(500kcal) 
TEFQ - 
disinhibition 
Fasted: 
Obese > lean: mPFC, frontal gryus, ACC, fusiforum gyrus,  
Lean > Obese: Temporal gryus 
Fed: 
Obese > Lean: mPFC, frontal + temporal gyrus, hippocampus, 
precuneus 
Lean > Obese: None 
Correlations with questionnaire scoers: 
disinhibition correlated negatively with ACC 
Del Parigi et 
al. 2005 
H215O 
PET  
21 obese; 10 
male 
20 lean; 10 
male 
Obese vs. lean Tasting liquid meal Fasted 
(36h) 
TEFQ -
disinhibition 
Obese > Lean: 
Increase: insula, midbrain 
Decrease: OFC, posterior cingulate gyrus and temporal gyrus 
Correlations: TEFQ correlates with insula 
Lean > Obese: 
None 
Del Parigi et 
al. 2007 
H215O 
PET 
9 dieters, 20 
non-dieters; 
female 
Sucessful dieters 
(non-obese) vs. non-
dieters (obese) 
Resting scan or after 
tasting meal or solution 
Overnight 
fast, Fed 
TEFQ - 
restraint 
Solution > Fasted:Dieters > non-dieters Æ none 
                           Non-dieters > Dieters Æ Hippocampus 
Meal > Fasted: Dieters > non-dieters Æ DLPC, dorsal striatum,  
                       Non dieters > Dieters ÆOFC 
                       Correlations: Restraint positively coorelated with     
                       DPFC and negatively correlated with OFC 
Bohon et al. 
2009 
fMRI 21; female Non-obese, emotional 
vs. non-emotional 
eaters 
taste of chocolate milk vs. 
tasteless solution, and 
anticipated receipt of 
milkshake 
Fasted 4-6h DEBQ – 
emotional, 
PANAS: 
 
Negative > neutral mood: 
Anticipated receipt of milkshake: 
Emotional eaters Æ Parahippocampal gyrus, ACC 
Non-emotional eaters Æ all ROIs decreased 
Receipt of milkshake: 
Emotional eaters Æ ACC, pallidum, thalamus 
Passamonti 
et al.  2009 
fMRI 21; 11 male Non-obese Viewing of appetizing or 
bland food 
Fasted (2h) DEBQ - 
external  
Viewing appetizing > bland foods: 
vACC, DLPFC, frontal pole, temporal gyrus, pCC, ventral striatum, 
amygdala 
Correleations when vieing appetizing > bland foods: 
External food sensitivity correlates with ventral striatum, amygdala, 
and ACC 
a Adult unless other indicated 
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Table 1.8. (CONTINUED). Human functional neuroimaging studies with individual differences in psychological traits (classified by co-
variable).  
Author/ 
year 
Type Subjectsa (n, 
sex) 
BMI Food stimulus Nutritional 
state 
Co-variable Brain reward activity (Increased if not other indicated) 
Beaver et al. 
2006 
fMRI 12; 5 males Non-obese Viewing appetizing, 
disgusting + bland food 
Fasted (2h) BAS – reward 
sensitivity 
Appetizing > Objects: insula, DLPFC, OFC, Parahippocampus 
Appetizing > Disgusting: OFC, Parahippocampus, DLPFC 
Appetizing > Bland: ventral striatum, insula, parahippocampus, 
DLPFC 
Disgusting > Bland: OFC, ventral striatum, insula 
Disgusting > Appetizing: insula, OFC 
Disgusting > Objects: insula, OFC 
Correleations: 
Correlates for appetizing food > bland foods/ non-foods s in ventral 
striatum, OFC, amygdala + midbrain (VTA), ventral pallidum 
Schienle et 
al. 2008 
fMRI 67; female Overweight bingers 
(BED), bulemics and 
overweight and lean 
controls 
Viewing high-caloric, 
distgust-inducing and non-
foods 
? BAS/ BIS 
without 
subscales, 
BED scales 
Food > Non-food  
All groups: Occipital, ACC, OFC, insula 
BED > Bulemics: lateral and medial OFC 
BED > overweight/ lean: medial OFC 
Bulemics > BED/ overweight/lean: insula, ACC 
Correleations with reward sensitivity: 
BED: ACC and medial OFC 
Bulemics: ACC, medial OFC, insula  
Correlations with BED: 
Insula 
Disgusting > Non-food: 
All groups: amygdala, insula, lateral OFC 
Bulemics > overweight controls: insula 
Lean > BED: insula and lateral OFC 
Killgore et.al. 
2006 
fMRI 13; female Non-obese Viewing of high-calorie and 
low-calorie 
? PANAS - mood Viewing high-calorie foods: 
Positive affect: lateral OFC 
Negative affect: medial OFC, ACC and insula 
Viewing low-calorie foods: 
Positive affect: medial OFC, insula 
Negative affect: lateral and medial OFC, and insula 
Uher et al. 
2004 
fMRI 19; female Healthy, anorexic and 
bulimic pateints (ED) 
Viewing food and non-food Fasted min. 
3h 
? Food > Non-food: 
ED > Healthy: vmPFC 
Healthy > ED:DLPFC 
Annorexia > Healthy: vmPFC 
Healthy > Annorexia: Parietal lobe 
Bulemic > Healthy: vmPFC 
Healthy > Bulemic: DLPFC 
Annorexia > Bulemic: PFC 
Bulemic > Annorexia: None 
Hare et al. 
2009 
fMRI 18 self-
controllers, 19 
non-self-
controlers 
Self-controllers vs. 
non self-controllers 
Choosing tasty vs. healthy 
foods 
? ? Self-controllers when choosing tasty > healthy foods: vmPFC, DLPFC 
a Adult unless other indicated 
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1.6. Summary introduction 
Evidence is accumulating that brain reward systems can interact with peripheral and 
central appetite signals that encode energy balance. Functional neuroimaging studies have 
established that brain activity, as measured by BOLD fMRI or PET, is increased in reward 
systems in response to imagining, smelling, tasting and viewing food cues. Differences are 
seen under fed or fasted (nutritional state) conditions in normal weight and obese 
subjects that provide new insights into the control of ingestive behaviour. Altered activity 
in reward systems is also associated with gender and individual differences in eating 
behaviours. Primarily pre-clinical studies have demonstrated that circulating insulin, leptin 
and PYY are able to inhibit and ghrelin to stimulate dopamine signaling in reward systems 
and thus influence the subjective reward value of food and hence motivation to eat. 
However, it is still unclear how nutritional state, circulating hormones and different food 
stimuli interact in humans (Van Vugt, 2009).  
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1.7. Hypotheses of thesis 
 
1.7.1. Fed-fasted fMRI study 
• Fasting biases brain reward systems towards high-calorie foods in humans. 
• Individual differences in eating behaviour and reward sensitivity alter the response 
of brain reward systems to high-calorie foods. 
 
1.7.2. Ghrelin fMRI study 
• The bias in brain reward systems to high-calorie foods when fasted is mediated by 
increases in circulating ghrelin. 
 
 
1.8. Aims of thesis 
 
1.8.1. Fed-fasted fMRI study 
• To investigate the interaction between nutritional state (fasted or fed) and caloric 
value of food stimuli on the appeal of food and on activity within brain reward 
systems using fMRI in healthy non-obese adults. 
• To investigate whether individual differences in activation in brain reward systems 
to different food stimuli when fasted are influenced by individual differences in 
eating behavior and reward sensitivity.  
 
1.8.2. Ghrelin fMRI study 
• To investigate whether ghrelin administration to fed healthy non-obese adults 
mimics the effect of fasting to bias brain reward system to high-calorie foods. 
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Chapter 2 
MATERIALS AND METHODS 
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2.1. Fed – fasted fMRI study 
 
2.1.1. Participants 
Twenty-five subjects (mainly PhD student working in the department) were recruited by 
word-of mouth at the Robert Steiner MRI Unit, Hammersmith Hospital, London. To avoid 
confounding factors and contraindications among participants in their response to 
experimental stimuli, individuals were excluded based on the following criteria: a) a 
positive eating disorder history by SCOFF questionnaire (Appendix 3) (Morgan et al., 
1999; Van Vugt, 2009; Born et al., 2010)), b) food preferences that were inconsistent 
with our food images e.g. vegetarian, vegan, gluten or lactose intolerant, d) recent 
change in weight (>5% change in the preceeding 3 months), e) smoking, f) left-
handedness, g) claustrophobia, h) pregnancy or breastfeeding, i) neurological or 
psychiatric history, j) use of street drugs, k) any metallic objects in subject’s body 
excluding MRI, e.g. pacemaker. Twenty healthy, non-obese volunteers with normal or 
corrected to normal vision completed the study (10 male, 10 female, mean ± SEM age 26 
± 1 years, range 19-35; body mass index (BMI) 22.1 ± 0.5 kg/m2, range 18.2-27.1, with 
only one subject having BMI>24.9). 
 The protocol was approved by the Local Research Ethics Committee (ethics 
number: 06/Q0406/18), and was performed in accordance with the principles of the 
Declaration of Helsinki. All participants provided written informed consent. 
 
 
2.1.2. Protocol 
Subjects were scanned after an overnight fast (15.9 ± 0.3h since supper) and avoided 
alcohol and vigorous exercise the day before and day of the study. They were told to eat 
their normal meals the day before the study but eat or drink nothing after supper other 
than water. On the day of the study, subjects were asked to continue fasting or eat a 
filling breakfast of their choice and keep a detailed food diary including saving of food 
packaging. Breakfast calorie content and macronutrient composition was determined using 
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standard dietary calculators in DietPlan6 (Forestfield Software Ltd, West Sussex, UK). 
Breakfast intake (mean ± SEM) was 724 ± 59 kCal (47 ± 4% of estimated resting energy 
expenditure using Schofield equation (Schofield, 1985) (age, weight-adjusted): RMR 
(kcal/24hrs) = 239 x ((0.062 x weight (kg) + 2.036), if age 18-29, RMR (kcal/24hrs) = 
239 x ((0.034 x weight (kg) + 3.538), if age 30-59, with macronutrient content: 51 ± 4% 
carbohydrate, 33 ± 3% fat, 15 ± 1% protein.  
 
Before and after scanning, volunteers completed 10cm visual analogue scales of appetite 
(VAS) containing the questions: “How hungry do you feel right now?” (hunger), “How full 
do you feel right now?” (full), “How pleasant would it be to eat right now?” 
(pleasantness), “How sick do you feel right now?” (nausea) and “How much do you think 
you could eat right now?” (volume able to eat) (Flint et al., 2000) (Appendix 10). VAS 
rating scores for before and after fMRI scanning were averaged for each subject to allow 
for changes in ratings over the period of the scanning session. Subject’s height and weight 
were also recorded.  
 
 
2.1.2.1. Questionnaires 
Subjects completed the Dutch Eating Behaviour Questionnaire (DEBQ) to measure eating 
restraint or extent of dieting regime (DEBQ-restraint; e.g. “I do deliberately eat less in 
order not to become heavier”), and external influences on eating behaviour (DEBQ-
external; e.g. “If I walk pass the bakery I have the desire to buy something delicious”) 
(van Strien, 1986) (Appendix 5). In addition, participants completed the Behavioural 
Activation / Behavioural Inhibition Scales (BAS/BIS). This questionnaire consists of three 
BAS scales that measure personality traits related to rewards sensitivity (goal drive, fun 
seeking and reward responsiveness) and one BIS scale related to responsiveness to 
punishment cues (Carver and White, 1994) (Appendix 4).  
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2.1.3. MRI scanning protocol 
In the MRI scanner subjects wore ear plugs and head phones to block of the hammering 
noise of the MRI scanner, had a keypad in right hand to rate fMRI pictures (see in detail 
below), and an alarm buzzer in left hand, while their head was padded with foam to avoid 
excessive head movement. 
 At the beginning of each scanning session, the patient tested that each button on 
the keypad worked and practiced rating the appeal of test animal and blurred pictures for 
about 2 minutes. 
Following this, four types of colour photographs were presented in a block design: 
(1) 54 high-calorie foods (e.g. burgers, cakes and chocolate), (2) 54 low-calorie foods 
(e.g. salads, fruits and vegetables, fish), (3) 54 non-food related household objects (e.g. 
furniture, clothing, electrical equipment) and (4) 192 Gaussian blurred images of the high-
calorie foods, low-calorie foods and object pictures (Figure 2.1.). Pictures were obtained 
from freely available websites and the International Affective Picture System (IAPS, NIMH 
Center for the Study of Emotion and Attention, University of Florida, Gainesville, FL, USA). 
Food and object pictures were of similar luminosity and resolution.  
 Food images were selected to represent familiar foods which are typical to the 
modern Western diet. The total caloric load, caloric density and macronutrient composition 
of the foods were determined using standard dietary calculators in DietPlan6 (Forestfield 
Software Ltd, West Sussex, UK) and are as follows - high calorie foods: 855 ± 108 kCal, 
317 ± 14 kCal/100g, 42 ± 1 % fat, 48 ± 2 % carbohydrate, 10 ± 1 % protein; low-calorie 
foods: 274 ± 33 kCal, 87 ± 9 kCal/100g, 35 ± 3 % fat, 43 ± 4 % carbohydrate, 23 ± 3 % 
protein; high-calorie vs. low-calorie foods: P<0.001 for energy content, density and % 
protein; P=0.03 for % fat; but not for % carbohydrate (P=0.14). 
 Pictures of non-food household objects and blurred pictures were included as non-
specific control stimuli in order to examine the effect of nutritional state (fed or fasted) on 
brain activation during other non-food related tasks. 
 Photographs were presented in 18 second blocks in a single run lasting 
approximately 17 minutes. Each block contained 6 different images from the same 
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category (high-calorie foods, low-calorie foods, household objects), with a total of 9 blocks 
of each type shown in one of two pseudorandom block orders with a randomised picture 
order within each block. Each high-calorie food block consisted of equal numbers of foods 
containing chocolate, non-chocolate sweet and savoury non-sweet foods (n=2 of each). 
Each image was displayed for 2500 ms, followed by a 500ms inter-stimulus interval of a 
fixation cross. Each food and object block was followed by a similar duration block of 6 
blurred pictures. The block of blurred pictures therefore allowed return of BOLD signal to 
baseline after blocks of categorical stimuli. 
 Images were viewed via a mirror mounted above an 8 channel RF head coil which 
displayed images from a projector using the IFIS image presentation system (In Vivo, 
Wurzburg, Germany) and ePrime 1.1 software (Psychology Software Tools Inc, Pittsburgh, 
PA, USA). Whilst each image was on display to subjects in the scanner, they were asked 
to immediately rate how ‘appealing’ each picture was to them at that moment on a scale 
of 1 to 5 using a hand-held keypad (1 = not at all, 2 = not really, 3 = neutral, 4 = a little, 
5 = a lot). The appeal rating was thus made and recorded simultaneously with the 
stimulus presentation used for fMRI activation (Figure 2.1.). 
 A 4Hz flashing visual checkerboard (alternating with a fixation cross in 5 blocks of 
24 seconds each) was viewed at the end of each scanning session as a control visual 
stimulus to look for non-specific changes in fMRI activation between fasted and fed states 
(Figure 2.1.). This scan lasted around 5 minutes.  
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Figure 2.1. functional MRI stimulation paradigm.                                                                     
 
 
 
 
 
 
       
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
Functional MRI stimulation paradigm showing blocks of high-calorie pictures (chocolate, sweet non-chocolate and 
savoury pictures), low-calorie pictures, object- and blurred pictures in a pseudorandomised design. Subjects are 
instructed to simultanously rate the appeal of each picure on a scale from 1-5. The 4Hz flashing checkerboard 
was used as a control stimulus. 
 
 
2.1.4. Imaging acquisition 
Imaging was conducted on a 3T Philips Intera whole body scanner. Whole-brain data were 
acquired with T2* weighted gradient-echo echoplanar imaging with an automated higher-
order shim procedure (44 ascending contiguous 3.25mm thick slices, 2 x 2 mm voxels; 
SENSE factor 2 repetition time (TR) 3000 ms; echo time (TE) 30 ms; 90º flip angle; FOV 
190x219, matrix 112x112), slice acquisition angle was -30º from AC-PC line to reduce 
frontal lobe signal drop out due to the air sinuses, with a z-shim gradient correction to 
compensate for through-plane susceptibility gradients (Deichmann et al., 2003). The first 
5 volumes of each fMRI run were discarded to allow for equilibrium effects. No 
High-calorie chocolate 
pictures
High-calorie sweet non-chocolate
pictures
High-calorie savoury
pictures
Low-calorie pictures
Object pictures
Blurred pictures
4Hz flashing
visual checkerboard
Picture appeal rating
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neuroanatomical abnormalities were seen on a high-resolution T1-weighted turbo field 
echo structural scan collected at each visit (TE 4.6 ms; TR 9.7 ms; flip angle 8°; FOV 240 
mm; voxel dimensions, 0.94 x 0.94 x 1.2 mm).  
 
 
2.1.5. Image pre-processing and statistical analysis 
SPM5 (update 826, Wellcome Dept. of Imaging Neuroscience, UCL, UK) was used for 
individual pre-processing. EPI images were corrected for slice timing as each slice is 
acquired at different time points. ArtRepair (Mazaika, 2007) was used to quantify relative 
head motion. A mean EPI image was created for each subject and registered to a standard 
EPI template in stereotatctic space using MNI coordinates (Monreal Neurological Institute, 
Quebec, Canada). The normalized images were smoothed with a three-dimensional 
isotropic Gaussian kernel of 8 mm full-width half-maximum (FWHM). A general linear 
model (GLM) was applied by convolution of the individual block onsets with the 
haemodynamic response function including the motion parameters as a regressor, with 
subsequent random effects contrast analysis (high-calorie vs. object, low-calorie vs. 
object, high-calorie vs. low-calorie, object vs. blurred, and visual checkerboard vs. fixation 
cross) (Beaver et al., 2006).  
 Since excessive head motion in general can produce artefactual brain activation, a 
cut off for head motion in this study was less than 10% of scans having greater than 0.3 
mm motion (average of all 6 directions) per scan. Two additional subjects were excluded 
from the analysis because of excessive head movement or image artefacts during fMRI 
scanning.  
 
 
2.1.5.1. Second-level group analysis for the fed – fasted visit 
Second level group random effects analysis was performed separately on the fasted and 
fed scans. A statistical threshold of P<0.001 uncorrected and cluster extent > 5 voxels (2 
x 2 x 2 mm) was used for activation using whole brain analysis with correction for multiple 
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comparisons made using false discovery rate (FDR) and family-wise error rate (FWER) at 
P<0.05. For a priori regions of interest (ROI) threshold was P<0.005 uncorrected with 
cluster extent > 5 voxels, with small volume correction (SVC) for multiple comparisons 
using FWR at P<0.05.  
Anatomical labelling of activations was checked with reference to neuroanatomical 
atlases (Duvernoy, 1995, 1999). For visualising activations, group maps were overlaid on 
the average of the mean EPI scans for each subject, averaged separately for the 1st and 
2nd visits, and then combined. 
In a separate group analysis, BMI was also included as a co-variate in the second 
level group random effects analysis to identify whether the activation in any of the ROIs 
for the high-calorie vs. low-calorie food contrast was influenced by BMI when fasting. 
Co-ordinates of peak voxel activation within each ROI were determined at the 
group level for fasted and fed visits. The co-ordinates of peak voxel activation within each 
ROI for the high-calorie vs. low-calorie foods contrast (or flashing checkerboard vs. 
fixation cross) at the group level for the relevant visit (or at just the fasted visit if no 
significant activation see at the fed visit) were then used to separately extract data on the 
magnitude of activation (beta value BOLD contrast) at the fasted and fed visits for 
individual subjects for the high-calorie vs. object, low-calorie vs. object, high-calorie vs. 
low-calorie and object vs. blurred picture (or flashing checkerboard vs. fixation cross) 
contrasts. Beta values were extracted separately for each hemisphere, and also combined 
to give average bilateral activation.  
 Comparison between groups was performed using 2-way paired Student’s t-test 
(fasted vs. fed). 2-way repeated measure ANOVA with post-hoc Student-Newman-Keuls 
test was performed to look at the interaction of breakfast consumption (fasted vs. fed) 
and food picture category (high-calorie vs. low-calorie) on BOLD activation in each ROI 
and appeal ratings. Equal variance between groups was confirmed using the Levene 
Median Test with a threshold P=0.01.  
Linear regression analysis was used to examine the relationship (Pearson 
correlation coefficient r) between the effect of breakfast consumption on brain activation 
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in each ROI and the effect of breakfast consumption on appeal bias for high-calorie foods. 
The dependent factor was the individual average bilateral BOLD contrast values for high-
calorie vs. low-calorie food contrasts in the fed state subtracted from values obtained in 
the fasted state. The independent factor was the individual appeal rating difference 
between high-calorie and low-calorie foods in the fed state subtracted from the rating 
difference obtained in the fasted state.  
 Unpaired t-test, or 2-way repeated measures ANOVA was used to compare 
between genders (male vs. female) and food category (high-calorie vs. low-calorie), the 
appeal of food pictures and brain activation in each ROI. The relationship between 
appetite VAS ratings and food picture appeal was examined using linear regression 
analysis.  
 Statistics was performed using SigmaStat 2.03 (SPSS, San Rafael, CA, USA). All 
data is presented as mean ± standard error of mean (SEM). Significance was taken as 
P<0.05. 
 
 
2.1.5.2. Brain activation correlation with questionnaire scores 
Statistical parametric maps (for high-calorie greater than low-calorie food picture 
contrast) were constructed to determine those voxels within each a priori ROI whose 
activity was significantly correlated with individual questionnaire scores (BAS-Drive, BAS-
Fun Seeking, BAS-Reward Responsiveness, BIS, DEBQ-Restraint, DEBQ-External) by their 
inclusion as covariates of interest in separate 2nd level group general linear models by 
random effects analysis.  
 The a priori ROI threshold for this analysis was P<0.005 uncorrected with cluster 
extent > 3 voxels, with small volume correction (SVC) for multiple comparisons using 
FWR at P<0.05. For visualising activations, group maps were overlaid on the average 
mean EPI scans for each subject. The co-ordinates of significant peak voxels for each 
correlation in each ROI were used to extract the magnitude of activation (BOLD contrast) 
for individual subjects for the high-calorie vs. low-calorie food contrast.  
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Simple linear regression was used to correlate questionnaire scores with brain 
activation in each ROI. The dependent factor was the individual unilateral BOLD contrast 
value for high-calorie vs. low-calorie food contrast and the independent factor was the 
individual questionnaire score. These co-ordinates were also used to separately extract 
data on the individual magnitude of activation for the object vs. blurred picture contrast 
followed by simple linear regression to correlate questionnaire scores with brain activation 
in each ROI for this contrast. Gender and visit number were also included as co-variates in 
multiple linear regression analysis. Statistics were performed using SigmaStat 2.03 (SPSS, 
San Rafael, CA, USA). All data is presented as mean ± SEM. Significance was taken as 
P<0.05. 
 
 
2.1.5.3. Regions of interest 
The following a priori ROIs were choosen for the first analysis (Figure 2.2., 2.3.): ventral 
striatum, anterior insula, amygdala, medial and lateral orbitofrontal cortex (OFC) for the 
picture viewing; lingual gyrus, calcarine sulcus and lateral geniculate nucleus for the 
flashing checkerboard.  
The following a priori ROIs were choosen for the second analysis (2.1.5.2.) (Figure 
2.2.): ventral striatum, anterior insula, amygdala, medial and lateral OFC, dorsolateral 
prefrontal cortex (DLPFC), dorsal and ventral anterior cingulate cortex (ACC) for the 
picture viewing.  
All ROIs were selected according to previous publications and standardized atlases. 
ROIs for the amygdala, anterior insula, and medial and lateral OFC used masks generated 
from the WFU Pickatlas (version 2.4), using the automated anatomical labeling atlas, 
using only voxels with y > 0 to define the anterior insula, the medial section of the middle 
orbital frontal cortex for the medial OFC, the inferior orbital frontal cortex for the lateral 
OFC (Tzourio-Mazoyer et al., 2002, Maldjian et al., 2003). The OFC ROIs were also 
masked with the overall EPI mask for the whole group at second level analysis for all visits 
to ensure that each voxel in the ROI was present for each subject at each visit to 
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compensate for varying degrees of signal drop out in the OFC between subjects and visits. 
The ventral striatum ROI used two 8mm diameter spheres centred at MNI co-ordinates x 
± 8 y 10 z -12 taken from a previous fMRI study of viewing appetizing vs. bland food 
pictures (Beaver et al., 2006). The dorsolateral prefrontal cortex (DLPFC) ROI used two 
10mm spheres centred at MNI co-ordinates x ± 26 y 52 z 34 taken from a previous fMRI 
study of viewing high-calorie vs. low-calorie food pictures (Killgore et al., 2003). The 
dorsal ACC ROI used a 14mm sphere centred at MNI co-ordinates x -2 y 12 z 40 taken 
from a previous fMRI study of viewing fearful vs. neutral face distractors (Bishop et al., 
2007). The ventral ACC ROI used two 14mm spheres centred at MNI co-ordinates x ± 15 
y 36 z -12, taken from a previous fMRI study of viewing negative and neutral words 
(Whalen et al., 1998). The lateral geniculate nucleus ROI used two 10mm spheres centred 
at MNI co-ordinates x ± 22 y -24 z -5 taken from a previous fMRI study viewing a flashing 
checkerboard (Schneider et al., 2004). To define the lingual gyrus and calcarine sulcus 
masks were generated from the WFU Pickatlas (version 2.4). 
 
 
Figure 2.2. ROIs for brain food reward and executive systems. 
 
 
 
 
 
 
 
All ROIs (amygdala, anterior insula, medial and lateral OFC, ACC and DLPFC) were selected according to previous 
publications and standardized atlases (WFU Pickatlas within SPM5). 
ventral striatum
amygdala
anterior insula
lateral OFC
medial OFC
DLPFC
dorsal ACC
ventral ACC
x -4 Y 46 z -14
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Figure 2.3.  ROIs for brain visual processing. 
 
 
 
 
 
All ROIs (lateral geniculate nucleus, lingual gyrus and calcarine sulcus) were selected according to previous 
standardized atlases (WFU Pickatlas within SPM5). 
The VTA is very difficult to study in humans using functional neuroimaging because of its 
small size, proximity to major blood vessels, susceptibility to motion artefacts related to 
cardiac and respiratory cycles, and difficulties in image registration to standard space. 
Therefore this ROI was not included in the analysis of this study (D’Ardenne et al., 2008). 
 
 
2.1.6. Summary fed-fasted fMRI study 
Twenty-five subjects were screened for this study but only 20 non-obese healthy adults 
were scanned on two separate mornings between 11am and noon, once after eating a 
filling breakfast (fed), and once after an overnight fast (fasted) in a randomised cross-
over design.  
Using functional magnetic resonance imaging (fMRI), the interaction between 
nutritional state (fed and fasted) and different food stimuli on brain food reward systems 
was analysed. This study also examined how blood oxygen level dependent (BOLD) 
activity within a priori ROI varied while viewing pictures of high-calorie and low-calorie 
foods. Pictures of non-food household objects and flashing checkerboard were included as 
control visual stimuli. During scanning, subjects rated the appeal of each picture.  
Questionnaires (BIS/BAS and DEBQ) were used to measure individual differences 
in reward sensitivity and eating behaviour to examine their influence on individual 
differences in activation in brain reward and executive systems. 
calcarine sulcus
lingual gurys
lateral geniculate nucleus
x -2 z -2
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2.2. Ghrelin fMRI study 
 
2.2.1. Participants 
Fourty-seven adults were screened for this study. Participants were recruited via poster, 
email and web-based advertisements and word of mouth. To reduce variability or 
confounds among participants in their response to experimental stimuli, individuals were 
excluded based on various criteria: abnormal eating habits (assessed by the Eating 
Attitude Test (Garner et al., 1982), SCOFF questionnaire (Morgan et al., 1999) (Appendix 
3), Dutch Eating Behaviour Questionnaire (DEBQ) (van Strien, 1986) (Appendix 5), 3-day 
dietary record (Appendix 7)), missing breakfast (more than 3 days per week), history of 
addiction within the last 5 years and severe depression (Beck Depression Inventory (BDI-
II>28)). Further exclusion criteria were as described previously for the fed-fasted fMRI 
study (see 2.1.1.).  
Twenty healthy, non-obese adults with normal or corrected to normal vision were 
eligible and agreed to take part in the study. Two participants withdrew from the study 
without any specified reason after completing 2 visits. Eighteen subjects completed the 
study (mainly students and health professionals working in the hospital; mixed gender (13 
male, 5 female as only women with regular menstrual cycle for the fMRI scanning were 
included); mixed ethnicity (white British n=9, other White n=1, Indian n=2, Chinese n=3, 
other Asian n=2, White and Asian n=1)). All subjects were either born in the UK or used 
to a Western diet. 
The study was performed on Ward C2 (Sir John McMichael Centre Clinical 
Investigation Unit) and the Robert Steiner MRI Unit at Hammersmith Hospital London. All 
subject’s characteristics are to be found in Table 2.1.  
The study was approved by the Local Research Ethics Committee Hammersmith 
Hospital (ethics number: 07/Q0406/19), and was performed in accordance with the 
principles of the Declaration of Helsinki. All participants provided written informed 
consent. 
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Table 2.1. Subjects characteristics (n = 18). 
 Mean ± SEM Range 
Age (years) 24.3 ± 1.5 19-41 
Height (m) 1.80 ± 0.0 1.59-1.91 
Weight (kg) 76.1 ± 3.7 50.7-104.5 
BMI (kg/m2) 24.3 ± 0.7 19.2-30.2 
Body fat (%) 16.9 ± 1.6 6.1-31.6 
LBM (kg) 63.3 ± 3.4 45.0-86.1 
 
 
2.2.2. Protocol 
 
2.2.2.1. Screening visit 
After a short telephone screening which included major inclusion and exclusion criteria 
(see 2.1.1.), subjects were invited for a 2 hour screening visit. Participants underwent a 
physical examination (including ECG). Height, weight and general screening blood tests 
(haematology, renal, liver and thyroid function) were measured. Body fat was measured 
by bio-electrical impedance analysis which measures electrical resistance to determine fat 
free mass (Bodystat 1500, Isle of Man, UK). Pregnancy was excluded using a urine HCG 
dipstick testing. Subjects had to fill in a metal check form to ensure they had no metal 
inside their body (Appendix 8). A three-day food diary to be completed at home and 
different questionnaires (see 2.1.1) were used to screen for mood and abnormal eating 
behaviour (Appendix 3 to 7). Subjects also had to choose a study lunch (macaroni cheese 
or chiken tikka masala curry) that they would be given at each study visit, with subjects 
initially given the pasta. The final meal was chosen from that with a pleasantness ratings 
of at least “Like moderately” at the screening visit (Appendix 2). 
 
2.2.2.2. Randomisation 
On the first study visit subjects were not given breakfast (remained fasted) and had saline 
administered (Fasted Dummy visit). This Fasted-Dummy visit was performed to habituate 
individuals to the study environment (chapter 4). 
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 During the subsequent three visits, participants were fed or fasted in a block 
randomised cross-over design and administration of ghrelin or saline during each fed visit 
was double-blinded and each fasted visit single-blinded, as follows: Fasted Saline, Fed 
Ghrelin, Fed Saline. There was an average of 20 (5-151) days (median, range) between 
each study visit.  
 
2.2.2.3. Day before each study visit 
Subjects completed a 3-day dietary record starting from the morning prior to the study 
day in order to confirm similar nutritional states and food intake between visits. 
Volunteers were told to avoid rigorous exercise and alcohol intake and to eat supper at 
8.00pm on the day before each study visit.  They were advised to eat a similar supper 
before each study visit.  
 
2.2.2.4. Study day 
After an overnight fast (nothing to eat or drink other than water), subjects arrived 
between 8am and 9.30am to Ward C2 of the Hammersmith Hospital. They had to remove 
all their metal and changed into blue hospital scrubs. They had to fill in a metal check 
form and mood/depression assessment questionnaires at each visit in order to ensure 
depression had not developed at the time of scanning (Appendix 8 and 9). All female 
volunteers were confirmed not to be pregnant via urine HCG dipstick testing. Females 
were only scanned in the follicular phase (day 2-10) of their menstrual cycle to avoid 
hormone-induced changes in food selection as food intake and fMRI responses to 
rewarding stimuli may vary over the menstrual cycle in response to changes in ovarian 
steroid hormone levels (Buffenstein et al., 1995, Dye and Blundell, 1997, Frank et al., 
2010).  
Subjects had their height, weight and body fat (bio-electrical impedance analysis) 
measured. A peripheral intravenous catheter was inserted into the subject’s left or right 
antecubital fossa to allow serial blood sampling at time points (t) = -15 ,0 ,40, 70, 150, 
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180 minutes with at least 30 minutes between insertion and first blood sampling to avoid 
stress responses (Figure 2.4.).  
 
2.2.2.5. Visual Analogue Scales 
Visual Analogue scale (VAS) ratings (0-10 cm) were recorded at 8 different time points: t 
= -15, 0, 40, 55, 70, 150, 180 and 210 minutes to measure hunger, sickness, 
pleasantness to eat, anxiety, volume of food wanting to eat, fullness, stress and 
sleepiness (Flint et al., 2000; Blundell et al., 2010) (Figure 2.4.) (Appendix 10). Subjects 
were asked to rate their hunger at 3 time points (after the Test and Rest scan and before 
the AMV scan while in the MRI scanner, using a 5 fingers keypad rating from 1) not at all 
to 5) a lot (Figure 2.5.). 
 
2.2.2.6. Blood pressure 
At each time point (t = -15, 0, 40, 55, 70, 150, 180 and 210 minutes) pulse, systolic and 
diastolic blood pressure was measured to ensure patient safety. 
 
2.2.2.7. Study breakfast 
Subjects did not know whether they would be given breakfast until t=0 minutes. On the 
first study visit, subjects were not given breakfast. During the subsequent three visits, 
participants were fed or fasted (not given any breakfast) in a randomised cross-over 
design (see 2.2.2.2.). On the fed visit, subjects consumed a fixed breakfast of 730 Kcal 
(14% protein, 31% fat and 55% carbohydrate) at t = 0 minutes consisting of 220ml 
orange juice, 40g Kelloggs bran flakes, 170ml semi-skimmed milk, 2 slices of wholemeal 
bread, each with 10g of margarine, one with 10g of Robertson strawberry jam and the 
other with one slice of Leerdamer cheese (8g) (Figure 2.4.). Subjects were told to finish 
all of the given food. They rated how tasty and pleasant the breakfast was on a 10cm 
scale. The average time to eat breakfast was 9.0 ± 1.1 minutes (mean ±  SEM). 
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2.2.2.8. Ghrelin injection 
At t = 55 minutes, subcutanous saline or octanylated ghrelin was injected into the 
abdomen at a dose of 3.6 nmol/kg (Figure 2.4.), as with earlier studies as the smallest 
effective dose from a dose-response pilot study performed in healthy volunteers (Dr. N. 
Neary and Dr. M. Druce, Department of Metabolic Medicine, Imperial College London, UK, 
personal communication, November 2003), in a concentration of 548 nmol/ml (Druce et 
al., 2005, Wynne et al., 2005a). All vials were coded by a member of the department not 
involved in the study, so that ghrelin and saline injections were blinded to the 
researchers. Human octanylated ghrelin was purchased from Penninsula Laboratories, St. 
Helens, Mereyside, UK. Bioactivity of the ghrelin vials had been demonstrated by acute 
feeding studies in mice as part of a previous human ghrelin feeding study (Ashby et al., 
2009).   
 
Preparation and Sterility of ghrelin 
The peptide was aliquoted into sterile glass vials under aseptic conditions and freeze-
dried. Although the material is packed and stored under vacuum, which destroys any 
active (aerobic) microorganisms, the freeze-dried peptide was also sent to the HHNT 
Microbiology Dept. for culture of all common pathogenic microorganisms as a further 
safety check. Absence of pyrogen contamination of every batch of peptide was confirmed 
by highly sensitive measurements of endotoxin content using a Limulus Amoebocyte 
Lyaste (LAL) test, performed by Associates of Cape Cod International, 3a Newton Court, 
Wavertree Technology Park, Liverpool. 
 
Potential toxicity of ghrelin 
For each batch of peptide aliquots, toxicity studies were carried out in mice. Greater than 
10 times the maximum dose to be given to man was administered by intraperitoneal 
injection to a minimum of 20 mice and compared to a saline injected control group. The 
animals were observed and, if no adverse effects were seen, one group of 10 mice was 
killed by a schedule 1 method after around 48 hours observation and the remaining 
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animals were killed after at least 14 days. Full necropsies with histological examination of 
all important internal organs, including lungs, heart, brain, and kidneys were performed 
under the supervision of an independent experienced rodent pathologist and a formal 
report was issued. 
 
2.2.2.9. Blood sampling 
Blood samples drawn at each time point were immediately transferred to chilled lithium 
heparin polyprooylene tubes, containing 4-(2-Aminoethyl)benzenesulfonyl fluoride 
hydrochloride (AEBSF) (A8456 Sigma-Aldrich), a protease inhibitor to prevent the 
breakdown of active ghrelin, and aprotinin (Nordic Phama UK), a protease inhibitor to 
prevent breakdown of other gut hormones, to give a final AEBSF and aprotinin 
concentration of 1 mg/ml whole blood and 200 kIU/ml whole blood respectively (Figure 
2.4., Appendix 11). 
Blood samples were centrifuged at 4ºC, 4000 rpm for 10 minutes. 150µl aliquots of 
separated plasma was immediately mixed with HCl (to prevent breakdown of active 
ghrelin) to give a final concentration of 0.05M, which was frozen and stored at -80ºC for 
future assaying of acylated ghrelin. One milliliter aliquots of seperated plasma were not 
mixed with HCl, frozen and stored at -80ºC for future assaying of adipocytes and gut 
hormones. The samples have not yet been analysed for gut hormones as additional 
subjects have been recruited to the study to improve statistical power and all blood 
samples need to be assayed together. 
 At each time point blood samples were taken to measure plasma glucose, and 
serum insulin, growth hormone, cortisol, prolactin, and triglycerides. All metabolic 
paramteres were measured in the Department of Clinical Biochemistry, Hammersmith 
Hospital and Charing Cross Hospital, using either an Abbott Architect ci8200 analyser 
(Abbott Diagnostics, Maidenhead, UK) or an Axsym analyser (Abbott Diagnostics, 
Maidenhead, UK) respectively. Intra-assay co-efficients of variation of all metabolic 
parameters were 1.0–5.0%. 
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2.2.2.10. Lunch 
After MRI scanning (t = 150 mins) each subject received the same and excess amount of 
lunch (macaroni cheese (per 100g: 205kCal, 6.5g protein, 18.9g carbohydrate and 11.5g 
fat; or chicken tikka masala (per 100 g: 150kCal, 6.6g protein, 13g carbohydrate, 8g fat). 
Men were presented with 2000g and women were presented with 1500g of excess lunch. 
Subjects were instructed to eat as much as they wanted until they felt comfortably full 
(Figure 2.4.; Appendix 2). Subjects rated how tasty and pleasant the lunch was on a 10 
cm scale. 
 
2.2.2.11. Three-day dietary record 
Subjects finished the 3-day dietary record at home until the evening after the study day 
(Figure 2.4.). Food diaries were analysed using dietary analysis software DietPlan6 
(Forestfield Software Ltd, West Sussex, UK).   
 
2.2.2.12. Picture scoring 
After the 4th study visit volunteers named all of the food pictures viewed during the fMRI 
scanning to ensure subjects were familiarized with the foods (percentage correctly 
recognised). Subjects also scored all of the food pictures viewed during the fMRI scanning 
to rate how much they usually like the food: hate a lot (score -3), hate somewhat (score -
2), hate a little (score -1), neither like nor hate (score 0), like a little (score +1), like 
somewhat (score +2) or like a lot (score +3); and how often they usually eat the food: 
never (score 0), 3 times or less per year (score 1), 6 times or less per year (score 2), 
once per month or less (score 3), 2-3 times per month (score 4), once per week (score 
5), 2-3 times per week (score 6), 4-6 times per week (score 7) or once per day or more 
(score 8). Scores were added separately for high-calorie and low-calorie foods to assess 
usual preferences and consumption of the high-calorie vs. low-calorie foods (Figure 2.4.).  
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Figure 2.4. Ghrelin study protocol. 
                        Fed            Injection                         Picture scoring 
          Cannula   or Fasted   Saline/ Ghrelin                Lunch          (last visit) 
 
 
Food diary                                  Food diary 
Started                    finished 
 day -1                                                                                   day +1 
 
Mins         -15   0      40  55  70                  150     180     210      
Bloods        x    x               x          x                            x          x  
VAS            x    x               x    x     x                            x          x        x 
  
Ghrelin study protocol: Each subject completed 4 study visits. After an early morning cannulation, subjects 
received breakfast or remained fasted. Before the fMRI scanning session, subjects received an injection of saline 
or ghrelin. After 1 hour of scanning, an ad libitum lunch was given. Blood samples were taken and Visual 
Analogue Scales filled in throughout the study morning. Food diaries had to be completed for 3 days starting the 
day prior to the study. On the last study visit subjects were instructed to score the food pictures seen in the MRI 
scanner.  
 
 
 
2.2.3. MRI scanning protocol 
After the injection, each subject underwent one hour fMRI session, starting at t = 70 mins 
(Appendix 12). 
 
Figure 2.5. Scanning protocol 
   5 mins      10 mins      10 mins      10 mins       5 mins      6 mins          5-10 mins 
 
                                          
 
Functional MRI scanning protocol lasting for about 60 mins: 1) Test run to get subjects used to the keypad 
button pressing, 2) Resting scan to look at brain activity in the absence of a task, 3) Two picture runs showing 
blocks of food- and object pictures alternating with blurred pictures, 4) Filed maps to reduce signal drop-out, 5) 
AMV – Audio-Motor-Visual task used as a control task, 6) Anatomical scans to look for abnormalities in the brain. 
 
The scanning protocol was similar to the fed-fasted fMRI study scanning protocol (see 
2.1.3.). Additions to that protocol in this study were as follows (Figure 2.5.): 
fMRI 
Hunger 
Rating  
Test 
run 
Resting 
scan 
Picture 
run 1 
Picture 
run 2 
Field 
maps 
AMV 
scan 
T1/T2/ 
FLAIR/DTI 
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Rating  
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(1) In the MRI scanner, subjects had a respiratory belt to measure breathing and a 
pulse oximeter to measure heart rate and blood oxygenation to monitor 
subject’s safety. 
(2) The software to display images in the MRI scanner was updated from ePrime 
1.1 to ePrime 2.0 (Psychology Software Tools Inc, Pittsburgh, PA, USA). 
(3) Fruit pictures as well as salad pictures showing excessive oil or dressing were 
removed from the low-calorie food picture paradigm and replaced by 14 new 
pictures as their sweetness or calorie content was felt to be too high to be 
included in the low-calorie pictures. The percentage of carbohydrates in the 
low-calorie pictures was now reduced and the amount of protein increased. The 
new total caloric load, caloric density and macronutrient composition of the 
foods were reassessed using Dietplan6 (Foresfield Software Ltd, West Sussex, 
UK) - high calorie foods: 834 ± 100 kCal, 321 ± 13 kCal/100g, 42 ± 2 % fat, 
48 ± 1 % carbohydrate, 10 ± 1 % protein; low-calorie foods: 157 ± 18 kCal, 
64 ± 5 kCal/100g, 35 ± 3 % fat, 35 ± 3 % carbohydrate, 29 ± 3 % protein; 
high-calorie vs. low-calorie foods: P<0.001 for energy content, density, % 
protein and % carbohydrate; and P=0.03 for % fat. 
(4) The high-calorie and low-calorie food and object picture number was increased 
from 54 to 60 pictures per category to allow equal numbers of blocks per run. 
(5) The food picture run (17 minutes) was divided into two runs each of 9 minutes 
to increase subject’s concentration and attention. Each run contained different 
pictures and contained 5 blocks each of high-calorie and low-calorie foods and 
objects interleaved with 31 blocks of blurred pictures (6 pictures per block). A 
different pseudorandomised block run order was used between each visit. 
(6) Fieldmaps were used to correct for geometric distortions caused by 
inhomogenities in the magnetic field which can lead to compression of the 
BOLD image or signal drop out in important brain reward areas such as the OFC 
(due to its air-filled sinuses). Therefore, two images of signal phase with 
slightly different echo times were acquired (Figure 2.5). The differences 
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between the two images results in an image of the intensity of the magnetic 
field across space (at any given location) which can be registered with the EPI 
image to correct geometric distortions (Huettel, 2004). The imaging parameters 
to acquire fieldmaps were as follows: TR 800 ms; TE 20ms, 90º flip angle; FOV 
190x219, 44 ascending contiguous 3.25mm thick slices, 2 x 2 mm voxels, ∂TE 
0 and 2.5. 
(7) The software to analyse fMRI data was changed from SPM5 to FSL (FMRIB’s 
Software Library, www.fmrib.ox.ac.uk/fsl). Advantages for using this software 
to analyse fMRI data included: ease of use, ability to easily script pre-
processing steps for multiple visits, improved visualization of registration steps, 
non-linear registration, and maintenance of results within subject space until 
the end of the analysis when registration to the T1 anatomical scan and hence 
to standard space was performed. 
(8) Instead of slice timing correction, this study now used temporal derivatives 
which measures the relative change of activation over time and is applied to 
the GLM to correct for differences in both slice timing and in the onset of the 
HRF after stimulus delivery between different voxels. 
(9) After the Test Run, subjects had a resting state fMRI scan for 10 minutes 
during which they were instructed to keep their eyes shut, not to fall asleep nor 
think of anything in particular (Figure 2.5.). This scan allows assessment of 
resting connectivity between brain regions, which shows how strongly 
coordinated activity is within brain networks in the absence of a task 
(Damoiseaux et al., 2006).  
(10) An auditory-motor-visual (AMV) task was performed for 6 minutes at the end of 
each scanning session as control stimuli to look for non-specific changes in fMRI 
activation between fasted and fed states, and fed saline and fed ghrelin 
injections (Figure 2.5.). The following brain areas will be assessed with this 
task: visual cortex (lingual gyrus, calcarine sulcus) and lateral geniculate 
nucleus, primary and secondary auditory cortex, primary motor cortex and 
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supplementary motor area. Subjects were told to perform two tasks 
simultanously:  
a. Watching a 4Hz colour flashing checkerboard while listening to a story, or 
b. Watching a 4Hz flashing checkerboard while pressing the right index finger 
once every second, or 
c. Listening to a story while pressing the right index finger once every second. 
The AMV scan fMRI data has not been analysed for this thesis.  
(11) After the Test and Resting scan and before the AMV scan subjects rated how 
hungry they felt using the hand-held keypad (5 = a lot, 4 = a little, 3 = 
neutral, 2 = not really, 1 = not at all) (Figure 2.5.).  
(12) Image acquisition (2.1.4) was similar to the first fed-fasted study except that 
the first 6 volumes rather than 5 volumes were discarded to allow for 
equllibrium effects. The number of volumes per scan was as follows: Rest scan 
192 volumes, Food picture run each 192 volumes, AMV scan 113 volumes. 
(13) Additionally to the first fed-fasted study, a second T1 image was collected as 
anatomical brain image used for image registration in case there were artefacts 
with the first T1 scan.  
(14) Fluid attenuation inversion recovery (FLAIR) was added into the protocol which 
is a special inversion recovery sequence with long TI to remove the effects of 
fluid from the resulting images. The FLAIR sequence was used to look at 
anatomical brain abnormalities and is described as follows: TR/TI=11000/2800, 
TE=125, Slices=30, Slice gap=1mm, acquired voxel size=0.65x0.97x4mm, rest 
slab=1, TSE factor=27.  
The "pathology weighted" T2 (turbo spin echo) sequence is important as most 
pathology contains more water than normal tissue around it which lights 
usually brighter on a T2 sequence (TR=3000, TE=80, Slices=28, Slice 
gap=1mm, acquired voxel size 0.57x0.72x4mm). The T2 and FLAIR scans were 
included to improve detection and assessment of any neurological abnormality 
that might be found as incidental findings (Figure 2.5.). 
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2.2.4. Image pre-processing  
FMRI data processing was carried out using FEAT (FMRI Expert Analysis Tool) version 
5.98, part of FSL (FMRIB’s Software Library, www.fmrib.ox.ac.uk/fsl). The following 
preprocessing was applied: motion correction using MCFLIRT (Jenkinson et al., 2002); 
fieldmap-based EPI unwarping using PRELUDE+FUGUE (Jenkinson, 2003, 2004); non-
brain removal using BET (Smith, 2002); spatial smoothing using a Gaussian kernel of 
FWHM 6.0mm; grand-mean intensity normalization of the entire 4D dataset by a single 
multiplicative factor and highpass temporal filtering (Gaussian-weighted least-squares 
straight line fitting, with sigma=100.0s). 
Time-series statistical analysis was carried out using FILM with local autocorrelation 
correction including picture onsets, temporal derivative and motion parameters as co-
variates (Woolrich et al., 2001). Registration to high resolution T1 structural and/or 
standard space images was carried out using FLIRT (Jenkinson and Smith, 2001, 
Jenkinson et al., 2002). Registration from high resolution structural to standard space was 
then further refined using FNIRT nonlinear registration (Anderson et al., 2007a, b). For 
the food pictures, higher level analysis was carried out using a fixed effect model to 
combine the 2 runs, by forcing the random effects variance to zero in FLAME (FMRIB’s 
Local Analysis of Mixed Effects) (Beckmann et al., 2003, Woolrich et al., 2004). One 
subject (20 year old male BMI 21.2 kg/m2) was removed from further analysis because of 
excess head movement (over 10% of scans showing motion >0.3mm/TR or average 
relative motion per scan >0.3mm). 
 
2.2.5. Image statistics 
Average group activation for each visit separately 
Higher level group whole brain analysis using FEAT version 5.98 with random effects 
analysis was performed to identify those voxels in the brain which are significantly more 
activated when viewing high-calorie foods (vs. objects) or low-calorie foods (vs. objects) 
for each visit separately, with correction for multiple comparisons made using false 
discovery rate (FDR) at P<0.05. 
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Combined activation averaged across 3 visits 
Significant activated voxels in the brain when viewing high-calorie foods > objects 
averaged across all three study visits (Fasted Saline, Fed Saline and Fed Ghrelin) were 
then determined using higher level group analysis using FEAT version 5.98 with random 
effects analysis and a whole brain statistical threshold of FDR P<0.05 (Figure 2.6.). 
Similar activation maps averaged across all visits were performed for the low-calorie foods 
> object contrast, and generally were contained within the mask of those voxels activated 
for the high-calorie > food contrast. 
 
Figure 2.6. Combined whole brain activation averaged across 3 visits. 
 
 
 
 
 
 
 
 
Combined whole brain activation across 3 visits (Fasted Saline, Fed Saline and Fed Ghrelin visit). Various brain 
areas were activated when viewing different pictures contrasts: RED when viewing high-calorie foods > object 
pictures, BLUE when viewing low-calorie foods > object pictures, YELLOW showing the overlap of activation of 
viewing high-calorie and low-calorie foods > object pictures. 
 
2.2.6. Regions of Interest (ROIs) 
A priori ROIs for this study were as follows: ventral striatum, amygdala, insula and 
anterior OFC. For the former the activation map produced for the high-calorie food > 
object contrast averaged across all three study visits at FDR P<0.05 (see 2.2.5) was 
masked with the ventral striatum, amygdala and insula ROIs determined by the cortical 
and subcortical structural Harvard FSL atlas (Shenton et al., 1995; Dreher et al., 2007; 
Van Vugt, 2009) (Figure 2.7.). For the OFC a cluster of activation in the anterior OFC 
x=28
OFC
x=20
Insula Amygdala
Ventral striatum
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(y>74) was used from the high-calorie food > object contrast across all three visits 
(Figure 2.7.). 
 
Figure 2.7. ROIs averaged across 3 visists. 
 
 
 
 
 
 
 
 
A priori ROIs (ventral striatum, amygdala, insula and anterior OFC): The activation map produced for the high-
calorie food > object contrast averaged across all three study visits at FDR P<0.05 was masked with the ventral 
striatum, amygdala and insula ROIs determined by the Harvard FSL atlas within FSL. For the OFC a cluster of 
activation in the anterior OFC was used from the high-calorie food > object contrast across all three visits. 
 
 
Extraction of magnitude of activation for each visit separately 
These ROI activation masks were then used to extract the average magnitude (beta 
values) of BOLD activation within each a priori ROI for each of the four visits separately 
(Fasted Dummy, Fasted Saline, Fed Saline and Fed Ghrelin) for each individual subject for 
each of the contrasts: high-calorie food > object, low-calorie > object, and object > 
blurred (as control) using FEAT query in FSL. Beta values were extracted separately for 
each hemisphere. Average BOLD activation for each of these contrasts within each ROI 
was then compared between visits using paired Students t-test or Wilcoxon Signed Rank 
test outside FSL using SigmaStat 2.03. 
 
z -16
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2.2.7. Statistical analysis 
Results are presented as mean value ± standard error of the mean (SEM). VAS scores and 
blood parameters were calculated as the total area under curve (AUC) in millimeters for 
the time course: -15 mins to 210 mins (VAS) and -15 mins to 180 mins (blood 
parameters). The study population demographics, dietary records, VAS, blood parameter 
and appeal ratings were compared between (i) Fasted Dummy and Fasted Saline, (ii) 
Fasted Saline and Fed Saline, or (iii) Fed Ghrelin and Fed Saline using paired Student’s t-
test or Wilcoxon Signed Rank post-hoc test if not normally distributed. Unpaired t-test was 
used for analysis of picture scores (recognition, liking, frequency) to compare between 
high-calorie and low-calorie foods or Mann-Whitney-Rank Sum test if not normally 
distributed.  
The relationships between hunger ratings (independent variable) and brain 
activation (dependant variable) or brain activation / VAS appetite scores (independent 
variable) and ad libitum lunch intake (dependant variable) were examined using linear 
regression analysis.  
Analyses were performed using Prism version 4.03 software (Graphpad Software, 
San Diego CA, USA), Microsoft Office Excel 2003 and SigmaStat 2.03. P<0.05 was 
considered to be statistically significant. 
 
 
2.2.8. Summary ghrelin fMRI study 
Eighteen non-obese healthy adults were scanned on 4 separate mornings starting 
between 10.36 am and 12.40 pm, twice after eating a fixed 730kCal breakfast (Fed Saline 
or Fed Ghrelin), and twice after an overnight fast (Fasted Dummy or Fasted Saline) in a 
randomised cross-over design. They were either given a subcutaneous injection of saline 
(Fasted Dummy, Fasted Saline, Fed Saline) or ghrelin (Fed Ghrelin). Using fMRI, the 
interaction between nutritional state (Fasted Saline vs. Fed Saline visit) and different food 
stimuli on brain food reward systems was analysed. It was further examined whether the 
effect of fasting on food reward can be mimicked by the orexigenic hormone ghrelin (Fed 
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Ghrelin vs. Fed Saline visit). This study further investigated the effect of activation in 
brain reward systems on subsequent food intake (ad libitum lunch). In order to measure 
appetite and hunger subjects were asked to complete VAS and three-day food diaries. 
During scanning, subjects rated their appeal of each picture and hunger on a 5-point 
scale. Blood samples were also taken throughout the study morning to measure glucose, 
insulin, triglycerides and growth hormone as well as stress responses (cortisol and 
prolactin). Finally this study investigated the reproducibility of fMRI data by comparing the 
Fasted Dummy and Fasted Saline visit.  
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Chapter 3 
RESULTS  
FED – FASTED fMRI STUDY 
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3.1. Appetite visual analogue scales 
Subjects rated higher scores for “hunger”, “pleasantness to eat”, and “volume able to eat” 
and lower scores for “fullness” when fasted compared to when fed both before and after 
the fMRI scan (P<0.001) (Figure 3.1., Table 3.1.). There was no significant difference in 
the change in VAS from before to after the fMRI scan between fasted and fed visits, 
although there was a tendency for fullness to decline more on the fed than fasted visit 
(P=0.08) (Table 3.1.).  
 
Figure 3.1. Pre (A) and post (B) – fMRI scan Visual Analogue Scales. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subjects rating of appetite in fasted (hatched bar) and fed states (dotted bar) (*** P<0.001). 
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Table 3.1. Appetite visual analogue scale (VAS) ratings.  
 Fed Fasted 
Appetite VAS Rating a   
Hunger 1.5 ± 0.2 7.7 ± 0.2 *** 
Nausea 1.6 ± 0.4 2.0 ± 0.4 
Pleasant 2.0 ± 0.3 8.1 ± 0.2 *** 
Volume 2.0 ± 0.2 7.8 ± 0.3 *** 
Full 6.9 ± 0.4 1.0 ± 0.2 *** 
Change in VAS over fMRI scan b   
Hunger 1.0 ± 0.4 0.9 ± 0.2 
Nausea - 0.4 ± 0.4 0.2 ± 0.2 
Pleasant 0.8 ± 0.4 0.4 ± 0.3 
Volume 0.6 ± 0.3 0.8 ± 0.3 
Full - 0.2 ± 0.3 - 1.2 ± 0.4 
a Appetite visual analogue scale (VAS) ratings (1-10) using average of values obtained before and after fMRI 
scan. Questions asked: “How hungry do you feel right now?” (hunger), “How sick do you feel right now?” 
(nausea), “How pleasant would it be to eat right now?” (pleasant), “How much do you think you could eat right 
now?” (volume), and “How full do you feel right now?” (full). bAfter minus before fMRI scan.  Data shown as 
mean ± SEM, n=20 per group: *** P<0.001 fed vs. fasted. 
 
 
3.2. Food picture appeal rating 
Both high-calorie and low-calorie food pictures (but not object and blurred pictures) were 
more appealing when fasted than when fed (P<0.001) (Figure 3.2., 3.3., Table 3.2., 3.4.). 
Furthermore, high-calorie and low-calorie foods were more appealing relative to object 
(and blurred) pictures when fasted compared to when fed (P<0.001) (Figure 3.2., 3.3., 
Table 3.2., 3.4.). However, there was no significant difference in the appeal of object 
relative to blurred pictures when fasted compared to when fed (P=0.14) (Table 3.2.).  
 Fasting affected the preference for high-calorie over low-calorie foods (P<0.001). 
High-calorie foods were less appealing than low-calorie foods when fed, but more 
appealing than low-calorie foods when fasted (P<0.001 fasted vs. fed) (Figure 3.2., 3.3, 
Table 3.2., 3.4.). These differences were irrespective of the type of high-calorie food in 
the picture: chocolate, sweet non-chocolate or savoury (Table 3.2.).  
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Figure 3.2. Appeal rating of pictures. 
 
 
 
 
 
 
 
 
 
Appeal rating of pictures (high-calorie foods, low-calorie foods, non-food related household objects, blurred) 
when fed (solid bar) and fasted (white bar). ** P<0.001 fasted vs. fed. 
 
Figure 3.3. Appeal rating difference. 
 
 
 
 
 
 
 
Difference between appeal ratings for high-calorie and low-calorie foods when eating (fed, solid bar) and 
skipping (fasted, white bar) breakfast. *** P<0.001 fed vs. fasted. 
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Table 3.2. Food picture appeal rating. 
Picture Appeal Rating Fed Fasted 
Absolute rating a   
High-calorie foods 2.15 ± 0.19 3.98 ± 0.13 *** 
Low-calorie foods 2.39 ± 0.16 3.74 ± 0.15 *** 
Household objects 2.41 ± 0.14 2.26 ± 0.16 
Blurred 1.91 ± 0.18 1.91 ± 0.19 
Chocolate high-calorie foods 2.29 ± 0.22 3.98 ± 0.18 *** 
Sweet non-chocolate high-calorie foods 2.27 ± 0.20 3.94 ± 0.15 *** 
Savoury high-calorie foods 2.00 ± 0.18 3.99 ± 0.13 *** 
Difference in rating between b   
High-calorie foods & objects - 0.26 ± 0.27 1.72 ± 0.23 *** 
Low-calorie foods & objects - 0.03 ± 0.22 1.48 ± 0.23 *** 
Chocolate high-calorie foods & objects - 0.12 ± 0.28 1.72 ± 0.26 *** 
Sweet non-chocolate high-calorie foods & 
objects 
- 0.14 ± 0.28 1.68 ± 0.23 *** 
Savoury high-calorie foods & objects - 0.41 ± 0.26 1.73 ± 0.23 *** 
High-calorie & low-calorie foods - 0.23 ± 0.11 0.24 ± 0.12 *** 
Chocolate high-calorie & low-calorie foods - 0.10 ± 0.15 0.25 ± 0.19 ** 
Sweet non-chocolate high- & low-calorie foods - 0.12 ± 0.14 0.20 ± 0.11 * 
Savoury high-calorie & low-calorie foods - 0.39 ± 0.10 0.25 ± 0.12 *** 
Objects & blurred 0.51 ± 0.21 0.35 ± 0.19 
Food picture appeal rating (a1=not at all, 2=not really, 3=neutral, 4=a little, 5=a lot; b1st category minus 2nd 
category). Data shown as mean±SEM, n=20 per group: * P<0.01, ** P<0.005, *** P<0.001 fed vs. fasted.
  
 
 
3.2.1. Relationship between Appeal and VAS 
The individual differences in the appeal of high-calorie foods (compared to objects) 
between fasted and fed states also correlated with the individual differences in ‘hunger’ 
(r=+0.55, P=0.01) and ‘pleasantness to eat’ (r=+0.63, P=0.003) (Figure 3.4.).  
Inividual differences in hunger positively correlated with individual differences in 
appeal bias towards high-calorie foods in the fed state (r=+0.60, P=0.002) but not in the 
fasted (r=+0.14, P=0.7) state when viewing high-calorie over low-calorie foods (Figure 
3.5.).  
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Figure 3.4. Correlation between differences in appeal ratings for high-calorie 
foods and appetite VAS between fasted and fed visits.  
 
 
 
 
 
 
 
 
 
Correlations for high-calorie foods (relative to objects) between fasted and fed states and changes in (A) ‘hunger’ 
and (B) ‘pleasantness to eat’ VAS ratings between fasted and fed states.   
 
 
Figure 3.5. Relationship between absolute hunger ratings and appeal rating bias. 
 
 
 
 
 
 
 
 
 
 
Relationship between VAS hunger ratings and individual differences in appeal ratings when viewing high-calorie 
over low-calorie foods at the fasted (black triangles) and fed (black squares) visit.  
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3.3. ROI analysis 
The nutritional state and caloric value of the food stimuli had a significant interactive 
effect on brain activation in each ROI (Figure 3.6., Table 3.4.).  
There was no significant activation of the ventral striatum, anterior insula, 
amygdala, medial OFC and lateral OFC on viewing high-calorie compared to low-calorie 
foods when fed (P=0.4-0.9). When fasted, there was significantly greater activation 
bilaterally in each of these ROIs on viewing high-calorie compared to low-calorie foods 
(P<0.01 to <0.001) (Figure 3.6., Table 3.3.). The magnitude of activation was also 
significantly greater for high-calorie than low-calorie foods when fasted but not when fed 
(P=0.03-0.002) (Figure 3.6., Table 3.4.).  
There were no voxels within any of the ROIs whose activation showed a significant 
correlation with BMI for the high-calorie vs. low-calorie food contrast when fasted 
(surviving SVC when including BMI as a covariate in the GLM). 
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Figure 3.6. Brain activation in the fed and fasted state to food pictures.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Left hand side: area of (a) ventral striatum, (b) amygdala, (c) anterior insula, (d) medial OFC and (e) lateral OFC 
showing increased group activation for viewing high-calorie relative to low-calorie foods when fasted. Color bar 
indicates T values. Activations are thresholded at P<0.005 uncorrected, minimum cluster size 5 voxels, overlaid 
onto the average EPI scan for all subjects. Co-ordinates are given in standard MNI space. By contrast, no voxels 
were activated above this threshold when fed (statistical parametric maps not shown).  Right hand side: average 
bilateral activation (contrast beta value relative to objects) in peak activated voxel in each ROI for high-calorie 
(black square, solid line) and low-calorie (white triangle, dotted line) foods when fed and fasted. ***P<0.001 
high-calorie vs. low-calorie. 
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Table 3.3. Co-ordinates of peak activated voxel with ROIs. 
ROI H Fed Fasted 
  x y z v Z x y z v Z 
Ventral striatum L - - - - ns -12 10 -12 55 3.02 * 
a 
 R - - - - ns 14 14 -14 9 3.03 * b 
Amygdala L - - - - ns -18 0 -12 22 3.31** b 
 R - - - - ns 34 2 -24 29 4.47 ** d 
Insula L - - - - ns -40 4 2 655 4.45 ** 
c 
 R - - - - ns 38 16 -14 38 3.80 ** 
b 
Medial OFC L - - - - ns -8 50 -12 144 3.56 ** b 
 R - - - - ns 12 46 -6 215 3.52 ** 
b 
Lateral OFC L - - - - ns -38 20 -12 133 3.91 ** b 
 R - - - - ns 30 34 -16 403 3.90 ** b 
Acivation within ROI at 2nd level group analysis for high- vs. low-calorie food picture contrast in fasted and fed 
state (n=20 per group). Results represent co-ordinates of peak statistical voxel (x, y, z in MNI space) for each 
hemisphere (H), number of voxels within cluster (v, 2 x 2 x 2 mm), and Z statistic using statistical threshold 
P<0.005, minimum 5 voxel cluster size. Uncorrected: *P= 0.001, **P<0.001; family wise error (FWE) small 
volume correction (SVC): aP=0.05, bP<0.05, cP<0.005, dP<0.001. 
 
Table 3.4. Appeal ratings and magnitude of activation within ROI. 
ROI H Fed  Fasted 
  High-Calorie Low-calorie  High-Calorie Low-calorie 
Appeal rating  -0.258 ± 0.270 -0.028 ± 0.222  1.716 ± 0.227 a *** 1.475 ± 0.226 *** 
Ventral striatum L 0.044 ± 0.046 0.085 ± 0.057  0.206 ± 0.060 b 0.056 ± 0.048 
 R 0.064 ± 0.054 0.043 ± 0.055  0.201 ± 0.057 c 0.007 ± 0.050 
Amygdala L 0.004 ± 0.047 0.045 ± 0.045  0.323 ± 0.075 b ** 0.129 ± 0.047 
 R 0.078 ± 0.038 0.071 ± 0.041  0.100 ± 0.060 c -0.073 ± 0.069 
Insula L 0.066 ± 0.053 0.044 ± 0.044  0.197 ± 0.050 c -0.032 ± 0.058 
 R 0.093 ± 0.054 0.121 ± 0.053  0.128 ± 0.071 c -0.034 ± 0.070 * 
Medial OFC L 0.038 ± 0.111 -0.078 ± 0.114  0.245 ± 0.098 c - 0.131 ± 0.110 
 R 0.107 ± 0.060 0.067 ± 0.053  0.153 ± 0.045 c -0.055 ± 0.051 
Lateral OFC L -0.088 ± 0.104 - 0.045 ± 0.105  0.044 ± 0.079 b -0.239 ± 0.090 
 R 0.014 ± 0.060 0.002 ± 0.063  0.087 ± 0.065 c - 0.055 ± 0.067 
Appeal rating difference (compared to object pictures) and magnitude of activation at peak voxel within ROI for 
each hemisphere (H) depending on nutritional state (fasted vs. fed) and food picture (high-calorie vs. low-
calorie). Co-ordinates of peak voxel determined from high-calorie vs. low-calorie foods contrast when fasted. 2-
way repeated measures ANOVA using nutritional state and food picture as factors, and ß values extracted at peak 
voxel for individual subject contrast estimates (vs. objects) for high-calorie and low-calorie foods (n=20 per 
group): aP<0.05, bP<0.01, cP<0.001 for high-calorie vs. low-calorie foods within fed or fasted; *P<0.05, 
**P<0.01, ***P<0.001 for fed vs. fasted within low-calorie or high-calorie. 
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3.3.1. Relationship between brain activation and food appeal 
ROI activations were correlated with subjective appeal scores in individual subjects to 
examine the relationship between the effect of nutritional state (fed or fasted) on brain 
reward systems and food appeal. The increase in appeal rating bias for high-calorie over 
low-calorie foods with fasting was positively correlated with the change in activation in 
both the medial OFC (r=+0.49, P=0.029), and lateral OFC (r=+0.48, P = 0.034) for the 
high-calorie vs. low-calorie food contrast with fasting (Figure 3.7.). However no significant 
correlations were seen for any of the other ROIs. 
 
Figure 3.7. Relationship between brain activation and food appeal. 
 
 
 
 
 
 
 
 
 
 
Difference in activation (contrast beta value) within lateral (a) and medial (b) OFC (average bilateral) on viewing 
high-calorie vs. low-calorie foods between fasted and fed states correlates with difference in appeal ratings for 
high-calorie relative to low-calorie foods between fasted and fed states.  
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3.4. Whole brain analysis 
Additional brain areas were activated when viewing high-calorie than low-calorie foods 
when fasted but only few areas when fed using whole brain analysis (Table 3.5., 3.6.). 
More reward areas were activated at the fasted visit but not at the fed Saline visit. Visual 
areas were activated at both visits. 
 
Table 3.5. Whole brain analysis in fasted state.  
Region H Z v x y z 
Cerebellum L 5.25 a b 2014 -36 -46 -32 
Cerebellum R 3.94 a 50 18 -74 -24 
Inferior temporal/cerebellum R 5.07 a b 2577 28 -40 -30 
Posterior cingulated L 4.85 a 176 -8 -24 50 
Ventroanterior insula L 4.49 a 928 -36 10 -16 
Ventroanterior insula R 4.47 a 177 34 2 -24 
Ventroposterior insula R 4.45 a 92 38 -10 -14 
Pre-frontal/orbitofrontal cortex L 4.30 a 84 -26 48 34 
Premotor cortex/dorsal cingulate L/R 4.24 a 492 2 2 70 
Dorsolateral pre-frontal cortex L 4.15 a 19 -24 36 54 
Premotor/motor cortex L 4.13 a 329 -46 4 54 
STG/temporal pole L 4.06 a 44 -38 18 -28 
Motor cortex L 3.98 a 9 -16 -8 54 
Posterior hippocampus L 3.97 a 33 -20 -38 2 
Hippocampus (posterior)/lingual gyrus L 3.81 a 129 -14 -46 -4 
Somatosensory cortex L 3.97 a 195 -34 -40 64 
Visual cortex (cuneus) L 3.94 a 305 -8 -78 0 
Orbitofrontal cortex (medial) R 3.90 a 48 30 34 -16 
Orbitofrontal cortex (medial) L 3.89 a 92 -20 66 6 
Orbitofrontal cortex (lateral) R 3.86 a 42 42 40 -2 
Somatosensory R 3.86 a 30 54 -24 44 
Orbitofrontal cortex (medial) L 3.75 a 59 -14 56 -8 
Dorsolateral pre-frontal cortex R 3.73 a 20 26 34 54 
Dorsal medial pre-frontal cortex R 3.63 a 10 10 28 62 
Lateral occipital/inferior parietal lobule L 3.72 a 19 -54 -72 18 
Motor cortex R 3.72 a 28 56 -10 24 
Cerebellum R 3.68 a 40 12 -54 -52 
Premotor cortex R 3.66 a 65 58 14 34 
Motor cortex L 3.59 a 16 -20 -8 74 
Insula/parietal operculum L 3.57 a 11 -50 -24 24 
Dorsal anterior cingulate R 3.66 a 147 8 20 30 
Dorsal anterior cingulate L 3.56 a 28 -10 14 36 
Activation within whole brain at 2nd level group analysis for high-calorie vs. low-calorie food picture contrast 
when fasted (n=20 per group). Results represent co-ordinates of peak statistical voxel (x, y, z in MNI space) 
within each cluster for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm), and Z statistics 
using statistical threshold P<0.001, minimum 5 voxel cluster size. Correction for multiple corrections: aFDR 
P<0.05; bFWE P<0.05. 
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Table 3.6. Whole brain analysis in fed state. 
Region H Z v x y z 
Central operculum/insula R 4.34 13 36 -8 18 
Visual cortex R 4.08 116 50 -62 -12 
Anterior fusiform cortex/  
temporo-occipital boundary 
L 3.63 51 -38 -50 -14 
Visual cortex L 3.50 44 -48 -66 -2 
Activation within whole brain at 2nd level group analysis for high-calorie vs. low-calorie food picture contrast 
when fed (n=20 per group). Results represent co-ordinates of peak statistical voxel (x, y, z in MNI space) within 
each cluster for each hemisphere (H), number of voxels within cluster (v), and Z statistics using statistical 
threshold P<0.001, minimum 5 voxel cluster size. No peak voxels survived correction for multiple corrections: 
FDR or FWE P<0.05. 
 
 
3.5. Control activation 
 
3.5.1. Object vs. blurred picture contrast 
The nutritional state had no significant effect on the activation in each ROI when viewing 
household objects vs. blurred pictures (P=0.3-0.8) (Figure 3.8.).  
 
Figure 3.8. Brain activation when viewing objects vs. blurred pictures. 
 
 
 
 
 
 
 
Activation (contrast beta value) in peak activated voxel (from high-calorie vs. low-calorie foods contrast in fasted 
state) within each ROI (average bilateral) on viewing objects relative to blurred pictures when fed (solid bar) and 
fasted (white bar). *P<0.05 fasted vs. fed. 
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3.5.2. Visual checkerboard 
The occipital cortex and lateral geniculate nucleus showed no significant difference in 
activation on viewing a 4Hz flashing checkerboard between fed and fasted states (P=0.1-
0.9) (Figure 3.9. a-c, Table 3.7.).  
 
Figure 3.9. Brain activation when viewing 4Hz visual checkerboard. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a,b) Group brain activation in occipital cortex and lateral geniculate nucleus when viewing flashing checkerboard 
(relative to fixation cross) when (a) fed and (b) fasted. Colour bar indicates T values. Activations are thresholded 
at *P<0.05 uncorrected, minimum cluster size 5 voxels. Co-ordinates are given in standard MNI space. (c) 
Activation (contrast beta value) in peak activated voxel (from fasted state) within each ROI (lingual gyrus, 
calacrine sulcus, lateral geniculate nucleus (LGN), average bilateral) on viewing flashing checkerboard (relative 
to fixation cross) when fed (solid bar) and fasted (white bar). *P<0.05 fasted vs. fed.  
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Table 3.7. Co-ordinates of activated voxels when viewing 4Hz flashing  
checkerboard. 
ROI H Fed Fasted 
  x y z v Z x Y z v Z 
Calacrine  L -10 -102 -10 734 7.67 ** d -12 -98 -10 749 6.98 ** d 
sulcus R 22 -94 -4 423 6.90 ** d 22 -94 -2 444 6.98 ** d 
Lingual  L -14 -98 -12 558 6.35 ** d -14 -98 -12 623 6.58 ** d 
gyrus R 24 -94 -8 797 6.35 ** d 10 -92 -10 814 6.82 ** d 
Lateral  L -20 -28 -4 98 4.13 ** c -22 -26 -6 106 4.33 ** c 
geniculate n. R 24 -28 -2 67 3.91 ** b 24 -26 -6 31 3.55 ** a 
Activation within regions of interest (ROI) at 2nd level group analysis for flashing checkerboard vs. fixation cross 
contrast in fasted and fed state (n=20 per group). Results represent co-ordinates of peak statistical voxel (x, y, z 
in MNI space) for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm), and Z statistic using 
statistical threshold P<0.005, minimum 5 voxel cluster size. Uncorrected: **P<0.001; FWE small volume 
correction (SVC): aP<0.05, bP<0.01, cP<0.005, dP<0.001. 
 
3.5.3. Reaction time for appeal rating 
There was no significant difference in the reaction time for appeal rating of any of the 
picture categories between the fasted and fed state (P=0.4-0.9) (Table 3.8.), suggesting 
the absence of non-specific effect of nutritional state on the picture viewing and rating 
task. 
 
Table 3.8. Picture rating reaction time.  
Picture Rating Reaction Time (msec) Fed Fasted 
High-calorie foods 1271 ± 57 1282 ± 48 
Low-calorie foods 1318 ± 57 1292 ± 51 
Household objects 1280 ± 50 1207 ± 56 
Blurred 1058 ± 69 1024 ± 69 
Data shown as mean ± SEM, n=20 per group. 
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3.6. Relationship with questionnaire scores 
 
3.6.1. Behavioural Activation and Inhibition Scale (BAS / BIS) 
Mean ± SEM (range) questionnaire scores were as follows: BIS: 21.8 ± 0.86 (15-28); BAS 
drive: 10.6 ± 0.49 (range 8-15); BAS fun seeking: 12.2 ± 0.61 (7-16); BAS reward 
responsiveness: 16.9 ± 0.45 (14-20). 
 BAS-drive scores were significantly positively correlated with activation to high-
calorie relative to low-calorie foods in the ventral striatum (x 12, y 10, z -16: 57 voxels, 
SVC FWE P=0.025; r=+0.68, P<0.001), but no other ROIs (Figure 3.10. a). BAS-drive did 
not differ between genders (male 10.3 ± 0.5 vs. female 10.9 ± 0.9, P=0.56) and the 
positive correlation between ventral striatum activation and BAS-drive remained 
significant (P=0.001), when including gender and visit number as independent variables 
(though they were not significant variables themselves: P=0.7 and 0.4 respectively).  
 
 
3.6.2. Dutch Eating Behaviour Questionnaire (DEBQ) 
Mean ± SEM (range) questionnaire scores were as follows: DEBQ-restraint 19.8 ± 1.1 
(11-32); DEBQ-external: 34.8 ± 0.87 (27-43).  
 DEBQ-restraint score was positively correlated with activation to high-calorie 
relative to low-calorie foods in the DLPFC (-32, 54, 28: 9 voxels, P<0.001, SVC FWE 
P=0.04; r=+0.69, P<0.001) and dorsal ACC (-6, 10, 36: 12 voxels, P=0.001, SVC FWE 
P=0.04; r=+0.63, P=0.003) (Figure 3.10. b,c)..  
By contrast, DEBQ-restraint was negatively correlated with activation for high-
calorie relative to low-calorie foods in the amygdala (-30, -4, -22: 4 voxels, P=0.001, SVC 
FWE P=0.04; r=-0.53, P=0.015), and left lateral OFC (-38, 28, -22: 243 voxels, P<0.001, 
SVC FWE P=0.003; r=-0.83, P<0.001) (Figure 3.10. d,e).  
There was a tendency for a negative correlation of DEBQ-restraint with activation 
in the right lateral OFC but it did not survive SVC for multiple comparisons (2 clusters: 38, 
36, -10: 7 voxels, P<0.001, SVC FWE P=0.16; r=-0.68, P=0.001; and 44, 30, -18: 28 
voxels, P=0.001, SVC FWE P=0.26; r=-0.64, P=0.002). 
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Dietary restraint did not differ significantly between genders (male 18.0 ± 1.4 vs. 
female 21.6 ± 1.5, P=0.10). Furthermore the negative correlations between dietary 
restraint and amygdala and left lateral OFC activation (P=0.015 and <0.001 respectively), 
and the positive correlations with DLPFC and dorsal ACC activation (P=0.004 and 0.005 
respectively), remained significant when including gender and visit number as 
independent variables, though they were not significant variables themselves (gender: 
P=0.3-1.0, visit number: P=0.1-0.9).  
 Examination of the spread of dietary restraint between subjects, revealed 
one outlier with particularly high dietary restraint (score of 32) (Figure 3.10. b-c). 
Exclusion of this outlier from the linear regression analysis did not qualitatively alter the 
correlations between DEBQ-restraint and activation to high-calorie relative to low-calorie 
foods in the ROIs although the results for DLPFC and dorsal ACC did not quite reach 
statistical significance (amygdala: r=-0.52, P=0.02; left lateral OFC: r=-0.78, P<0.001; 
DLPFC: r=+0.45, P=0.05; dorsal ACC: r=+0.43, P=0.06).  
 
There was no significant correlation between BAS-drive nor DEBQ-restraint with activation 
to viewing object compared to blurred pictures in any ROI (r=-0.02 to +0.31, P=0.2-0.9). 
There was no significant correlation between the difference in appeal rating between high-
calorie and low-calorie foods and BAS-drive (r=+0.13, P=0.6) nor DEBQ-restraint 
(r=+0.10, P=0.7). 
There was no significant correlation seen between activation in any ROI and DEBQ-
external eating behaviour when including the latter as an independent variable in the 
GLM. 
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Figure 3.10. Relationship between brain activation and questionnaire scores.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Left hand side: Statistical parametric maps indicating significant group correlations between brain activation in a 
priori regions of interest  when viewing high-calorie compared to low-calorie food pictures when fasted, and (a) 
reward sensitivity (BAS drive) in ventral striatum, or dietary restraint in (b) DLPFC, (c) dorsal ACC, (d) amygdala 
and (e) lateral OFC.  Colour bar indicates T values. Activations are thresholded at P<0.005 uncorrected, 
minimum cluster size 3 voxels, overlaid onto the average EPI scan for all subjects. Co-ordinates are given in 
standard MNI space. n=20 per group. Right hand side: Correlation of individual differences in brain activation for 
high-calorie vs. low-calorie food contrast at peak voxel in (a) ventral striatum, (b) DLPFC, (c) dorsal ACC, (d) 
amygdala and (e) lateral OFC, and (a) reward sensitivity (BAS drive) or (b-e) dietary restraint for each individual 
subject (n=20).   
R 
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3.7. Summary results fed – fasted fMRI study 
In twenty non-obese healthy adults, fasting selectively increased activation to pictures of 
high-calorie over low-calorie food in the ventral striatum, amygdala, anterior insula, and 
medial and lateral orbitofrontal cortex (OFC). Furthermore, fasting enhanced the 
subjective appeal of high-calorie more than low-calorie foods, and the change in appeal 
bias towards high-calorie foods was positively correlated with medial and lateral OFC 
activation. 
 Individual differences in reward drive positively correlated with activation in the 
ventral striatum when viewing high-calorie compared to low-calorie foods. Dietary 
restraint positively correlated with activation in the dorsolateral prefrontal cortex (DLPFC) 
and dorsal anterior cingulate cortex (ACC) when viewing high-calorie compared to low-
calorie foods, but negatively correlated with activation in the amygdala and lateral 
orbitofrontal cortex (OFC). 
 
 
3.8. Limitations of fed – fasted fMRI study 
For the fed visit, the size of the breakfast consumed by the subject was variable. Subjects 
were told to have a filling breakfast of their choice one hour before they arrived for fMRI 
scanning. The breakfast intake was 724 ± 59 kCal (mean ± SEM). In order to compare 
brain activity between subjects it is important to have the same macronutrient 
composition consumed by each of them. For that reason, questionnaire scores were not 
correlated to brain activation in this study.  
 
The subject’s appetite on the study day could also be influenced by food intake the night 
prior to the study day and irregular eating habits habits (not eating meals at typical times 
or not eating breakfast). Indeed, research underlined that the effect of skipping breakfast 
on subsequent intake depends on the usual breakfast habits (Schlundt et al., 1992). This 
study did not control for food intake nor assess participant’s normal eating habits by using 
dietary records. However, only one subject reported to eat breakfast only 3 days per 
week, 2 eat breakfast 4 days a week, and 70% eat breakfast every day.  
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Females were not scanned in the same phase of their menstrual cycle. There is evidence 
for hormone-induced changes in food selection in the luteal phase of the menstrual cycle. 
Thus, food intake as well as fMRI responses to rewarding stimuli can vary over the 
menstrual cycle in response to changes in ovarian steroid hormone levels (Buffenstein et 
al., 1995; Dye and Blundell, 1997; Dreher et al., 2007; Van Vugt, 2009, Frank et al., 
2010).  
 
In this study, there was no blood collection to measure gut hormones involved in appetite 
regulation. It is therefore impossible to relate changes in brain activation in the fed and 
fasted state to changes in anorexigenic and orexigenic gut hormones.  
 
Geometric distortions caused by inhomogenities in the magnetic field can reduce brain 
activation in certain areas such as the frontal cortex due to vicinity to air-filled sinuses. It 
is possible to correct the inhomogenities by using field maps (Huettel, 2004). In this 
study, field maps have not been acquired due to delayed sequence development. Signal 
such as activation in the orbitofrontal cortex may have been lost in this study which then 
could have biased the significance of the results. 
 
Studies in animals and humans have shown that anxiety and stress can alter feeding 
behavior (Adam and Epel, 2007; Chandarana et al., 2009; Born et al., 2010). The 
participants in this study had no dummy visit to acclimatize to the study and scanning, 
although many subjects had previously experienced MRI scans. Therefore, stress and 
anxiety may have influenced the study results and especially the activation in important 
brain reward systems. Nevertheless, the order of the study visits was counterbalanced 
and so the differences between the fed and fasted visits should remain the same even 
when including a sham visit. 
 
In the subsequent Ghrelin fMRI study, these limitations were corrected: every subject had 
the same breakfast, subjects were instructed to eat the same dinner the night before each 
study visit and to keep a food diary of intake the day before the study to improve and 
check for similar prior food intake. Blood was collected throughout the study morning to 
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measure gut hormones. Field maps were acquired during each fMRI scanning session. A 
dummy visit was also included in the ghrelin fMRI study. The following chapter shows the 
importance of dummy visits in feeding studies. 
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Chapter 4 
REPRODUCIBILITY OF  
EATING BEHAVIOUR STUDIES 
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4.1. General limitations of eating behaviour studies 
Measuring eating behaviour can be very challenging. Self-report measures of appetite 
such as Visual Analaogue Scale (VAS) have been previously questioned in terms of their 
reproducibility. However, VAS are easily used and translated, and appear to be valid, 
sensitive and unbiased measurement tools for regular use in standard practice and have 
been therefore used in this Ghrelin fMRI study (Blundell et al., 2010). 
Furthermore, appetite studies are mostly used within laboraties and therefore not 
performed under real-life circumstances which could influence eating behaviour (Blundell 
et al., 2010). For example, venepuncture to withdraw bloods on different time points has 
been shown to acutely increase circulating cortisol concentrations because of stress-
induced cortisol release related to the novelty of the first study visit (Chandarana et al., 
2009). The effects of unfamiliar study protocols and venepuncture could alter gut 
hormone concentrations or appetite. Several research studies including the Ghrelin fMRI 
study have adopted the standard protocol of waiting for subjects to “recover” after 
cannula insertion prior to commencing assessments (Chandarana et al., 2009). 
Additionally, feeding behaviour studies in animals and humans have shown that anxiety 
and stress can alter ad libitum food intake. Functional MRI studies have previously 
demonstrated that stress can alter responses in brain reward systems (Adam and Epel, 
2007; Chandarana et al., 2009; Blundell et al., 2010; Born et al., 2010). In the Ghrelin 
fMRI study, participants had one dummy visit to acclimatize to the hospital environment, 
research study protocol and MRI scanning protocol. The following chapter will analyse 
different measures of appetite and fMRI responses comparing the 2 identical fasted study 
fMRI visits.  
 
4.2. Fasted Dummy versus Fasted Saline visit (sub-study, ghrelin fMRI study) 
The initial Fasted Dummy visit has been compared with the subsequent Fasted Saline visit 
for the following parameters: VAS hunger, fullness, pleasantness, stress, anxiety, and 
sickness VAS ratings, serum cortisol and prolactin levels, lunch intake and pleasantness, 
fMRI appeal rating and fMRI BOLD signal to food pictures. Each measure was also used to 
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examine the correlation between the two fasted visits. Study characteristics and other 
comparisons are shown in the following table (Table 4.1.). There was a median interval of 
18 days between the 2 visits (range 6-151 days). Percentage intake of fat was 
significantly less at supper prior to the study visit and intake of carbohydrates significantly 
increased at the Fasted Dummy visit compared to the Fasted Saline visit (P<0.05). The 
time of injection to the first food picture run and time of injection to lunch was 
significantly longer at the Fasted Dummy visit (P<0.05). 
 
Table 4.1. Subject characteristics. 
 Fasted Dummy Fasted Saline 
N 17 17 
Age (years) 24.6 ± 1.6 24.6 ± 1.6 
Height (m) 1.80 ± 0.0 1.80 ± 0.0 
Weight (kg) 76.1 ± 3.7 76.3 ± 3.6 
BMI (kg/m2) 24.2 ± 0.7 24.1 ± 0.7 
Body fat (%) 16.6 ± 1.7 17.1 ± 1.6 
LBM (kg) 63.7 ± 3.5 64.6 ± 3.3 
Day of menstrual cycle (females) 5.2 ± 1.2 5.2 ± 1.2 
Food intake at supper prior to study   
                        Energy (kcal) 962 ± 135 1012 ± 179 
                        Protein (%) 19 ± 3 21 ± 2 
                        Fat (%) 30 ± 4 40 ± 5* 
                        Carbohydrate (%) 51 ± 5 38 ± 5* 
Food intake whole day prior to study   
                        Energy (kcal) 2142 ± 191 2645 ± 397 
                        Protein (%) 16 ± 1 17 ± 1 
                        Fat (%) 29 ± 3 37 ± 4 
                        Carbohydrate (%) 55 ± 3 46 ± 3 
Time fasting since supper (hrs) 17.4 ± 0.3 17.1 ± 0.3 
Time sleep (hrs) 7.4 ± 0.2 7.0 ± 0.3 
Time injection to first food fMRI scan (hrs) 0.8 ± 0.1 0.6 ± 0.0* 
Time injection to lunch (hrs) 1.7 ± 0.1 1.6 ± 0.0* 
Absolute Head motion (mm) 0.4 ± 0.1 0.2 ± 0.0 
n=17 per group, Mean ± SEM, *P<0.05. 
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4.2.1. VAS appetite scores and food intake 
Analysis of VAS ratings revealed that there was no significant difference between the 
Fasted Dummy and the Fasted Saline visit in hunger ratings (P=0.65) but there was a 
trend for fullness to be greater (P=0.07), and pleasantness-to-eat to be lower (P=1.0) on 
the Fasted Dummy visit (Figure 4.1.). There was an 8% increase in energy intake 
(P=0.04) at the Fasted Saline visit compared to the Fasted Dummy visit (Figure 4.2., 
Table 4.2.). There was no significant difference in lunch tastiness (P=0.18) but a trend for 
lunch pleasantness to be greater at the Fasted Saline visit (P=0.07) (table 4.2.). 
 
Figure 4.2. Ad libitum lunch intake.  
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Ad libitum lunch intake for fasted visits (Fasted Dummy, dark blue bar and Fasted Saline, green dotted bar), 
n=17 per group. Data are expressed as mean ± SEM, *P<0.05.  
 
 
Table 4.2. Ad libitum lunch intake for fasted visits.  
 Fasted Dummy Fasted Saline 
Lunch intake   
Total lunch food (kcal) 1320 ±  81 1428 ±  101* 
Lunch tastiness 5.9 ±  0.3 6.4 ±  0.3 
Lunch pleasantness 6.0  ±  0.4 6.8 ±  0.3 
n=17 per group, data shown as mean ± SEM, *P<0.05 Fasted Dummy vs. the Fasted Saline. 
* 
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Figure 4.1. VAS appetite scores. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absolute VAS scores for hunger, fullness and pleasantness to eat ratings for fasted visits (Fasted Dummy, dark 
blue bar and Fasted Saline, green dotted bar), (A-C) time course of VAS scores, (D-F) mean AUC for each VAS 
score. n=15 per group (2 subjects have been excluded from the analysis because of incomplete data sets), data 
are expressed as mean ± SEM, *P<0.05. 
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4.2.2. Stress ratings  
Analysis of VAS stress ratings revealed that there was no significant difference between 
the Fasted Dummy and the Fasted Saline visit in stress (P=0.26), but anxiety (P=0.01), 
and sickness (P=0.01) ratings were significantly higher at the Fasted Dummy visit (Figure 
4.3.).      
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Figure 4.3. VAS stress scores.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absolute VAS scores for stress, anxiety and sickness ratings for fasted visits (Fasted Dummy, dark blue bar and  
 
Fasted Saline, green dotted bar), (A-C) time course of VAS stress scores, (D-F) AUC for each VAS stress score, 
n=15 per group (2 subjects have been excluded from the analysis because of incomplete data set), data are 
expressed as mean ± SEM, *P<0.05.  
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4.2.3. Serum stress hormones 
There was no significant difference between the Fasted Dummy and the Fasted Saline visit 
in serum cortisol (P=0.95), or prolactin (P=0.58) levels (Figure 4.4.).  
 
Figure 4.4. Cortisol and prolactin serum levels for fasted visits. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Cortisol and prolactin serum levels for fasted visits (Fasted Dummy, dark blue bar and Fasted Saline, green 
dotted bar), (A, B) time course of serum cortisol and prolactin levels, (C, D) AUC for each serum stress hormone, 
n=17 per group, data are expressed as mean ± SEM, *P<0.05. 
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4.2.4. Food picture appeal rating 
High-calorie foods were less appealing at the Fasted Dummy visit compared to the Fasted 
Saline visit (P<0.05) (but not low-calorie food, object and blurred pictures (P=0.77-0.96) 
(Figure 4.5.; Table 4.3.). High-calorie foods were more appealing relative to low-calorie 
foods at the Fasted Saline (P=0.01), but not at the Fasted Dummy visit (P=0.48) (Figure 
4.5.; Table 4.3.). These differences were seen for both chocolate and sweet non-chocolate 
(both P<0.005) but not savoury high-calorie foods (P=0.13) (Table 4.3.).  
There was a significantly greater appeal rating for the high-calorie (chocolate, 
sweet non-chocolate and savoury) and low-calorie foods relative to object pictures at both 
the Fasted Dummy and the Fasted Saline visit (P<0.001) (Figure 4.5.; Table 4.3.). There 
was no significant difference in the appeal of object relative to blurred pictures at either 
the Dummy Saline or the Fasted Saline visit (P=0.78) (Table 4.3.).  
 
Figure 4.5. Picture appeal rating.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Appeal rating of pictures (high-calorie foods: white bar, low-calorie foods: striped bar, non-food related 
household objects: black bar, blurred pictures: dotted bar), Fasted Dummy vs. Fasted Saline visit, n=17 per 
group, data are expressed as mean ± SEM, *P<0.05. 
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Table 4.3. Picture appeal rating. 
Picture Appeal Rating Fasted Dummy 
visit 
Fasted Saline 
visit 
Absolute rating a   
High-calorie foods 4.01 ± 0.12 4.28 ± 0.11* 
Low-calorie foods 3.91 ± 0.09 3.91 ± 0.11 
Household objects 2.68 ± 0.15 2.62 ± 0.20 
Blurred 2.20 ± 0.17 2.18 ± 0.20 
Chocolate high-calorie foods 4.03 ± 0.13 4.30 ± 0.11*** 
Sweet non-chocolate high-calorie foods 3.99 ± 0.13 4.28 ± 0.11*** 
Savoury high-calorie foods 3.99 ± 0.16 4.21 ± 0.16 
Difference in rating between b   
High-calorie foods & objects 1.33 ± 0.18 1.60 ± 0.23 
Low-calorie foods & objects 1.23 ± 0.18 1.26 ± 0.25 
Chocolate high-calorie foods & objects 1.35 ± 0.18 1.63 ± 0.19* 
Sweet non-chocolate high-calorie foods & objects 1.32 ± 0.20 1.26 ± 0.24* 
Savoury high-calorie foods & objects 1.31 ± 0.19 1.54 ± 0.28 
High-calorie & low-calorie foods 0.09 ± 0.13 0.34 ± 0.12** 
Chocolate high-calorie & low-calorie foods 0.12 ± 0.15 0.37 ± 0.13* 
Sweet non-chocolate high-calorie & low-calorie foods 0.08 ± 0.13 0.36 ± 0.10*** 
Savoury high-calorie & low-calorie foods 0.07 ± 0.17 0.29 ± 0.18 
Objects & blurred 0.47 ± 0.22 0.43 ± 0.20 
Picture appeal rating a1=a lot, 2=a little, 3=neutral, 4=not really, 5=not at all; b1st category minus 2nd category, 
Fasted Dummy vs. Fasted Saline visit, n=17 per group, data are expressed as mean ± SEM, ***P<0.005, 
**P<0.01 *P<0.05. 
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4.2.5. Reaction time for appeal rating 
There was a significant increased reaction time for appeal rating of all picture categories 
at the Fasted Dummy compared to the Fasted Saline visit (P<0.05) (Table 4.4.). 
 
Table 4.4. Picture rating reaction time.  
Picture Rating Reaction Time (msec) Fasted Dummy visit Fasted Saline visit 
High-calorie foods 1395 ± 41 1226 ± 38** 
Low-calorie foods 1398 ± 42 1250 ± 39* 
Household objects 1399 ± 40 1227 ± 40** 
Blurred 1127 ± 24 1008 ± 22* 
Data shown as mean ± SEM, n=17 per group, *P<0.05, **P<0.01, ***P<0.001. 
 
4.2.6. Brain activation  
 
4.2.6.1. Region of interest (ROI) analysis  
Activation in the left ventral striatum on viewing high-calorie foods vs. objects (P=0.03) at 
the Fasted Dummy visit was significantly greater compared to the Fasted Saline visit. This 
was not seen however for the right ventral striatum (P=1.0) or bilateral ventral striatum 
(p=0.31) nor for low-calorie foods vs. objects (P=0.16-0.81) (Figure 4.6., Table 4.5). 
Activation in the right ventral striatum (but not the left or bilateral ventral striatum 
(P=0.18-0.92)) when viewing household objects vs. blurred pictures (P=0.02) at the 
Fasted Dummy visit was significantly greater compared to the Fasted Saline visit (Table 
4.5.). 
There was no significant difference in activation in the insula (P=0.20-0.56), 
amygdala (P=0.30-0.96), or anterior OFC (P=0.23-1.0) on either side or bilaterally for 
high-calorie foods vs. objects, low-calorie foods vs. objects or objects vs. blurred pictures 
between the Fasted Dummy and Fasted Saline visit (Table 4.5.). 
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Figure 4.6. Ventral striatum activation to food pictures at fasted visits.  
 
 
 
 
 
 
Left hand side: area of left ventral striatum showing activation for viewing high-calorie (HC) foods and low-
calorie (LC) foods relative to objects (Obj) for the Fasted Dummy (dark blue clusters) and for the Fasted Saline 
visit (green clusters). Yellow colour: overlap of activation for both visits. Activation thresholded at FDR P<0.05, 
n=17. Co-ordinates are given in standard MNI space.  
Right hand side: average activation of the left ventral striatum (contrast beta value) for high-calorie (HC) and 
low-calorie (LC) foods relative to objects (Obj) and objects relative to blurred (Blur) pictures between the Fasted 
Dummy (blue bar) and the Fasted Saline visit (green dotted bar). n=17 per group, data are expressed as mean 
± SEM *P<0.05. ROI mask determined by overlap of Havard FSL atlas for nucleus accumbens with combined 
contrast Fasted Saline, Fed Saline, Fed Ghrelin for high-calorie foods relative to objects collapsed across visits 
FDR P<0.05. 
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Table 4.5. Magnitude of Activation within ROIs for fasted visits. 
ROI H Fasted Dummy visits Fasted Saline visit 
  
High-calorie vs Object Low-calorie vs Object Object vs Blurred High-calorie vs Object Low-calorie vs Object Object vs Blurred 
Ventral 
striatum L 0.127 ± 0.031 0.087 ± 0.015 0.013 ± 0.033 0.042 ± 0.030* 0.052 ± 0.032 0.017 ± 0.033 
 R 0.081 ± 0.03 0.031 ± 0.022 0.095 ± 0.036 0.084 ± 0.039 0.082 ± 0.031 0.011 ± 0.028* 
 Bilateral 0.210 ± 0.050 0.120 ± 0.020 0.110 ± 0.060 0.130 ± 0.060 0.130 ± 0.060 0.030 ± 0.060 
Amygdala L 0.204 ± 0.056 0.059 ± 0.056 0.182 ± 0.056 0.170 ± 0.063 0.097 ± 0.06 0.121 ± 0.037 
 R 0.202 ± 0.049 0.105 ± 0.047 0.157 ± 0.059 0.169 ± 0.039 0.109 ± 0.052 0.102 ± 0.037 
 Bilateral 0.410 ± 0.100 0.160 ± 0.100 0.340 ± 0.110 0.340 ± 0.090 0.210 ± 0.100 0.220 ± 0.070 
Insula L 0.190 ± 0.039 0.131 ± 0.024 0.292 ± 0.038 0.150 ± 0.033 0.066 ± 0.050 0.227 ± 0.022 
 R 0.173 ± 0.026 0.140 ± 0.024 -0.025 ± 0.228 0.123 ± 0.035 0.057 ± 0.048 0.020 ± 0.018 
 Bilateral 0.360 ± 0.060 0.2720 ± 0.040 0.000 ± 0.060 0.270 ± 0.070 0.120 ± 0.100 0.050 ± 0.030 
Anterior OFC L 0.202 ± 0.053 0.130 ± 0.04 0.137 ± 0.042 0.262 ± 0.031 0.196 ± 0.063 0.139 ± 0.044 
 R 0.122 ± 0.044 0.066 ± 0.036 0.159 ± 0.068 0.122 ± 0.06 0.070 ± 0.059 0.196 ± 0.052 
 Bilateral 0.320 ± 0.090 0.260 ± 0.070 0.300 ± 0.100 0.380 ± 0.080 0.260 ± 0.110 0.330 ± 0.090 
Average magnitude of activation within regions of interest (ROIs) for each hemisphere (H) at the Fasted Dummy visit and the Fasted Saline visit. Beta values extracted for each 
individual subject contrast estimates (vs. objects) for high-calorie and low-calorie foods and objects vs. blurred picture contrast: n=17 per group, data are expressed as mean 
± SEM, *P<0.05 for Fasted Dummy visit vs. Fasted Saline visit. 
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4.2.6.2. Whole brain analysis 
Additional brain areas were activated on viewing high-calorie and low-calorie foods 
relative to objects at the Fasted Dummy visit and the Fasted Saline visit using whole brain 
analysis (coordinates are given in Tables 4.6.-4.9.).  
 
Compared to the first fasted fMRI study, less brain areas were activated when viewing 
high-calorie food pictures at the Fasted Dummy visit in the second study which can be due 
to the fact that the second study involved cannulation on a hospital ward. This might have 
afftected the stress level of the study participants. Also, the two fMRI studies used 
different softwares and atlases to analyse the data which may have biased the type of 
regions who are activated in each study. The second fMRI study used a different fMRI 
analysis software because is contains improved tools and is easier to use, especially for 
scripting purposes. 
 
Notably was also the quantity of areas activated when comparing the Fasted Dummy with 
the Fasted Saline visit. For both contrast, viewing high-calorie and low-calorie foods vs. 
objects, at the Fasted Dummy visit more brain areas were activated. Especially when 
viewing low-calorie foods, half as many brain areas were activated on the Fasted Saline 
visit. Also the type of areas activated at each visit was slightly different for the two fasted 
visits. For example, the accumbens was only activated at the Fasted Dummy visit whereas 
at the Fasted Saline visit only the Parahippocampus and hippocampus were activated 
when viewing high-calorie and low-calorie foods vs. objects. 
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Table 4.6. Whole brain analysis at the Fasted Dummy visit for viewing high-
calorie foods (vs.objects).  
Region H Z v x y z 
Occipital Pole R .82 13452 12 -92 0 
Inferior Frontal Gyrus, pars triangularis R 5.44 427 46 44 8 
Insular Cortex  R 4.94 976 40 6 -14 
Inferior Frontal Gyrus, pars triangularis L 4.37 201 -42 38 8 
Anterior Cingulate Gyrus  R 4.27 476 4 40 8 
Inferior Temporal Gyrus, temporooccipital part  R 4.27 322 54 -46 -22 
Precentral Gyrus R 4.13 91 50 6 26 
Supramarginal Gyrus, anterior division  R 4.09 34 52 -34 50 
Lateral Occipital Cortex, superior division  L 3.99 252 -22 -66 44 
Supramarginal Gyrus, anterior division L 3.95 103 -46 -36 38 
Orbitofrontal cortex L 3.86 90 -26 34 -16 
Frontal Pole  R 3.73 128 26 64 6 
Insular Cortex  L 3.57 82 -32 16 10 
Orbitofrontal Cortex R 3.5 61 26 32 -20 
Posterior Cingulate Gyrus R 3.35 211 4 -28 26 
Inferior Temporal Gyrus, temporooccipital part  L 3.35 32 -48 -46 -22 
Postcentral Gyrus  L 3.28 5 -54 -16 46 
Temporal Fusiform Cortex  R 3.27 15 30 -4 -40 
Accumbens  R 3.18 30 10 18 0 
Anterior Cingulate Gyrus  L 3.17 21 -10 24 22 
Frontal Pole  L 3.09 23 -24 46 26 
Precentral Gyrus  L 3.04 35 -44 -16 42 
Inferior Frontal Gyrus, pars opercularis  R 3.04 14 48 18 30 
Middle Frontal Gyrus  L 3.03 5 44 22 42 
Middle Frontal Gyrus  R 2.81 6 38 6 54 
Activation within whole brain analysis for high-calorie picture contrast (relative to objects) at the Fasted Dummy 
visit (n=17 per group). Results represent co-ordinates of the peak voxel (x, y, z in MNI space (in mm)) of the 
cluster for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm). Threshold correction for multiple 
corrections: FDR P<0.05 and minimum 5 voxel cluster size. 
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Table 4.7. Whole brain analysis at the Fasted Dummy visit for viewing low-
calorie foods (vs.objects). 
Region H Z v x y z 
Occipital Pole L 7.05 9787 -14 -90 -10 
Insular Cortex  R 4.72 649 38 6 -14 
Occipital Fusiforum Gyrus R 4.26 624 16 -74 40 
Inferior Frontal Gyrus R 5.13 462 46 42 8 
Insular Cortex L 4.89 443 -40 -4 2 
Lateral Occipital Cortex L 3.9 157 -24 -68 44 
Precentral Gyrus L 3.51 82 -40 -8 42 
Inferior Frontal Gyrus L 3.46 43 -36 34 10 
Accumbens L 3.08 40 -12 12 -8 
Supramarginal Gyrus, anetrior division L 3.34 31 -48 -36 36 
Orbitofrontal Cortex L 3.7 31 -28 36 -16 
Caudate R 3.39 29 10 22 4 
Anterior Cingulate Gyrus R 3.45 28 4 38 10 
Thalamus R 3.18 28 22 -30 -4 
Inferior Temporal Gyrus R 3.79 26 56 -48 -24 
Precuneous Cortex R 3.34 25 6 -74 56 
Postcentral Gyrus R 3.14 23 58 -14 24 
Postcentral Gyrus  L 3.47 22 -50 -18 36 
Precentral Gyrus R 3.02 21 46 6 28 
Frontal Pole R 3.16 20 24 48 26 
Orbitofrontal Cortex R 3.17 19 26 36 -18 
Middle Frontal Gyrus R 3.2 12 38 6 54 
Precentral Gyrus L 2.9 11 -48 2 28 
Amygdala R 3.04 5 22 -2 -16 
Activation within whole brain analysis for low-calorie picture contrast (relative to objects) at the Fasted Dummy 
visit (n=17 per group). Results represent co-ordinates of the peak voxel (x, y, z in MNI space (in mm)) of the 
cluster for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm). Threshold correction for multiple 
corrections: FDR P<0.05 and minimum 5 voxel cluster size. 
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Table 4.8. Whole brain analysis at the Fasted Saline visit for viewing high-calorie 
foods (vs.objects).  
Region H Z v x y z 
Intracalcarine cortex R 6.19 11206 12 -88 0 
Insular Cortex L 4.88 285 -38 -6 8 
Oritofrontal Cortex L 4.68 401 -26 36 -16 
Parahippocampal Gyrus, posterior division L 4.6 745 -20 -30 -6 
Insular Cortex R 4.55 191 38 8 -14 
Lateral Occipital Cortex L 3.97 40 -20 -62 42 
Inferior Frontal Gyrus R 3.89 18 50 42 8 
Inferior Frontal Gyrus L 3.77 59 -42 36 8 
Amygdala R 3.6 92 18 2 -14 
Inferior Temporal Gyrus R 3.5 96 50 -58 -12 
Pallidum R 3.48 23 16 2 -4 
Anterior Cingulate Gyrus R 3.41 69 0 40 -2 
Precuneous Cortex L 3.28 46 -18 -72 34 
Postcentral Gyrus L 3.26 25 -46 -18 38 
Inferior Temporal Gyrus L 3.25 18 -48 -46 -24 
Parahippocampal Gyrus R 3.19 15 18 6 -30 
Amygdala L 3.17 29 -18 2 -16 
Frontal Pole  R 3.16 17 26 44 -18 
Postcentral Gyrus L 3.12 16 -62 -18 20 
Precentral Gyrus L 3.01 15 -50 4 24 
Activation within whole brain analysis for high-calorie picture contrast (relative to objects) at the Fasted Saline 
visit (n=17 per group). Results represent co-ordinates of the peak voxel (x, y, z in MNI space (in mm)) of the 
cluster for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm). Threshold correction for multiple 
corrections: FDR P<0.05 and minimum 5 voxel cluster size. 
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Table 4.9. Whole brain analysis at the Fasted Saline visit for viewing low-calorie 
foods (vs.objects).  
Region H Z v x y z 
Occipital Pole R 6.41 6297 14 -100 8 
Hippocampus L 4.63 207 -22 -30 -6 
Lateral Occipital Cortex R 3.99 98 28 -66 46 
Orbitofrontal Cortex L 3.92 76 -26 34 -16 
Thalamus  R 3.77 148 20 -28 -4 
Superior Parietal Lobule L 3.66 12 -30 -62 -46 
Inferior Frontal Gyrus R 3.49 51 42 44 10 
Anterior Cingulate Gyrus L 3.18 8 -10 28 -6 
Insular Cortex R 3.16 5 40 6 -12 
Pallidum L 3.14 13 -12 -2 -6 
Thalamus L 3.08 7 -12 -16 -4 
Amygdala R 3.07 5 16 0 -22 
Activation within whole brain analysis for low-calorie picture contrast (relative to objects) at the Fasted Saline 
visit (n=17 per group). Results represent co-ordinates of the peak voxel (x, y, z in MNI space (in mm)) of the 
cluster for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm). Threshold correction for multiple 
corrections: FDR P<0.05 and minimum 5 voxel cluster size. 
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4.2.7. Correlations between Fasted visits 
 
4.2.7.1. Appetite visual analogue scores  
Hunger, pleasantness-to-eat and fullness VAS AUC ratings were positively correlated 
between Fasted Dummy and Fasted Saline visits (r=+0.63-0.89, P<0.005) (Figure 
4.7.). 
 
Figure 4.7. Correlations of appetite VAS ratings between fasted visits. 
 
 
 
 
 
Correlations of appetite VAS ratings (AUC): (A) hunger (n=15), (B) pleasantness to eat (n=15) and (C) fullness 
(n=13) between the Fasted Dummy and the Fasted Saline visit. Some subjects have been excluded from the 
analysis because of incomplete data sets. r represents Pearson correlation coefficient. 
 
4.2.7.2. Lunch intake 
Lunch intake correlated positively between the Fasted Dummy and the Fasted Saline visits 
(r=+0.89, P<0.005) (Figure 4.8.). 
 
Figure 4.8. Correlation of ad libitum lunch intake between fasted visits.  
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Correlation of ad libitum lunch intake between the Fasted Dummy and Fasted Saline visit. n=17 per group, r 
represents Pearson correlation coefficient. 
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How hungry do you feel right now?
0
500
1000
1500
2000
0 500 1000 1500 2000
Fasted Saline visit
F
a
st
e
d
 D
u
m
m
y
 v
is
it
r=+0.63, P<0.005 
A How pleasant do you feel right now?
0
500
1000
1500
2000
0 500 1000 1500 2000
Fasted Saline visit
F
a
st
e
d
 D
u
m
m
y
 v
is
it
B 
r=+0.70, P<0.005 
How full do you feel right now?
0
200
400
600
800
1000
0 200 400 600 800 1000
Fasted Saline visit
F
a
st
e
d
 D
u
m
m
y
 v
is
it
C 
r=+0.89, P<0.005 
 157 
4.2.7.3. Stress ratings 
Stress, anxiety and sickness ratings correlated positively between the Fasted Dummy and 
the Fasted Saline visit (r=+0.70-0.96, P<0.005) (Figure 4.9.). 
 
 Figure 4.9. Correlations of VAS stress ratings between fasted visits. 
 
 
 
 
 
Correlations of VAS stress ratings (AUC): (A) stress (n=13), (B) anxiety (n=15) and (C) sickness (n=15) 
between the Fasted Dummy and the Fasted Saline visit. Some subjects have been excluded from the analysis 
because of incomplete data set. r represents Pearson correlation coefficient. 
 
4.2.7.4. Serum stress hormones 
Serum prolactin levels at the Fasted Dummy visit correlated positively with levels at the 
Fasted Saline visit (r=+0.69, P=0.003) (Figure 4.10.). However, there was no significant 
correlation for the serum cortisol levels between the fasted visits (r=+0.38, P=0.15) 
(Figure 4.10.). 
 
Figure 4.10. Correlations of stress hormone levels between fasted visits. 
 
 
 
 
 
Correlations of serum stress hormone levels (AUC) for (A) cortisol (n=16) and (B) prolactin (n=16) between the 
Fasted Dummy and the Fasted Saline visit. Some subjects have been excluded from the analysis because of 
incomplete data set. r represents Pearson correlation coefficient.  
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4.2.7.5. Appeal rating 
Appeal ratings for high-calorie and low-calorie food, object and blurred pictures correlated 
positively between the fasted visits (r=+0.52-0.87, P<0.05) (Figure 4.11.). 
 
Figure 4.11. Correlations of appeal rating scores between fasted visits.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Correlations of appeal rating scores for (A) high-calorie foods (blue circles), (B) low-calorie foods (green 
squares), (C) objects (pink triangles) and (D) blurred pictures (orange squares) between the Fasted Dummy and 
the Fasted Saline visit. n=17, r represents Pearson correlation coefficient.  
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4.2.7.6. Brain activation 
There was a trend towards a positive correlation of the activation of the anterior OFC 
between the fasted visits when viewing high-calorie foods vs. object pictures (left: 
r=+0.47, P=0.06, right: r=+0.41, P=0.11, bilateral: r=+0.46, P=0.07), low-calorie foods 
vs. object pictures (left: r=+0.47, P=0.06, right: r=+0.28, P=0.29; bilateral: r=+0.46, 
P=0.06) and a significant correlation for objects vs. blurred pictures (left: r=+0.51, 
P=0.04, right: r=+0.61, P=0.009; bilateral: r=+0.58, P=0.02) (Figure 4.12.). None of the 
activation for any of the picture contrasts in the other ROIs correlated between the two 
fasted visits. 
  
Figure 4.12. Correlation of anterior OFC activation between fasted visits. 
 
 
 
 
 
 
 
Correlation of activation (contrast beta value) of the anterior OFC (average bilateral) between the Fasted Dummy 
and the Fasted Saline visit on viewing (A) high-calorie foods over objects (blue circles), (B) low-calorie foods 
over objects (green squares) and (C) objects over blurred (pink triangles) pictures. n=17, r represents Pearson 
correlation coefficient. 
Anterior OFC viewing high-calorie foods 
-0.6
-0.3
0.0
0.3
0.6
0.9
1.2
-1.0 -0.5 0.0 0.5 1.0 1.5
Bold contrast
Fasted Saline
B
O
L
D
 c
o
n
tr
a
s
t 
F
a
s
te
d
 D
u
m
m
y
-0.6
-0.3
0.0
0.3
0.6
0.9
1.2
-1.0 -0.5 0.0 0.5 1.0 1.5
Bold contrast
Fasted Saline
B
O
L
D
 c
o
n
tr
a
s
t 
F
a
s
te
d
 D
u
m
m
y
-0.6
-0.3
0.0
0.3
0.6
0.9
1.2
-1.0 -0.5 0.0 0.5 1.0 1.5
Bold contrast
Fasted Saline
B
O
L
D
 c
o
n
tr
a
s
t 
F
a
s
te
d
 D
u
m
m
y
Anterior OFC viewing low-calorie foods Anterior OFC viewing obj vs. blur pictures 
r=+0.46, P=0.06 r=+0.58, P=0.02 r=+0.46, P=0.07 
A B C 
 160 
4.2.8. Summary reproducibility of eating behaviour studies 
This chapter examined the reproducibility of appetite fMRI studies by comparing two 
identical study fMRI visits in which one was the Fasted Dummy visit and one the Fasted 
Saline visit. Appetite studies have shown that stress can alter food intake and responses 
in brain reward systems (Adam and Epel, 2007; Chandarana et al., 2009; Blundell et al., 
2010; Born et al., 2010).  
There was significantly lower ad libitum lunch intake, and significantly higher 
anxiety and sickness ratings at the Fasted Dummy visit compared to the Fasted Saline 
visit although the stress ratings and stress hormone levels were not significantly different 
between the two visits. There was also a trend towards greater fullness, lower rating of 
prospective pleasantness-to-eat and actual pleasantness of lunch at the Fasted Dummy 
visit. High-calorie foods were significant less appealing at the Fasted Dummy visit 
compared to the Fasted Saline visit, resulting in high-calorie foods being no more 
appealing than low-calorie foods at the Fasted Dummy visit (unlike at the Fasted Saline 
visit). Therefore pleasantness and food appeal visit were reduced and anxiety increased at 
the Fasted Dummy compared to the Fasted Saline visit. This confirms that it might be 
important to include a dummy visit to acclimatise volunteers to the study environment.  
Interestingly, all appetite and stress / anxiety measures (excluding serum cortisol 
levels) correlated positively between the Fasted Dummy and the Fasted Saline visit.  
Activation in the ventral striatum was significantly higher at the Fasted Dummy 
visit compared to the Fasted Saline visit when viewing high-calorie foods vs. objects. This 
may be be explained by habituation of the ventral striatum activation to viewing high-
calorie foods on subsequent visits which will be discussed in more detail in chapter 6.2. 
There was no significant positive correlation of activation in any ROI between the fasted 
visits but there was a trend towards positive correlation of anterior OFC activation 
between the Fasted Dummy and the Fasted Saline visit. Therefore, the test-retest 
reliability of the fMRI activation to food and non-food pictures was not as robust with the 
exception of the anterior OFC activation. Problems with fMRI reproducibilty between visits 
have been found in other studies and will be discussed in section 6.4. 
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Chapter 5 
RESULTS 
GHRELIN fMRI STUDY 
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5.1. General subject’s characteristics 
In this chapter, the Fasted Saline visit has been compared with the Fed Saline visit (5.2.), 
and the Fed Saline visit has been compared with the Fed Ghrelin visit by using the 
following measurements: VAS appetite and stress ratings, fMRI hunger rating, blood 
appetite and stress hormones, lunch intake, tastiness and pleasantness, dietary records, 
fMRI appeal rating and fMRI BOLD signal. For the Fasted/ Fed Saline comparison this 
chapter also analysed relationships between brain reward activations and appetite 
measures. Study characteristics and general comparisons (e.g. food picture ratings) are 
shown below (Table 5.1., Figure 5.1.). There was a significant difference of the percentage 
carbohydrate intake at supper prior to the study day between the Fasted and Fed Saline 
visit with increased intake on the Fed Saline day (P=0.006). Time fasting since supper 
(P<0.001) was significantly longer on the Fasted Saline visit. The days of menstrual cycle 
were significantly less at the Fed Ghrelin visit compared to the Fed Saline visit (P=0.049). 
There were no significant differences in any other characteristic.  
 163 
Table 5.1. Subject characteristics. 
 Fasted Saline Fed Saline Fed Ghrelin 
N 17 17 17 
Gender    
                        Male 13 13 13 
                        Female 4 4 4 
Age (years) 24.9 ± 1.6 24.9 ± 1.6 25.0 ± 1.6 
Height (m) 1.80 ± 0.0 1.80 ± 0.0 1.80 ± 0.0 
Weight (kg) 76.3 ± 3.6 76.4 ± 3.7 76.5 ± 3.7 
BMI (kg/m2) 24.1 ± 0.7 24.2 ± 0.7 24.2 ± 0.7 
Body fat (%) 17.1 ± 1.6 17.9 ± 1.8 17.6 ± 1.5 
LBM (kg) 64.6 ± 3.3 61.1 ± 4.0 61.0 ± 4.2 
Day of menstrual cycle (females) 5.2 ± 1.2 8.8 ± 1.3 4.6 ± 1.4* 
Time since last visit (days) 18.0 ± 9.0 17.0 ± 7.2 24.5 ± 6.9 
Food intake at supper prior to study    
                        Energy (kcal) 1012 ± 179 1103 ± 188 980 ± 173 
                        Protein (%) 21 ± 2 21 ± 3 18 ± 2 
                        Fat (%) 40 ± 5 34 ± 5 33 ± 4 
                        Carbohydrate (%) 38 ± 5** 45 ± 5 49 ± 4 
Food intake whole day  prior to study    
                        Energy (kcal) 2645 ± 397 2488 ± 273 2209 ± 218 
                        Protein (%) 17 ± 1 17 ± 1 18 ± 1 
                        Fat (%) 38 ± 4 32 ± 2 35 ± 2 
                        Carbohydrate (%) 45 ± 3 52 ± 3 46 ± 3 
Time fasting since supper at t=0 (hrs) 17.1 ± 0.2*** 14.6 ± 0.2 14.8 ± 0.3 
Time sleep (hrs) 7.0 ± 0.2 7.3 ± 0.2 7.3 ± 0.4 
Time t=0 to injection 1.0 ± 0.1 1.0 ± 0.0 1.0 ± 0.1 
Time injection to first food fMRI scan 
(hrs) 
0.6 ± 0.0 0.6 ± 0.0 0.7 ± 0.0 
Time injection to lunch (hrs) 1.6 ± 0.0 1.6 ± 0.0 1.6 ± 0.0 
Questionnaires    
          Positive Affect           30.6 ± 1.3 32.6 ± 1.4 31.4 ± 1.4 
          Negative Affect         15.7 ± 1.7 13.5 ± 0.8 15.4 ± 1.3 
Absolute Head motion (mm) 0.2 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 
n=17 per group, Mean ± SEM, *P<0.05, **P<0.01, ***P<0.005 vs Fed Saline (paired t-test between Fasted 
Saline vs. Fed Saline and Fed Saline vs Fed Ghrelin visit). 
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5.1.1. Picture ratings at end of study 
Ninety-five percent of the low-calorie foods and 97 percent of the high-calorie foods were 
correctly identified by the subjects (P=0.24) (Figure 5a). On average they liked the high-
calorie foods more than the low-calorie foods (P<0.001) (Figure 5a). The differences were 
seen for each type of high-calorie foods: chocolate (P<0.001), sweet non-chocolate 
(P<0.001) and savoury (P=0.02). However, on average they ate the low-calorie foods 
more often than high-calorie foods (P=0.003) (Figure 5.1.). 
  
Figure 5.1. Food picture ratings.  
 
 
 
 
 
 
Food picture ratings. (A) Recognition, (B) liking and (C) frequency of consumption of food pictures (high-calorie: 
white bar; low-calorie: striped bar), n = 17 per group, Data expressed as mean ± SEM, *P<0.05, **P<0.01, 
***P<0.005. 
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5.2. Fasted Saline visit versus Fed Saline visit 
 
5.2.1. Appetite visual analogue scores and food intake 
At the Fasted Saline visit, ratings for hunger (P<0.001), pleasantness to eat (P<0.001), 
volume able to eat (P<0.001) were significantly greater than at the Fed Saline visit while 
fullness was significantly lower (P<0.001) (Figure 5.3.). There was a 15% increase in 
energy intake at lunch (P=0.002) at the Fasted Saline visit compared to the Fed Saline 
visit (Figure 5.2.). There was no significant difference in lunch tastiness (P=0.40) between 
the two visits but there was a tendency for lunch pleasantness to be greater on the Fasted 
Saline visit (P=0.06) (Table 5.2.). 
 
Figure 5.2. Ad libitum lunch intake.  
 
 
 
 
 
 
 
Ad libitum lunch intake for each visit separately (Fasted Saline, green dotted bar, Fed Saline, orange bar), n=17 
per group, data are expressed as mean ± SEM, ***P<0.0055. 
 
Table 5.2. Ad libitum lunch intake.  
 Fasted Saline Fed Saline 
Lunch intake   
Total lunch (kcal) 1428 ± 101 1237 ± 103*** 
Lunch tastiness 6.4 ± 0.3 5.8 ± 0.4 
Lunch pleasantness 6.8 ± 0.3 6.1 ± 0.3 
n=17 per group, data shown as mean ± SEM, Fasted Saline vs. Fed Saline visit, ***P<0.005. 
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Figure 5.3. VAS appetite scores.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absolute VAS scores for hunger, pleasantness to eat, volume able to eat and fullness ratings for each visit 
separately (Fasted Saline, green dotted bar and Fed Saline, orange bar), (A-D) time course of VAS scores, (E-H) 
mean AUC for each score, n=15 per group (2 subjects have been excluded from the analysis because of 
incomplete data), data are expressed as mean ± SEM, ***P<0.005.  
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5.2.2. Hunger scores during scanning 
The average hunger rating during scanning was significantly higher on the Fasted Saline 
than the Fed Saline visit (P<0.001) (Figure 5.4.).  
 
Figure 5.4. Hunger rating during scanning.  
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Average hunger score during scanning for each visit separately (Fasted Saline, green dotted bar; Fed Saline, 
orange bar), n=17 per group. Data are expressed as mean ± SEM, ***P<0.005.  
 
5.2.3. Stress response and serum stress levels 
There was no significant difference in VAS stress (P=0.79), anxiety (P=0.59) or sickness 
(P=0.60) ratings between the Fasted Saline and the Fed Saline visit (Figure 5.5.). Serum 
cortisol (P=0.71) and prolactin (P=0.34) levels were also not significantly different 
between the two visits (Figure 5.6.).  
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Figure 5.5. VAS stress scores. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absolute VAS scores for stress, anxiety and sickness ratings for each visit separately (Fasted Saline, green 
dotted bar and Fed Saline visit, orange bar), (A-C) time course of stress scores, (D-F) mean AUC for each score, 
n=15 per group (2 subjects have been excluded from the analysis because of incomplete data set). Data 
expressed as mean ± SEM, *P<0.05. 
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Figure 5.6. Cortisol and prolactin serum levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cortisol and prolactin serum levels for each visit separately (Fasted Saline, green dotted bar and Fed Saline visit, 
orange bar), (A, B) time course of stress hormones, (C, D) AUC for each serum stress hormone, n=17 per group, 
data are expressed as mean ± SEM, *P<0.05. 
 
5.2.4. Metabolic parameters 
Serum insulin and triglycerides were significant greater at the Fed Saline visit compared to 
the Fasted Saline visit due to post-prandial increases after eating breakfast (P<0.05).  
There was no significant difference in serum growth hormone (P=0.15) between the visits 
but there was a tendency for plasma glucose to be higher on the Fed Saline visit as due to 
levels rising after breakfast (P=0.08) (Figure 5.7.). 
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Figure 5.7. Metabolic parameters.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glucose, insulin, growth hormone (GH) and tryglyceride (TG) levels for each visit separately (Fasted Saline visit, 
green dotted bar and Fed Saline visit, orange bar), (A-D) time course of metabolic parameters, (E-H) AUC for 
each metabolic parameter, n=16 per group (1 subject has been excluded from the analysis because of 
incomplete data set), data expressed as mean ± SEM, *P<0.05. 
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5.2.5. Dietary records 
There were no significant differences in energy intake nor macronutrient composition over  
the rest of the study day after lunch, nor when lunch and the rest of study day were 
combined, nor the day after the study visit, between the Fasted Saline and Fed Saline 
visits (P=0.29-0.87). However when including breakfast, total energy intake over the 
study day and % carbohydrate consumed were both significantly greater at the Fed Saline 
visit compared to the Fasted Saline visit (both P<0.005) (Figure 5.8.).  
 172 
Figure 5.8. Food intake on study day and day after study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intake of energy (A-D) and macronutrients (E-G) over the rest of the study day (day 2), the rest of the study 
day combined with lunch (day2), the whole day of the study day (day 2), and one day after the study day (day 
3), comparison between Fasted Saline visit (green dotted bar) and Fed Saline visit (orange bar), n=13 per group 
(4 subjects have been excluded from the analysis because of incomplete data set). Data are expressed as mean 
± SEM. ***P<0.005.  
Fasted Saline Fed Saline
D 
C 
B 
Day 2 - Rest of day
0
10
20
30
40
50
60
Protein Fat CHO
%
Day 2- Rest of day
0
1000
2000
3000
4000
Energy
K
c
a
l
Day 3
0
10
20
30
40
50
60
Protein Fat CHO
%
Day 3
0
1000
2000
3000
4000
Energy
K
c
a
l
Day 2 All Day
0
10
20
30
40
50
60
Protein Fat CHO
%
Day 2 Lunch + Rest of day
0
10
20
30
40
50
60
Protein Fat CHO
%
Day 2- Lunch + Rest of day
0
1000
2000
3000
4000
Energy
K
c
a
l
Day 2- All Day
0
1000
2000
3000
4000
Energy
K
c
a
l
A E 
F 
G 
H 
*** *** 
 173 
5.2.6. Food picture appeal rating  
High-calorie foods (and for both sweet and savoury sub-categories) were more appealing 
at the Fasted Saline visit compared to the Fed Saline visit (P<0.05), but not low-calorie 
foods, object or blurred pictures (P=0.25-0.86) (Figure 5.9., Table 5.3.). High-calorie 
foods were more appealing than low-calorie foods at the Fasted Saline (P<0.05) but not at 
the Fed Saline visit (P=0.30) (Figure 5.9., Table 5.3.). The significance of this was 
dependent on the type of high-calorie food: being significant for chocolate or sweet non-
chocolate (P<0.05) but not savoury high-calorie foods (P=0.13) (Table 5.3.). All 
categories of high-calorie foods and low-calorie foods were more appealing than both 
object and blurred pictures at both visits (P<0.001) (Figure 5.9., Table 5.3.). There was 
no significant difference in the appeal of object relative to blurred pictures at the Fasted 
Saline compared to the Fed Saline visit (P=0.94) (Table 5.3.).  
 
Figure 5.9. Picture appeal rating. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appeal rating of pictures (high-calorie foods: white bar, low-calorie foods: striped bar, non-food related 
household objects: black bar, blurred pictures: dotted bar), Fasted Saline vs. Fed Saline visit, n=17 per group. 
Data are expressen as mean ± SEM, *P<0.05. 
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Table 5.3. Picture appeal rating. 
Picture Appeal Rating Fasted Saline visit Fed Saline visit 
Absolute rating a   
High-calorie foods 4.28 ± 0.11 3.95 ± 0.12* 
Low-calorie foods 3.91 ± 0.11 3.76 ± 0.15 
Household objects 2.62 ± 0.20 2.64 ± 0.19 
Blurred 2.18 ± 0.20 2.20 ± 0.19 
Chocolate high-calorie foods 4.30 ± 0.11 4.06 ± 0.12* 
Sweet non-chocolate high-calorie foods 4.28 ± 0.11 4.00 ± 0.14* 
Savoury high-calorie foods 4.21 ± 0.16 3.90 ± 0.17* 
Difference in rating between b   
High-calorie foods & objects 1.60 ± 0.23 1.29 ± 0.24** 
Low-calorie foods & objects 1.26 ± 0.25 1.12 ± 0.26 
Chocolate high-calorie foods & objects 1.63 ± 0.19 1.36 ± 0.21* 
Sweet non-chocolate high-calorie foods & objects 1.26 ± 0.24 1.30 ± 0.25** 
Savoury high-calorie foods & objects 1.54 ± 0.28 1.20 ± 0.28* 
High-calorie & low-calorie foods 0.34 ± 0.12 0.17 ± 0.16 
Chocolate high-calorie & low-calorie foods 0.37 ± 0.13 0.24 ± 0.17 
Sweet non-chocolate high-calorie & low-calorie foods 0.36 ± 0.10 0.18 ± 0.14 
Savoury high-calorie & low-calorie foods 0.29 ± 0.18 0.08 ± 0.21 
Objects & blurred 0.43 ± 0.20 0.44 ± 0.18 
a Picture appeal rating (1=a lot, 2=a little, 3=neutral, 4=not really, 5=not at all; b 1st category minus 2nd 
category), Fasted Saline vs. Fed Saline, n=17 per group, data are expressed as mean ± SEM, *P<0.05, 
**P<0.01, ***P<0.005. 
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5.2.7. Reaction time for appeal rating 
There was no significant difference in the reaction time for appeal rating of any of the 
picture categories between the Fasted and Fed Saline visit (Table 5.4.), suggesting the 
absence of non-specific effect of visit type on the picture viewing and rating task. 
 
Table 5.4. Picture rating reaction time.  
Picture Rating Reaction Time (msec) Fasted Saline visit Fed Saline visit 
High-calorie foods 1226 ± 38 1330 ± 38 
Low-calorie foods 1250 ± 39 1332 ± 40 
Household objects 1227 ± 40 1349 ± 39 
Blurred 1008 ± 22 1098 ± 25 
Data shown as mean ± SEM, n=17 per group. 
 
 
5.2.8. Brain activation 
 
5.2.8.1. Region of interest (ROI) analysis 
Activation in the left (P=0.008) and bilateral (P=0.04) anterior OFC on viewing high-
calorie foods vs. objects at the Fasted Saline visit was significantly greater compared to 
the Fed Saline visit. This was not seen however for the right anterior OFC (P=0.31) nor for 
low-calorie foods vs. objects (P=0.38-0.88) (Figure 5.10., Table 5.5.). 
 There was no significant difference in activation in the ventral striatum, insula and 
amygdala on either side or bilaterally when viewing high-calorie foods vs. objects or low-
calorie foods vs. objects between the Fasted Saline and Fed Saline visits (P=0.13-0.97) 
(Table 5.5.). 
 Activation in the ventral striatum, insula, amygdala and anterior OFC when viewing 
household objects vs. blurred pictures was not significant different between the Fasted 
Saline and Fed Saline visits (P=0.5-0.91) (Table 5.5.). 
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Figure 5.10. Brain activation for Fasted Saline and Fed Saline visits.  
 
 
 
 
 
 
 
 
Left hand side: area of anterior OFC showing activation for viewing high-calorie (HC) and low-calorie (LC) foods 
relative to objects (Obj) for the Fasted Saline (green clusters) and for the Fed Saline visit (orange clusters). 
Yellow colour: overlap of activation for both visits. Activation thresholded at FDR P<0.05, n=17. Co-ordinates are 
given in standard MNI space.  
Right hand side: average activation in the bilateral anterior OFC (contrast beta value) for high-calorie (HC) and 
low-calorie (LC) foods relative to objects (Obj) and objects relative to blurred (Blur) pictures between the Fasted 
Saline (green dotted bar) and Fed Saline visits (orange bar). n=17 per group, data expressed as mean activation 
± SEM, *P<0.05. ROI mask determined by anterior OFC cluster (y>74) with combined contrast Fasted Saline, 
Fed Saline, Fed Ghrelin for high-calorie food > object contrast collapsed across visits thresholded at FDR P<0.05. 
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 Table 5.5. Magnitude of Activation within ROIs for Fasted Saline and Fed Saline visit. 
 
ROI H Fasted Saline visits Fed Saline visit 
  
High-calorie vs 
Object 
Low-calorie vs 
Object Object vs Blurred 
High-calorie vs 
Object 
Low-calorie vs 
Object 
Object vs 
Blurred 
Ventral 
striatum L 0.042 ± 0.030 0.052 ± 0.032 0.017 ± 0.033 0.052 ± 0.048 0.013 ± 0.044 0.004 ± 0.044 
 R 0.084 ± 0.039 0.082 ± 0.031 0.011 ± 0.028* 0.067 ± 0.032 0.015 ± 0.037 0.003 ± 0.047 
 Bilateral 0.130 ± 0.060 0.130 ± 0.060 0.030 ± 0.060 0.120 ± 0.060 0.030 ± 0.070 0.010 ± 0.080 
Amygdala L 0.170 ± 0.063 0.097 ± 0.06 0.121 ± 0.037 0.163 ± 0.051 0.063 ± 0.046 0.087 ± 0.061 
 R 0.169 ± 0.039 0.109 ± 0.052 0.102 ± 0.037 0.155 ± 0.062 0.082 ± 0.053 0.055 ± 0.071 
 Bilateral 0.340 ± 0.090 0.210 ± 0.100 0.220 ± 0.070 0.320 ± 0.110 0.140 ± 0.090 0.140 ± 0.130 
Insula L 0.150 ± 0.033 0.066 ± 0.050 0.227 ± 0.022 0.130 ± 0.041 0.091 ± 0.034 0.047 ± 0.043 
 R 0.123 ± 0.035 0.057 ± 0.048 0.020 ± 0.018 0.124 ± 0.038 0.110 ± 0.036 -0.013 ± 0.047 
 Bilateral 0.270 ± 0.070 0.120 ± 0.100 0.050 ± 0.030 0.250 ± 0.080 0.200 ± 0.070 0.030 ± 0.090 
Anterior OFC L 0.262 ± 0.031 0.196 ± 0.063 0.139 ± 0.044 0.134 ± 0.051** 0.139 ± 0.051 0.144 ± 0.060 
 R 0.122 ± 0.06 0.070 ± 0.059 0.196 ± 0.052 0.066 ± 0.048 0.059 ± 0.049 0.168 ± 0.073 
 Bilateral 0.380 ± 0.080 0.260 ± 0.110 0.330 ± 0.090 0.200 ± 0.090* 0.170 ± 0.090 0.310 ± 0.130 
Average magnitude of activation within regions of interest (ROIs) for each hemisphere (H) at the Fasted Saline and the Fed Saline visit. Beta values extracted for each 
individual subject contrast estimates (vs. objects) for high-calorie and low-calorie foods and objects vs. blurred picture contrast: n=17 per group, data are expressed as 
mean SEM, *P<0.05, **P<0.01 for Fasted Saline vs. Fed Saline visit. 
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5.2.8.2. Whole brain analysis 
Additional brain areas were activated on viewing high-calorie foods relative to objects at 
the Fasted Saline visit (Table 4.8., 4.9.) and the Fed Saline visit (Table 5.6., 5.7.) using 
whole brain analysis.  
 
A similar number of brain regions where activated at the Fasted and Fed Saline visit. Also 
the type of regions activated where similar for the high-and low-calorie food contrast (vs. 
objects). However, the parahippocampus and hippocampus were only activated at the 
Fasted Saline visit but not at the Fed Saline visit. 
 
Table 5.6. Whole brain analysis at the Fed Saline visit for viewing high-calorie 
foods (vs.objects).  
Region H Z v x y z 
Occipital pole L 5.96 -8 -92 -6 -8 
Precuneous Cortex  R 4.55 28 -62 42 28 
Insula Cortex R 4.45 36 6 -16 36 
Orbitofrontal Cortex L 4.41 -26 36 -16 -26 
Inferior Frontal Gyrus, pars triangularis R 4.02 40 40 6 40 
Insula Cortex L 4.01 -38 4 -14 -38 
Thalamus L 3.81 -20 -30 -4 -20 
Precuneous Cortex  L 3.68 -24 -68 44 -24 
Superior Parietal Lobe L 3.57 -32 -48 44 -32 
Amygdala R 3.51 16 0 -14 16 
Inferior Frontal Gyrus, pars triangularis L 3.3 -42 42 10 -42 
Precentral Gyrus  R 3.22 50 6 22 50 
Postcentral Gyrus  R 3.22 64 -16 28 64 
Orbitofrontal Cortex R 3.19 26 34 -12 26 
Anterior Cingulate Gyrus L 3.17 -4 -6 26 -4 
Anterior Supramarginal Gyrus L  3.12 -46 -32 34 -46 
Activation within whole brain analysis for high-calorie picture contrast (relative to objects) at the Fed Saline visit 
(n=17 per group). Results represent co-ordinates of the peak voxel (x, y, z in MNI space (in mm)) of the cluster 
for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm). Threshold correction for multiple 
corrections: FDR P<0.05 and minimum 5 voxel cluster size. 
 
 179 
Table 5.7. Whole brain analysis at the Fed Saline visit for viewing low-calorie 
foods (vs.objects).  
Region H Z v x y z 
Occipital Pole L 6.8 7284 -8 -94 -6 
Insula Cortex R 4.56 109 40 -2 -2 
Inferior Frontal Gyrus R 3.87 101 44 42 6 
Orbitofrontal Cortex L 4.42 77 -26 36 -16 
Lateral Occipital Cortex, superior división R 4.13 64 28 -60 42 
Insula Cortex L 4.03 38 -36 2 -12 
Postcentral Gyrus R 3.66 28 62 -14 26 
Amygdala R 3.23 8 18 0 -12 
Intracalcarine Cortex L 3.09 5 -22 -78 10 
Thalamus L 3.19 5 -22 -30 -2 
Orbitofrontal Cortex R 3.05 5 28 20 -8 
Activation within whole brain analysis for low-calorie picture contrast (relative to objects) at the Fed Saline visit 
(n=17 per group). Results represent co-ordinates of the peak voxel (x, y, z in MNI space (in mm)) of the cluster 
for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm). Threshold correction for multiple 
corrections: FDR P<0.05 and minimum 5 voxel cluster size. 
 
5.2.9. Relationship between brain activation and hunger rating  
At the Fasted Saline visit, activation in each ROI for each contrast did not correlate with 
hunger rating in the scanner (r=-0.34-0.44, P=0.08-0.19). By contrast, at the Fed Saline 
visit, average hunger rating in the scanner positively correlated with activation in the left 
ventral striatum (P=0.01), right anterior OFC (P=0.004) and left (P=0.045) and right 
(P=0.009) insula when viewing high-calorie foods vs. objects. Average hunger rating in 
the scanner also tended to positively correlate with activation in these ROIs when viewing 
low-calorie foods vs. objects (P=0.06-0.1). There were no significant correlations for 
activation when viewing objects vs. blurred pictures (r=-0.45-0.09, P>0.05) at the Fed 
Saline visit (Figure 5.11.). There was no positive correlation between any other ROI and 
the average hunger rating in the scanner for all contrasts (P>0.05).  
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Figure 5.11. Relationship between brain activation and hunger ratings at the Fed 
Saline visit. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Relationships between activation (contrast beta value) within left ventral striatum (a), left insula (b), right insula 
(c) and right anterior OFC (d) on viewing high-calorie (HC) foods (vs. objects (Obj) (left graphs), and low-calorie 
(LC) foods (vs. objects) (right graphs) and hunger rating in the scanner at the Fed Saline visit. n=16 (one 
subject missing due to incomplete data set), r represents Pearson correlation coefficient.  
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5.2.10. Relationship between brain activation and lunch intake 
At the Fasted Saline visit, activation in the right insula when viewing high-calorie foods 
(vs. objects) positively correlated with ad libitum lunch intake (P=0.03) (Figure 5.13.). 
None of the other ROIs for any of the contrasts correlated with lunch intake at the Fasted 
Saline visit (r=-0.33-0.39, P=0.12-0.98). 
At the Fed Saline visit, activation in the left anterior OFC (P=0.016), left (P=0.03) 
and right (P=0.009) insula when viewing high-calorie foods vs. objects positively 
correlated with ad libitum lunch intake (Figure 5.12.). There was no positive correlation 
between activation in any ROI on viewing low-calorie foods vs. objects (P=0.21-0.98) and 
lunch intake at the Fed Saline visit other than a tendency for the left (P=0.09) and right 
(P=0.05) insula to be positively correlated with lunch intake. There was no correlation 
between activation in any ROI on viewing objects vs. blurred pictures and lunch intake at 
the Fed Saline visit (P=0.19-0.81).  
 Interestingly, there was no positive correlation between VAS hunger (P=0.33 and 
0.46), volume able to eat (P=0.17 and 0.29) nor pleasantness to eat (P=0.25 and 0.55) 
ratings just before lunch (time point +150 mins) and ad libitum lunch at either the Fasted 
Saline (Figure 5.14.) or the Fed Saline visit (Figure 5.15.).  
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Figure 5.12. Relationship between brain activation and lunch intake at the Fed 
Saline visit.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Relationship between activation (contrast beta value) within (a) left anterior OFC, (b) left insula and (c) right 
insula on viewing high-calorie (HC) foods (vs. objects (Obj)) (left graphs), and low-calorie (LC) foods (vs. 
objects) (right graphs) and ad libitum lunch intake at the Fed Saline visit. n=17, r represents Pearson correlation 
coefficient.  
R insula (Local vs. Obj) 
Fed Saline
0
500
1000
1500
2000
2500
-0.5 0 0.5 1
Bold contrast
L
u
n
c
h
 i
n
ta
k
e
 (
K
c
a
l)
L insula (Local vs. Obj) 
Fed Saline
0
500
1000
1500
2000
2500
-0.5 0 0.5 1
Bold contrast
L
u
n
c
h
 i
n
ta
k
e
 (
K
c
a
l)
L insula (Hical vs. Obj) 
Fed Saline
0
500
1000
1500
2000
2500
-0.5 0 0.5 1
Bold contrast
L
u
n
c
h
 i
n
ta
k
e
 (
K
c
a
l)
L ant OFC (Hical vs. Obj) 
Fed Saline
0
500
1000
1500
2000
2500
-0.5 0 0.5 1
Bold contrast
L
u
n
c
h
 i
n
ta
k
e
 (
K
c
a
l)
L ant OFC (Local vs. Obj) 
Fed Saline
0
500
1000
1500
2000
2500
-0.5 0 0.5 1
Bold contrast
L
u
n
c
h
 i
n
ta
k
e
 (
K
c
a
l)
R insula (Hical vs. Obj) 
Fed Saline
-1
500
1000
1500
2000
2500
-0.5 0 0.5 1
Bold contrast
L
u
n
c
h
 i
n
ta
k
e
 (
K
c
a
l)
    HC > Obj     LC > Obj 
r=+0.48, P=0.053 r=+0.61, P=0.009 
c           Right insula 
b        Left insula 
r=+0.54, P=0.030 r=+0.43, P=0.087 
r=+0.57,  P=0.016  r=+0.41, P=0.100 
a     Left anterior OFC 
    HC > Obj     LC > Obj 
    HC > Obj     LC > Obj 
 183 
Figure 5.13. Relationship between brain activation and lunch intake at the Fasted 
Saline visit.  
 
 
 
 
 
Relationship between activation (contrast beta value) within (a) right insula on viewing high-calorie (HC) foods 
(vs. objects (Obj)) (left graph), and low-calorie (LC) foods (vs. objects) (right graph) and ad libitum lunch intake 
at the Fasted Saline visit. n=17, r represents Pearson correlation coefficient.  
 
Figure 5.14. Relationship between VAS appetite scores and lunch intake at the 
Fasted Saline visit.  
 
 
 
 
Relationship between VAS (a) hunger-, (b) volume- and (c) pleasantness to eat ratings and ad libitum lunch 
intake at the Fasted Saline visit. n=17, r represents Pearson correlation coefficient.  
 
Figure 5.15. Relationship between VAS appetite scores and lunch intake at the 
Fed Saline visit. 
 
 
 
 
Relationship between VAS (a) hunger-, (b) volume- and (c) pleasantness to eat ratings and ad libitum lunch 
intake at the Fed Saline visit. n=17, r represents Pearson correlation coefficient.  
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5.3. Fed Saline visit versus Fed Ghrelin visit 
 
5.3.1. Appetite visual analogue scores and food intake 
Using the Area under curve (AUC), there was no significant difference in hunger (P=0.60), 
pleasantness (P=0.53), volume able to eat (P=0.89) and fullness (P=0.55) between the 
Fed Saline and the Fed Ghrelin visit (Figure 5.16.). There was also no significant 
difference for ad libitum energy intake (P=0.98), lunch tastiness (P=0.53) and 
pleasantness (P=0.49) between the two visits (Figure 5.17., Table 5.8.). Ghrelin was 
injected at t = +55 minutes, therefore the above measures were also analysed for time 
point t = +55, +70 and +150 minutes only, using a paired t-test. Results show that there 
were no significant differences in hunger (P=0.2-0.42), pleasantness (P=0.6-0.97), 
volume able to eat (P=0.4-0.88) and fullness (P=0.19-0.73) between the Fed Saline and 
the Fed Ghrelin visit (Figure 5.16.).  
 
Figure 5.17. Ad libitum lunch intake. 
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Ad libitum lunch intake for each visit separately (Fasted Saline, green dotted bar, Fed Ghrelin, orange bar), n=17 
per group, data are expressed as mean ± SEM, P*<0.05. 
 
Table 5.8. Ad libitum lunch intake.  
 Fed Saline Fed Ghrelin 
Lunch intake   
Total lunch in Kcal 1237 ± 103 1235 ± 104  
Lunch tastiness 5.8 ± 0.4 5.8 ± 0.3 
Lunch pleasantness 6.1 ± 0.3 5.8 ± 0.3 
n=17 per group, data shown as mean ± SEM, Fed Saline vs. Fed Ghrelin visit, *P<0.05. 
Fed Saline
Fed Ghrelin
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Figure 5.16. VAS appetite scores.  
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Absolute VAS scores for hunger, pleasantness to eat, volume able to eat and fullness ratings for each visit 
separately (Fed Saline, orange bar; Fed Ghrelin, purple spriped bar), (A-D) time course of VAS scores, (E-H) 
mean AUC for each score, n=15 per group (2 subjects have been excluded from the analysis because of 
incomplete data set), data are expressed as mean ± SEM, *P<0.05. 
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5.3.2. Hunger scores during MRI scanning 
The average hunger rating during MRI scanning did not significantly differ between the 
Fed Saline and Fed Ghrelin visit but there was a tendency for hunger ratings to be greater 
at the Fed Ghrelin visit (P=0.10) (Figure 5.18.).  
 
Figure 5.18. Hunger rating during scanning. 
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Average hunger scores during scanning for each visit separately (Fed Saline, orange bar; Fed Ghrelin, purple 
striped bar), n=17 per group, data are expressed as mean ± SEM, *P<0.05.  
 
5.3.3. Stress ratings and serum stress levels 
There was no significant difference in stress (P=0.15), anxiety (P=0.52) and sickness 
(P=0.24) AUC ratings between the Fed Saline and the Fed Ghrelin visit nor at the t= +55, 
t= +70 and +150 mins time points (P=0.17-0.92) (Figure 5.19.). AUC serum cortisol 
levels were also not significantly different between the two visits (P=0.50) although levels 
were significantly greater after ghrelin injection compared to injection of saline at t= 
+70mins, (P=0.02), but not at t= +150 mins (P=0.25) (Figure 5.20.). However, serum 
cortisol levels increased significantly at t = +180mins (P=0.005) on the ghrelin compared 
to saline injection day. AUC serum prolactin levels were significantly greater on the Fed 
Ghrelin visit compared to the Fed Saline visit (P<0.001) and at both t= +70 and +150 
mins (P=0.002-0.01) (Figure 5.20.). 
Fed Saline
Fed Ghrelin
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Figure 5.19. VAS stress scores. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absolute VAS scores for stress, anxiety and sickness ratings for each visit separately (Fed Saline, orange bar and 
Fed Ghrelin visit, purple striped bar), (A-C) time course of stress scores, (D-F) mean AUC for each score, n=15 
per group (2 subjects have been excluded from the analysis because of incomplete data set), data are expressed 
as mean ± SEM, *P<0.05. 
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Figure 5.20. Cortisol and prolactin serum levels.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Serum cortisol and prolactin levels for each visit separately (Fed Saline, orange bar and Fed Ghrelin visit, purple 
striped bar), (A, B) time course of stress hormones, (C, D) mean AUC for each serum stress hormone, n=17 per 
group, data are expressed as mean ± SEM, *P<0.05, **P<0.01, ***P<0.005. 
 
5.3.4. Metabolic parameters 
AUC plasma glucose (P=0.02) and serum growth hormone (P=0.002) levels were 
significantly increased at the Fed Ghrelin visit compared to the Fed Saline visit and at t= 
+70 (P=0.008-0.02) and +150 minutes time points (P=0.02), and for growth hormone at 
t = +180 minutes (P=0.02). There were no significant differences in AUC serum insulin 
(P=0.79) and triglyceride (P=0.44) levels between the two visits, nor at t= +70 and +150 
minutes (P=0.06-0.45), except for insulin which showed a tendency to be significantly 
decreased at t= +70 minutes after injection of ghrelin (P=0.06) (Figure 5.21.). 
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Figure 5.21. Metabolic parameters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glucose, insulin, growth hormone (GH) and tryglyceride (TG) levels for each visit separately (Fed Saline visit, 
orange bar and Fed Ghrelin visit, purple striped bar), (A-D) time course of metabolic parameters, (E-H) mean 
AUC for each metabolic parameter, n=16 per group (2 subjects have been excluded from the analysis because of 
incomplete data set), data are expressed as mean ± SEM, *P<0.05, **P<0.01, ***P<0.005. 
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5.3.5. Three-day-dietary records 
There were no significant differences in energy intake nor macronutrient composition over  
the rest of the study day after lunch, nor when breakfast and lunch and the rest of study 
day were combined, nor when lunch and the rest of the study day were combined, nor the 
day after the study visit, between the Fed Saline and Fed Ghrelin visits (P=0.23-0.56) 
(Figure 5.22.). 
 
Figure 5.22. Food intake on study day and day after study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Intake of energy (A-D) and macronutrients (E-G) over the rest of the study day (day 2), the rest of the study 
day combined with lunch (day2), the whole day of the study day (day 2), and one day after the study day (day 
3), comparison between Fed Saline visit (green dotted bar) and Fed Ghrelin visit (orange bar), n=13 per group 
(4 subjects have been excluded from the analysis because of incomplete data set). Data are expressed as mean 
± SEM. *P<0.05, **P<0.01, ***P<0.005.  
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5.3.6. Food picture appeal rating  
High-calorie foods were more appealing at the Fed Ghrelin visit compared to the Fed 
Saline visit (P=0.02) but not low-calorie food, object and blurred pictures (P=0.5-0.9) 
(Figure 5.23., Table 5.9.). This was significant for the chocolate high-calorie food sub-
category (P=0.01) but not the sweet non-chocolate or savoury high-calorie foods 
(P=0.07-0.17).  
 High-calorie foods were more appealing than low-calorie foods at the Fed Ghrelin 
visit (P<0.05) but not at the Fed Saline visit (P=0.30) (Figure 5.23., Table 5.9.). These 
differences at the Fed Ghrelin visit were dependent on the type of high-calorie food in the 
picture since differences were significant for chocolate and sweet non-chocolate (P<0.05) 
but not savoury high-calorie foods (P=0.50) (Table 5.9.).  
All categories of high-calorie foods and low-calorie foods were more appealing than 
both object and blurred pictures at both visits (P<0.001) (Figure 5.23., Table 5.9.). There 
was no significant difference in the appeal of object relative to blurred pictures at the Fed 
Saline visit compared to the Fed Ghrelin visit (P=0.37) (Table 5.9.).  
 
Figure 5.23. Picture appeal rating.  
  
 
 
 
 
 
 
 
 
 
 
Appeal rating of pictures (high-calorie foods: white bar, low-calorie foods: striped bar, non-food related 
household objects: black bar, blurred pictures: dotted bar), Fed Saline vs. Fed Ghrelin, n=17 per group, data are 
expressed as mean ± SEM, *P<0.05. 
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Table 5.9. Picture appeal rating. 
Picture Appeal Rating Fed Saline visit Fed Ghrelin 
Absolute rating a   
High-calorie foods 3.95 ± 0.12 4.15 ± 0.12* 
Low-calorie foods 3.76 ± 0.15 3.85 ± 0.13  
Household objects 2.64 ± 0.19 2.65 ± 0.17 
Blurred 2.20 ± 0.19 2.30 ± 0.17 
Chocolate high-calorie foods 4.06 ± 0.12 4.32 ± 0.13* 
Sweet non-chocolate high-calorie foods 4.00 ± 0.14 4.18 ± 0.13  
Savoury high-calorie foods 3.90 ± 0.17 4.00 ± 0.17  
Difference in rating between b   
High-calorie foods & objects 1.29 ± 0.24  1.47 ± 0.23 
Low-calorie foods & objects 1.12 ± 0.26 1.19 ± 0.25 
Chocolate high-calorie foods & objects 1.36 ± 0.21 1.62 ± 0.23* 
Sweet non-chocolate high-calorie foods & objects 1.30 ± 0.25 1.48 ± 0.24 
Savoury high-calorie foods & objects 1.20 ± 0.28 1.31 ± 0.25 
High-calorie & low-calorie foods 0.17 ± 0.16 0.28 ± 0.13 
Chocolate high-calorie & low-calorie foods 0.24 ± 0.17 0.43 ± 0.14 
Sweet non-chocolate high-calorie & low-calorie foods 0.18 ± 0.14 0.29 ± 0.12 
Savoury high-calorie & low-calorie foods 0.08 ± 0.21 0.12 ± 0.17 
Objects & blurred 0.44 ± 0.18 0.34 ± 0.20 
Picture appeal rating (a1=a lot, 2=a little, 3=neutral, 4=not really, 5=not at all; b1st category minus 2nd 
category), Fed Saline vs. Fed Ghrelin, n=17 per group, data are expressed as mean ± SEM, *P<0.05, **P<0.01, 
***P<0.005.  
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5.3.7. Reaction time for appeal rating 
The reaction time for appeal rating of both food categories and object pictures at the Fed 
Ghrelin visit was significantly shorter compared to the Fed Saline visit (P<0.05), but not 
for rating blurred pictures (P=0.09) (Table 5.10.). 
 
Table 5.10. Picture rating reaction time.  
Picture Rating Reaction Time (msec) Fed Saline visit Fed Ghrelin visit 
High-calorie foods 1330 ± 38 1220 ± 38** 
Low-calorie foods 1332 ± 40 1209 ± 38* 
Household objects 1349 ± 39 1238 ± 40*** 
Blurred 1098 ± 25 1022 ± 22 
Data shown as mean ± SEM, n=17 per group, Fed Saline vs. Fed GHrelin visit: *P<0.05, **P<0.01, ***P<0.005. 
  
 
5.3.8. Brain activation 
5.3.8.1. Region of interest (ROI) analysis 
Activation in the right (P=0.04) and bilateral (P=0.04) anterior OFC on viewing high-
calorie foods vs. objects at the Fed Ghrelin visit was significantly greater compared to the 
Fed Saline visit. There was a tendency for activation in left anterior OFC (P=0.06) on 
viewing high-calorie foods vs. objects, and also for low-calorie foods vs. objects in the left, 
right and bilateral anterior OFC (P=0.07-0.11), to be greater at the Fed Ghrelin than Fed 
Saline visit (Figure 5.24., Table 5.11.). 
There was no significant difference in activation in the ventral striatum, insula and 
amygdala on either side or bilaterally when viewing high-calorie foods vs. objects or low-
calorie foods vs. objects between the Fed Saline and the Fed Ghrelin visit (P=0.14-0.98) 
(Table 5.11).  
Activation in the ventral striatum, insula, amygdala and anterior OFC when viewing 
objects vs. blurred pictures was not significant different between the Fed Saline and Fed 
Ghrelin visits (P=0.12-0.89) (Table 5.11.). 
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When observing statistical activation maps for individual visits, there was evidence 
of significant activation in the left ventral striatum at the Fed Ghrelin visit when viewing 
high-calorie foods vs. objects which was not apparent at the Fasted Saline and Fed Saline 
visits nor on viewing low-calorie foods vs. objects. However such comparisons can be 
misleading because of activation for some visits and contrasts being at just sub-threshold 
levels. 
Nevertheless there was a weak tendency for activation in the left ventral striatum 
on viewing high-calorie foods vs. objects to be greater at the Fed Ghrelin visit compared 
to the Fed Saline visit (P=0.14). As discussed in Chapter 6.2. this had the effect of 
tending to  reverse the decrease in ventral striatum activation to high-calorie foods seen 
after the initial Fasted Dummy visit (Figure 5.25. A-D). 
 
Figure 5.24. Anterior OFC activation for Fed Saline and Fed Ghrelin visit. 
  
 
 
 
 
 
Left hand side: area of anterior OFC showing activation for viewing high-calorie (HC) and low-calorie (LC) foods 
relative to objects (Obj) for the Fed Saline (orange clusters) and for the Fed Ghrelin visit (pink clusters). Yellow 
colour: overlap of activation for both visits. Activation thresholded at FDR P<0.05, n=17. Co-ordinates are given 
in standard MNI space.  
Right hand side: average activation in the bilateral anterior OFC (contrast beta value) for high-calorie (HC) and 
low-calorie (LC) foods relative to objects (Obj) and objects relative to blurred (Blur) pictures between the Fed 
Saline (orange bar) and the Fed Ghrelin visit (striped purple bar). n=17 per group, data expressed as mean 
activation ± SEM, *P<0.05. ROI mask determined by anterior OFC cluster (y>74) from combined contrast Fasted 
Saline, Fed Saline, Fed Ghrelin for high-calorie food > object contrast collapsed across visits thresholded at FDR 
P<0.05.
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Figure 5.25. Ventral striatum activation for Fed Saline and Fed Ghrelin visit. 
 
 
 
 
 
 
 
 
 
 
 
 
Top figure: area of ventral striatum showing activation for viewing high-calorie (HC) and low-calorie (LC) foods relative to objects (Obj) for the (A) Fasted Dummy visit (dark 
blue cluster) and Fasted Saline visit (green cluster), (B) Fasted Saline visit (green cluster) and Fed Saline visit (orange cluster) and (C) for the Fed Ghrelin visit (pink clusters) 
and the Fed Saline visit (orange cluster). Yellow colour: overlap of activation for both visits. Activation thresholded at FDR P<0.05, n=17. Co-ordinates are given in standard 
MNI space.  
Bottom figure: average activation in the left ventral striatum (contrast beta value) for high-calorie (HC) and low-calorie (LC) foods relative to objects (Obj) and objects relative 
to blurred (Blur) pictures between the Fasted Dummy (dark blue bar), Fasted Saline (dotted green bar), Fed Saline (orange bar), and Fed Ghrelin (striped purple bar) visits. 
n=17 per group, data expressed as mean activation ± SEM, *P<0.05. ROI mask determined by overlap of Harvard FSL atlas for nucleus accumbens with combined contrast 
Fasted Saline, Fed Saline, Fed Ghrelin for high-calorie foods > object contrast collapsed across visits FDR P<0.05. 
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Table 5.11. Magnitude of Activation within ROIs for Fed Saline and Fed Ghrelin visit. 
ROI H Fed Saline visit Fed Ghrelin visit 
  
High-calorie vs Object Low-calorie vs Object Object vs Blurred High-calorie vs Object Low-calorie vs Object Object vs Blurred 
Ventral 
striatum L 0.052 ± 0.0448 0.013 ± 0.044 0.028 ± 0.040 0.141 ± 0.029 0.067 ± 0.028 0.062 ± 0.041 
 R 0.067 ± 0.032 0.015 ± 0.037 0.003 ± 0.047 0.108 ± 0.019 0.065 ± 0.027 -0.005 ± 0.035 
 Bilateral 0.120 ± 0.060 0.030 ± 0.070 0.010 ± 0.080 0.250 ± 0.040 0.130 ± 0.050 -0.070 ± 0.050 
Amygdala L 0.163 ± 0.051 0.063 ± 0.046 0.087 ± 0.061 0.168 ± 0.037 0.133 ± 0.053 0.126 ± 0.053 
 R 0.155 ± 0.062 0.082 ± 0.053 0.055 ± 0.071 0.187 ± 0.052 0.111 ± 0.050 0.141 ± 0.053 
 Bilateral 0.320 ± 0.110 0.140 ± 0.090 0.140 ± 0.130 0.350 ± 0.080 0.240 ± 0.100 0.270 ± 0.100 
Insula L 0.130 ± 0.041 0.091 ± 0.034 0.047 ± 0.043 0.116 ± 0.030 0.065 ± 0.030 0.074 ± 0.038 
 R 0.124 ± 0.038 0.110 ± 0.036 -0.013 ± 0.047 0.125 ± 0.028 0.085 ± 0.033 0.030 ± 0.030 
 Bilateral 0.250 ± 0.080 0.200 ± 0.070 0.030 ± 0.090 0.240 ± 0.050 0.150 ± 0.060 0.100 ± 0.060 
Anterior OFC L 0.134 ± 0.051 0.107 ± 0.048 0.144 ± 0.06 0.290 ± 0.044 0.201 ± 0.050 0.078 ± 0.073 
 R 0.066 ± 0.048 0.059 ± 0.049 0.168 ± 0.073 0.191 ± 0.045* 0.162 ± 0.061 0.096 ± 0.067 
 Bilateral 0.200 ± 0.090 0.170 ± 0.090 0.310 ± 0.130 0.480 ± 0.080* 0.360 ± 0.100 0.170 ± 0.140 
Average magnitude of activation within each regions of interest (ROI) for each hemisphere (H) at the Fed Saline visit and the Fed Ghrelin visit. Beta values extracted for each 
individual subject contrast estimates (vs. objects) for high-calorie and low-calorie foods (n=17 per group) and objects vs. blurred picture contrast: *P<0.05 for Fed Saline visit 
vs. Fed Ghrelin visit. 
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5.3.8.2. Whole brain analysis 
Additional brain areas were activated on viewing high-calorie foods relative to objects at 
the Fed Saline visit (Table 5.6., 5.7.) and the Fed Ghrelin (Table 5.12. and 5.13.) visit 
using whole brain analysis.  
 
The number of activated brain areas when viewing particularly high-calorie foods was 
increased at the Fed Ghrelin visit but not at the Fed Saline visit. Especially the 
hippocampus, parahippocamous and accumbens are only activated on the Fed Ghrelin visit 
but not at the Fed Saline visit. 
 
When comparing all four study visits the results show activation especially in the 
accumbens only at the Fasted Dummy visit and Fed Ghrelin visit, in the parahippocampus 
and hippocampus only at the Fasted Saline and Fed Ghrelin visit and in the amygdala only 
at the Fasted Saline and Fed Saline visit. The number of brain regions was notably high at 
the Fasted Dummy and the Fed Ghrelin visit and low at the Fasted and Fed Saline visit for 
both contrasts (H>O, L>O). In general, the number of areas activated when viewing low-
calorie foods compared to when viewing high-calorie foods was reduced for all visits. All 
areas had activation in the visual cortices (Occipital cortex and intracalcarine cortex).   
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Table 5.12. Whole brain analysis at the Fed Ghrelin visit for viewing high-calorie 
foods (vs.objects).  
Region H Z v x y z 
Occipital pole L 
6.32 8257 -14 -94 -2 
Orbitofrontal Cortex L 
4.64 201 -26 34 -16 
Insula Cortex L 
4.19 105 -36 -4 4 
Parahippocampus Gyrus L 
4.13 129 -18 -2 -20 
Accumbens  L 
4.1 243 -8 8 -4 
Hippocampus L 
4.01 205 -26 -30 -4 
Lateral Occipital Cortex R 
4.04 144 30 -60 50 
Orbitofrontal Cortex R 
3.97 70 26 36 -20 
Insula Cortex R 
3.9 139 42 -4 0 
Parahippocampus Gyrus R 
3.79 134 14 -30 -8 
Inferior Frontal Gyrus L 
3.69 50 -42 38 8 
Supramarginal Gyrus, anterior division L 
3.68 30 -62 -22 34 
Paracingulate Gyrus L 
3.53 41 -6 48 -8 
Anterior Cingulate Gyrus R 
3.47 62 2 40 0 
Postcentral gyrus L 
3.41 51 -46 -18 42 
Posterior Cingulate Gyrus L 
3.33 82 -2 -34 30 
Accumbens R 
3.36 40 8 16 -2 
Inferior Frontal Gyrus R 
3.6 39 44 40 8 
Thalamus R 
3.43 33 12 -2 8 
Precentral Gyrus R 
3.3 19 46 4 20 
Pallidum R 
3.28 16 16 -4 -2 
Lateral Occipital Cortex L 
3.18 23 -46 -62 -8 
Superior Frontal Gyrus L 
3.15 14 -16 -8 56 
Parietal Operculum L 
3.07 8 -38 -38 28 
Subcallosal Cortex R 
3.05 7 2 20 2 
Activation within whole brain analysis for high-calorie picture contrast (relative to objects) at the Fed Ghrelin 
visit (n=17 per group). Results represent co-ordinates of the peak voxel (x, y, z in MNI space (in mm)) of the 
cluster for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm). Threshold correction for multiple 
corrections: FDR P<0.05 and minimum 5 voxel cluster size. 
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Table 5.13. Whole brain analysis at the Fed Ghrelin visit for viewing low-calorie 
foods (vs.objects).  
Region H Z v x y z 
Occipital Pole R 
6.99 7700 12 -90 -2 
Orbitofrontal Cortex L 
4.27 121 -24 36 -16 
Insula Cortex  R 
4.38 81 40 -4 4 
Insula Cortex L 
4.37 67 -38 -6 8 
Postcentral Gyrus L 
3.67 39 -64 -16 22 
Orbitofrontal Cortex R 
3.44 38 20 34 -24 
Posterior Cingulate Gyrus L 
3.19 31 -4 -36 26 
Lateral Occipital Cortex, superior division  R 
3.41 29 28 -62 46 
Supramarginal Gyrus  L 
3.28 15 -48 -36 34 
Precentral Gyrus L 
3.41 13 -52 -12 40 
Hippocampus R 
3.52 13 24 -28 -6 
Precentral Gyrus  R 
3.35 10 48 -12 54 
Inferior Frontal Gyrus L 
3.09 5 -50 6 22 
Activation within whole brain analysis for low-calorie picture contrast (relative to objects) at the Fed Ghrelin visit 
(n=17 per group). Results represent co-ordinates of the peak voxel (x, y, z in MNI space (in mm)) of the cluster 
for each hemisphere (H), number of voxels within cluster (v, 2x2x2mm). Threshold correction for multiple 
corrections: FDR P<0.05 and minimum 5 voxel cluster size. 
 
 
5.4. Summary results ghrelin fMRI study 
VAS hunger, pleasantness to eat, volume able to eat were significantly greater and 
fullness ratings significantly lower at the Fasted Saline visit compared to the Fed Saline 
visit, but not at the Fed Ghrelin visit compared to the Fed Saline visit. Hunger rating 
during MRI scanning was significantly greater at the Fasted Saline visit compared to the 
Fed Saline visit, and there was a tendency for hunger rating during scanning to be greater 
at the Fed Ghrelin visit compared to the Fed Saline visit.  
 Ad libitum lunch intake was 15% greater at the Fasted Saline visit compared to the 
Fed Saline visit and there was a tendency for lunch pleasantness to be greater at the 
Fasted Saline visit, but there was no significant difference in lunch tastiness between the 
two visits. However there was no significant difference for at libitum lunch intake, 
tastiness and pleasantness between the Fed Saline and the Fed Ghrelin visits. 
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Analysis of VAS stress ratings revealed that there were no significant differences in 
stress, anxiety and sickness, between the Fasted and Fed Saline, and the Fed Saline and 
Fed Ghrelin visits although there was a tendency of stress and sickness to be greater after 
ghrelin injection at the Fed Ghrelin visit. Serum prolactin and cortisol levels were 
significantly elevated after the injection at the Fed Ghrelin visit compared to the Fed 
Saline visit, but not at the Fasted Saline compared to Fed Saline visit. 
Analysis of metabolic parameters revealed that serum insulin and triglyceride levels 
but not plasma glucose and serum growth hormone levels were increased at the Fed 
Saline visit compared to the Fasted Saline visit. At the Fed Ghrelin visit plasma glucose 
and serum growth hormone levels but not serum insulin and triglyceride levels were 
significantly higher compared to the Fed Saline visit. 
High-calorie foods were more appealing than low-calorie foods at the Fasted Saline 
and Fed Ghrelin visits but not at the Fed Saline visit. Chocolate and sweet non-chocolate 
but not savoury high-calorie foods were more appealing than low-calorie foods at the 
Fasted Saline and Fed Ghrelin visits, but not the Fed Saline visit. High-calorie foods and 
low-calorie foods were more appealing relative to object pictures at each of the three 
visits. There was no significant difference in the appeal of object relative to blurred 
pictures between any of the three visits. Interestingly, the reaction time for appeal rating 
of both food categories and object pictures at the Fed Ghrelin visit was significantly 
shorter compared to the Fed Saline visit but not for rating blurred pictures. These 
differences in reaction time for appeal rating were not seen between the Fasted and Fed 
Saline visit. 
At both the Fasted Saline and Fed Ghrelin visits, anterior OFC activation on viewing 
high-calorie foods was significantly greater than the Fed Saline visit. There was a trend for 
the anterior OFC activation to low-calorie foods to be greater at the Fed Ghrelin than Fed 
Saline visit, but this was not seen for the Fasted Saline compared to the Fed Saline visit. 
There was no significant difference in activation in any other ROI for any other picture 
contrast between any of the three visits.  
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There was a weak trend for activation in the ventral striatum on viewing high-
calorie foods to be greater at the Fed Ghrelin visit than the Fed Saline visit. This trend was 
was not apparent for the Fasted Saline compared to the Fed Saline nor for the low-calorie 
foods. Interestingly this ventral striatum activation to high-calorie foods was also apparent 
at the Fasted Dummy visit but was less apparent at the Fasted Saline visit (see discussion 
6.3.2.). 
This study was thus able to demonstrate that fasting and ghrelin both increased 
the appeal of high-calorie over low-calorie foods and increased anterior OFC activation to 
high-calorie foods. The effects on OFC activation to low-calorie foods were less marked, 
with only a trend seen for ghrelin administration. 
 
At the Fed Saline visits, individual activation in the ventral striatum, anterior OFC and 
insula when viewing high-calorie foods positively correlated with individual hunger ratings 
in the scanner. The correlations with activation to low-calorie foods showed similar trends.  
No such correlations were seen at the Fasted Saline visits. 
 
At the Fed Saline visit, activation in the anterior OFC, and insula when viewing high-
calorie foods correlated positively with ad libitum lunch intake with a trend for activation 
to low-calorie foods. At the Fasted Saline visit, only activation in the insula when viewing 
high-calorie foods positively correlated with ad libitum lunch intake with no trend seen for 
low-calorie foods. By contrast, there was no positive correlation between VAS appetite 
ratings just before lunch and ad libitum lunch at either the Fed Saline or Fasted Saline 
visits. 
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6.1. Discussion for Fed–Fasted fMRI study and Fasted Saline vs. Fed Saline 
comparison from ghrelin fMRI study 
 
6.1.1. The main findings of the fed-fasted fMRI are: 
(i) Greater hunger, pleasantness to eat, volume able to eat and less fullness when 
fasted compared to when fed. 
(ii) Food picture appeal bias towards high-calorie foods when fasted. 
(iii) Ventral striatum, amygdala, insula, medial and lateral OFC show greater activation 
to high-calorie compared to low-calorie foods, when fasting but not when fed.  
(iv) Individual differences in appeal of high-calorie foods positively correlated with 
individual differences in hunger and pleasantness to eat between fasted and fed 
visits. 
(v) Individual differences in appeal bias to high-calorie over low-calorie foods positively 
correlated with differences in activation in both the medial OFC and lateral OFC for 
the high-calorie vs. low-calorie contrast between fasted and fed visits. 
 
 
6.1.2. The main findings of the Fasted Saline vs. Fed Saline comparison from the 
ghrelin study are: 
(i) Greater hunger, pleasantness to eat, volume able to eat and less fullness at the 
Fasted Saline visit compared to the Fed Saline visit.  
(ii) Ad libitum lunch intake was increased by 15% at the Fasted Saline visit compared 
to the Fed Saline visit and there was a tendency for lunch pleasantness (but not 
tastiness) to be greater on the Fasted Saline visit. 
(iii) High-calorie foods were more appealing at the Fasted Saline visit compared to the 
Fed Saline visit but not low-calorie foods. 
(iv) Activation in the anterior OFC to high-calorie foods was significantly increased at 
the Fasted Saline compared to the Fed Saline visit but not low-calorie foods. 
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(v) At the Fed Saline visit, but not the Fasted Saline visit, hunger rating positively 
correlated with activation in the ventral striatum, anterior OFC and insula to high-
calorie foods with a similar trend for low-calorie foods. 
(vi) At the Fed Saline visit, activation in the insula and anterior OFC when viewing high-
calorie foods correlated with lunch intake with a similar trend for low-calorie foods. 
(vii) At the Fasted Saline visit, activation in the insula when viewing high-calorie foods 
positively correlated with lunch intake, but not for low-calorie foods. 
(viii) There was no positive correlation between VAS appetite scores (just before lunch) 
and lunch intake at either fed or fasted visits. 
 
6.1.3. Effect of nutritional state on food appeal 
In the two fMRI studies, hunger and pleasantness were increased and fullness was 
decreased at the fasted visits compared to the fed visits.  
 It is suggested that subjects’ palatability of food is altered in the fed, compared 
with the fasting state (Berridge, 1991). The two fMRI studies found that high-calorie foods 
were more appealing than low-calorie foods at the fasted visit but not at the fed visit. 
These results were further supported by data from the first fed/fasted study when 
individual differences in the appeal of high-calorie foods between the fed and fasted state 
also correlated with the individual differences in hunger and pleasantness to eat. 
The second Fasted / Fed Saline study also showed that ad libitum lunch intake at 
the Fasted Saline visit was significantly increased compared to the Fed Saline visit and 
that there was a tendency for lunch pleasantness to be greater at the Fasted Saline visit. 
These findings confirm that nutritional state (fasting, e.g. not eating breakfast) impacts on 
the appeal and pleasantness of food (Cabanac, 1971; Uher et al., 2006; Stoeckel et al., 
2007). 
Cross-sectional studies have shown connections between lack of breakfast 
consumption, and increased daily fat intake, subsequent consumption of high fat snacks, 
and more binge eating disorder in children and adults (Rampersaud et al., 2005; Masheb 
and Grilo, 2006; Niemeier et al., 2006; van der Heijden et al., 2007; Dubois et al., 2008; 
 205 
Marin-Guerrero et al., 2008; Timlin et al., 2008). Missing breakfast is positively related to 
greater weight gain in normal-weight adolescents (Berkey et al., 2003; Timlin et al., 
2008) and during the transition between adolescence to early adulthood (Rampersaud et 
al., 2005; Niemeier et al., 2006; van der Heijden et al., 2007). Eating breakfast is linked 
to healthier food choices such as more vegetables and milk, fewer soft drinks, and a lower 
intake of french fries in children and adults (Rampersaud et al., 2005; van der Heijden et 
al., 2007; Dubois et al., 2008). Thus, the findings from these studies suggest a potential 
brain reward mechanism influencing food preference by which fasting may lead to weight 
gain. Indeed, fasting leads to increased impulsive snacking and fat intake in obese 
individuals in a caloric restriction weight-reduction programme (Schlundt et al., 1992). 
The results of these studies however would therefore support the advice for regular 
consumption of a healthy breakfast (Rampersaud et al., 2005).  
 
The effect of skipping breakfast on subsequent intake of fatty, calorie-rich foods and 
impulsive snacking depends on the usual breakfast habits (Schlundt et al., 1992). The 
majority of the subjects of the two studies ate breakfast regularly. However, there was a 
difference in the type of breakfast subjects were given in the two fMRI studies. At the first 
fed-fasted fMRI study they were instructed to eat a filling breakfast of their own choice 
whereas in the Fasted / Fed Saline fMRI study they were given a fixed breakfast. Being 
able to choose a breakfast such as in the first fMRI study will lead people to eat what they 
like, whereas in the second study the breakfast was probably not the most favourite food 
for all the volunteers. Furthermore even though the calorie content of breakfast for the 
second study was chosen to be the same as the average for the first study, an identical 
amount of calories was given for for men and women and for subjects of different size. 
Thus, the food type and volume of the breakfast relative to body habits were different in 
the two studies. This may explain why differences between appetite ratings between the 
fasted and fed visit were greater at the first fed-fasted study compared to the second 
Fasted / Fed Saline study. These differences in appetite ratings between the two studies 
were paralleled in the food picture appeal ratings. Both studies showed that food picture 
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appeal is biased towards high-calorie foods when not eating breakfast. However, the 
differences of appeal ratings were greater between the fed and fasted visit in the first fed-
fasted study where subject had a filling breakfast of their own choice.  
This could explain why although skipping breakfast in the second fMRI study led to 
greater food intake at lunch it did not lead to any overall reduction in energy intake or 
macronutrient content between the Fasted and Fed Saline visit over the whole study day. 
Another explanation is that the test lunch contained only one savoury high-calorie food 
which may have impaired the ability to separate differences in food intake between the 
visits. This assumption could be underpinned with the appeal rating data which showed 
that although high-calorie foods were more appealing than low-calorie foods at the Fasted 
Saline visit this significance was dependent on the type of high-calorie food: being 
significant for chocolate or sweet non-chocolate but not savoury high-calorie foods. 
In future studies it would be interesting to vary the breakfast size according to the 
subjects dietary needs calculated using resting energy expenditure which adjusts for age, 
gender and weight, and to give a test lunch buffet consisting of a mixture of sweet and 
savoury low-calorie and high-calorie foods.  
 
6.1.4. Effect of food type on brain reward systems 
The sensory properties of foods play a very important role in the way people select their 
food and how much they eat (Sorensen et al., 2003; Stoeckel et al., 2008). The findings 
of the first fed-fasted study showed that viewing pictures of high-calorie over low-calorie 
foods increased activation in the ventral striatum, amygdala, anterior insula, and medial 
and lateral OFC. The second Fasted/ Fed Saline study showed that viewing pictures of 
high-calorie foods over objects increased activation in the anterior OFC. 
These findings agree with earlier PET and BOLD imaging research in non-obese 
healthy volunteers, that compared to non-food-pictures, visual food stimuli induce greater 
activity in the amygdala, ACC, insula, OFC, DLPFC and striatum  (Gordon et al., 2000, 
LaBar et al., 2001, Morris and Dolan, 2001, Wang et al., 2004, Holsen et al., 2005, 
Simmons et al., 2005, St-Onge et al., 2005, Porubska et al., 2006, Fuhrer et al., 2008, 
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Schur et al., 2009). Activity is also greater in the ventral striatum, OFC, amygdala and 
insula when viewing appetizing compared with bland or disgusting foods (Beaver et al., 
2006, Calder et al., 2007). Compared to low-calorie food pictures, viewing high-calorie 
food stimuli induces greater activity in the insula, medial OFC, medial and dorsolateral PFC 
(Gordon et al., 2000, Killgore et al., 2003, Siep et al., 2009). Activity is also greater in the 
amygdala and OFC when chosing highly preferred foods from a menu (Hinton et al., 
2004).  
 
6.1.5. Combined effect of nutritional state and food type on brain reward 
systems 
Nutritional state (fasting) impacts on food reward and increases the appeal of food 
(Cabanac, 1971; Uher et al., 2006; Stoeckel et al., 2007). Animal and human studies 
have demonstrated that food restriction increases the rewarding properties of drugs of 
misuse (Palmiter, 2007). The sensation of reward is also influenced by energy status, as 
the subject’s palatability of food is altered in the fasted compared to the fed state 
(Berridge, 1991). 
 The novelty of the two fed/ fasted studies was that an interaction has been shown 
between nutritional state and food category (high-calorie foods) on the activation of brain 
reward systems. When fasted (first fed-fasted study), activation in the ventral striatum, 
amygdala, anterior insula, and medial and lateral OFC was increased on viewing pictures 
of high-calorie over low-calorie foods. However, the second Fasted / Fed Saline study 
showed that viewing pictures of high-calorie foods over objects only increased activation 
in the anterior OFC. These differences in activations in the two fMRI studies could be 
justified by various factors which are explained in the following section (‘Activation in the 
ventral striatum’). The results however agree with previous imaging studies that have 
looked at individual components of nutritional state and food category. They show that in 
a fasted state, the calorie content of food pictures modulates the activation of brain 
reward systems such as the in the insula, OFC, ventral striatum and amygdala when 
viewing high-calorie over low-calorie foods in lean subjects (Frank et al., 2010, Gordon et 
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al., 2000, Killgore et al., 2003, Siep et al., 2009), when viewing appetizing over disgusting 
(or bland) foods in lean subjects (Beaver et al., 2006, Calder et. al. 2007) and when 
choosing highly preferred foods from a menu in obese subjects (Hinton et al., 2004, Piech 
et al., 2009). 
 
6.1.6. Activation in the ventral striatum 
In the fed-fasted fMRI study, activation in this brain region was increased when fasted 
(compared to when fed) on viewing high-calorie foods which is in agreement with previous 
research (Beaver et al., 2006; Rolls and McCabe, 2007; Stoeckel et al., 2008; Stoeckel et 
al., 2009). This may be due to the ventral striatum playing an incentive motivational role 
in food intake and activation of this reward system enables behavioural responses 
necessary for obtaining a goal object, aimed at anticipated food receipt (Berridge, 1996, 
Kelley, 2004). There was however no activation in the second Fasted/ Fed Saline fMRI 
study when viewing high-calorie foods at the Fasted Saline visit which may be explained 
by various reasons: 
(i) The breakfast was equal for men and women whereas in the first study 
subjects where instructed to have a filling breakfast of their choice. This 
resulted in the differences in VAS appetite ratings and appeal scores 
between the fasted and fed visit being greater in the first study compared to 
the second study.  
(ii) In the second study, the Fasted and Fed Saline visit were randomised 
together with the Fed Ghrelin visit to either the 2nd, 3rd or 4th study visit. 
Viewing the food pictures for the 3rd or 4th time (compared to the fed-fasted 
study) may reduce the novelty and motivation to receive the high-calorie 
food pictures and therefore decrease activation in the ventral striatum. 
Indeed, the second study has shown that activation in the ventral striatum 
was decreased between the Fasted Dummy and Fasted Saline visit. These 
findings are supported by recent research showing that contextual novelty 
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enhances neural responses underlying reward representation in the ventral 
striatum (Guitart-Masip et al., 2010). 
(iii) In the second study, a different atlas (as part of the new fMRI analysis 
software) was used to draw the regions of interest such as the ventral 
striatum. In the first study the automated anatomical labeling atalas (AAL) 
as part of SPM 5 software was used and in the second study, the Havard 
atlas as part of the FSL software. This could lead to differences in the 
anatomical location of each ROI. 
(iv) Finally, there were differences between the studies in how the relevant 
voxels in the ROIs were defined. The first study looked at differences in 
activation at peak voxel (defined as most significant difference in activation 
when viewing high-calorie over low-calorie foods at the fasted visit), 
whereas the second study looked at the differences in average activation 
within those voxels in the whole ROI that were activated on average across 
3 visits for high-calorie foods compared to objects. This alternative method 
using union fMRI was chosen because there were voxels whose activity was 
greater for high-calorie than low-calorie foods at both the Fed Saline and 
Fasted Saline visits, while in the first study there were only significant 
voxels at the fasted visit. 
 
The second fMRI study found that individual hunger ratings positively correlated with 
activation in the ventral striatum when viewing high-calorie foods but only at the Fed 
Saline visit, with a similar trend for low-calorie foods. This may be explained by a 
threshold effect when fasting with a non-linear relationship between activation and hunger 
once a certain hunger level is reached when fasted. Below this level, varying degrees of 
satiation in the fed state may can still correlate with activation in the ventral striatum. 
This hypothesis is supported by results from the first fMRI study when individual 
differences in hunger positively correlated with individual differences in appeal bias 
towards high-calorie foods in the fed state but not in the fasted state.  
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6.1.7. Activation in the insula cortex 
In the first fMRI study, activation in the insula was significantly increased when viewing 
high-calorie foods only in the fasted state. This is in accordance with previous studies 
which showed that fasting increased insula activation when viewing food relative to non-
food pictures (Gordon et al., 2000; St-Onge et al., 2005; Schur et al., 2009; Siep et al., 
2009), high-calorie over low-calorie foods (Frank et al., 2010), viewing and smelling food 
(Wang et al., 2004; Wang et al., 2009) and after choosing high-incentive over low-
incentive foods written on a menu (Hinton et al., 2004).  
The second fMRI study showed that individual hunger ratings are positively 
correlated with activation in the insula when viewing high-calorie foods only at the Fed 
Saline visit with a similar trend for low-calorie foods. This disagrees with a previous study 
which demonstrated that subjective ratings of hunger when fasted for at least 5 hours 
correlated with activation in the insula to food pictures (Porubska et al., 2006). As 
discussed for the ventral striatum above these differences may be related to threshold 
effects and the duration of fasting.  
The insula cortex has been suggested to play an important role in taste processing 
and belongs to the “visceral stimulation network” (Welzl et al., 2001; Porubska et al., 
2006; James et al., 2009). Previous studies suggested that representations of experience 
with food (colour, taste, flavour, reward value) are generated in the insula (de Araujo et 
al., 2003; Haase et al., 2009a). Bender and colleagues demonstrated that the insula is 
activated to taste versus tasteless stimuli irrespective of taste (sweet, sour and salty) 
(Bender et al., 2009). Thus, this region of the insula is responsible in encoding taste 
irrespective of taste demand (Bender et al., 2009). Haase et al. confirmed insula 
activation in response to sweet, sour and salty taste in both hungry and satiety states 
(Haase et al., 2009a). However, none of these studies commented on the calorie content 
of the food.  
The findings of the second fMRI study are the first to show that activation in the 
insula when viewing high-calorie foods positively correlated with ad libitum lunch intake at 
both the Fasted and Fed Saline visits, with a trend for activation to low-calorie foods at 
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the Fed Saline visit only. As with the hunger rating correlations discussed above, this 
demonstrates that when fasted, correlations with appetite measures are only seen for 
activation to high-calorie foods, while when fed they are seen for high-calorie and a 
tendency for low-calorie foods. This again supports the interaction between nutritional 
state and biases towards high-calorie foods (see section below entitled “Activation in the 
OFC”).  
 
6.1.8. Activation in the amygdala 
In the first, but not second fMRI study there was increased activation in the amygdala 
when viewing high-calorie over low-calorie foods on the fasted visit. This is in agreement 
with earlier neuroimaging research showing that fasting (vs. post-prandial state) activates 
the amygdala when viewing food over non-food pictures (LaBar et al., 2001; Morris and 
Dolan, 2001; Holsen et al., 2005; Fuhrer et al., 2008; Schur et al., 2009; Siep et al., 
2009), when choosing high-incentive over low-incentive foods written on a menu (Hinton 
et al., 2004) or when imagining and chosing attractive written dishes from a restaurant 
menu (Piech et al., 2009). The amygdala has been implicated in emotional processing 
particularly responses of positive and negative affect, reward processing, and behaviour 
(Pessoa and Ungerleider, 2004). Suggested reasons for the lack of differences in 
activation in the amygdala between nutritional states in the second fMRI study are similar 
to these discussed above for the ventral striatum, principally the different preload 
(breakfast), the novelty effect of the Fasted Dummy visit, the different anatomical labeling 
atalas and the different statistical fMRI analysis approach. 
 
6.1.9. Activation in the orbitofrontal cortex (OFC) 
In the two fMRI studies, activation in the OFC was significantly increased when viewing 
high-calorie foods in the fasted compared to the fed state. In the first fed/fasted fMRI 
study, activation in the medial and lateral OFC was significantly increased on viewing 
high-calorie over low-calorie foods in the fasted but not the fed state. These findings of an 
interaction between activity in brain reward systems with food type and nutritional state is 
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in agreement with a previous H215O PET study, which showed that fasting (vs. post-
prandial state) activates the medial OFC when choosing high-incentive over low-incentive 
foods written on a menu (Hinton et al., 2004). Other fMRI studies have also demonstrated 
that compared to low-calorie food pictures, viewing high-calorie food stimuli induces a 
greater activation in the OFC (Gordon et al., 2000; Killgore et al., 2003; Goldstone et al., 
2009; Siep et al., 2009; Frank et al., 2010). In normal weight subjects in a fasted hungry 
state, visual food versus non-food stimuli are reported to produce greater activation in the 
OFC, using functional imaging techniques (Holsen et al., 2005). However, the findings of 
this research study are the first to show that fasting also enhances the subjective appeal 
of high-calorie more than low-calorie foods, and the change in appeal bias towards high-
calorie foods is positively correlated with medial and lateral OFC activation (Goldstone et 
al., 2009). This suggests a role for the OFC in the representation of food reward value.  
 Furthermore the second fMRI study revealed that hunger ratings were positively 
correlated with activation in the OFC when viewing high-calorie foods in the fed state with 
a similar trend for low-calorie foods, but not in the fasted state. However, appeal rating 
differences between the Fasted Saline and Fed Saline visit did not correlate with 
differences in activation in the OFC in the second study. As discussed earlier (‘Activation in 
the ventral striatum (i)), this could be explained by smaller changes in appetite and food 
appeal between the fasted and fed visits due to the fixed breakfast given in the second 
study, compared to the first study (Goldstone et al., 2009).  
A large meta-analysis of the existing neuroimaging data has shown that activity in 
the OFC is related to the monitoring and learning of reward value of reinforcers 
(Kringelbach & Rolls, 2004). New research suggests that specific brain reward areas are 
divided into specific functional subregions. The reward value of a reinforcer is assigned in 
more anterior parts of the OFC, where it can be modulated by hunger and other internal 
states, and can be used to influence subsequent behaviour, stored for monitoring, 
learning and memory, and made available for subjective hedonic experience (Kringelbach 
et al., 2003; Kringelbach and Rolls, 2004; Kringelbach, 2005).  
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In the second study, anterior OFC activation to high-calorie foods (but not low-
calorie foods) positively correlated with ad libitum lunch intake in the fed state only. As 
described for the insula and ventral striatum, this may be explained by a threshold effect 
in the fasted state. Furthermore one previous fMRI study has examined the relationship 
between non-task related BOLD activation and subsequent caloric intake (lunch) in the 
fasted state under hormonal manipulation (Batterham et al., 2007). This study showed 
that after infusion of saline (low PYY levels) resting activity in the hypothalamus correlated 
with subsequent caloric intake. On the PYY infusion day, activation in the OFC predicted 
subsequent caloric intake. Therefore, in the presence of PYY, a postprandial satiety factor, 
brain activity predicting caloric intake appeared to switch from a homeostatic area 
(hypothalamus) to a hedonic area (OFC). My results are entirely consistent with this since 
correlations of OFC activation and lunch intake were only seen in the fed state in which 
PYY levels would be expected to be higher compared to the fasted state.  
 An interesting finding of this study was that there was no positive correlation 
between VAS appetite ratings just before lunch and ad libitum lunch intake at the Fed 
Saline or Fasted Saline visits. As this study showed positive correlations of insula and 
anterior OFC activation and ad libitum lunch intake, this is the first study to show that 
brain activity when viewing food pictures may be a better predictor of subsequent food 
intake then appetite ratings (Blundell et al., 2010). One possible explanation could be that 
subjects use different VAS rating strategies while BOLD activation is a less subjective 
measure to compare between subjects.  
 
6.1.10. Control tasks 
The assessment of activity during control tasks (viewing object vs. blurred pictures) 
suggests that the results of the two fed/fasted studies are unlikely to be due to any non-
specific changes in BOLD fMRI signal of nutritional state as there was no significant 
differences in activation in brain reward systems when viewing objects over blurred 
pictures (Noseworthy et al., 2003). Visual cortices (occipital cortex and lateral geniculate 
nucleus) showed also no significant difference in activation on viewing a 4Hz flashing 
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checkerboard between fed and fasted states in the first fed-fasted study. The analysis of 
the AMV task of the second Fasted-Fed Saline study will hopefully confirm these non-
specific changes in brain activation. 
Previously, caffeine has been shown to have the potential to modify fMRI results, 
as the BOLD signal is a function of both neural activity and changes in vascular tone 
through coupling of neural activity to the haemodynamic response. Therefore any 
manipulation that alters vascular tone can alter BOLD responses. For example, caffeine 
blocks adenosine receptors, resulting in vasoconstriction. A previous study demonstrated 
that in high caffeine users BOLD signal changes are increased after visual stimulation 
compared to low caffeine users (Laurienti et al., 2002). The same group of researchers 
further showed that acute caffeine intake reduces cerebral perfusion and increase BOLD 
signal intensity compared to placebo in response to passive visual (flashing checkerboard) 
and passive auditory (bursts of white noise) stimuli (Laurienti et al., 2003).  
Therefore any pharmacological or nutritional manipulation has the potential to non-
specifically alter BOLD responses and so control tasks should be included as standard.   
 
6.1.11. Study limitations 
There are several limitations that should be taken into account when making any 
conclusions from these two studies about the effects of nutritional state on brain 
responses to food pictures:  
1. A relatively small numbers of subjects leading to possibility of type I errors, especially 
given the number of comparisons done. For this reason the number of ROIs was kept 
limited. However confirmation of the findings will need to be made with a larger cohort. 
2. The sample size has been determined using previous publications. Without prior power 
calculations the probability of type II error is increased. The conclusions therefore remain 
preliminary until they are re-examined in further study populations with larger subject 
numbers. 
3. Different pre-loads were given between the 2 studies - a filling breakfast of the 
subject’s own choice vs. a fixed breakfast. In order to compare brain activity between 
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subjects it is important to have the same macronutrient composition consumed by each of 
them. 
4. The second study attempted to control for food intake on the night prior to each study 
visit. They were instructed to have the same type and amount of food for supper at 8pm 
the night prior to each study day. However, in the second study participants consumed 
more carbohydrates at the Fed Saline visit compared to the Fasted Saline visit. The first 
study did not control for these variations which could influence food intake on the study 
days.  
5. The results from these studies may not be directly relevant to overweight/ obese 
subjects as there may be differential effects on food reward systems in obese subjects. 
Increased BMI has been correlated with decreased ability to inhibit food intake 
(Myslobodsky, 2003; Nederkoorn et al., 2006a; Lowe et al., 2009; Nederkoorn et al., 
2009) and with reduced satiety (le Roux et al., 2006). Obese and postobese subjects have 
been found to have altered activity at rest in brain reward systems after eating a meal 
(DelParigi et al., 2004; Le et al., 2006; Le et al., 2007). Obese subjects have further 
exaggerated activation of brain reward systems when viewing high-calorie vs. low-calorie 
foods (Rothemund et al., 2007; Stoeckel et al., 2008; Martin et al., 2009). There was no 
significant correlation between BMI and activation for the high-calorie vs. low-calorie food 
contrast when fasted in any ROI in the first fed/fasted fMRI study. This may be explained 
by the homogenous group of the study subjects with an average BMI of 22.1 ± 0.5 kg/m2 
(range 18.2-27.1) who were all non-obese or overweight on BMI criteria. Therefore it was 
not possible to investigate the effect of BMI on activation in brain reward systems. This 
can be addressed in future studies by comparing non-obese and obese subjects. 
6.  This studies used a mixed-block fMRI picture paradigm which was not designed to 
differentiate whether different categories of high-calorie foods produced differential 
activation in reward systems. Although there was a suggestion that sweet high-calorie 
foods tended to be of greater appeal than savoury high-calorie foods when fasted, the 
study was not designed or powered to examine this in detail. The heterogeneous ethnicity 
in this study could also bias the preference and reward for certain food types. Future 
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studies can address this specifically using an event-related fMRI design or blocks 
separating sweet and savoury high-calorie foods with sufficient numbers of different high-
calorie pictures and using a homogenous ethinicty group used to a western diet. Previous 
taste fMRI studies have distinguished between tasting sweet, sour, salty and tastless 
solutions (Bender et al., 2009; Haase et al., 2009; Spetter et al., 2010) but differential 
effects of sweet vs. savoury food pictures on brain activation have yet to be reported. 
7. In order to improve the results when running appetite fMRI studies it may be 
important to implement an inital dummy visit to acclimatise (stress, anxiety) subjects to 
the MRI scanning and the fMRI protocol, although many subjects in the first study had 
previously experienced MRI scans (Chandarana et al., 2009). A Fasted Dummy visit was 
applied in the second fMRI study. The results and discussion of the impact of such Fasted 
Dummy visit will be shown in section 6.4. 
8. The fist study did not control for the day of menstrual cycle although there is evidence 
for variation in appetite and fMRI brain response to rewarding stimuli over the menstrual 
cycle (days 2-10 after day of first bleed) in women (Dreher et al., 2007; Van Vugt, 2009, 
Frank et al., 2010). The second fMRI study controlled for menstrual cycle. 
9. The first fMRI study did not collect field maps (due to delayed sequence development), 
a method to correct for geometric distortions in brain reward areas such as the medial 
OFC located at the bottom edge of the frontal cortex.  
 
6.1.12. Conclusion of effects of nutritional state on brain responses to food 
pictures  
The two studies have highlighted brain areas involved in appetite reward circuitry whose 
activity may vary depending on nutritional state and type of food stimulus. The results 
demonstrate that in healthy subjects, fasting increases activity in brain reward systems 
when viewing high-calorie compared to low-calorie foods, including ventral striatum, 
amygdala, insula, OFC, increases appeal of and preference for high-calorie foods. 
Furthermore activity in these brain regions, especially to high-calorie foods when fed, is 
predicted by hunger and predicts subsequent food intake.  
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 An increase in activation in brain reward systems when fasting while viewing high-
calorie foods may be explained by a change in neuroendocrine factors. Endocannabinoid, 
serotonergic, opioid, orexin and dopaminergic pathways change with nutritional state and 
may be responsible for the changing activity in brain reward systems in response to 
appetizing visual food cues (Cardinal et al., 2002; Kringelbach and Rolls, 2004; Volkow 
and Wise, 2005; Palmiter, 2007; Berthoud and Morrison, 2008). As discussed in the 
Introduction, imaging studies in humans have provided evidence of dopamine involvement 
in the motivational properties of food intake (Volkow and Wise, 2005). The mechanism by 
which nutritional state and food stimulate dopamine signaling is unclear. A new concept 
has been put forward that suggest hormones such as leptin, insulin and ghrelin directly 
affect the dopamine reward pathways. These hormones activate receptors on VTA 
dopamine neurons, thereby either stimulate (ghrelin) or inhibit (leptin and insulin) 
dopamine signaling in the NAc. The NAc (ventral striatum) receives and projects onto the 
VTA, insula and OFC (Verhagen and Engelen, 2006; Fields et al., 2007; Van Vugt, 2009).  
 Leptin shows a direct inhibitory effect on dopaminergic neurons projecting to the 
ventral striatum in rodents (Cota et al., 2006).  Functional MRI studies using visual food 
have shown that obese humans with a very rare condition of leptin deficiency, leptin 
replacement reduces hunger, ‘liking’ of food as well as brain activation in the insula and 
ventral striatum (Baicy et al., 2007; Farooqi et al., 2007). However, although I did not 
meaure leptin levels in the first study, and have yet to assay the samples in the second 
study, it is unlikely that plasma leptin levels changed in the current studies as the time 
between eating breakfast and imaging was relatively short (1.2 ± 0.1hrs) (Korbonits et al., 
1997; Hinton et al., 2004).  
In humans, gastric distension and other anorexigenic gut hormones such as PYY 
and insulin that are released after eating a meal may also mediate the effects on brain 
reward systems seen in this study (Anthony et al., 2006; Batterham et al., 2007; Wang et 
al., 2008; Guthoff et al., 2009). 
 The stomach-derived orexigenic hormone ghrelin is a prime candidate since its 
plasma levels increase with fasting and descrease after eating a meal. Ghrelin appears to 
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modulate the response to food cues of a neural network involved in reward and the 
regulation of feeding (Malik et al., 2008). How ghrelin acts on the brain is not known, but 
several potential mechanisms have been indentified as previously described (See section 
1.4.7. in Introduction). However, it remains unclear whether ghrelin may have a selective 
effect on viewing high-calorie vs. low-calorie food pictures during negative energy balance 
such as observed in the present study.  
The next Section (discussion of Ghrelin fMRI Study) will address the hypothesis 
that changes in ghrelin may be responsible for the effects of fasting on food reward. This 
study examined whether ghrelin administration to fed healthy volunteers is able to mimic 
fasting to increase activation in brain reward systems when viewing high-calorie foods. 
 
 
6.2. Discussion Fed Ghrelin vs. Fed Saline fMRI study 
 
6.2.1. The main findings of this study are as follows: 
(i) There was no significant difference in VAS appetite scores and lunch intake 
between the Fed Ghrelin and Fed Saline visit but there was a tendency for 
hunger ratings to be greater at the Fed Ghrelin visit. 
(ii) High-calorie foods were more appealing than low-calorie foods at the Fed 
Ghrelin but not Fed Saline visit. High-calorie foods (but not low-calorie foods) 
were significantly more appealing at the Fed Ghrelin visit compared to the Fed 
Saline visit (as with the Fasted Saline visit). 
(iii) Activation in the anterior OFC on viewing high-calorie foods at the Fed Ghrelin 
visit was significantly greater compared to the Fed Saline visit (as with the 
Fasted Saline visit). 
(iv) There was a slight tendency for greater activation in the ventral striatum to 
high-calorie foods at the Fed Ghrelin compared to the Fed Saline visit. 
(v) Plasma glucose and serum GH levels were significantly increased at the Fed 
Ghrelin visit compared to the Fed Saline visit. 
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(vi) After ghrelin injection serum cortisol and prolactin levels were significantly 
increased compared to injection of saline, but there was no difference in 
anxiety or stress VAS ratings. 
 
6.2.2. Effect of ghrelin on appetite ratings and lunch intake 
Between the Fed Ghrelin and the Fed Saline visits there were no significant differences in 
VAS appetite ratings (hunger, fullness, pleasantness and volume able to eat) or ad libitum 
lunch intake. This could be due to various reasons: 
1. The relatively small number of subjects (n=17) participating in this study, although the 
only fMRI study which administered ghrelin used only 20 subjects for their analysis 
(Malik et al., 2008). Previous ghrelin administration studies used 16 or less patients 
(Druce et al., 2006; Ashby et al., 2009).  
2. Some of the patients described a burning pain while giving the ghrelin or saline 
injections which lasted for about 30 seconds. This could lead to increased stress and 
therefore decreased hunger. However, the VAS stress ratings showed no significant 
differences between the Fed Saline and Fed Ghrelin visits. Prolactin and cortisol levels 
increased after injection of ghrelin which is in agreement with a previous study (Tong 
et al., 2010). A previous study showed that increased appetite and cravings for foods 
high in sugar and fat is caused by high cortisol levels (Epel et al., 2001).  
3. Ghrelin may not have been absorbed well in some subjects as ghrelin was injected 
subcutaneously. This would disagree with previous studies in healthy volunteers, 
obese patients and dialysis patients where a subcutaneous injection of ghrelin 
increased ghrelin plasma levels, increased appetite, and increased energy intake at the 
subsequent meal (Druce et al., 2006; Ashby et al., 2009). Although ghrelin levels have 
yet to be measured for my study, pilot measurements from 3 other subjects given the 
same dose of ghrelin from the same batch, has shown levels of 300-1800 pg/mL 15 
mins after subcutaneous injection (Milliplex assay, Millipore Corporation, St. Charles, 
MO, USA) suggesting achievement of high levels of active ghrelin. Furthermore serum 
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GH levels rose after ghrelin injection confirming bioactivity of the ghrelin injection 
(Wren et al., 2001). 
4. The effect of ghrelin had worn off by lunch. In this study, there was a long gap between 
ghrelin injection and lunch (95 minutes) to enable the scanning to take place. In 
contrast to the results of this study, Neary et al. demonstrated that only 30 minutes 
after a subcutaneous injection of ghrelin, energy intake is increased by 28 percent in 
cancer patients with anorexia (Neary et al., 2004). Druce et al. showed that 
subcutaneous ghrelin increases food intake in obese as well as lean healthy subjects 
by 20 percent only 30 minutes after injection (Druce et al., 2005; Druce et al., 2006). 
Other studies demonstrated that ghrelin injection to malnourished dialysis patients 
increases food intake by 25 percent after only 30 minutes of ghrelin injection (Wynne 
et al., 2005b; Ashby et al., 2009). Previous researchers have shown a decline in total 
and acylated ghrelin 15 to 75 minutes after subcutaneous injections (Neary et al., 
2004; Druce et al., 2005; Wynne et al., 2005b). Although pilot studies in 3 subjects 
from my study have shown acylated ghrelin levels 75-450 pg/mL, which are still 
elevated above pre-injection levels (<50 pg/mL), 95 mins after subcutaneous 
injection, it may not be the absolute ghrelin levels but the direction of change of 
ghrelin levels that may be important. Possibly high levels of desacyl ghrelin due to 
breakdown of acylated ghrelin may antagonize the orexigenic effect of acyl ghrelin.  
5. The absent effect of ghrelin to increase lunch intake could have also been caused by 
showing food pictures in the scanner abolishing the difference between the Fed Saline 
and Fed Ghrelin visit due to the impact of ‘sensory-specific satiety’ (SSS). This SSS 
causes a dropping in ratings of pleasantness relative to foods that have not been eaten 
when a food is repeatedly viewed, smelled or consumed (Rolls et al., 1981, 
Kringelbach et al., 2003, O'Doherty et al., 2000, Small et al., 2001). 
6. Recent research suggests that ghrelin enhances sweet food consumption and 
preference regardless of its caloric content in rodents (Disse et al., 2010). This study 
used savoury pasta or curry for lunch without any sweet component and the nature of 
the study meal might play an important role when investigating ghrelin’s ability to 
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increase food intake. This is supported by the food appeal data in the MRI scanner 
showing that while high-calorie food pictures were more appealing relative to low-
calorie food pictures at the Fed Ghrelin but not at the Fed Saline visit, the effects was 
greatest for sweet chocolate or sweet non-chocolate foods compared to savoury high-
calorie foods. In a previous study where they showed 27 percent increase in energy 
intake after injection of ghrelin in healthy volunteers, researchers used Madeira cake 
or cinnamon and raisin loaf as the ad libitum meal (Druce et al., 2005). Another 
feeding study used sweet brioche rolls as the ad libitum meal in malnourished dialysis 
patients (Wynne et al., 2005b). This may help to explain why my ghrelin fMRI study 
showed no difference in food intake, as ghrelin might enhance the intake of sweet and 
not savoury foods. Although some of the previous ghrelin studies on food intake used 
savoury test meals as in this ghrelin fMRI study (Neary et al., 2004), these studies 
used an intravenous infusion rather than a subcutanous injection of ghrelin, fasted 
rather then fed subjects, or patients with cachexia rather than healthy volunteers 
(Neary et al., 2004; Ashby et al., 2009). In future studies, it would be useful to 
employ either a different test lunch such as cake as in previous studies or a buffet 
meal where volunteers can choose between high-calorie sweet, high-calorie savoury, 
low-calorie sweet and low-calorie savoury foods.  
 
6.2.3. Effect of ghrelin on brain reward systems 
At the Fed Ghrelin visit, there was a significant increase in activation of the anterior OFC 
on viewing high-calorie foods, compared to the Fed Saline visit. As previously described in 
more detail (see Section 30 in Introduction) circulating ghrelin may act indirectly on brain 
reward systems through the hypothalamus (Saper et al., 2002; Kelley, 2004) or also act 
directly on dopamine neurons in the VTA (Abizaid et al., 2006, Zigman et al., 2006) 
(Cummings et al., 2007). Ghrelin can act on the VTA via orexin-producing neurons in the 
lateral hypothalamus (LH). Ghrelin-induced feeding is suppressed in orexin knockout mice 
(Toshinai et al., 2003). Orexin neurons can project to brain reward centres especially VTA 
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(Chemelli et al., 1999). Recent studies have shown that orexin is involved in motivated 
behaviour for drugs of abuse as well as natural rewards (Cason et al., 2010). 
 
Malik and colleagues demonstrated that intravenous ghrelin administration to healthy 
volunteers leads to increased activation to food (vs. non-food) pictures in the amygdala, 
OFC, anterior insula, and striatum and hippocampus using fMRI (Malik et al., 2008). My 
study did not show any activation in the insula and amygdala. This may be due to several 
differences between my study and that of Malik et al.: 
1. Inclusion of male subjects only in the study by Malik et al. Previous 
neuroimaging data suggested that the two genders respond differently in their 
brain reward activation to food stimuli (Del Parigi, 2002; Smeets et al., 2006; 
Wang et al., 2009; Frank et al., 2010). 
2. Malik et al. showed no measurements of stress hormone levels compared to my 
ghrelin fMRI study, where stress hormone levels were not significant different 
between fasted visits. However, as described in more detail in Section 6.4., 
anxiety and stress are suggested to alter feeding behavior (Adam and Epel, 
2007; Chandarana et al., 2009). In this ghrelin fMRI study but not in the Malik 
study each participant had one Fasted Dummy visit to acclimatize to the 
hospital environment and to the fMRI protocol. Indeed, VAS anxiety and 
sickness rating at the Fasted Dummy visit were significant increased compared 
to the Fasted Saline visit. The Malik study showed borderline significant 
increases for irritable and nausea feelings in the ghrelin relative to the control 
condition. In order to explore the possibility that the results in the group that 
received ghrelin were due to ‘order’ effects, Malik et al. subsequently recruited 
an additional eight subjects who underwent the same paradigm with the 
exception that they only received normal saline rather than ghrelin. In this 
group of subjects there was no significant difference in food hedonic ratings and 
no increased activation in brain reward systems. In the control group were also 
increases of borderline significance in the subjective ratings for irritable and 
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bored in the second relative to the first block of images but nausea levels did 
not change.  
3. There was a difference between the two studies in the route of ghrelin 
administration: the Malik study used an intravenous ghrelin injection rather 
then a subcutaneous ghrelin injection in my study. Therefore the effect on food 
intake and appetite ratings might be different between the two studies as 
subcuatnous injection might cause extra stress and therefore influence 
appetite. After ghrelin injection serum cortisol and prolactin levels were 
significantly increased compared to injection of saline, but there was no 
difference in anxiety or stress VAS ratings. 
4. As they left a three hour interval between giving breakfast and fMRI scanning, 
the effect of the meal may have been attenuated after this period and therefore 
the effect of the fed state may be less marked (subjects were less satiated) 
which could lead to increased appetite at the time of scanning in the Malik 
study.  
5. The researchers in the Malik study have no control of the subjects being awake 
in the MRI scanner as no active behavioural task (passive picture viewing) was 
performed such as the appeal rating of the pictures like in this study. However, 
in the Mailk study approximately 30 min later after the scanning, subjects were 
shown all 45 food images that they had viewed in the scanner intermixed with 
26 novel food images and were asked to state whether or not they had seen 
each image while in the scanner. This recognition/ memory task was performed 
to ensure that subjects were paying attention to the images during the scan. 
6. The Malik study further showed food pictures only but did not distinguish 
between the hedonic value of foods such as high- and low-calorie foods. 
Therefore the effect of differences between food versus non-food might be 
greater than the effect of high-or low-calorie pictures versus objects.  
7. Different methods for determining ROIs for magnitiude of activation were 
performed in two studies. Mailk et al. created t-statistical maps to compare 
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BOLD signal in response to food vs. Non-food pictures at a specific voxel in the 
brain for the t-test contrast for ghrelin > saline visit (difference in post- vs pre- 
injection scan to control for differences in baseline on each study day to 
improve the ability to detect differences between study days). They then 
extracted the magnitude of activation of significant peak activated voxels. In 
my ghrelin fMRI study, significant activated voxels in the brain were determined 
when viewing high-calorie foods > objects averaged across all three study visits 
(Fasted Saline, Fed Saline and Fed Ghrelin) were determined and ROIs were 
defined using an anatomical labeling atlas. The average activation in in each 
ROI was then extracted to calculate the magnitude of activation between each 
contrast to compere between visits. Future analysis should look at a direct t-
test comparison of whole brain activation data between ghrelin and saline fed 
visits (with appropriate correction for multiple comparisons) from my study. 
8. The Malik study did not apply field maps to correct for OFC signal compression 
or drop out compared to my ghrelin fMRI study.  
9. In disagreement with this study, Malik found a difference in activation in the 
amygdala when given ghrelin which could be explained by the different 
approach to correct for study ‘order’ as they calculated the difference in 
activation pre-and post-injection of ghrelin (see above 7.). The test/ re-test 
results of Section 4.2.7.6. (Chapter 4) showed no significant correlations 
between fasted visits (Fasted Dummy vs. Fasted Saline) in any ROI expecpt 
with a tendency for the anterior OFC. This could clarify that there was no 
significant difference in the amygdala activation between the Fed Ghrelin and 
Saline visit.  
 
6.2.4. Effect of ghrelin on the anterior OFC 
In agreement with the Mailk study (Malik et al., 2008), my ghrelin fMRI study showed 
greater anterior OFC activation when viewing high-calorie foods at the Fed Ghrelin 
compared to Fed Saline visit. There was no significant difference in activation in this area 
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when viewing low-calorie foods. These results were similar to that seen in the comparison 
between Fasted Saline and Fed Saline visits. A study by Malik and colleagues found that 
effects of ghrelin on the OFC response were correlated with self-rated hunger ratings 
(Malik et al., 2008). This was not seen in this study which may be due to the fact that 
subjects were given scanned about 1.5 hours after breakfast whereas in the Malik study 
breakfast was served 3 hours before the scanning, thus subjects might have been less 
hungry in the ghrelin fMRI study.  
 
6.2.5. Effect of ghrelin on the ventral striatum 
The Malik study showed increased striatum activation when viewing food over scenery 
pictures after infusion of ghrelin compared to saline. This is in agreement with the findings 
of my ghrelin fMRI study as there was a tendency for increased ventral striatum activation 
at the Fed Ghrelin visit compared to the Fed Saline visit. As previously discussed (see 
Introduction), ghrelin has been found to induce feeding through activation of midbrain 
dopamine neurons which project to the ventral striatum (Jerlhag et al., 2006; Jerlhag et 
al., 2007). Ghrelin increases dopamine in the ventral striatum when locally administered 
into the VTA (Naleid et al., 2005).  
An interesting finding of the current ghrelin fMRI study was that activation in the 
ventral striatum when viewing high-calorie foods over objects was increased at the Fasted 
Dummy and tended to be so at the Fed Ghrelin visit compared to both the Fasted Saline 
and Fed Saline visit. One possible explanation for this may be that after the initial Fasted 
Dummy visit there is habituation of the ventral striatum activation which is reversed by 
ghrelin. Indeed neuroimaging research suggests that the ventral striatum is involved in 
reward expectancy and novelty processing of rewards (Guitart-Masip et al., 2010). In that 
study subjects viewed different types of indoor and outdoor pictures (novel or non-novel 
cues) and following each picture received a novel or expected cue. Activation in the 
ventral striatum was increased when the cue was novel compared to when not novel 
(Guitart-Masip et al., 2010). This is in agreement with my ghrelin fMRI study as at the 
Fasted Dummy visit, the food pictures were novel but on the following Fasted and Fed 
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Saline visit the food pictures were no longer novel with an associated decrease in 
activation of the ventral striatum irrespective of nutritional state. The novel suggestion of 
my study was that ghrelin tended to reactivate the ventral striatum to high-calorie foods 
despite their lack of novelty as a stimulus.  
Interestingly, my ghrelin fMRI study also showed that the reaction time for appeal 
ratings of all the pictures (but not blurred pictures) were significantly increased at the Fed 
Ghrelin visit compared to the Fed Saline visit. This maybe be explained by ghrelin which is 
suggested to increase the motivation to receive new rewards (‘wanting’) (Berridge, 1996; 
Guitart-Masip et al., 2010). As discussed later (section 6.4.) previous research 
hypothesizes that subjects are indeed able to react faster to novel items via enhanced 
energisation of action through reward and ghrelin might be involved in this enhancement 
(Bunzeck et al., 2009). 
The increased picture appeal rating reaction time could also been linked to 
increased attention to visual food stimuli by increasing activation in the hippocampus and 
amygdala through the effect of ghrelin (Vuilleumier and Driver, 2007; Malik et al., 2008). 
Also, this ghrelin fMRI study demonstrated that ghrelin increases cortisol levels although 
not significantly different from the Fed Saline visit. Previous studies suggest cortisol to 
increase vigilant attention (Hopper et al., 2004).  
 
6.2.6. Limitations of the Ghrelin fMRI study 
1. This study will have produced supraphysiological pharmacological plasma ghrelin 
levels which leads to a cautious interpretation of the results. In future studies it 
would be appropriate to use a ghrelin antagonist or GOAT inhibitor to block the 
action of ghrelin to investigate its physiological effect on brain reward systems in 
humans.  
2. To date it has not been possible to measure acylated and total ghrelin from the 
current study to assess whether appropriate ghrelin levels have been achieved in 
all subjects. This may affect the final analyses. 
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3. It would be useful to repeat a similar study with two different groups of subjects, 
such as obese versus lean to examine as obese subjects might have an altered 
signaling in brain reward systems after ghrelin injection.  
4. The fixed ad libitum lunch should be substituted by a free meal buffet choice, 
consisting of high-calorie and low-calorie, savoury and sweet components. 
5. The amount of breakfast was not individually calculated for each individual 
according to their gender, body weight and daily energy needs, which may have 
increased the variance between subjects. 
6. The same pictures were shown at each visit reducing the novelty of the pictures at 
subsequent visits. Using similar types of food picture which are different in exact 
nature between visits may have helped avoid this problem especially as regard 
ventral striatum activation. 
 
6.2.7. Conclusion Fed Ghrelin vs. Fed Saline fMRI study  
This is the first study in humans which has shown that ghrelin mimics fasting to bias food 
appeal towards high-calorie, especially sweet, foods and the associated activation of the 
anterior OFC when viewing and rating high-calorie foods. The effects on appeal of and 
activation to low-calorie foods were not significant. There was also a suggestion that 
ghrelin may also reverse the suppression of activation in the ventral striatum when food 
pictures are no longer novel. Interestingly these findings were seen despite there being no 
significant differences in VAS appetite scores or ad libitum lunch intake between the Fed 
Ghrelin and Saline visit. This is either due to the fact that the effects of ghrelin of food 
reward are independent of hunger (Disse et al., 2010) or that elements of the protocol 
design (e.g. timing of meal after injection, stress of MRI scanning, showing food pictures) 
prevented differences in hunger being identified. 
Additional factors to nutritional state and hormones may drive hunger and food 
reward. Individual differences in psychological cues such as reward sensitivity and dietary 
restraint have been previously described to affect eating behaviour. Identifying the neural 
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pathways that regulate cognitive, emotional and appetitive responses to different foods is 
particularly relevant to understanding individual differences in eating behaviour.  
 
 
6.3. Discussion Behavioural Questionnaires (sub-study, fed-fasted fMRI study) 
 
6.3.1. The main findings of this sub-study are as follows: 
(i) Individual differences in dietary restraint (measured by DEBQ-restraint) positively 
correlated with activation to high-calorie vs. low-calorie foods in both the DLPFC and 
dorsal ACC, and negatively correlated with activation in both the amygdala and 
lateral OFC, when fasted overnight. 
(ii) Reward sensitivity (measured by BAS-drive) positively correlated with activation to 
high-calorie vs. low-calorie foods in the ventral striatum. 
These findings were independent of gender which itself appeared to have no influence on 
activation.   
 
6.3.2. The effect of reward sensitivity on brain reward systems 
My study demonstrated a positive correlation between reward sensitivity and activation in 
the ventral striatum to high-calorie over low-calorie foods. This latter result is consistent 
with a previous study which reported that BAS-drive scores predicted activation to 
appetizing relative to bland food pictures in the ventral striatum when healthy non-obese 
subjects had not eaten for 2 hours (Beaver et al., 2006). As previously decribed 
(introduction), the ventral striatum plays an incentive motivational role in food intake 
(Berridge, 1996; Kelley, 2004). Obesity, food craving, overeating, binge eating and drug 
abuse are associated with increased levels of reward drive and sensitivity (Davis et al., 
2004; Dawe and Loxton, 2004; Schienle et al., 2009). These data suggest that heightened 
activity of the ventral striatum to high-calorie foods may be a mechanism for translating 
reward drive into over-consumption of rewarding foods and hence weight gain. There was 
no correlation seen in our study between BAS-fun seeking nor BAS-reward responsiveness 
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in any ROI. This may be because these questions measure the tendency to seek out novel 
rewarding experiences and positive hedonic responses to the actual receipt of rewards 
(Beaver et al., 2006). By contrast BAS-drive assesses both hedonic and motivational 
behavioural responses to reward cues in the immediate environment such as in our fMRI 
paradigm of rewarding food stimuli (Carver and White, 1994). 
 
6.3.3. The effect of dietary restraint on brain reward systems 
The results of my study showed that individual differences in dietary restraint positively 
correlated with activation to high-calorie over low-calorie foods in both the DLPFC and 
dorsal ACC when fasted overnight. 
 As previously decribed (introduction) the dorsal ACC is the cognitive subdivision 
involved in modulation of attention or executive function, influencing response selection, 
motivation, conflict monitoring and cost/benefit or reward/risk assessment, and is 
influenced by anxiety and fearful situations (Bush et al., 2000; Carter and van Veen, 
2007). This is consistent with the novel finding in this study of greater activation of the 
dorsal ACC when fasted in those with higher levels of dietary restraint when viewing high-
calorie vs. low-calorie foods. Foods of higher caloric and reward value would be predicted 
to produce greater conflict and altered reward/risk ratio, and hence engagement of the 
dorsal ACC in subjects with higher dietary restraint. The consequent mismatch between 
perceived risk of weight gain and food reward under this highly appetitive motivational 
state would require greater self-control. 
The DLPFC is crucial for cognitive regulation of behaviour, goal-directed decisions 
and exercising self-control (Heekeren et al., 2004; Rorie and Newsome, 2005; Hare et al., 
2009; Kable and Glimcher, 2009). Self-reported dieters with greater self-control over 
choosing foods to eat on the basis of health than taste show greater activation in the left 
DLPFC during a food picture choice paradigm using fMRI (Hare et al., 2009). Activation of 
the DLPFC has previously been reported when addicts view a variety of different drug-
related cues that induce craving especially when drug use is expected (Wilson et al., 
2004), and subjects view high-calorie compared to low-calorie foods especially when 
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fasted (Killgore et al., 2003; Goldstone et al., 2009; Schur et al., 2009). The results of 
this study showing increased activation of the left DLPFC in those with higher levels of 
dietary restraint when viewing high-calorie vs. low-calorie foods are consistent with these 
roles of the DLPFC to exert self-control in decision making. The dorsal ACC is reciprocally 
interconnected with the dorsal PFC. Since top-down control appears to be mostly 
implemented in the DLPFC, it is suggested that following detection of conflict by the ACC, 
the lateral areas of the dorsal PFC are engaged in order to reduce conflict (Carter and van 
Veen, 2007).  
 
This study further showed that individual differences in dietary restraint negatively 
correlated with activation in both the amygdala and lateral OFC to high-calorie over low-
calorie foods when fasted overnight. 
 As previously described, the lateral OFC is involved in encoding reward value and 
taste processing (Kringelbach and Rolls, 2004), while the amygdala is involved in 
emotional processing and responses (Pessoa and Ungerleider, 2004). Some amygdala 
functions are carried out in concert with the OFC, such as updating the values of expected 
outcomes stored in the OFC (Holland and Gallagher, 2004).  
 Previous neuroimaging studies have shown greater activity in the lateral OFC and 
amygdala when viewing appetizing compared to bland or disgusting foods, and high-
calorie compared to low-calorie foods, particularly when fasted (Beaver et al., 2008; Schur 
et al., 2009). In this study activity in the lateral OFC and amygdala was lower in those 
with high dietary restraint which suggests that the executive control system (DLPFC-
dorsal ACC) may have modulated the encoding of reward value and emotional responses 
in these regions to high-calorie compared to low-calorie foods. These findings are 
supported by recent studies that voluntary inhibition of hunger during food stimulation 
(visual, taste and smell) leads to decreased activation in the amygdala and OFC using 
18FDG PET (Wang et al., 2009).  
 These results are in agreement with earlier studies in previously obese subjects 
who have tried to diet. Successful dieters who had higher levels of dietary restraint 
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demonstrated greater dorsal PFC activation, albeit on the right, when tasting a liquid meal 
than non-dieters using 15O-water positron emission tomography (PET) (DelParigi et al., 
2007). In the combined groups dietary restraint was positively correlated with dorsal PFC 
activation and negatively correlated with OFC activation (DelParigi et al., 2007). 
Successful weight-loss maintainers also showed greater activation using fMRI in bilateral 
frontal regions to both high-calorie and low-calorie foods compared to normal weight and 
obese control women (McCaffery et al., 2009).  
The findings from this analysis expand the conclusion from earlier studies to 
include a role for the dorsal ACC and amygdala in addition to the left DLPFC in the 
cognitive and affective control of food intake related to dietary restraint in non-obese 
subjects, and emphasize the interaction with different food categories (high-calorie vs. 
low-calorie), which was either not previously investigated or found in previously obese 
subjects (DelParigi et al., 2007; McCaffery et al., 2009). Furthermore the results from this 
study in non-obese subjects without eating disorders are supported by reports of reduced 
left DLPFC activation to tasting food in obese compared to non-obese subjects (Le et al., 
2006), and to food vs. non-food pictures in patients with bulimia nervosa (Uher et al., 
2004), which may contribute to reduced-self control leading to overeating. Increased 
dorsal ACC activation has also been reported in patients recovered from compared to 
ongoing anorexia nervosa, and patients with bulimia nervosa compared to both non-obese 
controls and patients with binge eating disorder, where conflict between increased desire 
to eat and fear of weight gain would be hypothesized to be greater in the former group in 
each comparison (Uher et al., 2003; Schienle et al., 2009).  
 The findings of my study are however in contrast to a recently published study 
comparing brain activation when passively viewing highly vs. moderately palatable foods 
in fasted normal weight non-dieting women with low or high measures of dietary restraint. 
They found lower activation in the left DLPFC in subjects with high restraint, and no 
reported differences in amygdala, OFC or dorsal ACC (Coletta et al., 2009). Potential 
explanations for these differences between this study and our study may be related to 
differences in the scan timing, fasting duration and hence degree of hunger (afternoon 
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scan after 8h fast; morning scan after 16h fast), method of statistical comparison (t-test 
between highest and lowest quartiles of restraint; correlation with restraint score), 
restraint questionnaires used (Herman and Polivy’s Restraint Scale; DEBQ-restraint), task 
paradigm (passive viewing; rating appeal of pictures), and choice of food picture 
categories (highly vs. moderately palatable foods with latter containing some non low-
calorie foods e.g. bread, potato; high-calorie vs. low-calorie foods). 
Interestingly, Coletta et al. did observe that after consumption of a 500 kCal pre-
load subjects with higher restraint had greater activation in OFC, left DLPFC and insula to 
passively viewing highly vs. moderately palatable foods than those with lower restraint 
scales (Coletta et al., 2009). As the OFC is involved in reward processing and the DLPFC in 
cognitive processing, these findings raise the potential confounding phenomenon of 
counter-regulatory eating and disinhibition. Herman and Polivy (1984) have suggested 
that restrained eaters are concerned about their body weight leading them to control their 
food intake cognitively. At the same time, their ‘all or none’ approach to food makes them 
more likely to overeat forbidden foods under emotional distress (‘disinhibition’). Their 
history of disinhibition-induced overeating also causes their “satiety boundary” to be 
shifted upward so that once they become disinhibited, food intake continues beyond the 
point at which further food intake would normally be inhibited (Herman and Polivy, 1984; 
Heatherton et al., 1992). When primed by recent food intake they may in fact find food 
more rewarding and hence overeat (‘counter-regulatory eating’). These interpretations are 
supported by the findings of several studies that dietary restraint did not predict calorie 
intake in acute feeding studies or over weeks and months of observational studies (Stice 
et al., 2004; Stice et al., 2007; Stice et al., 2010). 
 Although the results of my study in the fasted state may reflect the consequences 
of high dietary restraint in the context of disinhibition due to exposure to highly palatable 
food cues, they might not reflect the situation in the presence of disinhibition due to 
emotional distress, social context, counter-regulatory eating responses and priming to 
ingestion of food. It is also unclear whether our findings in non-obese subjects might be 
different from those seen in currently or previously obese objects. 
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Indeed longitudinal studies have suggested that high dietary restraint (especially 
flexible restraint which able to appropriately adapt to context) may be able to counteract 
disinhibtion, and hence the interaction of these factors may be the best predictor of 
weight change (Hays and Roberts, 2008; Savage et al., 2009; Teixeira et al., 2010; 
Bryant et al., 2010). Comparison of the correlation of measures of dietary restraint (both 
flexible and rigid) and disinhibition between fasted and fed (using a fixed pre-load) states 
with activation to different food pictures using a similar experimental fMRI paradigm to 
this study will therefore be of interest to further investigate these interactions. 
Comparison of never, currently and previously obese subjects will also be of interest. 
 
6.3.4. The effect of external eating on brain reward systems 
Surprisingly the results of my study did not show any correlation between activation to 
high-calorie over low calorie foods in any ROI with DEBQ-external scores, a measure of 
sensitivity to the hedonic attributes of food, e.g. desire to eat or buy food that looks or 
smells delicious. This is in contrast to a previous study of obese subjects (with and without 
type 2 diabetes mellitus) in whom DEBQ-external scores were positively correlated with 
activation in the medial OFC when viewing food over non-food pictures. The differences 
between these findings and the current results may be related to differences in the study 
cohort (obese, non-obese), duration of fasting (3h, 16h), food picture contrast (mixture of 
high-calorie and low-calorie foods vs. non-food, high-calorie vs. low-calorie foods), range 
of individual DEBQ-external scores in each cohort, and task involved (passive viewing, 
rating appeal) (Chechlacz et al., 2009). Future studies using a similar paradigm to ours 
would benefit from including a cohort of subjects with a wide range of individual scores for 
both DEBQ-external and DEBQ-restraint. 
However, the findings of my study were in agreement with another fMRI study of 
non-obese subjects fasted for at least 2 hours in which no correlation of DEBQ-external 
scores was found with BOLD activation per se to viewing (but not rating) appetizing over 
bland foods in the amygdala, striatum or ACC (Passamonti et al., 2009). Researchers of 
this study did find correlations of external food sensitivity with changes in connectivity 
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between regions when viewing appetizing over bland foods. Connectivity changes between 
ventral striatum (source) and amygdala were positively correlated and between ventral 
striatum and dorsal ACC were negatively correlated with DEBQ-external score; while 
connectivity changes between amygdala (source) and both ventral and dorsal ACC were 
negatively correlated with DEBQ-external score (Passamonti et al., 2009). This evidence 
for variation in network coupling among neural structures implicated in feeding as 
opposed to activation itself is worthy of further exploration through such a functional 
connectively analysis in further analysis of our cohort. 
 
6.3.5. Study limitations 
1. Relatively small number of subjects compared to the number of examined 
correlations of several different psychological traits with activation in eight a priori 
ROIs. There is therefore a significant risk of a Type 1 error in the findings of this 
study since data has not been corrected for multiple correlations. The conclusions 
therefore remain preliminary until they are re-examined in further study 
populations with larger subject numbers. 
2. Relatively small number of subjects with high dietary restraint scores which is over 
30 according to the cut-off level in the DEBQ. Future studies using a similar 
paradigm would benefit from including a cohort of subjects with a wide range of 
individual scores for both DEBQ-external and DEBQ-restraint.  
3. In further analysis of this study it is also important to use the functional 
connectively analysis approach as there is evidence for variation in network 
coupling among neural structures implicated in feeding as opposed to activation 
itself. 
 
6.3.6. Conclusion correlations with behavioural questionnaires (sub-study, fed-
fasted fMRI study) 
These executive-control (DLPFC and dorsal ACC) and affective-reward systems (amygdala 
and lateral OFC) are therefore implicated in mediating how evaluation and processing of 
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foods of differing caloric and reward values are influenced by cognitive factors controlling 
eating behaviour that promote or avoid weight gain. This provides a neurobiological 
network that may underlie the relationship between individual personality traits and 
excessive or reduced intake of high-calorie foods. This raises the possibility that 
modulation of the executive-affective top-down system by behavioural programs or other 
interventions may help maintenance of a healthy weight by encouraging dietary restraint 
towards high-calorie foods (Shaw et al., 2005; Uher et al., 2005; Camus et al., 2009). 
Verification of the importance of this network in the promotion or avoidance of weight gain 
will however need inclusion of subjects with differing weight histories, analysis of 
interactions between dietary restraint and other psychological traits that influence eating 
behaviour, such as disinhibition, and the effects of recent food intake in larger longitudinal 
studies. 
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6.4. Discussion of reproducibility of eating behaviour studies 
Measuring eating behaviour can be very challenging as appetite studies are not performed 
under real-life conditions. It is therefore suggested to include practice dummy visit to 
acclimatise the patients to the study environment (Blundell et al., 2010). 
In this sub-study of the ghrelin fMRI study, patients always had one initial Fasted 
Dummy visit before any other visit to help with habituation to the protocol. The results 
from the Fasted Dummy visit were compared to the Fasted Saline visit for the following 
measurements: VAS appetite scores, VAS stress scores, blood stress hormones, lunch 
intake, food picture appeal rating and fMRI activation to food and object pictures. 
 
6.4.1. Main findings of this sub-study: 
The Fasted Dummy and Fasted Saline visits were identical apart from the order in which 
they occurred. The Fasted Dummy was always first while the Fasted Saline visit was either 
the 2nd, 3rd or 4th visit. 
(i) Differences in mean results between fasted visits: 
a. VAS appetite scores did not differ between the fasted visits but there was a 
trend for fullness to be greater and pleasantness to be reduced on the 
Fasted Dummy visit. 
b. Lunch intake was significantly reduced and there was a tendency for lunch 
pleasantness to be reduced at the Fasted Dummy visit. 
c. Anxiety and nausea ratings were significantly higher at the Fasted Dummy 
visit. 
d. High-calorie foods (but not low-calorie foods or objects) were less appealing 
on the Fasted Dummy visit. High-calorie foods were more appealing than 
low-calorie foods at the Fasted Saline visit but not at the Fasted Dummy 
visit. 
e. There was a significant decrease in the reaction time for appeal rating of 
any of the picture categories at the Fasted Saline visits compared to the 
Fasted Dummy visit. 
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f. Activation in the ventral striatum when viewing high-calorie foods (but not 
low-calorie foods) was significantly greater at the Fasted Dummy compared 
to the Fasted Saline visit (while there was no difference for amygdala, 
insula or anterior OFC). 
(ii) Correlation between results from the fasted visits: 
a. VAS appetite scores and lunch intake were positively correlated between the 
fasted visits. 
b. VAS stress ratings and plasma prolactin, but not serum cortisol, were 
positively correlated between fasted visits. 
c. Appeal ratings for all pictures types positively correlated between fasted 
visits. 
d. There was a tendency for a positive correlation of anterior OFC activation to 
high-calorie or low-calorie foods, and a significant positive correlation to 
objects pictures between the fasted visits. However there was no correlation 
for activation in any of the other ROIs (amygdala, insula or anterior OFC) to 
any food picture between fasted visits. 
 
 
6.4.2. Differences in results between fasted visits 
Stress and novelty can alter the results of appetite studies. Previous research suggests 
that anxiety and stress can alter feeding behaviour (Adam and Epel, 2007; Chandarana et 
al., 2009). This is in agreement with the results from this study because anxiety and 
sickness ratings were significantly elevated on the Fasted Dummy visit. Also, ad libitum 
lunch intake was significantly decreased on the Fasted Dummy visit. Studies in humans 
and rats show that stress alters the intake of high-calorie, high-palatable food (Adam and 
Epel, 2007). Nevertheless, there were no significant differences in VAS appetite ratings 
between the visits but there was a trend for VAS fullness to be greater and pleasantness 
to be reduced on the Fasted Dummy visit. Furthermore the appeal data demonstrated that 
at the Fasted Dummy visit appeal bias towards high-calorie foods was absent compared to 
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the Fasted Saline visit. This supports the assumption that appetite and therefore the 
intake of highly palatable energy dense food is generally decreased on the first study visit 
and that a dummy visit is important to acclimatise the patients to the study environment 
before making any assumptions about a stimuli (food/ hormone) to influence appetite 
(Chandarana et al., 2009). This is further supported by previous research which has 
shown that the study visit order can affect anxiety, plasma cortisol, and plasma PYY3–36, 
with increased anxiety and cortisol concentrations on the first study day (Chandarana et 
al., 2009). Plasma cortisol area under the curve (AUC) correlated positively with plasma 
PYY3–36 AUC. PYY3-36 is a satiety hormone released from the gut and elevated after food 
intake. Cortisol may influence the reward value of food via neuroendocrine/peptide 
mediators such as leptin, insulin and NPY. However my study did not show a significant 
difference in serum cortisol levels between fasted visits. In this study correlations between 
appetite ratings and appetite hormones have not yet been performed. Nevertheless, the 
findings of this study confirm that accurate assessments of appetite, feeding behavior, 
and gut hormone concentrations benefit from subject acclimatization to the study protocol 
(Chandarana et al., 2009).  
Interestingly, there was a significant difference in the percentage intake of fat and 
carbohydrates between the Fasted Saline and Fasted Dummy visit the supper prior to the 
study day with in increased intake of carbohydrates on the Fasted Dummy visit and 
increased intake of fat at the Fasted Saline visit. Although there is no evidence that these 
differences in macronutrient composition could affect appetite the next study day however 
in the future studies a fixed meal for each subjects should be recommended. 
Activation in brain reward systems did not differ between the fasted visits except for the 
ventral striatum. Activation was significantly reduced when viewing high-calorie foods over 
objects at the Fasted Saline visit suggesting habituation of ventral striatum activation. 
This function of the ventral striatum was discussed in more detail in the ghrelin discussion 
(Section 6.2.5.). The results of this analysis agree with the hypothesis that the ventral 
striatum is involved in reward expectancy and novelty processing (Guitart-Masip et al., 
2010) because the activation was reduced on subsequent visits. This data is supported by 
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the picture reaction time for appeal rating of any of the picture categories which was 
significant increased at the Fasted Dummy compared to the Fasted Saline visit. It could be 
possible that the ‘wanting’ of the reward was increased at the first visit because the 
reward was novel (Guitart-Masip et al., 2010). Indeed, previous research hypothesizes 
that behaviorally, subjects are able to react faster to novel items via enhanced 
energisation of action through reward (Bunzeck et al., 2009). 
 This demonstrates the importance of counter-balancing the order of any 
intervention in fMRI studies when looking at ventral striatum activation. This may not 
always be easy to do, for example in examing the effects of bariatric surgery, or chronic 
dietary or drug interventions, in which case a control group with no or placebo 
intervention should be included. 
 
6.4.3. Correlations of results between fasted visits 
Appetite studies are suggested to be biased as they are not performed under real-life 
circumstances (Blundell et al., 2010). Previous studies however show that VAS appetite 
and stress ratings, ad libitum lunch intake, and appeal ratings positively correlated 
between the fasted visits thus demonstrating the reliability and reproducibility of the 
appetite data from this study.  
 Unfortunately the test-retest reliability of the fMRI activation to food and non-food 
pictures was not as robust with the exception of the anterior OFC activation. One reason 
for the anterior OFC to be more reproducible than the other ROIs may be explained by the 
function of the OFC in encoding reward value. The task in the MRI scanner was to 
specifically rate the appeal of the food pictures at each of the visits. These results are 
similar to a previous research study where activation in the OFC was decreased after 
investigators specifically asked the subjects to actively inhibit their desire for food and 
suppress their feelings of hunger while they were presented with foods (food was placed 
on their tongues so they could taste it) rather than passively tasting (Wang et al., 2009).  
The other ROIs in my study showed greater variations between visits and subjects. 
This occurred despite controlling for confounding variables between visits including the 
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time of the menstrual cycle, time since supper and the type of food at supper as well as 
the time of the day. There was however a significant difference in the macronutrient 
composition at supper prior to the study between the fasted visits. Fat intake was 
increased before the Fasted Saline visit and carbohydrate intake was increased before the 
Fasted Dummy intake although subjects where instructed to eat the same supper before 
each study visit. This difference in food intake could influence measurements at each visit 
particularly brain reward activation, however to date no study investigated the effect of 
macronutrtient composition at supper on brain reward activation. 
 Problems with fMRI reproducibilty between visits have been found in other studies. 
Meta-analysis of fMRI signals when performing a classification learning task known to 
activate frontostriatal circuitry have generally found similar results across visits, though 
there is often a widespread varialibility (Aron et al., 2006). A number of previous imaging 
studies have examined the reproducibility of fMRI signals in experiments with visual 
stimuli (Rombouts et al., 1997; Machielsen et al., 2000), fear and disgust (Stark et al., 
2004), auditory stimuli (Kiehl and Liddle, 2003), working memory (Wei et al., 2004), and 
sensorimotor control (Loubinoux et al., 2001). The test-retest interval for most of these 
studies was only short (e.g. a few weeks). This was similar in this study, where fMRI 
sessions were on average 20 days apart. In the study of Stark et al. the interval was only 
1 week and they used a repeated picture presentation as in this fMRI study (Stark et al., 
2004). The result was that previously observed brain activations (thalamus, visual cortex, 
amygdala, hippocampus, and PFC) dissappeared when viewing disgust-inducing pictures, 
with the exception of the temporo-occipital activation. In contrast, a study by Aron et al. 
showed that behavioural performances and fronto-striatal activation were highly 
concordant at a group level at both time points. This research examined eight, healthy 
adults on two sessions, 1 year apart, while performing a classification learning task (Aron 
et al., 2006). The relatively low magnitude of activation in brain reward systems during 
food reward based tasks such as our study compared to the activation seen when 
performing cognitive tasks may also increase variability because of low signal / noise 
ratio. 
 241 
Researchers take a critical view on the reproducibility of fMRI data (Aron et al., 
2006). They criticize the statistical approach to analyse fMRI data specifically to assess 
reliability. Previous test-retest studies used an approach where they compared group 
activation maps or single-subject activation maps at different time-points. This is not ideal 
for test-retest reliability (Aron et al., 2006) as thresholding of images can exaggerate very 
small differences between maps; the signal levels could be highly reliable, yet small 
differences in the signal or noise could result in substantial differences in the threshold 
maps due to nonlinearity of the thresholding operation. Aron and colleagues extracted 
signal change for each subject at each time point and computed intra-class correlation 
coefficients (ICCs) to assess reliability (Aron et al., 2006). ICC represents the ratio 
between-subject variance to total variance and is the appropriate metric for assessing 
within-subject reliability, rather than Pearson’s correlation coefficient, because the 
observations are not independent (Shrout and Fleiss, 1979). However this Fasted Dummy/ 
Fasted Saline fMRI study did not compare group or single activation maps but calculated 
the average activation in particular identical voxels between each visit. In future studies it 
would be useful to use this statistical approach to test fMRI reproducibility.  
 Another important characteristic of an fMRI task is that it is shown to exhibit 
minimal practice effects. The nature of the task in Arons study was identical for the 2 
sessions, but the material to be learned changed in each session (Shrout and Fleiss, 
1979). In this Fasted Dummy/ Fasted Saline fMRI study, the same pictures were used in a 
pseudo-randomised block design. In future fMRI studies it might be helpful to choose 
similar pictures but with different colours and shapes of the food pictures for each of the 
study visits. However, the disadvantage to apply this to further studies is that changes in 
brain reward system are very small in appetite studies and differences in activations when 
viewing foods may vary when different food pictures are presented at different study 
visits. Therefore, it would be interesting to assess the reproducibility of the audio-motor-
visual task of the ghrelin fMRI study or the visual checkerboard of the first fed-fasted fMRI 
study which activates other networks rather than the brain reward system. Unfortunately 
due to MRI scanner problems there was not enough time to analyse this data. 
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6.4.4. Conclusion reproducibility of eating behaviour studies  
Since appetite studies cannot be performed in a fully controlled environment, stress could 
potentially influence data collection, especially fMRI data where only small differences in 
BOLD activation are normally found between visits and subjects. The data of this sub-
analysis showed that measures of appetite and stress vary between two fasted visits and 
that subjects show blunted bias to high-calorie foods and appetite on the Fasted Dummy 
visit. Activation in brain reward systems decreased in the ventral striatum when viewing 
high-calorie foods at the subsequent Fasted Saline compared to the initial Fasted Dummy 
visit. Therefore subject acclimatization to the study protocol should be considered when 
planning feeding behaviour studies.  
  
This is the first study to retest fMRI changes between two identical visits using a food 
reward task. There is a considerable variance in activations between visits. Only one brain 
area, the anterior OFC activation showed a trend towards a positive correlation between 
the two fasted visits. Maybe the OFC is the only brain region which activates consistently 
in food reward tasks during fMRI studies. Data from large populations must be obtained to 
further investigate intra- and intersubject variance, and more insight into possible 
confounding factors (gender, age, psychological factors) is needed to reduce or control 
this variance. 
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6.5. Overall discussion, conclusion and impact on public health 
In this research project, I was able to use the technique of fMRI to investigate the 
complex regulation of appetite and food intake. Previous research has focused on the 
homeostatic system and internal hormonal signals interacting with this system. However, 
in the last decade, researchers have increasingly looked at hedonic corticolimbic areas in 
brain reward systems and their impact on eating behaviour and the development of 
obesity (Figure 1.5.). This system is influenced by the (i) environment, such as viewing 
different types of food (external cues), (ii) nutritional state, such as being fasted or fed, 
(iii) by internal cues, such as appetite hormones (ghrelin, PYY, GLP-1, leptin), and (iv) 
individual differences in eating behaviour and food preferences (psychological cues) 
(Figure 1.1.). 
 
6.5.1. Summary of the most relevant findings of all the fMRI studies in this PhD 
thesis: 
(i) Hunger and pleasantness are increased and fullness decreased when fasted 
compared to when fed (Study 1 - Chapter 3 and Study 2 – Chapter 5, Section 
5.2.); and there is tendency for hunger to be greater after injection of ghrelin 
(Study 2 – Chapter 5, Section 5.3.).  
(ii) Ad libitum lunch intake is increased when fasted compared to when fed (Study 
2 – Chapter 5, Section 5.2.). However, ad libitum lunch intake was not 
increased by ghrelin (Study 2 – Chapter 5, Section 5.3.). 
(iii) Food picture appeal is biased towards high-calorie foods when fasted and after 
injection of ghrelin, especially for the high-calorie sweet but not svaoury foods 
(Study 1 - Chapter 3 and Study 2 – Chapter 5, Section 5.2. and 5.3.).  
(iv) Activation in the ventral striatum, amygdala, insula, medial and lateral OFC 
respond to visual food stimuli, especially high-calorie compared to low-calorie 
foods when fasting but not when fed in the first study (Goldstone et al., 2009) 
(Study 1 - Chapter 3). 
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(v) Activation in the anterior OFC when viewing high-calorie foods is increased 
when fasted compared to when fed (Study 2 – Chapter 5, Section 5.2.) and 
after injection of ghrelin compared to injection of saline in fed subjects, 
mimicking the effects of fasting (Study 2 – Chapter 5, Section 5.3.).  
(vi) Activation in the ventral striatum is increased at the Fasted Dummy visit and 
tended to be increased at the Fed Ghrelin visit when viewing high-calorie foods, 
but not at the Fasted Saline and Fed Saline visit or when viewing low-calorie 
foods (Study 2 – Chapter 4 and Chapter 5, Section 5.3.).  
(vii) Individual differences in appeal correlated with individual differences in hunger 
and pleasantness-to-eat, and also activation in both the medial OFC and lateral 
OFC for the high-calorie vs. low-calorie contrast between fasted and fed states 
(Study 1 - Chapter 3).  
(viii) Activation in each ROI for each contrast did not correlate with hunger rating in 
the scanner at the Fasted Saline visit. By contrast, at the Fed Saline visit, 
average hunger rating in the scanner positively correlated with activation in the 
ventral striatum, anterior OFC and insula when viewing high-calorie foods vs. 
objects and when viewing low-calorie foods vs. objects (Study 2 – Chapter 5, 
Section 5.2.).  
(ix) When fasted, activation in the insula when viewing high-calorie (but not low-
calorie) foods positively correlated with lunch intake. When fed, activation in 
the insula and anterior OFC when viewing high-calorie foods correlated with 
lunch intake (with a trend for low-calorie foods). However, VAS hunger ratings 
(just before lunch) did not correlate with food intake (Study 2 – Chapter 5, 
Section 5.2.).  
(x) Individual differences in dietary restraint positively correlated with activation to 
high-calorie vs. low-calorie foods in both the DLPFC and dorsal ACC, and 
negatively correlated with activation in both the amygdala and lateral OFC, 
when fasted overnight (Study 1 - Chapter 3).  
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(xi) Reward sensitivity positively correlated with activation to high-calorie vs. low-
calorie foods in the ventral striatum (Study 1 - Chapter 3). 
(xii) Lunch intake was significantly increased and there was a tendency for lunch 
pleasantness to be increased at the Fasted Saline visit compared to the Fasted 
Dummy visit (Study 2 – Chapter 4).   
(xiii) Anxiety and sickness ratings were scored significantly higher at the Fasted 
Dummy visit compared to the Fasted Saline visit (Study 2 – Chapter 4). 
(xiv) High-calorie foods were less appealing on the Fasted Dummy visit visit 
compared to the Fasted Saline visit (Study 2 – Chapter 4).  
(xv) VAS appetite and stress scores, lunch intake, and appeal ratings positively 
correlated between fasted visits (Study 2 – Chapter 4). 
(xvi) There was a tendency for or a significant positive correlation of anterior OFC 
activation to high-calorie and low-calorie foods and object pictures between the 
Fasted Dummy and Fasted Saline visit (Study 2 – Chapter 4).  
 
In the ghrelin fMRI study, I was able to replicate some of the results of the first fed-fasted 
fMRI study although the two study protocols were different in several points.  
This is the first study to show that ghrelin mimics fasting by biasing appeal towards 
high-calorie foods and activating the OFC toward high-calorie foods. These studies 
especially proved that the OFC plays an important role in encoding the reward value of 
high-calorie and low-calorie foods and that the ventral striatum may be implicated in 
novelty processing when viewing high-calorie foods.  
 
In summary, these results demonstrated that nutritional state and ghrelin play an 
important role in influencing the hedonic brain reward system and therefore food appeal 
and pleasantness in an environment where high-palatable, high-calorie foods are 
constantly available (Cabanac, 1971, Uher et al., 2006, Stoeckel et al., 2007). As both 
fMRI studies examined healthy volunteers it needs to be further investigated how brain 
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reward systems differ in lean and obese people and what are the differences in their 
underlying physiological mechinsms. 
 
6.5.2. How can these findings be linked to obesity? 
As previously described, natural rewards such as palatable food and ghrelin can affect 
dopamine signaling in the brain reward system (Nestler, 2001; Naleid et al., 2005).  
Human key focus in research of addiction disorders and obesity is that hypo-
dopaminergic functioning (Reward Deficiency Syndrome - RDS) in brain reward pathways 
is a key risk factor for their development (Blum et al., 2000). The premise is that 
addictive substances such as food, which increase brain dopamine levels, are used as a 
form of “self-medication” to boost a sluggish dopamine system and increase hedonic 
capacity and promote excessive behaviour. The same arguments have been recently 
extended to the risk for obesity; focusing on dopamine D2 receptors. There is reasonable 
evidence that individuals with the Taq1A+ allele (polymorphism of D2 receptor) have 
reduced brain dopamine function due to a 30-40% reduction in D2 receptor density in the 
striatal region (Stice et al., 2008). 
The counter argument is that hyper-sensitivity to reward contributes to increased 
risk of obesity because of enhanced motivation to approach pleasurable activities such as 
eating (Beaver et al., 2006, Davis et al., 2007). Addictive drugs and food could also share 
a tolerance of their rewarding properties by the downregulation of dopamine receptors in 
the striatum (Volkow et al., 2002), and a decrease in the function of the extended 
amygdala, which produces negative affect and anxiety associated with abstinence (Koob, 
2006). There is now evidence that highly palatable foods cause the same neuroadaptions 
which increase strong cravings, and contribute to the symptoms of withdrawl (Grigson, 
2002, Pelchat, 2002). Davis and Carter suggest a dual vulnerability to addictions whereby 
both hypo-dopaminergic functioning and hyper-sensitivity to reward can confer risk, albeit 
in different individuals and perhaps with different levels of severity (Davis and Carter, 
2009).   
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Obese patients, especially women, binge eaters and patients with increased reward 
sensitivity previously showed increased activation in brain reward areas when viewing or 
tasting high-calorie foods compared to their lean counterparts (Gautier et al., 2000; 
Gautier et al., 2001; DelParigi et al., 2004; DelParigi et al., 2005; Le et al., 2006; 
DelParigi et al., 2007; Le et al., 2007; Rothemund et al., 2007; Stice et al., 2008; 
Stoeckel et al., 2008; Bohon et al., 2009; Martin et al., 2009; Schienle et al., 2009; 
Stoeckel et al., 2009; Davids et al., 2010; Stice et al., 2010). In bulimia nervosa patients, 
who had increased ventral striatum volumes, BMI and purgeing severity were correlated 
with striatal grey matter volume abnormalities (Schafer et al., 2010). A voxel-based 
morphometric functional MRI study showed that pathologic “sweet tooth” was associated 
with grey matter volume loss in the right anterior insula, the lateral OFC, the DLPFC and 
temporal poles; hyperphagia was associated with bilateral grey matter loss in 
anteromedial portions of the OFC (Whitwell et al., 2007). The new insight into the 
meachnisms of brain reward systems and their role in eating behaviour may be used to 
provide rationale for new psychological or pharmacological approaches for treatment of 
obesity (Adan et al., 2008). For example, targeting specific regions of the brain reward 
systems with new strategies of deep brain stimulation for managing eating disorders 
(Halpern et al., 2008; Camus et al., 2009). Another pharmacological treatment could 
involve ghrelin antagonists to block the action of ghrelin and its receptor in order to 
suppress its action on brain reward systems.  
 
The findings of the fMRI studies in this thesis are potentially of relevance to understand 
some of the factors which play a role in the development of obesity and how rewarding 
properties of food become represented in terms of subjective hedonic values and can 
contribute in driving excessive food intake. 
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6.6. Future work 
 
6.6.1. Ghrelin fMRI study 
- Increase the number of subjects to at least 20. In fMRI, especially food reward tasks, it 
is only possible to measure small changes in brain reward systems, so the higher the 
number of subjects, the more likely the result is robust. 
- Include obese subjects and compare them to lean controls in the fasted and fed state to 
analyse differences in brain reward systems. 
- Assess resting state functional connectivity to examine the effect of ghrelin in brain 
reward systems when no stimulus is applied. Resting connectivity allows the assessment 
of coordinated activity between brain regions in the absece of an external input 
(Damoiseaux et al., 2006). These include brain regions involved in executive functioning 
or ‘executive control network’ (ECN, involving anterior cingulate and dorsolateral pre-
frontal cortex), and random episodic silent thought, the so-called ‘default-mode network’ 
(DMN, involving the precuneus, posterior cingulate and pre-frontal cortex). Motivational 
salience networks involving the anterior cingulate and frontoinsular cortex are also 
described (Seeley et al., 2007). A recent study demonstrate that nicotine administration in 
abstinent smokers to suppress craving modulates dynamic interactions between large-
scale cognitive brain networks in the resting state, for example inverse coupling between 
the DMN and ECN (Cole et al., 2010). It is unknown how the activity in these resting state 
networks is altered during states of increased hunger (where attention may switch away 
from random silent thought to thinking about food) and/or whether additional resting 
state networks are activated (e.g. within brain centres involved in reward, craving, 
pleasure and emotion). This data will be analysed to see how activity and connectivity in 
resting state networks changes when healthy non-obese subjects are fasted or given the 
hormone ghrelin.  
- Analyse audio-motor-visual scans to look for non-specific changes in activation in brain 
reward systems. 
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- Measure gut hormones, including acylated and total ghrelin, PYY, GLP-1, PP and leptin to 
correlate them with activation in brain reward systems and feeding behaviour. 
- Include different test lunch; ghrelin is suggested to preferentially increase the appeal 
and perhaps intake of sweet over savoury food such as used in our study (pasta and 
curry). It would be also interesting to use different types of foods at lunch, such as high-
calorie sweet, high-calorie savoury, low-calorie sweet and low-calorie savoury food, thus 
subjects need to make a choice such as when rating the appeal of the food pictures in the 
scanner. 
- Investigate the effect of ghrelin on dopamine release in humans. Previous PET imaging 
studies showed smoking-induced dopamine realease in the ventral striatum using bolus-
plus-continuous-infusion of (11)C-raclopride (D2 recpetor antagonist) (Brody et al., 2010) 
or amphetamine-induced dopamine release in the ventral striatum using [(11)C]-(+)-4-
propyl-9-hydroxynaphthoxazine ((+)-PHNO) (D2/D3 recpetor agonist) (Willeit et al., 
2008). 
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Appendix 1. Patient information sheet 
 
Ref number 07/Q0406/19    Version 03   11/10/2007 
 
Robert Steiner MRI Unit, Imaging Sciences Department 
MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College 
Hammersmith Hospital Campus 
Du Cane Road, London W12 0NN 
 
THIS INFORMATION SHEET IS VALID FOR USE UNTIL: 30th September 2009 
 
INFORMATION SHEET FOR RESEARCH PARTICIPANTS 
 
You will be given a copy of this Information Sheet and a signed copy of your consent 
form to keep, should you decide to participate in the study. 
 
STUDY TITLE: HOW DOES GHRELIN INCREASE APPETITE IN THE BRAIN:  
A FUNCTIONAL MAGNETIC RESONANCE IMAGING STUDY? 
 
You are being invited to take part in a research study. Before you decide, it is important for 
you to understand why the research is being done and what it will involve. Please take time to 
read the following information carefully and discuss it with friends, relatives and your GP if you 
wish. Ask us if there is anything that is not clear or if you would like more information. Take 
time to decide whether or not you wish to take part. 
 
We will be happy to let you have a copy of the leaflet entitled ‘Medical Research and You’ 
published by Consumers for Ethics in Research (CERES). This leaflet gives more information 
about medical research and looks at some questions you may want to ask.  
 
If you do decide to take part, please let us know beforehand if you have been involved in any 
other study during the last year. You are free to withdraw at any time without explanation. 
Thank you for reading this. 
 
 
WHAT IS THE PURPOSE OF THE STUDY? 
 
Ghrelin is a naturally-occurring substance found in the blood of healthy people. It is made in 
the stomach, released when fasting and levels in the blood fall after a meal. Ghrelin is known 
to increase appetite in healthy individuals. This study aims to see how ghrelin acts in the brain 
to increase appetite. This is an important step towards finding out how ghrelin naturally 
regulates appetite. This will help with the development of medicines to treat obesity and loss 
of appetite.  
 
 
WHY HAVE I BEEN CHOSEN? 
 
Healthy individuals are being recruited to take part in this study.  
 
You should not take part in this study if you:  
1) have any illnesses which we feel make you unsuitable  
2) if you take any medication which we feel make you unsuitable 
3) if you are pregnant or breast feeding 
4) if you have given blood in the last three months 
 
It is important that you should not become pregnant during the course of the study or for 
one month following the study, as the effects of ghrelin in pregnancy are not known. It is 
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therefore important that you have adequate and reliable contraception during this period. 
DO I HAVE TO TAKE PART? 
 
It is up to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to take 
part you are still free to withdraw at any time and without giving a reason.  
 
 
WHAT WILL HAPPEN TO ME IF I TAKE PART? 
 
Screening visit 
 
If you agree to take part in this study, you will first be examined by one of the research doctors 
and have a number of blood tests after an overnight fast (no more than 50ml blood equivalent 
to around 3 tablespoons), a pregnancy test (if female) and a heart recording (ECG) to ensure 
you are fit and healthy. You will be asked to complete a few short questionnaires about your 
eating habits, personality and mood, and keep a record of all food and drink consumed for 
three days. You will also be asked to taste a number of different meals which will be used later 
on in the study.  
 
You will also have your height and weight taken and your body fat content measured using a 
‘bio-electrical impedance’ machine. This is a painless safe method which involves measuring 
the electrical current from your body and takes only about 5 minutes. As long as these 
medical checks are satisfactory and you are still happy to participate, you will then be asked to 
attend for the first of up to 4 study visits. 
 
With your permission, we will also take a sample of DNA from blood or saliva to look for 
changes in your genes that may be involved in the how the body controls appetite, body 
weight and responds to ghrelin. This will enable us to see what effect such changes may have 
on your response to the injections. 
 
 
Number of visits 
 
You will be asked to attend the Clinical Investigation Ward at Hammersmith Hospital as an 
outpatient on up to another 4 occasions, following your screening interview, each separated 
by at least 3 days. These will be completed on dates convenient to you and the investigators, 
but should usually be completed within a maximum of 3 months. 
 
Study design 
  
On each study visit you will be asked to have nothing to eat and only water to drink from 8 pm 
on the evening before the study. You will be asked to attend in the morning and each visit will 
last around 5 hours. You will be asked to abstain from alcohol and strenuous exercise for 24 
hours before the visit. We will also ask you to keep a record of all food and drink consumed for 
three days before the visit, the day of the visit and for one day afterwards. You will also have a 
pregnancy test on each visit (if female), and have your height, weight and body fat content 
measured. You will also complete questionnaires about your mood on each study visit. 
  
On each study day you will have a small plastic cannula tube inserted into a vein in one arm.  
A vein is the type of blood vessel commonly used for taking blood samples. You may feel 
some discomfort whilst the cannula is being inserted. After the cannula tube has been inserted 
this will be used to take blood samples. We will also ask you to score how you are feeling (e.g. 
rating your hunger) by placing a mark on a line called a visual analogue scale.  
 
You will then be either given a moderate size breakfast to eat over 20 minutes, or continue 
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fasting. On each of the visits, you will then receive either a saline (salt water) or ghrelin 
injection under the skin on the thigh or tummy. You may fell some slight discomfort at the time 
of the injection. 
 
The saline is a placebo or dummy treatment that is commonly used in studies of this nature. It 
contains no active ingredient and is not expected to alter your appetite. The saline treatment 
will serve as a baseline measurement to which all the active treatments are compared. This is 
a randomised, double-blind trial. This means that neither you, nor your research doctors, will 
know what treatment you are being given on some visits (although, if your doctor needs to find 
out, he/she can do so).  Throughout the study, we will monitor your heart rate and blood 
pressure. 
 
Further blood samples will be taken and you will be asked to complete further visual analogue 
scales over the visit. The total amount of blood taken on each study visit will not be more than 
150ml (about 10 tablespoonfuls). The total amount of blood taken over all your visits will not 
be more than 500 ml (a little less than a pint and the same amount taken when making a 
single donation of blood for blood transfusion). During these visits you will be seated or lying 
on a couch, and can read or watch television.  
 
Thirty minutes after the injection, you will have a magnetic resonance imaging (MRI) brain 
scan by lying in an MRI scanner for up to 1 hour. This will take place in the Robert Steiner 
Magnetic Resonance Imaging Unit, nearby the Clinical Investigation Ward. This will enable us 
to look at the structure and activity of your brain.  
 
During the functional brain scans we look at the activity of the brain at rest, while you look at a 
variety of pictures on a screen, and perform simple tasks like viewing a flashing light, pressing 
a button, reading, listening, speaking, recalling, thinking about words or numbers. You will be 
asked to make responses to the pictures while in the scanner using a keypad. You will have 
the opportunity to practice lying in the scanner while looking at various pictures on the screen. 
This will enable us to ensure that you can follow the instructions and lie still while in the 
scanner. 
 
At the end of the brain scan you will be taken back to the Clinical Investigation Ward. Fifteen 
minutes after the end of the MRI scan you will be presented with a buffet meal and you will be 
asked to eat as much as you want of the meal until you feel comfortably full.  
 
We will continue to monitor you for another hour after the buffet meal, after which you are free 
to go (4 hours after the cannula was inserted). At the end of the final visit you will also be 
asked to score how much you usually like to eat the foodstuffs shown in the food pictures 
using a visual analogue scale. 
 
 
WHAT DO I HAVE TO DO? 
 
The only restrictions on your lifestyle are that you will be asked to have nothing to eat and only 
water to drink from 8pm on the night before the meal days. You will need to keep a record of 
all food and drinks consumed in the three days before every study and for the twenty-four 
hours afterwards. For twenty-four hours before each study meal you will be asked to refrain 
from taking strenuous exercise and drinking alcohol. 
 
Female volunteers should have adequate contraception for the period of the study and for one 
month afterwards as the effects of ghrelin in pregnancy are not known. Pregnancy tests will be 
carried out to confirm that women of child bearing age are not pregnant on the morning before 
each study injection. 
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WHAT IS THE DRUG THAT IS BEING TESTED? 
 
Ghrelin is a naturally occurring hormone found in the circulation of healthy people. Ghrelin has 
been used in several other studies in our department and worldwide, in men and women, 
without harmful effects. The dose of ghrelin that you will be given are small and will increase 
the levels of ghrelin in your body to a levels naturally found after a prolonged fast. 
 
 
WHAT ARE THE SIDE EFFECTS OF TAKING PART? 
 
From our previous studies we do not expect any significant side effects, but the unexpected 
can occur.  During the study, at least one experienced doctor will monitor you closely. If you 
suffer from any ill effects during the study you should report them to the doctors monitoring 
you immediately. If you suffer from any ill effects afterwards you should report them to one of 
the research doctors at the contact number below or when you next see them. You may ask 
for the study to stop at any time without giving a reason.  If any unexpected side effects occur, 
the study will be stopped.  
 
MRI is a powerful, diagnostic body scanning technique, which is used in hospitals worldwide 
to create images of the inside of the body. MRI has been used safely for several decades and 
has no known side-effects. Each scan is directed to the specific requirements of your referring 
doctor or to research study in which you are taking part. 
 
 
WHAT ARE THE POSSIBLE DISADVANTAGES AND RISKS OF TAKING PART? 
 
Ghrelin has been administered in several studies by our laboratory and therefore we do not 
anticipate any problems with the injection. Insertion of the cannula (drip) into your arm on 
each of the study days may cause minor discomfort or superficial bruising, as may the 
injection of saline or ghrelin under the skin. 
 
Magnetic resonance imaging (MRI) is a procedure that allows doctors to look inside the body 
by using a scanner that sends out a strong magnetic field and radio waves. MRI does not use 
X-rays. This procedure is used routinely for medical care and is very safe for most people, but 
you will be monitored during the entire MRI scan in case any problems occur. The risks of 
having an MRI scan are:  
 
• The MRI scanner contains a very strong magnet. Therefore, you will not be able to have 
the MRI if you have any type of metal implanted in your body, for example, any pacing 
device (such as a heart pacer), any metal in your eyes, or certain types of heart valves or 
brain aneurysm clips. Someone will ask you questions about this before you have the 
MRI. 
 
• There is not much room inside the MRI scanner. You may be uncomfortable if you do not 
like to be in close spaces (“claustrophobia”). During the procedure, you will be able to talk 
to and hear the MRI staff through a speaker and earphone system, and, in the event of an 
emergency, you can tell them to stop the scan. You will be closely monitored and 
repeatedly checked on to make sure you are as comfortable as possible. While your head 
is in the scanner, we will support it, so you can’t move it. If this upsets you, you will be able 
to signal and speak to the investigator and stop the scan through the use of a radio 
system and a signaling button. You will have the opportunity during the first MRI scan to 
ensure that you can tolerate having the scan before the next two scans are done. 
 
• The MRI produces a “hammering noise”. You will wear earplugs and headphones to 
prevent discomfort or damage to hearing. The headphones will also allow you to be able 
to hear us talk to you. 
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• You will be fully awake during the MRI scan and will not be sedated at any time. We will 
make every effort to ensure your comfort during this experiment. 
 
It should be noted that the MRI brain scan cannot be viewed as a comprehensive health 
screening procedure. However, vary rarely, unexpected information can be detected which 
may warrant further investigation. In this event, you will be informed and a report will be sent 
to your GP, who will arrange further tests and coordinate your further care. In the rare event 
that we find a significant abnormality on your structural brain scan on the first visit this may 
exclude you from continuing with the rest of the study. 
 
It is possible that if the treatment is given to a pregnant woman it will harm the unborn child. 
Pregnant women must therefore not take part in this study; neither should women who plan to 
become pregnant during the study. Women who are at risk of pregnancy will be asked to have 
a pregnancy test before taking part, to exclude the possibility of pregnancy. Women who could 
become pregnant must use an effective contraceptive during the course of this study. Any 
woman who finds that she has become pregnant while taking part in the study should 
immediately tell her research doctor. 
 
 
WHAT ARE THE POSSIBLE BENEFITS OF TAKING PART? 
 
The information that we get from this study will help us to better understand normal appetite 
regulation and may help us to better treat future patients who suffer from being overweight or 
reduced appetite.  
 
If any of the screening questionnaires or blood tests reveal any medical problems (e.g. 
depression, diabetes, high cholesterol, thyroid, kidney or liver problems), your GP will be 
informed so that they can coordinate your further care, arrange any further tests, and refer you 
on to Hospital Doctors if necessary. 
 
 
WHAT IF NEW INFORMATION BECOMES AVAILABLE? 
 
Sometimes during the course of a research project, new information becomes available about 
the treatment that is being studied. If this happens, your research doctor will tell you about it 
and discuss with you whether you want to continue in the study. If you decide to continue in 
the study you will be asked to sign an updated consent form. Also, on receiving new 
information your research doctor might consider it to be in your best interests to withdraw you 
from the study.  
 
 
WHAT HAPPENS WHEN THE RESEARCH STUDY STOPS? 
 
Once the study has finished, the results of the study can be made available to you and/or your 
GP should you wish. If you have any problems immediately following the study, then you 
should contact one of the research doctors on the numbers provided below.  
 
 
WHAT IF SOMETHING GOES WRONG? 
 
In the event of any adverse events occurring as a consequence of your participation in this 
study, you will be compensated through the Imperial College School of Medicine’s ‘No-fault’ 
Compensation scheme. 
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WILL MY TAKING PART IN THIS STUDY BE KEPT CONFIDENTIAL? 
 
All information which is collected about you during the course of the research will be kept 
strictly confidential. Any information about you which leaves the hospital will have your name 
and address removed so that you cannot be recognised from it. 
 
It is a requirement that your GP is informed, with your consent, of your participation in this 
study, at the start of the study.     
 
 
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? 
 
The results are likely to be published in the year following the study. Your confidentiality will 
be ensured at all times and you will not be identified in any publication. At the end of the 
study, the results of the study can be made available to you and/or your GP should you wish.   
 
 
WHO IS ORGANISING AND FUNDING THE RESEARCH? 
 
This study is being organised and funded by the Department of Imaging Sciences, MRC 
Clinical Sciences Centre and the Department of Metabolic Medicine, Imperial College London. 
 
 
PAYMENT 
 
You will receive a fixed payment to cover expenses including travel costs. This sum of £20 for 
the screening visit and £50 for each injection visit will be paid when you have completed your 
visits. 
 
 
WHO HAS REVIEWED THE STUDY? 
 
This study has been reviewed by the Hammersmith Hospitals Research Ethics Committee.  
 
 
CONTACT FOR FURTHER INFORMATION 
 
If you experience any problems during the study, you may withdraw at any stage. The doctor 
involved in the study, Dr Goldstone, will be available by telephone during working hours (020 
8383 1029 or via the paging system 0845 0921000 bleep 5530). The hospital switchboard 
(020 8383 1000) has home and mobile phone numbers for all the doctors involved in the study 
and can contact them at any time outside normal working hours. 
 
If you agree to take part in the trial, you will also be given the mobile phone numbers of the 
doctors. 
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Appendix 2. Food preference scale 
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Appendix 3. SCOFF 
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Appendix 4. BIS/ BAS Questionnaire 
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Appendix 5. DEBQ 
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Appendix 6. PANAS Questionnaire 
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Appendix 7. Dietary record (example page) 
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Appendix 8. MRI Metall Check List 
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Appendix 9. Mood/ Depression questionnaire 
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Appendix 10. Visual Analaogue Scale 
 
 
Time                  -15 
 
 
 
 
HOW HUNGRY DO YOU FEEL RIGHT NOW? 
 
 
 
NOT AT ALL       EXTREMELY 
 
 
 
 
 
 
 
 
 
HOW SICK DO YOU FEEL RIGHT NOW? 
 
     
 
NOT AT ALL       EXTREMELY 
 
 
 
 
 
 
 
 
 
HOW PLEASANT WOULD IT BE TO EAT RIGHT NOW? 
 
  
 
NOT AT ALL       EXTREMELY 
 
 
 
 
 
 
 
 
 
HOW ANXIOUS DO YOU FEEL RIGHT NOW? 
 
     
 
NOT AT ALL       EXTREMELY 
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Time                  -15 
 
 
 
 
HOW MUCH DO YOU THINK YOU COULD EAT RIGHT NOW? 
 
  
 
NOTHING       A LARGE AMOUNT 
 
 
 
 
 
 
 
 
 
HOW FULL DO YOU FEEL RIGHT NOW? 
 
  
 
NOT AT ALL       EXTREMELY 
 
 
 
 
 
 
 
 
 
HOW STRESSED DO YOU FEEL RIGHT NOW? 
 
 
 
NOT AT ALL       EXTREMELY 
 
 
 
 
 
 
 
 
 
HOW SLEEPY DO YOU FEEL RIGHT NOW? 
 
  
 
NOT AT ALL       EXTREMELY 
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Appendix 11. Blood sample preparation 
 
 
1. AEBSF (protease inhibitor to prevent breakdown of active ghrelin). 
 
Sigma A856-500MG £252.50 per 500mg  
 
Added in advance to 10ml orange plastic lithium heparin tubes to which add whole blood. 
 
Bottle contains 500mg powder. 
Add 2ml distilled water to AEBSF bottle = 250mg/ml = 0.25 mg/ul 
Final [AEBSF] = 1mg / ml whole blood. 
10ml blood tubes. 
Need to add 40ul AEBSF solution per 10ml blood tube = 10mg. 
Store tubes at -80C. 
Defrost day before into fridge. 
 
2. Trasylol = Aprotinin (protease inhibitor to prevent breakdown of certain gut hormones). 
 
Order Nordic Pharma UK 01189298233 
Cost £20.53 per 50ml bottle (+£20 admin charge if < £300 order) 
Need to complete named patient form and covering letter stating that for research. 
 
Add 200ul to each 10ml orange blood tube day before study and store in fridge. 
 
 
3. HCl (to prevent breakdown of active ghrelin). 
 
Added to plasma (not whole blood). 
Add to aliquots to which will add plasma for active ghrelin (yellow A tubes) on day before 
study and store in fridge. 
 
Stock [HCl] = 11M. 
Dilute 784ul of stock with 10ml distilled water to give 10.784ml 0.8M HCl. 
 
Add 10ul of 0.8M HCl to 150ul plasma to give final [HCl] = 0.05M 
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Appendix 12. fMRI scanning sheet 
 
 
